0001683168-25-004666.txt : 20250620 0001683168-25-004666.hdr.sgml : 20250620 20250620170029 ACCESSION NUMBER: 0001683168-25-004666 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 98 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250620 DATE AS OF CHANGE: 20250620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NOCERA, INC. CENTRAL INDEX KEY: 0001756180 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - LIVESTOCK & ANIMAL SPECIALTIES [0200] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 161626611 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41434 FILM NUMBER: 251062157 BUSINESS ADDRESS: STREET 1: 2030 POWERS FERRY RD., SE, SUITE 212 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: (404) 816-8240 MAIL ADDRESS: STREET 1: 2030 POWERS FERRY RD., SE, SUITE 212 CITY: ATLANTA STATE: GA ZIP: 30339 10-Q/A 1 nocera_i10qa1-033125.htm AMENDMENT NO. 1 NOCERA, INC. 10-Q/A
true --12-31 2025 Q1 To report segment information 0001756180 0001756180 2025-01-01 2025-03-31 0001756180 2025-05-15 0001756180 2025-03-31 0001756180 2024-12-31 0001756180 us-gaap:SeriesAPreferredStockMember 2025-03-31 0001756180 us-gaap:SeriesAPreferredStockMember 2024-12-31 0001756180 2024-01-01 2024-03-31 0001756180 2023-12-31 0001756180 2024-03-31 0001756180 us-gaap:CommonStockMember 2023-12-31 0001756180 us-gaap:PreferredStockMember 2023-12-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2023-12-31 0001756180 us-gaap:RetainedEarningsMember 2023-12-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2023-12-31 0001756180 us-gaap:NoncontrollingInterestMember 2023-12-31 0001756180 us-gaap:CommonStockMember 2024-12-31 0001756180 us-gaap:PreferredStockMember 2024-12-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2024-12-31 0001756180 us-gaap:RetainedEarningsMember 2024-12-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2024-12-31 0001756180 us-gaap:NoncontrollingInterestMember 2024-12-31 0001756180 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001756180 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2024-01-01 2024-03-31 0001756180 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2024-01-01 2024-03-31 0001756180 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001756180 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001756180 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2025-01-01 2025-03-31 0001756180 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2025-01-01 2025-03-31 0001756180 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001756180 us-gaap:CommonStockMember 2024-03-31 0001756180 us-gaap:PreferredStockMember 2024-03-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2024-03-31 0001756180 us-gaap:RetainedEarningsMember 2024-03-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2024-03-31 0001756180 us-gaap:NoncontrollingInterestMember 2024-03-31 0001756180 us-gaap:CommonStockMember 2025-03-31 0001756180 us-gaap:PreferredStockMember 2025-03-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2025-03-31 0001756180 us-gaap:RetainedEarningsMember 2025-03-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2025-03-31 0001756180 us-gaap:NoncontrollingInterestMember 2025-03-31 0001756180 NCRA:XFCSaleMember us-gaap:RestrictedStockMember 2020-12-30 2020-12-31 0001756180 NCRA:MeixinMember 2022-09-06 2022-09-07 0001756180 NCRA:XincaMember 2024-01-30 2024-01-31 0001756180 NCRA:SYCultureMember 2024-04-13 2024-04-14 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:ThreeCustomersMember 2024-01-01 2024-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FourCustomersMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:AllCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:AllCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierAMember 2025-01-01 2025-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierAMember 2024-01-01 2024-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierBMember 2025-01-01 2025-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierBMember 2024-01-01 2024-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierCMember 2025-01-01 2025-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierCMember 2024-01-01 2024-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierDMember 2025-01-01 2025-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierDMember 2024-01-01 2024-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierEMember 2025-01-01 2025-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierEMember 2024-01-01 2024-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierFMember 2025-01-01 2025-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierFMember 2024-01-01 2024-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierGMember 2025-01-01 2025-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierGMember 2024-01-01 2024-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierHMember 2025-01-01 2025-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierHMember 2024-01-01 2024-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierIMember 2025-01-01 2025-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:SupplierIMember 2024-01-01 2024-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:AllSuppliersMember 2025-01-01 2025-03-31 0001756180 NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember NCRA:AllSuppliersMember 2024-01-01 2024-03-31 0001756180 NCRA:DueFromThirdPartiesMember 2025-03-31 0001756180 NCRA:ECommerceLiveStreamSalesDepositsMember 2025-03-31 0001756180 NCRA:XincaEmployeeLoansMember 2025-03-31 0001756180 NCRA:SYMediaDepositsMember 2025-03-31 0001756180 NCRA:PriorYearReceivablesFromGZGSIMember 2025-03-31 0001756180 NCRA:FundsMember 2025-03-31 0001756180 NCRA:FundsMember 2024-12-31 0001756180 NCRA:CurrentMember 2025-03-31 0001756180 NCRA:CurrentMember 2024-12-31 0001756180 NCRA:NoncurrentMember 2025-03-31 0001756180 NCRA:NoncurrentMember 2024-12-31 0001756180 us-gaap:LandMember 2025-03-31 0001756180 us-gaap:LandMember 2024-12-31 0001756180 us-gaap:EquipmentMember 2025-03-31 0001756180 us-gaap:EquipmentMember 2024-12-31 0001756180 NCRA:MeixinMember 2025-03-31 0001756180 NCRA:MeixinMember 2024-12-31 0001756180 NCRA:XincaMember 2025-03-31 0001756180 NCRA:XincaMember 2024-12-31 0001756180 NCRA:SYMediaMember 2025-03-31 0001756180 NCRA:SYMediaMember 2024-12-31 0001756180 NCRA:CITICCarLoanMember 2025-03-31 0001756180 NCRA:CITICCarLoanMember 2024-12-31 0001756180 NCRA:ClassCWarrantMember 2021-04-01 0001756180 NCRA:ClassDWarrantMember 2021-04-01 0001756180 NCRA:ClassCWarrantMember 2021-09-27 0001756180 NCRA:ClassDWarrantMember 2021-09-27 0001756180 NCRA:UnderwritersMember NCRA:PublicOffering2022Member 2022-09-23 0001756180 NCRA:UnderwritersMember NCRA:PublicOffering2022Member 2022-09-22 2022-09-23 0001756180 us-gaap:WarrantMember 2024-12-31 0001756180 us-gaap:WarrantMember 2024-01-01 2024-12-31 0001756180 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001756180 us-gaap:WarrantMember 2025-03-31 0001756180 country:CN srt:MinimumMember 2025-03-31 0001756180 country:TW 2025-03-31 0001756180 country:US 2025-01-01 2025-03-31 0001756180 2019-01-01 2019-12-31 0001756180 country:US 2019-12-31 0001756180 NCRA:PRCMember 2025-01-01 2025-03-31 0001756180 NCRA:PRCMember 2024-01-01 2024-03-31 0001756180 2024-01-01 2024-12-31 0001756180 NCRA:MountainShareTransferLLCMember 2025-03-31 0001756180 NCRA:MountainShareTransferLLCMember 2024-12-31 0001756180 NCRA:EstateOfYinChiehChengMember 2025-03-31 0001756180 NCRA:EstateOfYinChiehChengMember 2024-12-31 0001756180 NCRA:FengHuaChenMember 2025-03-31 0001756180 NCRA:FengHuaChenMember 2024-12-31 0001756180 2022-08-09 2022-08-11 0001756180 us-gaap:CommonStockMember 2022-08-11 0001756180 NCRA:PublicOfferingMember 2022-08-09 2022-08-11 0001756180 NCRA:XincaMember 2024-02-19 2024-02-20 0001756180 NCRA:XincaMember 2024-02-20 0001756180 NCRA:SYCultureMember 2024-04-13 2024-04-14 0001756180 NCRA:SYCultureMember 2024-04-14 0001756180 NCRA:ClassAWarrantsConvertedToCommonStockMember NCRA:WarrantClassAMember 2025-02-06 2025-02-07 0001756180 NCRA:ClassAWarrantsConvertedToCommonStockMember us-gaap:CommonStockMember 2025-02-06 2025-02-07 0001756180 NCRA:ClassAWarrantsConvertedToCommonStockMember NCRA:WarrantClassAMember 2025-02-11 2025-02-12 0001756180 NCRA:ClassAWarrantsConvertedToCommonStockMember us-gaap:CommonStockMember 2025-02-11 2025-02-12 0001756180 NCRA:MrYinChiehChengMember NCRA:SeriesAWarrantMember 2018-12-26 2018-12-27 0001756180 NCRA:SeriesAWarrantMember NCRA:MrYinChiehChengMember 2018-12-27 0001756180 NCRA:MrShunChihChuangMember NCRA:ClassAWarrantMember 2020-05-29 2020-06-01 0001756180 NCRA:MrHsienWenYuMember NCRA:ClassAWarrantMember 2020-05-29 2020-06-01 0001756180 NCRA:MrShunChihChuangMember NCRA:ClassAWarrantMember 2020-06-01 0001756180 NCRA:TwoEmployeesMember NCRA:ClassAWarrantMember 2020-05-29 2020-06-01 0001756180 NCRA:ClassAWarrantMember NCRA:TwoEmployeesMember 2020-06-01 0001756180 NCRA:MrMichaelALittmanMember NCRA:ClassAWarrantMember 2020-05-29 2020-06-01 0001756180 NCRA:MrMichaelALittmanMember NCRA:ClassAWarrantMember 2020-06-01 0001756180 NCRA:MrMichaelALittmanMember NCRA:ClassBWarrantMember 2020-05-29 2020-06-01 0001756180 NCRA:MrMichaelALittmanMember NCRA:ClassBWarrantMember 2020-06-01 0001756180 NCRA:MrMichaelALittmanMember NCRA:ClassAWarrantMember 2021-08-09 2021-08-11 0001756180 NCRA:MrMichaelALittmanMember NCRA:ClassBWarrantMember 2021-08-09 2021-08-11 0001756180 NCRA:MrShunChihChuangMember NCRA:ClassAWarrantMember 2021-11-30 2021-12-02 0001756180 NCRA:MrHsienWenYuMember NCRA:ClassAWarrantMember 2021-11-30 2021-12-02 0001756180 NCRA:MrShunChihChuangMember NCRA:ClassAWarrantMember 2021-12-02 0001756180 NCRA:TwoEmployeesMember NCRA:ClassAWarrantMember 2021-11-30 2021-12-02 0001756180 NCRA:ClassAWarrantMember NCRA:TwoEmployeesMember 2021-12-02 0001756180 NCRA:MrShunChihChuangAndFiveConsultantsMember 2021-12-30 2021-12-31 0001756180 NCRA:ChenChunChungMember 2022-12-21 2022-12-22 0001756180 NCRA:TraDigitalMember 2022-12-21 2022-12-22 0001756180 us-gaap:InvestorMember 2023-03-20 2023-03-22 0001756180 NCRA:YuHaoChangMember 2023-10-10 2023-10-11 0001756180 NCRA:AndyChinAnJinMember 2023-12-02 2023-12-05 0001756180 NCRA:AnyChinAnJinMember 2024-08-25 2024-08-26 0001756180 us-gaap:SeriesAPreferredStockMember 2021-08-31 0001756180 2021-08-31 0001756180 NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 NCRA:CateringMember 2025-01-01 2025-03-31 0001756180 NCRA:ECommerceMember 2025-01-01 2025-03-31 0001756180 NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 NCRA:CateringMember 2024-01-01 2024-03-31 0001756180 NCRA:ECommerceMember 2024-01-01 2024-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerAMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerAMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerBMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerBMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerCMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerCMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerDMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerDMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerEMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerEMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerFMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerFMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerGMember NCRA:CateringMember 2025-01-01 2025-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CustomerGMember NCRA:CateringMember 2024-01-01 2024-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CateringMember 2025-01-01 2025-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CateringMember 2024-01-01 2024-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q/A

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2025

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM _______ TO ___________

 

COMMISSION FILE NO.: 001-41434

 

NOCERA, INC.

(Exact name of registrant as specified in charter)

 

Nevada   16-1626611
(State or other jurisdiction of incorporation)   (IRS Employer Identification No.)

 

3F (Building B), No. 185, Sec. 1, Datong Rd., Xizhi Dist., New Taipei City 221, Taiwan (R.O.C.)

(Address of principal executive offices and zip code)

 

(886)-910-163-358

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share NCRA The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “small reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer ☒   Smaller reporting company 
    Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No

 

There were 14,367,539 shares outstanding of the registrant’s common stock, par value $0.001 per share, as of May 15, 2025.

 

   

 

 

Explanatory Note

 

The purpose of this Amendment No. 1 (this “Amendment No. 1”) to the Quarterly Report on Form 10-Q of Nocera, Inc. (the “Company”) for the quarter ended March 31, 2025 (the “Original Form 10-Q”) is to amend the financial statements related notes of the Company to include disclosures related to segment reporting as required by Accounting Standards Codification Topic 280, “Segment Reporting.”

 

This amendment is being filed in response to a comment received from the Staff of the Securities and Exchange Commission and is intended to provide the required disclosures regarding the Company’s operating segments, including segment revenues, profit or loss, and other relevant information, as applicable. The amendments reflect the proper presentation and classification of segment information in the financial statements and provide the necessary related disclosures in the notes to the financial statements.

 

No other changes have been made to the Original Form 10-Q. This Amendment No. 1 does not reflect events occurring after the date of the original filing and does not modify or update any other disclosures made in the Original Form 10-Q.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

 

TABLE OF CONTENTS

 

 

Cautionary Statement Regarding Forward-Looking Statements  
     
PART I FINANCIAL INFORMATION 4
     
ITEM 1. INTERIM UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS 4
  INTERIM UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS 4
  INTERIM UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 5
  INTERIM UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 6
  INTERIM UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY 7
  NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) 8
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 30
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 49
ITEM 4. CONTROLS AND PROCEDURES 49
     
PART II OTHER INFORMATION 51
     
ITEM 1. LEGAL PROCEEDINGS 51
ITEM 1A. RISK FACTORS 51
ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 51
ITEM 3 DEFAULTS UPON SENIOR SECURITIES 51
ITEM 4 MINE SAFETY DISCLOSURES 51
ITEM 5 OTHER INFORMATION 51
ITEM 6 EXHIBITS 52
     
SIGNATURES 53

 

 

 

 

 

 3 

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements discuss matters that are not historical facts. Because they discuss future events or conditions, forward-looking statements may include words such as “anticipate,” “believe,” “estimate,” “intend,” “could,” “should,” “would,” “may,” “seek,” “plan,” “might,” “will,” “expect,” “predict,” “project,” “forecast,” “potential,” and “continue” or the negatives thereof or similar expressions. Forward-looking statements speak only as of the date they are made, are based on various underlying assumptions and current expectations about the future and are not guarantees of future performance. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, level of activity, performance or achievement to be materially different from the results of operations or plans expressed or implied by such forward-looking statements. You are cautioned to not place undue reliance on these forward-looking statements, which speak only as of their dates.

 

We cannot predict all the risks and uncertainties that may impact our business, financial condition or results of operations. Accordingly, the forward-looking statements in this Quarterly Report on Form 10-Q should not be regarded as representations that the results or conditions described in such statements will occur or that our objectives and plans will be achieved, and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements. These forward-looking statements are found at various places throughout this Quarterly Report on Form 10-Q and include information concerning possible or projected future results of our operations, including statements about potential acquisition or merger targets, strategies or plans; business strategies; prospects; future cash flows; financing plans; plans and objectives of management; any other statements regarding future acquisitions, future cash needs, future operations, business plans and future financial results; and any other statements that are not historical facts.

 

These forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to a variety of factors and risks, including, but not limited to, those set forth under “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the Securities and Exchange Commission (“SEC”) on May 6, 2025.

 

Many of those risks and factors are outside of our control and could cause actual results to differ materially from the results expressed or implied by those forward-looking statements. Considering these risks, uncertainties and assumptions, the events described in the forward-looking statements might not occur or might occur to a different extent or at a different time than we have described. All subsequent written and oral forward-looking statements concerning other matters addressed in this Quarterly Report on Form 10-Q and attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this Quarterly Report on Form 10-Q.

 

Except to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

 

 

 

 

 

 4 

 

 

PART I FINANCIAL INFORMATION

 

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

 

NOCERA, INC.

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(Stated in US Dollars except for Number of Shares)

         
  

March 31,

2025

   December 31, 2024 
   (Unaudited)   (Audited) 
         
ASSETS          
Current assets          
Cash and cash equivalents  $531,771   $484,161 
Accounts receivable   134,106    144,509 
Inventories, net   9,608     
Advance to suppliers   1,732    8,404 
Prepaid expenses and other assets, net   598,199    643,169 
Financial assets at fair value through profit or loss       210 
Total current assets   1,275,416    1,280,453 
Property and equipment, net   1,342,060    1,391,845 
Intangible assets - customer relations   93,749    97,825 
Investment   27,435    27,206 
Goodwill   2,077,728    2,077,728 
Other non-current asset   4,373    7,505 
Total assets  $4,820,761   $4,882,562 
LIABILITIES AND EQUITY          
Liabilities          
Current liabilities          
Accounts payable  $13,717   $ 
Other payables and accrued liabilities   395,793    376,660 
Contract liabilities   78,875    72,505 
Due to related parties   38,518    27,116 
Warrant liability   85,273    76,847 
Long-term secured other borrowing – current portion   28,868    6,631 
Dividend payable   54,312    54,312 
Income tax payable   11,028    25,126 
Total current liabilities   706,384    639,197 
Long-term secured other borrowing       23,786 
Total liabilities   706,384    662,983 
Commitments and contingencies (Note 20)        
Shareholder’s Equity          
Common stock ($0.001 par value; authorized 200,000,000 shares; 14,247,539 shares and 14,047,539 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively) (1)   14,247    14,047 
Preferred stock ($0.001 par value; authorized 10,000,000 shares; Series A Preferred Stock, 2,000,000 authorized, 80,000 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively)   80    80 
Additional paid-in capital (1)   25,350,065    25,200,265 
Statutory and other reserves   191,219    191,219 
Accumulated losses   (21,486,898)   (21,238,881)
Accumulated other comprehensive income   15,253    12,415 
Total Nocera, Inc.’s shareholders’ equity   4,083,966    4,179,145 
Non-controlling interests   30,411    40,434 
Total shareholders’ equity   4,114,377    4,219,579 
Total liabilities and shareholders’ equity  $4,820,761   $4,882,562 

 

See notes to the condensed consolidated financial statements which are an integral part of these unaudited condensed financial statements.

 

 

 

 5 

 

 

NOCERA, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Stated in US Dollars except for Number of Shares)

(UNAUDITED)

         
   Three months ended March 31, 
   2025   2024 
   $   $ 
Net sales   4,534,128    4,899,880 
Cost of sales   (4,483,178)   (4,815,919)
Gross profit   50,950    83,961 
           
Operating expenses          
General and administrative expenses   (334,371)   (451,464)
Total operating expenses   (334,371)   (451,464)
           
Loss from operations   (283,421)   (367,503)
           
Other income   25,804    195,573 
Loss before income taxes   (257,617)   (171,930)
           
Income tax expense       (124,146)
Net loss   (257,617)   (296,076)
           
Less: Net loss attributable to non-controlling interests   (9,600)   (7,500)
Net loss attributable to the company   (248,017)   (288,576)
           
Comprehensive Income          
Net loss   (257,617)   (296,076)
Foreign currency translation (loss) gain   (2,838)   57,307 
Total comprehensive loss   (260,455)   (238,769)
           
Less: Net loss attributable to non-controlling interests   (9,600)   (7,500)
Less: Foreign currency translation loss attributable to non-controlling interest   (423)   1,878 
Comprehensive loss attributable to the Company   (250,432)   (233,147)
           
Loss per share          
Basic   (0.0175)   (0.0241)
Diluted   (0.0175)   (0.0241)
           
Weighted average number of common shares outstanding          
Basic   14,159,761    11,956,987 
Diluted   14,159,761    11,956,987 

 

See notes to the condensed consolidated financial statements which are an integral part of these unaudited condensed financial statements. 

 

 

 

 6 

 

 

NOCERA, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Stated in US Dollars except for Number of Shares)

(UNAUDITED)

         
   Three months ended March 31, 
   2025   2024 
   $   $ 
Cash flows from operating activities:          
Net loss   (257,617)   (296,076)
Adjustments to reconcile net income to net cash used in operating activities:          
Depreciation expenses   33,674    22,559 
Deferred income tax       (922)
Amortization of intangible assets   4,076    4,076 
Gain on disposal of financial assets at FVTPL   (3)    
Gain on fair value change of financial assets at FVTPL       (2,409)
Share-based compensation       14,999 
Changes in operating assets and liabilities:          
Accounts receivable, net   11,262    (4,171)
Inventories   (9,936)    
Advance to suppliers   6,672     
Prepaid expenses and other assets, net   48,927    (117,346)
Other non-current assets   3,076    69 
Accounts payable   13,717     
Advance from customers   5,802     
Other payables and accrued liabilities   30,905    116,070 
Income tax payable   (14,083)    
Subtract non-cash gain (loss) on warrant liability   8,426    (197,843)
Net cash used in operating activities   (115,102)   (460,994)
           
Cash flows from investing activities:          
Net cash inflow from acquisition of a subsidiary       201,863 
Proceeds from gain on disposal of financial assets at FVTPL   213     
Net cash provided by investing activities   213    201,863 
           
Cash flows from financing activities:          
Repayment of short-term bank loan       (60,678)
Proceeds from issuance of common stock   150,000     
Repayment of secured other borrowings   (1,817)    
Net cash provided by (used in) financing activities   148,183    (60,678)
           
Effect of exchange rate changes on cash and cash equivalents   14,316    52,006 
Net increase (decrease) in cash and cash equivalents   47,610    (267,803)
Cash and cash equivalents at beginning of period   484,161    1,229,580 
Cash and cash equivalents at end of period   531,771    961,777 

 

See notes to the condensed consolidated financial statements which are an integral part of these unaudited condensed financial statements. 

 

 

 

 7 

 

 

NOCERA, INC.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(Stated in US Dollars except Number of Shares)

(UNAUDITED)

                                   
   Common Stock  Preferred stock  Additional
Paid-in
  Statutory
and
other
  Accumulated  Accumulated
Other
Comprehensive
  Total
Nocera Inc.’s
Shareholders’
  Non-
controlling
  Total
Shareholders’
 
   Stock  Amount  Stock  Amount  Capital  Reserves  Losses  Loss  Equity  Interests  Equity 
       $       $   $   $   $   $   $   $   $ 
Balance as of January 1, 2024  11,156,987   11,157   80,000   80   21,931,112   191,219   (18,868,420)  98,906   3,364,054   84,325   3,448,379 
Foreign currency translation Adjustments                       (57,307)  (57,307)  (3,288)  (60,595)
Common stock issuance  1,800,000   1,800         1,978,200            1,980,000      1,980,000 
Share-based compensation              14,999            14,999      14,999 
Net loss                    (288,576)     (288,576)  (7,500)  (296,076)
Balance as of March 31, 2024  12,956,987   12,957   80,000   80   23,924,311   191,219   (19,156,996)  41,599   5,013,170   73,537   5,086,707 
                                             
                                             
                                             
Balance as of January 1, 2025  14,047,539   14,047   80,000   80   25,200,265   191,219   (21,238,881)  12,415   4,179,145   40,434   4,219,579 
Foreign currency translation Adjustments                       2,838   2,838   (423)  2,415 
Common stock issuance  200,000   200         149,800            150,000      150,000 
Net loss                    (248,017)     (248,017)  (9,600)  (257,617)
Balance as of March 31, 2025  14,247,539   14,247   80,000   80   25,350,065   191,219   (21,486,898)  15,253   4,083,966   30,411   4,114,377 

 

See notes to the condensed consolidated financial statements which are an integral part of these unaudited condensed financial statements.

 

 

 

 

 8 

 

 

NOCERA, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

Note 1      PRINCIPAL ACTIVITIES AND ORGANIZATION

 

The consolidated financial statements include the financial statements of Nocera, Inc. (“Nocera” or the “Company”) and its subsidiaries, Grand Smooth Inc. Limited (“GSI”) and Guizhou Grand Smooth Technology Ltd. (“GZ GST” or “WFOE”), and Meixin Institutional Food Development Co., Ltd. (“Meixin”) that is controlled through contractual arrangements. The Company, GSI, GZ GST and Mexin are collectively referred to as the “Company”.

 

Nocera was incorporated in the State of Nevada on February 1, 2002 and is based in New Taipei City, Taiwan (R.O.C.). It did not engage in any operations and was dormant from its inception until its reverse merger with GSI on December 31, 2018.

 

Reverse Merger

 

Effective December 31, 2018, Nocera completed a reverse merger transaction (the “Transaction”) pursuant to an Agreement and Plan of Merger (the “Agreement”), with (i) GSI, (ii) GSI’s shareholders, Yin-Chieh Cheng and Bi Zhang, who together owned shares constituting 100% of the issued and outstanding ordinary shares of GSI (the “GSI Shares”) and (iii) GSI Acquisition Corp. Under the terms of the Agreement, the GSI Shareholders transferred to Nocera all of the GSI Shares in exchange for the issuance of 10,000,000 shares (the “Shares”) of Nocera’s common stock (the “Share Exchange”). As a result of the reverse merger, GSI became Nocera’s wholly-owned subsidiary and Yin-Chieh Cheng and Bi Zhang, the former shareholders of GSI, became Nocera’s controlling shareholders. The share exchange transaction with GSI was treated as a reverse merger, with GSI as the accounting acquirer and Nocera as the acquired party.

 

GSI is a limited company established under the laws and regulations of Hong Kong on August 1, 2014, and is a holding company without any operations.

 

GZ WFH was incorporated in Xingyi City, Guizhou Province, People’s Republic of China (“PRC”) on October 25, 2017, and is engaged in providing fish farming containers service, which integrates sales, installments, and maintenance of aquaculture equipment. The registered capital of GZ WFH is RMB$5,000,000 (equal to US$733,138).

 

On November 13, 2018, GSI incorporated GZ GST in PRC with registered capital of US$15,000.

 

Divestiture

 

On September 21, 2020, the Company filed a Current Report on Form 8-K outlining the lack of communication that led to the termination by Nocera of its relationship with its former variable interest entity, Guizhou Wan Feng Hu Intelligent Aquatic Technology Co. Limited (“GZ WFH”) and its management, and termination of the variable interest entity agreements between the parties.

 

Subsequently on October 8, 2020, Zhang Bi and GZ WFH entered into a Settlement Agreement and Release with Nocera wherein all claims as to GZ WFH’s debt (claim to shares in Nocera or GZ GST) were compromised, settled, and otherwise resolved as to any and all claims or causes of action whatsoever against Nocera for any matter, action, or representation as to Nocera, and any debt to ownership of Nocera or GZ GST up to the date of the agreement. The consideration for the agreement was mutual waiver of any and all claims against each other and GZ GST, and GZ WFH (including Zhang Bi) waived any claims to Nocera stock, meaning the 4,750,000 shares of common stock of Nocera owned by Zhang Bi were cancelled as part of the agreement. The Settlement Agreement and Release is attached hereto as Exhibit 10.8.

 

 

 

 9 

 

 

The VIE Agreements with XFC

 

On December 31, 2020, we exchanged 466,667 (post-split) shares of our restricted common stock to stockholders of Xin Feng Construction Co., Ltd., a Taiwan limited liability company (“XFC”), in exchange for 100% controlling interest in XFC. We also entered into contractual arrangements with a stockholder of XFC, that enabled us to have the power to direct the activities that most significantly affects the economic performance of XFC and receive the economic benefits of XFC that could be significant to XFC. On November 30, 2022, we entered into a Purchase of Business Agreement with Han-Chieh Shih (the “Purchaser”), in which we sold our controlling interest of XFC, to the Purchaser for a total purchase cash price of $300,000 (the “XFC Sale”). The closing of the XFC Sale occurred on November 30, 2022 and the XFC variable interest entity (“VIE”) agreements were terminated in connection with the XFC Sale. 

 

The VIE Agreements with Meixin

 

On September 7, 2022, we entered into a series of contractual agreements (collectively, the “Meixin VIE Agreements”) with the majority stockholder (the “Selling Stockholder”) of Meixin Institutional Food Development Co., Ltd., a Taiwan corporation and a food processing and catering company (“Meixin”), and Meixin, of which we purchased 80% controlling interest of Meixin for $4,300,000. The Meixin VIE Agreements essentially confer control and management of Meixin as well as substantially all of the economic benefits of the Selling Stockholder in Meixin to us.

 

The VIE Agreements with Xinca

 

On January 31, 2024, we entered into a Variable Interest Entity Purchase Agreement (“Xinca Purchase Agreement”) with Zhejiang Xinca Mutual Entertainment Culture Media Co., Ltd. (“Xinca”), a domestic funded limited liability company registered in China (P.R.C). The Xinca Purchase Agreement was entered into by our wholly-owned subsidiary and foreign enterprise, Shanghai Nocera Culture Co., Ltd. (“WFOE”), through a series of contractual agreements (“VIE Agreements”), in which we exchanged 1,800,000 shares of our restricted common stock for a 100% controlling interest in Xinca. As a result, the Company has been determined to be the primary beneficiary of Xinca and Xinca became a variable interest entity (“VIE”) of the Company.

 

We have entered into the following contractual arrangements with stockholders of Xinca, which enable us to (1) have the power to direct the activities that most significantly affect the economic performance of Xinca, and (2) receive the economic benefits of Xinca that could be significant to Xinca. We are fully and exclusively responsible for the management of Xinca, assume all of the risk of losses of Xinca, and have the exclusive right to exercise all voting rights of Xinca’s stockholders. Therefore, in accordance with ASC 810 “Consolidation,” we are considered the primary beneficiary of Xinca and have consolidated Xinca’s assets, liabilities, results of operations, and cash flows in the accompanying consolidated financial statements.

 

  (1) Voting Rights Proxy Agreement & Power of Attorney

 

Zong Hui and Upward Software (Shanghai) Co., Ltd. (the “Existing Stockholders”) have irrevocably authorized us, or the individual then designated by us (the “Attorney”), to exercise, on their behalf, the following rights available to them in their capacity as stockholders of Xinca under the then-effective articles of association of Xinca (collectively, the “Powers”): (a) to propose the convening of, and attend, stockholders’ meetings in accordance with the articles of association of Xinca on behalf of the Existing Stockholders; (b) to exercise voting rights on behalf of the Existing Stockholders on all matters required to be deliberated and resolved by the stockholders’ meeting, including, without limitation, the appointment and election of the directors and other executives to be appointed and removed by the stockholders of Xinca, and the sale or transfer of all or part of the equity held by stockholders in Xinca; (c) to exercise other stockholders’ voting rights under the articles of association of Xinca (including any other stockholders’ voting rights stipulated upon an amendment to such articles of association); and (d) other voting rights that stockholders shall enjoy under the laws of the People’s Republic of China (“China”), as amended, revised, supplemented, and re-enacted, regardless of whether they take effect before or after the conclusion of this Agreement. The Existing Stockholders shall not revoke the authorization and entrustment accorded to the Attorney unless we issue a written notice requesting the replacement of the Attorney. In such event, the Existing Stockholders shall immediately appoint such other person as we designate to exercise the foregoing Powers, and such new authorization and entrustment shall supersede, immediately upon its grant, the original authorization and entrustment.

 

 

 

 10 

 

 

  (2) Exclusive Business Cooperation Agreement

 

We agree to provide technical consulting and services, including management consulting services, general and financial advisory services, and various general and administrative services (collectively, the “Target Business”), to Xinca as its exclusive technical consulting and service provider in accordance with the terms set forth in this Agreement. Xinca agrees to accept the technical consulting and services provided by us. Xinca further agrees that, without our prior written consent, it shall not accept any technical consulting or services identical or similar to the Target Business from any third party during the term of this Agreement.

 

  (3) Equity Pledge Agreement

 

Under the Equity Interest Pledge Agreement between us and Zong Hui and Upward Software (Shanghai) Co., Ltd., the stockholders of Xinca have pledged all of their equity interests in Xinca to us to guarantee the performance of Xinca’s obligations under the Exclusive Business Cooperation Agreement. Under the terms of the agreement, in the event that Xinca or the stockholders breach their respective contractual obligations under the Exclusive Business Cooperation Agreement, we, as the pledgee, will be entitled to certain rights, including, but not limited to, the right to collect dividends generated by the pledged equity interests.

 

  (4) Exclusive Call Option Agreement

 

Xinca and its stockholders, Zong Hui and Upward Software (Shanghai) Co., Ltd., have entered into an Exclusive Call Option Agreement with us. Under this agreement, the Xinca stockholders have irrevocably granted us (or our designee) an exclusive option to purchase, to the extent permitted under the laws of China, part or all of their equity interests in Xinca. According to the Exclusive Call Option Agreement, the purchase price shall be the minimum price permitted under applicable Chinese law at the time the share transfer occurs.

 

The Equity Purchase Agreements with SY Culture

 

On April 14, 2024, we entered into a Equity Purchase Agreement with Hangzhou SY Culture Media Co. Ltd. (“SY Culture Purchase Agreement”), a domestic funded limited liability company registered in China (P.R.C). The SY Culture Purchase Agreement was entered into by our wholly-owned subsidiary and foreign enterprise, Gui Zhou Grand Smooth Technology Ltd. (“WFOE”), in which we exchanged 600,000 shares of our restricted common stock for a 100% equity in SY Culture.

 

Note 2      SUMMARY OF SIGNIFICANT ACCOUNTING POLICY

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, these financial statements do not include all of the information and footnotes required for complete financial statements and should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on May 6, 2025.

 

In the opinion of management, all adjustments (which include normal recurring adjustments) necessary to present a fair presentation of the Company’s unaudited condensed consolidated financial position as of March 31, 2025, its consolidated results of operations for the three months ended March 31, 2025, cash flows for the three months ended March 31, 2025 and change in equity for the three months ended March 31, 2025, as applicable, have been made. Operating results for the three months ended March 31, 2025 are not necessarily indicative of the operating results that may be expected for the year ending December 31, 2024 or any future periods.

 

 

 

 11 

 

 

Concentrations of Credit Risk

 

Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.

 

There were three customers who represent 69.67% of the Company’s total revenue for the three months ended March 31, 2024. There were four customers who represent 84.6% of the Company’s total revenue for the three months ended March 31, 2025.

 

The following table sets forth a summary of single customers who represent 10% or more of the Company’s total accounts receivable, net:

 

        
   March 31,
2025
   March 31,
2024
 
   (Unaudited)   (Audited) 
Percentage of the Company’s accounts receivable          
Customer A   21.46%    36.78% 
Customer B   24.24%     
Customer C   18.41%     
Customer D   20.49%     
Customer E       17.82% 
Customer F       15.07% 
    84.6%    69.67% 

 

The following table sets forth a summary of single suppliers who represent 10% or more of the Company’s total purchase:

   March 31,
2025
   March 31,
2024
 
   (Unaudited)   (Audited) 
Percentage of the Company’s purchase          
Supplier A   10.12%     
Supplier B   12.40%     
Supplier C   17.60%     
Supplier D   11.96%     
Supplier E       13.72% 
Supplier F       12.47% 
Supplier G       12.85% 
Supplier H       11.24% 
Supplier I       12.24% 
    52.08%    62.52% 

 

 

 

 12 

 

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers.”

 

The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies the following steps:

 

  · Step 1: Identify the contract(s) with a customer
     
  · Step 2: Identify the performance obligations in the contract
     
  · Step 3: Determine the transaction price
     
  · Step 4: Allocate the transaction price to the performance obligation in the contract
     
  · Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation

 

The Company mainly offers and generates revenue from the fish trading business, bento box and fruit and vegetable processing business, and E-commerce live streaming business. Revenue recognition policies are discussed as follows:

 

Aquatic product trading revenue

 

The Company engages in the trading of fish, primarily eels. Revenue is generated when the Company receives customer orders specifying product types and requirements. Upon receiving an order, the Company arranges the harvesting of the eels, inspects the products to ensure compliance with the customer’s specifications, and coordinates delivery. Revenue is recognized at a point in time when control of the goods is transferred to the customer, typically upon delivery, which is the point at which the performance obligation is satisfied.

 

Bento box and produce processing revenue

 

The Company also operates a bento box and fresh produce processing business, primarily involving vegetables and fruits. The revenue recognition model for this segment is similar to the aquatic product trading business. Upon receiving customer orders, the Company processes and packages the required food or agricultural products, ensures product quality and conformity to order specifications, and arranges delivery. Revenue is recognized at a point in time, generally upon the transfer of the processed goods to the customer.

 

E-commerce live-streaming commission revenue

 

The Company acts as an agent in facilitating the sale of third-party products through live-streaming e-commerce platforms. The Company does not take control of the goods sold, and commission revenue is recognized on a net basis. Revenue is recognized at the point in time when the underlying product is sold and shipment is confirmed by the seller, which indicates the Company has fulfilled its performance obligation of facilitating the sale. 

 

 

 

 13 

 

 

Recent Accounting Pronouncements

 

The FASB issued several updates during the period, none of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the consolidated financial statements upon adoption.

 

Note 3     ACCOUNTS RECEIVABLE

 

As of March 31, 2025 and December 31, 2024, accounts receivable consisted of the following:

           
    March 31,
2025
    December 31,
2024
 
    (Unaudited)     (Audited)  
    $     $  
Accounts receivable     134,106       144,509  
Total     134,106       144,509  

 

Note 4      INVENTORIES

 

As of March 31, 2025 and December 31, 2024, inventories consisted of the following:

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Raw materials   9,608     
Total   9,608     

 

Note 5     ADVANCE TO SUPPLIERS

 

Balances of advances to suppliers were $1,732 and $8,404 as of March 31, 2025 and December 31, 2024, respectively, which represented prepayments to suppliers for raw materials.

 

 

 

 

 14 

 

 

Note 6      PREPAID EXPENSES AND OTHER ASSETS, NET

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Prepaid Expenses   41,623    43,158 
Other receivables from third party   556,576    600,011 
Prepaid expenses and other assets, net   598,199    643,169 

 

Other receivables as of March 31, 2025 and December 31, 2024 were $598,199 and $643,169, respectively. Other receivables include e-commerce live stream receivables for goods and e-commerce sales deposit.

 

Other receivables from third parties primarily consist of amount due from third parties of $345,980, e-commerce live stream sales deposits of $5,487, and outstanding loans to certain employees totaling $15,326 from Xinca and $187,646 from SY Media, related to the Company’s participation in live stream events. These receivables are expected to be collected within normal payment cycles and are considered part of ongoing operations. Additionally, $1,106 relates to prior-year receivables from GZ GSI for fish sales in China. Management does not expect any collection issues.

 

Note 7      FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS

 

The fair value of each investment in equity instrument to be measured at fair value through profit or loss is as follows:

 

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
Financial assets mandatorily measured at fair value through profit or loss  $   $ 
Funds       210 
Total       210 
           
Current       210 
Non-Current        
Total       210 

 

Net gain on disposal of financial assets at FVTPL of $3 was recognized in the consolidated statement of profit or loss for the period ended March 31, 2025.

 

As of December 31, 2024, no financial assets at fair value through profit or loss were pledged with banks as collaterals.

 

 

 

 

 15 

 

 

Note 8      PROPERTY AND EQUIPMENT, NET

 

As of March 31, 2025 and December 31, 2024, property and equipment consisted of the following:

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Land   877,870    877,870 
Equipment   901,356    911,280 
Less: Accumulated depreciation   (437,166)   (397,305)
Property and equipment, net   1,342,060    1,391,845 

 

Depreciation expenses for the three months ended March 31, 2025 and 2024 were $33,674 and $22,559, respectively.

 

Note 9     GOODWILL AND OTHER INTANGIBLE ASSETS

 

As of March 31, 2025 and December 31, 2024, goodwill consisted of the following:

 

Goodwill

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Goodwill - Meixin   3,905,735    3,905,735 
Goodwill - Xinca   1,351,703    1,351,703 
Goodwill - SY Media   230,015    230,015 
Less: Impairment   (3,409,725)   (3,409,725)
Goodwill, net   2,077,728    2,077,728 

 

 

 

 16 

 

 

Customer relations

           
    March 31,     December 31,  
    2025     2024  
    (Unaudited)     (Audited)  
    $     $  
Acquisitions     135,325       135,325  
Less: Accumulated amortization     (41,576 )     (37,500 )
Customer relations, net     93,749       97,825  

 

Note 10       OTHER BORROWINGS

 

Others loans consisted of the following:

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
           
Secured car loan from CITIC Bank wholly repayable  $28,868   $30,417 
Total secured car loan wholly repayable within 1 year   28,868    6,631 
Secured car loan from CITIC Bank wholly repayable more than 1 year       23,786 
Total  $28,868   $30,417 

 

Note 11     WARRANTS

 

On April 1, 2021, the Company entered into a securities purchase agreement with certain investors for an aggregate of 80,000 shares of its preferred stock at a per share purchase price of $2.50. As part of the transaction, the investors received one Class C warrant and one Class D warrant for the subscription of each preferred share. The Class C warrants consist of the right to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $2.50 per share exercisable for 36 months from the date of inception. The Class D warrants consist of the right to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $5.00 per share exercisable for 36 months from the date of inception. The subscription was completed on August 10, 2021.

 

On September 27, 2021, the Company entered into another securities purchase agreement with the same investors, pursuant to which the Company issued in a registered direct offering, an aggregate of 48,000 shares of common stock of the Company at a per share purchase price of $2.50. In addition, the investors also received one Class C warrant and one Class D warrant for the subscription of each preferred share. The Class C warrants consist of the right to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $2.50 per share exercisable for 36 months from the date of inception. The Class D warrants consist of the right to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $5.00 per share exercisable for 36 months from the date of inception.

 

In connection with the public offering and pursuant to a registration statement on Form S-1, amended (File No. 333-264059), originally filed with the SEC on April 1, 2022, and declared effective by the SEC on August 10, 2022 (the “Registration Statement”), the public offering price of each Unit was $3.50, and each unit consisting of one share of common stock and a warrant to purchase two shares of common stock from the date of issuance until the fifth anniversary of the date of issuance. The Shares and the Warrants comprising the Units were immediately separable and issued separately in the Offering, which closed on August 15, 2022.

 

 

 

 17 

 

 

In connection with the public offering and pursuant to the underwriting agreement between us and the underwriters named therein, we granted the underwriters a 45-day option to purchase up to 282,000 additional shares of common stock and warrants, equivalent to 15% of the Units sold in the public offering, at the public offering price per Unit, less underwriting discounts and commissions, to cover over-allotments, if any. On September 23, 2022, the underwriters exercised their option to purchase an additional 282,000 warrants from us for gross proceeds of $2,820. The warrants were issued to the underwriters on September 26, 2022.

 

The exercise price of the Warrants shall be decreased to the reset price, which means the greater of (i) 50% of the exercise price and (ii) 100% of the last volume weighted average price immediately preceding the 90th calendar day following the initial issuance date (the greater of (i) and (ii), the “Reset Price”) if, on the date that is 90 calendar days immediately following the initial issuance date, the Reset Price is less than the exercise price on that date.

 

The following is a reconciliation of the beginning and ending balances of warrants liability measured at fair value on a recurring basis using Level 3 inputs:

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Balance at the beginning of period   76,847    874,116 
Fair value change of warrants included in earnings   8,426    (797,269)
Balance at the end of the period   85,273    76,847 

 

The following is a summary of the warrant activities:

                 
   

Number of

Warrants

   

Average

Exercise Price

   

Weighted

Average

Remaining

Contractual

Term in

Years

 
                   
Outstanding as of January 1, 2025     2,239,870       2.14       2.63  
Exercisable as of January 1, 2025     2,239,870       2.14       2.63  
Granted                  
Exercised / surrendered                  
Expired                  
Outstanding as of March 31, 2025     2,239,870       2.14       2.38  
Exercisable as of March 31, 2025     2,239,870       2.14       2.38  

 

 

 

 

 18 

 

 

Note 12      LEASES

 

The Company has two non-cancelable lease agreements for certain of the office and accommodation as well as fish farming containers for research and development of advanced technology for water circulation in fish farming containers with original lease periods expiring between 2024 and 2025. The lease terms may include options to extend or terminate the lease when it is reasonably certain the Company will exercise that option. The Company recognizes rental expense on a straight-line basis over the lease term.

 

The components of lease expense for the three months ended March 31, 2025 and March 31, 2024 were as follows:

               
    Statement of Income Location   Three months ended
March 31, 2025
    Three months ended
March 31, 2024
 
        (Unaudited)     (Unaudited)  
        $     $  
Lease Costs                    
Operating lease expense   General and administrative expenses     18,573       18,791  
Total net lease costs         18,573       18,791  

 

Note 13     OTHER PAYABLES AND ACCRUED LIABILITIES

           
    March 31,
2025
    December 31,
2024
 
    (Unaudited)     (Audited)  
    $     $  
Accrued Expenses     211,426       262,156  
Others     184,367       114,504  
Total     395,793       376,660  

  

As of March 31, 2025, other payables and accrued expenses were $395,793, respectively, compared to $376,660 as of December 31, 2024.

 

As of March 31, 2025, other payables and accrued expenses were $184,367 and $211,426, respectively, compared to $114,504 and $262,156 as of December 31, 2024. The accrued expenses in both periods primarily relate to audit fees. Other payables mainly consisted of amounts related to e-commerce intermediary transactions, specifically payables arising from cross-border settlements with Chinese e-commerce platforms amounting to $176,374 as of March 31, 2025 and $100,379 as of December 31, 2024.

 

 

 

 19 

 

 

Note 14      INCOME TAXES

 

The Company and its subsidiary, and the consolidated VIE file tax returns separately.

 

1) Value-added tax (“VAT”)

 

PRC

 

Pursuant to the Provisional Regulation of the PRC on VAT and the related implementing rules, all entities and individuals (“taxpayers”) that are engaged in the sale of products in the PRC are generally required to pay VAT, at a rate of which was changed from 16% to 13% on April 1, 2019 of the gross sales proceeds received, less any deductible VAT already paid or borne by the taxpayers. GZ WFH also subjected to 10% for the installment service provided.

 

Taiwan

 

Pursuant to the Value-added and Non-value-added Business Tax Act and the related implementing rules, all entities and individuals (“taxpayers”) that are engaged in the sale of products in the Taiwan are generally required to pay VAT, at a rate of 5%.

 

2) Income tax

 

United States

 

On December 22, 2017, the Tax Cuts and Jobs Act (the “Tax Act”) was signed into legislation. The Tax Act significantly revises the U.S. corporate income tax by, among other things, lowering the statutory corporate tax rate from 34% to 21%, imposing a mandatory one-time tax on accumulated earnings of foreign subsidiaries, introducing new tax regimes, and changing how foreign earnings are subject to U.S. tax.

 

On December 22, 2017, Staff Accounting Bulletin No. 118 (“SAB 118”) was issued to provide guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740. The Company has completed the assessment of the income tax effect of the Tax Act and there were no adjustments recorded to the provisional amounts.

 

The Coronavirus Aid, Relief and Economy Security Act (the “CARES Act”) was signed into law on 27 March 2020. The CARES Act temporarily eliminates the 80% taxable income limitation (as enacted under the Tax Cuts and Jobs Act of 2017) for net operating loss (“NOL”) deductions for 2018-2020 tax years and reinstated NOL carrybacks for the 2018-2020 tax years. Moreover, the CARES Act also temporarily increases the business interest deduction limitations from 30% to 50% of adjusted taxable income for the 2019 and 2020 taxable year. Lastly, the Tax Act technical correction classifies qualified improvement property as 15-year recovery period, allowing the bonus depreciation deduction to be claimed for such property retroactively as if it was included in the Tax Act at the time of enactment. The Company does not anticipate a significant tax impact on its financial statements and will continue to examine the impact the CARES Act may have on its business.

 

 

 

 

 20 

 

 

The Company evaluated the Global Intangible Low Taxed Income (“GILTI”) inclusion on current earnings and profits of greater than 10% owned foreign controlled corporations. The Company has evaluated whether it has additional provision amount resulted by the GILTI inclusion on current earnings and profits of its foreign controlled corporations. The law also provides that corporate taxpayers may benefit from a 50% reduction in the GILTI inclusion, which effectively reduces the 21% U.S. corporate tax rate on the foreign income to an effective rate of 10.5%. The GILTI inclusion further provides for a foreign tax credit in connection with the foreign taxes paid. In 2019, the Company recorded a GILTI inclusion of $152,829. The Company has elected to treat the financial statement impact of GILTI as current period expenses.

 

The reverse merger was completed on December 31, 2018 and the tax losses of the US subsidiary was not in the scope as of December 31, 2018. As of December 31, 2019, net operating loss carried forward which was available to offset future taxable income for the Company in the United States was $99,817. There was a full valuation allowance applied against these loss carry forward as management determined it was not more likely than not that these net operating losses would be utilized in the foreseeable future.

 

Hong Kong

 

The HK tax reform has introduced two-tiered profits tax rates for corporations. Under the two-tiered profits tax rates regime, the profits tax rate for the first HK$2 million (approximately $257,931) of assessable profits will be lowered to 8.25% (half of the rate specified in Schedule 8 to the Inland Revenue Ordinance) for corporations. Assessable profits above HK$2 million (approximately $257,931) will continue to be subject to the rate of 16.5% for corporations. Because the Company assessed that the HK entity will not earn a profit greater than HK$2 million (approximately $257,931), it is subject to a corporate income tax rate of 8.25%.

 

As of December 31, 2021, the Company’s subsidiary in Hong Kong had net operating loss carry forwards available to offset future taxable income. The net operating losses will be carryforward indefinitely under Hong Kong Profits Tax regulation. There is a full valuation allowance applied against these loss carry forward as management determined it was not more likely than not that these net operating losses would be utilized in the foreseeable future.

 

PRC

 

WFOE and the consolidated VIE established in the PRC are subject to the PRC statutory income tax rate of 25%, according to the PRC Enterprise Income Tax law.

 

In accordance with the relevant tax laws and regulations of the PRC, a company registered in the PRC is subject to income taxes within the PRC at the applicable tax rate on taxable income. All the PRC subsidiaries were subject to income tax at a rate of 25% for the year ended December 31, 2021. According to PRC tax regulations, the PRC net operating loss can generally carry forward for no longer than five years starting from the year subsequent to the year in which the loss was incurred.

 

 

 

 

 

 21 

 

 

Taiwan

 

The Company’s loss before income taxes is primarily derived from the operations in Taiwan and income tax expense is primarily incurred in Taiwan.

 

As a result of amendments to the “Taiwan Income Tax Act” enacted by the Office of the President of Taiwan on February 7, 2018, the statutory income tax rate increased from 17% to 20% and the undistributed earnings tax, or a surtax, decreased from 10% to 5% effective from January 1, 2018. As a result, the statutory income tax rate in Taiwan was 20% for the years ended August 31, 2021 and 2020. An additional surtax, of which rate was reduced from 10% to 5% being applied to the Company starting from September 1, 2018, is assessed on undistributed income for the entities in Taiwan, but only to the extent such income is not distributed or set aside as a legal reserve before the end of the following year. The 5% surtax is recorded in the period the income is earned, and the reduction in the surtax liability is recognized in the period the distribution to stockholders or the setting aside of legal reserve is finalized in the following year.

 

The components of the income tax expense are:

        
  

Three months ended

March 31,

 
   2025   2024 
   (Unaudited)   (Audited) 
   $   $ 
Current       124,146 
Total income tax expense       124,146 

 

The reconciliation of income taxes expenses computed at the Taiwan statutory tax rate (2022: at PRC statutory rate) applicable to income tax expense is as follows:

        
  

Three months ended

March 31,

 
   2025   2024 
   (Unaudited)   (Audited) 
Taiwan (2021-PRC) income tax statutory rate   20.00%    20.00% 
Tax effect of non-deductible expenses   (14.51%)   (11.84%)
Tax effect of stock-based compensation   %    (0.6%)
Tax effect of non-taxable income   (1.60%)   % 
Impact of different tax rates in other jurisdictions   %    (0.02%)
Others   (3.89%)   (1.7%)
Changes in valuation allowance   %    (%)
Effective tax rate       (6.1%)

 

 

 

 

 22 

 

 

The valuation allowance as of March 31, 2025 and December 31, 2024 was primarily provided for the deferred income tax assets if it is more likely than not that these items will expire before the Company is able to realize its benefits, or that the future deductibility is uncertain. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible or utilizable. Management considers projected future taxable income and tax planning strategies in making this assessment. The movement for the valuation allowance is as following:

        
  

March 31,

2025

  

December 31,

2024

 
   (Unaudited)   (Audited) 
   $   $ 
Balance at beginning of the period or year, as applicable   95,844    95,844 
Additions of valuation         
Reductions of valuation         
Balance at the end of the period or year, as applicable   95,844    95,844 

 

PRC Withholding Tax on Dividends

 

The current PRC Enterprise Income Tax Law imposes a 10% withholding income tax for dividends distributed by foreign-invested enterprises to their immediate holding companies outside the PRC. A lower withholding tax rate will be applied if there is a tax treaty arrangement between the PRC and the jurisdiction of the foreign holding company. Distributions to holding companies in Hong Kong that satisfy certain requirements specified by PRC tax authorities, for example, will be subject to a 5% withholding tax rate.

 

As of December 31, 2021, the Company had not recorded any withholding tax on the retained earnings of its foreign-invested enterprises in the PRC, since the Company intended to reinvest its earnings to potentially continue its business in mainland China, namely the manufacturing of the RASs through GZ GST, and its foreign-invested enterprises do not intend to declare dividends to their immediate foreign holding companies.

 

As of March 31, 2022, the Company had not recorded any withholding tax on the retained earnings of its foreign-invested enterprises in the PRC, and the Company decided not to reinvest its earnings since it is not continuing its business in mainland China, and its foreign-invested enterprises do not intend to declare dividends to their immediate foreign holding companies.

 

 

 

 

 

 23 

 

 

Note 15     RELATED PARTY BALANCES AND TRANSACTIONS

 

Due to related parties

 

The balance due to related parties was as following:

           
    March 31,
2025
    December 31,
2024
 
    $     $  
Mountain Share Transfer, LLC (1)     7,681       7,681  
Estate of Mr. Yin-Chieh Cheng (2)     19,435       19,435  
Feng-Hua Chen (3)     11,402        
      38,518       27,116  

___________________ 

Note:

 

(1) Mountain Share Transfer, LLC is company 100% controlled by Erik S. Nelson, the previous corporate secretary and director of the Company. The balances represented the amount paid on behalf of the Company for its daily operation purpose.
   
(2) The amount due to Mr. Yin-Chieh Cheng relates to a prior arrangement. Mr. Yin-Chieh Cheng was vacant as of July 8, 2023, and the Company is evaluating settlement with the estate.
   
(3) Feng-Hua Chen is the Chief Operating Officer of the company, the balances represented the amount paid on behalf of the Company for its daily operation purpose.

 

As of March 31, 2025, the Company had outstanding balances with related parties that are non-trade in nature, unsecured, non-interest bearing, and repayable on demand. These balances arose in the ordinary course of operations.

 

During the period, the Company received a financial communication from the estate of the former Chief Executive Officer and Chair of the Board, Lu Min-Huay Cheng, which is considered a related party due to the former executive’s prior leadership position and significant ownership interest. The nature of the transaction involves the repayment of loans, debt, and other liabilities owed to the estate. While the agreement does not specify individual dollar amounts, the Company has agreed to settle these obligations over a 12-month period beginning January 25, 2025. As of the reporting date, management continues to evaluate the terms and monitor the settlement process. 

 

Note 16    COMMON STOCK

 

The Company’s authorized number of common stock is 200,000,000 shares with par value of $0.001 each. On August 11, 2022, the Company effected a 2:3 reverse stock split for each share of common stock issued and outstanding. As a result of reverse stock split, the Company’s common stock issued and outstanding decreased from 10,707,150 shares to 7,138,587 shares. All shares and associated amounts have been retroactively restated to reflect the stock split on August 11, 2022. As of March 31, 2025 and December 31, 2024, issued common stock were 14,247,539 shares and 14,047,539, respectively.

 

On August 11, 2022, the Company’s common stock commenced trading on The Nasdaq Capital Market under the symbol “NCRA” on a post-reverse stock split basis. During the public offering, 1,880,000 common stocks, at par value $0.001 each, were issued at the offering price $3.5 each. The Company received total gross proceeds of $6.58 million from the public offering and after deducting the underwriting commissions, discounts and offering expenses, the Company received net proceeds of approximately $5.3 million.

 

 

 

 24 

 

 

All number of shares, share amounts and per share data presented in the accompanying unaudited consolidated financial statements and related notes have been retroactively restated to reflect the reverse merger transaction and subsequent issuance of shares stated above, except for authorized shares of common stock, which were not affected.

 

Issuance of Common Stock

 

  · On February 20, 2024, we entered into VIE Agreement with Xinca and issued 1,800,000 shares of our common stock in exchange of 100% controlling of Xinca;
     
  · On April 14, 2024, we entered into an Equity Purchase Agreement with SY Culture and issued 600,000 shares of our common stock in exchange of 100% equity of SY Culture.
     
  · On February 7, 2025, our shareholder exercised 150,000 shares of Warrant Class A in exchange of 100,000 shares of common stock.
     
  · On February 12, 2025, our shareholder exercised 150,000 shares of Warrant Class A in exchange of 100,000 shares of common stock.

  

Note 17      SHARE-BASED COMPENSATION

 

On December 27, 2018, Nocera granted Mr. Yin-Chieh Cheng quarterly option awards of 250,000 Series “A” Warrants for 20 quarters (5 years) for a total of 5,000,000 Series “A” Warrants with exercise price of $0.50 per share, subject to continued employment for services as Chairman of the Board and a Director.

 

On June 1, 2020, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu 50,000 shares of Class A warrants and 60,000 shares of Class A warrants separately, each with exercise price of $0.50 per share, for serving as the Company’s Chief Financial Officer and Chief Operating Officer. The Company also granted 2 employees 50,000 shares of Class A warrants with exercise price of $0.50 per share. The Class A warrants consist of the right to purchase one share for $0.50 per share from the date of issuance until April 23, 2026.

 

On June 1, 2020, Nocera granted Mr. Michael A. Littman 50,000 shares of Class A warrants with exercise price of $0.50 per share and 50,000 shares of Class B warrants with exercise price of $1.00 per share. Mr. Littman exercised 50,000 shares of Class A warrants and 50,000 shares of Class B warrants on August 11, 2021. The Class B warrants consist of the right to purchase one share for $1.00 per share separately from the date of issuance until April 23, 2026.

 

On December 1, 2021, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu 75,000 shares of Class A warrants and 60,000 shares of Class A warrants separately, each with exercise price of $0.50 per share, for serving as the Company’s Chief Financial Officer and Chief Operating Officer. The Company also granted 2 employees 70,000 shares of Class A warrant with exercise price of $0.50 per share.

 

On December 31, 2021, the Company issued an aggregate of 505,000 shares of common stock to Mr. Shun-Chih Chuang and a total of five consultants in consideration for services rendered.

 

On December 22, 2022, the Company issued 150,000 and 75,000 shares of common stock to Chen-Chun Chung and TraDigital respectively in consideration for services rendered.

 

 

 

 

 25 

 

 

On March 22, 2023, the Company issued 450,000 shares of our common stock to our investor relation company, Hanover One International, Inc.

 

On October 11, 2023, the Company issued 20,000 shares of our common stock to our consultant, Yu-Hao Chang.

 

On December 5, 2023, the Company issued 60,000 shares of our common stock to our Chief Executive Officer, Andy Chin-An Jin.

 

On August 26, 2024, the Company issued 180,000 shares of our common stock to our Chief Executive Officer, Andy Chin-An Jin.

 

The estimated fair value of share-based compensation for employees is recognized as a charge against income on a ratable basis over the requisite service period, which is generally the vesting period of the award. The fair value of stock option grant was estimated on the date of grant using the Black-Scholes option pricing model under the following assumptions:

           
    March 31,
2025
    March 31,
2024
 
             
Dividend yield     N/A       N/A  
Risk-free interest rate     4.2%       1.16%  
Expected term (in years)     2.74       4.31  
Volatility     36.25%       48.15%  

  

The Company estimated the grant date fair value of time-based stock option awards using the Black-Scholes option valuation model, which requires assumptions involving an estimate of the fair value of the underlying common stock on the date of grant, the expected term of the options, volatility, discount rate and dividend yield. The Company calculated expected option terms based on the “simplified” method for “plain vanilla” options due to the limited exercise information. The “simplified method” calculates the expected term as the average of the vesting term and the original contractual term of the options. The Company calculated volatility using the average adjusted volatility of quick company’s feature of Capital IQ for a period of time reflective of the expected option term, while the discount rate was estimated using the interest rate for a treasury note with the same contractual term as the options granted. Dividend yield is estimated at our current dividend rate, which adjustments for any known future changes in the rate.

 

For the years ended December 31, 2024, $60,831 share-based compensation expenses were recognized into additional paid-in capital of the Company, respectively.

  

Note 18     PREFERRED STOCK

 

In August 2021, the Company issued 80,000 preferred shares, par value $0.001 per share, at an issue price of $2.50 per share to certain investors credited as fully paid. The preferred shares are non-voting and non-redeemable. The holder of the preferred shares will have priority over the holders of the common stock of the Company on the assets and funds of the Company available for distribution in a distribution of assets on liquidation, winding up or dissolution of the Company. The holder of the preferred shares shall not have the right to attend or vote at any general meeting of the Company (except a general meeting for winding up of the Company or a resolution is to be proposed which if passed would vary or abrogate the rights or privileges of such holder).

 

On August 11, 2022, the Company effected a 2:3 reverse stock split for each share of common stock issued and outstanding. As a result of reverse stock split, the shares of common stock issuable upon the conversion of Series A Preferred Stock decreased from 80,000 shares to 53,334 shares.

 

 

 

 26 

 

 

Note 19     (LOSS) INCOME PER SHARE

 

The following table sets forth the computation of basic and diluted income (loss) per common share for the quarters ended March 31, 2025 and 2024.

        
  

For three months ended

March 31,

 
   2025   2024 
   (Unaudited)   (Unaudited) 
   $   $ 
Numerator:          
Net loss income attributable to the Company   (248,017)   (288,576)
           
Denominator:          
Weighted-average shares outstanding          
- Basic   14,159,761    11,956,987 
- Diluted   14,159,761    11,956,987 
           
Loss per share:          
- Basic   (0.0175)   (0.0241)
- Diluted   (0.0175)   (0.0241)

 

Note 20     COMMITMENTS AND CONTINGENCIES

 

Lease Commitment

 

The Company has entered into operating lease agreement for certain office and accommodation as well as fish farming containers for research and develop advanced technology for water circulation applying in fishery. Future minimum lease payments under non-cancellable operating leases with initial terms within one year.

 

The total future minimum lease payments under non-cancellable short-term leases as of March 31, 2025 are payable as follows:

     
   Lease Commitment 
   $ 
Within 1 year   1,827 
Total   1,827 

 

 

 

 

 27 

 

 

Note 21     SEGMENT REPORTING

 

Effective as of January 1, 2024, the Company adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The Company’s Chief Operating Decision Maker (“CODM”) is its Executive Director, Song-Yuan Teng, who is responsible for reviewing the results of operations and allocating resources across the Company’s reportable segments, including Fish Trading and Catering Services. These operating segments reflect the manner in which the CODM allocates resources and evaluates performance.

 

These segments align with how management evaluates performance and allocates resources. Segment performance is evaluated based on segment revenue and operating profit, which includes direct costs and segment-specific general and administrative expenses and tax, but excludes corporate overhead and interest.

 

The summary of key information by segments for the three months ended March 31, 2025 and 2024 was as follows:

 

For three months ended March 31, 2025

 

Schedule of segment information  Sales of Fish Trading   Sales of
Catering
   E-Commerce   Total 
                 
Revenue  $4,474,206   $2,089   $57,833   $4,534,128 
Cost of revenue  $4,465,209   $1,567   $16,402   $4,483,178 
Gross profit  $8,997   $522   $41,431   $50,950 
General and administrative expenses  $(60,323)  $(195,407)  $(78,641)  $(334,371)
Segment operating losses  $(51,326)  $(194,885)  $(37,210)  $(283,421)
Income tax expenses  $   $   $   $ 
Segment losses  $(51,326)  $(194,885)  $(37,210)  $(283,421)

 

For three months ended March 31, 2024

 

   Sales of Fish Trading   Sales of
Catering
   E-Commerce   Total 
                 
Revenue  $4,764,517   $86,373   $48,990   $4,899,880 
Cost of revenue  $4,754,614   $43,989   $17,316   $4,815,919 
Gross profit  $9,903   $42,384   $31,674   $83,961 
General and administrative expenses  $(27,955)  $(166,429)  $(257,080)  $(451,464)
Segment operating losses  $(18,052)  $(124,045)  $(225,406)  $(367,503)
Income tax expenses  $(124,146)  $   $   $(124,146)
Segment losses  $(142,198)  $(124,045)  $(225,406)  $(491,649)

 

 

 

 

 28 

 

 

The following tables set forth a summary of single customers who represent 10% or more of the Company’s segments revenue, net:

 

  Fish Trading 
   March 31, 2025   March 31, 2024 
           
Percentage of fish trading revenue          
Customer A   21.47%    37.45% 
Customer B   24.25%     
Customer C   18.42%     
Customer D   20.50%    10.01% 
Customer E       18.21% 
Customer F       15.35% 
    84.65%    81.01% 

 

   Catering 
   March 31, 2025   March 31, 2024 
         
Percentage of catering revenue          
Customer G   83.99%     
    83.99%     

  

Note 22      SUBSEQUENT EVENT

 

The Company has evaluated subsequent events through the issuance of the unaudited condensed consolidated financial statements and there are no subsequent events that would have required adjustment or disclosure in the consolidated financial statements.

 

 

 

 

 29 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q. Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in United States of America (“U.S. GAAP”).   In addition, our unaudited consolidated financial statements and the financial data included in this Quarterly Report on Form 10-Q reflect our reorganization and have been prepared as if our current corporate structure had been in place throughout the relevant periods. Actual results could differ materially from those projected in the forward-looking statements. For additional information regarding these and other risks and uncertainties, please see the items listed under the section captioned “Cautionary Statement Regarding Forward-Looking Statements” herein and the section captioned “Risk Factors” as well as any other cautionary language contained in our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 31, 2024. Except as may be required by law, we undertake no obligation to update any forward-looking statement to reflect events after the date of this Quarterly Report on Form 10-Q.

 

Operations Overview

 

As of December 31, 2019, we provide land-based recirculation aquaculture systems (“RASs”) for fish farming. Our primary business operations consist of the design, development and production of RASs large scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services. Through our branch office, we also procure and sell eel in Taiwan. In addition, as of December 2023. we sell food items, including our signature seafood porridge bowl, through our flagship bento box store located at the Ning Xia Night Market in the Datong District of Taipei City, Taiwan.

  

In October 2020, the government of Taiwan began supporting the Green Power and Solar Sharing Fish Farms initiative. In view of the opportunities resulting from this initiative, in October 2020, Nocera ceased all of its operations in China and moved all of its technology and back-office operations to Taiwan. We now only operate out of Taiwan.

 

Our current mission is to provide consulting services and solutions in aquaculture projects to reduce water pollution and decrease the disease problems of fisheries. Our goal is to become a global leader in the land-based aquaculture business. We are now poised to grow our existing operations in Taiwan and expand into the development and management of land-based fish farms in Taiwan and North and South America. We do not currently have any intentions of conducting operations in China or Hong Kong.

 

Effective December 31, 2020, we entered into a series of contractual agreements with Xin Feng Construction Co., Ltd., a funded limited liability company registered in Taiwan (R.O.C.), whereby we agreed to provide technical consulting and related services to XFC. On November 30, 2022, we entered into a Purchase of Business Agreement with Han-Chieh Shih, in which we sold our controlling interest of XFC, to the Purchaser for a total purchase cash price of $300,000. The closing of the XFC Sale occurred on November 30, 2022 and the XFC VIE agreements were terminated in connection with the XFC Sale. As of the filing date of this Annual Report on Form 10-K, we have no intention of providing services to construct indoor RASs and solar sharing fish farms in Taiwan.

 

As of September 30, 2021, we launched our first RAS demo site in Taiwan and engaged the demo site into the testing phase to raise eel. Currently, we are promoting our RASs in Taiwan and looking for opportunities to cooperate with local solar energy industry and to expand our business into the U.S. We believe the U.S. is a potentially lucrative market to penetrate.

 

 

 

 

 30 

 

 

On September 7, 2022, we entered into a series of contractual agreements with the majority stockholder of Meixin Institutional Food Development Co., Ltd., a Taiwan corporation and a food processing and catering company, and Meixin, of which we purchased 80% controlling interest of Meixin for $4,300,000. The Meixin VIE Agreements essentially confer control and management of Meixin as well as substantially all of the economic benefits of the Selling Stockholder in Meixin to us. As a result, we have been determined to be the primary beneficiary of Meixin and Meixin became our VIE.

 

On June 1, 2023, Gui Zhou Grand Smooth Technology Ltd. (“GZ GST”), one of our wholly owned subsidiaries, entered into that certain Share Purchase Agreement dated as of June 1, 2023, as amended, with Zhe Jiang Xin Shui Hu Digital Information, Ltd. (“Zhe Jiang”), pursuant to which GZ GST acquired all of the issued and outstanding equity securities of Zhe Jiang from the stockholders of Zhe Jiang (the “Zhe Jiang Acquisition”) in exchange for the issuance of 1,500,000 shares of our common stock, par value $0.001 per share. During the initial transaction process and our performing due diligence for the closing, we observed that time constraints have led to certain complexities and challenges in consummating the Acquisition within the originally planned timeframe. We are actively working with Zhe Jiang to resolve such complexities and challenges and will file a Current Report on Form 8-K if and when the Zhe Jiang Acquisition is consummated.

 

We employ a sales and marketing strategy targeting Taiwan government-supported solar fish farms. We are planning on expanding our sales and marketing model through the use of online marketing, data intelligence, and the establishment of a distributor network. The online marketing and data intelligence is designed to generate sales leads internationally outside of Taiwan that can be directed to our sales department for further follow-up.

 

We plan to sell and develop fish farms in Taiwan, the U.S. and Brazil. We expect to sell over five thousand tanks in the next five years. Our production facility is to be established in Taiwan, and we plan to sell the systems into the Americas and European countries as well.

 

We also intend to expend the fish farming demo sites in Taiwan by adding 20 units of RAS eel farming equipment with outsourcing construction services and build the catfish farm in the U.S. by the end of 2024 to promote our fish farming systems to the global market. We are expecting more customers from various countries actively inquiring about our equipment. As of February 16, 2023, we completed the acquisition of 229 acres of land in Montgomery County, Alabama, of which we intend to build RASs on that land for fish farming. We plan to enhance market penetration through the establishment of our own fish farms and diversify revenue streams through various sales channels.

 

In 2024, we initiated the e-commerce business in China, utilizing platforms like Douyin to expand our retail reach, utilizing interactive content and livestream shopping to drive engagement and sales. By integrating social commerce with our seafood resources, we enhance pricing advantages and optimize margins, strengthening our position in the evolving retail landscape.

 

 

 

 

 

 31 

 

 

Business Developments

 

The following highlights recent material developments in our business:

 

  · On September 8, 2022, we entered into a Real Estate Purchase Agreement with an unaffiliated third party pursuant to which we agreed to purchase 229 contiguous acres of land located in Montgomery County, Alabama (the “Land Acquisition”). We paid an earnest deposit of $20,000 on the land with the balance of $857,870 payable at closing. We borrowed $650,000 to fund the purchase price. The Land Acquisition closed on February 16, 2024. We intend to build RASs on the land for fish farming. The property includes a house, a manufactured home and a building site with sewer and power which we intend to develop into an office and dormitory for our future employees.

 

Key Factors Affecting our Performance

 

As a result of a number of factors, our historical results of operations may not be comparable to our results of operations in future periods, and our results of operations may not be directly comparable from period to period. Set forth below is a brief discussion of the key factors impacting our results of operations.

 

Known Trends and Uncertainties

 

Inflation

 

Prices of certain commodity products, including raw materials, are historically volatile and are subject to fluctuations arising from changes in domestic and international supply and demand, labor costs, competition, market speculation, government regulations, trade restrictions and tariffs. Increasing prices in the component materials for our goods may impact the availability, the quality and the price of our products, as suppliers search for alternatives to existing materials and increase the prices they charge. Our suppliers may also fail to provide consistent quality of product as they may substitute lower cost materials to maintain pricing levels. Nocera’s cost base also reflects significant elements for freight, including fuel, which has significantly increased due to the effects of the coronavirus (COVID-19) pandemic and Russia’s illegal military invasion of Ukraine. Rapid and significant changes in commodity prices such as fuel and plastic may negatively affect our profit margins if Nocera is unable to mitigate any inflationary increases through various customer pricing actions and cost reduction initiatives.

 

Geopolitical Conditions

 

Our operations could be disrupted by geopolitical conditions, trade disputes, international boycotts and sanctions, political and social instability, acts of war, terrorist activity or other similar events. From time to time, we could have a large revenue stream associated with a particular customer or a large number of customers located in a particular geographic region. Decreased demand from a discrete event impacting a specific customer, industry, or region in which we have a concentrated exposure could negatively impact our results of operations.

 

In February 2022, Russia initiated significant military action against Ukraine. In response, the U.S. and certain other countries imposed significant sanctions and export controls against Russia, Belarus and certain individuals and entities connected to Russian or Belarusian political, business, and financial organizations, and the U.S. and certain other countries could impose further sanctions, trade restrictions, and other retaliatory actions should the conflict continue or worsen. It is not possible to predict the broader consequences of the conflict, including related geopolitical tensions, and the measures and retaliatory actions taken by the U.S. and other countries in respect thereof as well as any counter measures or retaliatory actions by Russia or Belarus in response, including, for example, potential cyberattacks or the disruption of energy exports, is likely to cause regional instability, geopolitical shifts, and could materially adversely affect global trade, currency exchange rates, regional economies and the global economy. The situation remains uncertain, and while it is difficult to predict the impact of any of the foregoing, the conflict and actions taken in response to the conflict could increase our costs, reduce our sales and earnings, impair our ability to raise additional capital when needed on acceptable terms, if at all, or otherwise adversely affect our business, financial condition, and results of operations.

 

 

 

 32 

 

 

Foreign Currency

 

Our reporting currency is the U.S. dollar and our operations in Taiwan use their local currency as their functional currencies. Substantially all of our revenue and expenses are in NT dollars. We are subject to the effects of exchange rate fluctuations with respect to any of such currency. For example, the value of the NT dollar depends to a large extent on Taiwan government policies and Taiwan’s domestic and international economic and political developments, as well as supply and demand in the local market.

 

The income statements of our operations are translated into U.S. dollars at the average exchange rates in each applicable period. To the extent the U.S. dollar strengthens against foreign currencies, the translation of these foreign currencies denominated transactions results in reduced revenue, operating expenses and net income for our international operations. We are also exposed to foreign exchange rate fluctuations as we convert the financial statements of our foreign subsidiaries into U.S. dollars in consolidation.

  

Critical Accounting Policies, Estimates and Assumptions

 

We prepare our financial statements in conformity with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the financial reporting period. We continually evaluate these estimates and assumptions based on the most recently available information, our own historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Since the use of estimates is an integral component of the financial reporting process, actual results could differ from those estimates. Some of our accounting policies require higher degrees of judgment than others in their application. We consider the policies discussed below to be critical to an understanding of our financial statements.

 

The SEC defines critical accounting policies as those that are, in management’s view, most important to the portrayal of our financial condition and results of operations and those that require significant judgments and estimates.

 

The accounting principles we utilized in preparing our consolidated financial statements conform in all material respects to GAAP.

 

Reclassification

 

Certain prior period amounts have been reclassified to conform with current year presentation.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the allowance for doubtful receivables; the useful lives of property and equipment and intangible assets; impairment of long-lived assets; recoverability of the carrying amount of inventory; fair value of financial instruments; provisional amounts based on reasonable estimates for certain income tax effects of the Tax Cuts and Jobs Act (the “Tax Act”) and the assessment of deferred tax assets or liabilities. These estimates are often based on complex judgments and assumptions that management believes to be reasonable but are inherently uncertain and unpredictable. Actual results could differ from these estimates.

 

 

 

 33 

 

 

Financial Assets

 

The classification of financial assets depends on the nature and purpose of the financial assets and is determined at the time of initial recognition. Regular way purchases or sales of financial assets are recognized and derecognized on a trade date or settlement date basis for which financial assets were classified in the same way, respectively. Regular way purchases or sales are purchases or sales of financial assets that require delivery of assets within the time frame established by regulation or convention in the marketplace.

 

a)Category of financial assets and measurement

 

Financial assets are classified into the following categories: financial assets at FVTPL, investments in debt instruments and equity instruments at FVTOCI, and financial assets at amortized cost.

 

  1) Financial asset at FVTPL
     
    For certain financial assets which include debt instruments that do not meet the criteria of amortized cost or FVTOCI, it is mandatorily required to measure them at FVTPL. Any gain or loss arising from remeasurement is recognized in profit or loss. The net gain or loss recognized in profit or loss incorporates any interest earned on the financial asset.

 

  2) Investments in debt instruments at FVTOCI
     
   

Debt instruments with contractual terms specifying that cash flows are solely payments of principal and interest on the principal amount outstanding, together with objective of collecting contractual cash flows and selling the financial assets, are measured at FVTOCI.

 

Interest income calculated using the effective interest method, foreign exchange gains and losses and impairment gains or losses on investments in debt instruments at FVTOCI are recognized in profit or loss. Other changes in the carrying amount of these debt instruments are recognized in other comprehensive income and will be reclassified to profit or loss when these debt instruments are disposed.

 

  3) Investments in equity instruments at FVTOCI
     
   

On initial recognition, the Company may irrevocably designate investments in equity investments that is not held for trading as at FVTOCI.

 

Investments in equity instruments at FVTOCI are subsequently measured at fair value with gains and losses arising from changes in fair value recognized in other comprehensive income and accumulated in other equity.

 

Dividends on these investments in equity instruments at FVTOCI are recognized in profit or loss when the Company’s right to receive the dividends is established, unless the Company’s rights clearly represent a recovery of part of the cost of the investment.

 

 

 

 

 34 

 

 

  4) Measured at amortized cost
     
   

Cash and cash equivalents, commercial paper, debt instrument investments, notes and accounts receivable (including related parties), other receivables, refundable deposits and temporary payments (including those classified under other current assets and other noncurrent assets) are measured at amortized cost.

 

Debt instruments with contractual terms specifying that cash flows are solely payments of principal and interest on the principal amount outstanding, together with objective of holding financial assets in order to collect contractual cash flows, are measured at amortized cost.

 

Subsequent to initial recognition, financial assets measured at amortized cost are measured at amortized cost, which equals to carrying amount determined by the effective interest method less any impairment loss.

 

b)Impairment of financial assets

 

At the end of each reporting period, a loss allowance for expected credit loss is recognized for financial assets at amortized cost (including accounts receivable) and for investments in debt instruments that are measured at FVTOCI.

 

The loss allowance for accounts receivable is measured at an amount equal to lifetime expected credit losses. For financial assets at amortized cost and investments in debt instruments that are measured at FVTOCI, when the credit risk on the financial instrument has not increased significantly since initial recognition, a loss allowance is recognized at an amount equal to expected credit loss resulting from possible default events of a financial instrument within 12 months after the reporting date. If, on the other hand, there has been a significant increase in credit risk since initial recognition, a loss allowance is recognized at an amount equal to expected credit loss resulting from all possible default events over the expected life of a financial instrument.

 

The Company recognizes an impairment loss in profit or loss for all financial instruments with a corresponding adjustment to their carrying amount through a loss allowance account, except for investments in debt instruments that are measured at FVTOCI, for which the loss allowance is recognized in other comprehensive income and does not reduce the carrying amount of the financial asset.

 

c)Derecognition of financial assets

 

The Company derecognizes a financial asset only when the contractual rights to the cash flows from the financial asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership of the financial asset to another entity.

 

On derecognition of a financial asset at amortized cost in its entirety, the difference between the asset’s carrying amount and the sum of the consideration received and receivable is recognized in profit or loss. On derecognition of an investment in a debt instrument at FVTOCI, the difference between the asset’s carrying amount and the sum of the consideration received and receivable and the cumulative gain or loss that had been recognized in other comprehensive income is recognized in profit or loss. However, on derecognition of an investment in an equity instrument at FVTOCI, the cumulative gain or loss that had been recognized in other comprehensive income is transferred directly to retained earnings, without recycling through profit or loss.

 

 

 

 

 35 

 

 

Fair Value Measurement

 

We apply ASC Topic 820, Fair Value Measurements and Disclosures which defines fair value, establishes a framework for measuring fair value and expands financial statement disclosure requirements for fair value measurements.

 

ASC Topic 820 defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) on the measurement date in an orderly transaction between market participants in the principal or most advantageous market for the asset or liability.

 

ASC Topic 820 specifies a hierarchy of valuation techniques, which is based on whether the inputs into the valuation technique are observable or unobservable. The hierarchy is as follows:

 

  · Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
     
  · Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
     
  · Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. Unobservable inputs are valuation technique inputs that reflect our own assumptions about the assumptions that market participants would use in pricing an asset or liability.

 

Our management is responsible for determining the assets acquired, liabilities assumed and intangibles identified as of the acquisition date and considered a number of factors including valuations from an independent appraiser.

 

When available, we use quoted market prices to determine the fair value of an asset or liability. If quoted market prices are not available, we measure fair value using valuation techniques that use, when possible, current market-based or independently sourced market parameters, such as interest rates and currency rates.

 

Cash and Cash Equivalents

 

Cash and cash equivalents include all cash on hand and cash in bank with no restrictions. The balance of cash as of March 31, 2025 and 2024 were $531,771 and $961,777, respectively.

 

Accounts Receivable, Net

 

Accounts receivable are stated at the original amount less an allowance for doubtful accounts, if any, based on a review of all outstanding amounts at period end. An allowance is also made when there is objective evidence that we will not be able to collect all amounts due according to the original terms of the receivables. We analyze the aging of the customer accounts, coverage of credit insurance, customer concentrations, customer credit-worthiness, historical and current economic trends and changes in its customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.

 

 

 

 36 

 

 

Prepaid Expenses and Other Assets, Net

 

Prepaid expense and other assets, net consist of receivable from prepaid rent, etc. Management reviews its receivable balance each reporting period to determine if an allowance for doubtful accounts is required. An allowance for doubtful account is recorded in the period in which loss is determined to be probable based on an assessment of specific evidence indicating doubtful collection, historical experience, account balance aging, and prevailing economic conditions. Bad debts are written off against the allowance after all collection efforts have ceased.

 

Inventories

 

Inventories are stated at lower of cost or net realizable value. Cost is determined using the weighted average method. Inventories include raw materials, work in progress and finished goods. The variable production overhead is allocated to each unit of product on the basis of the actual use of the production facilities. The allocation of fixed production overhead to the costs of conversion is based on the normal capacity of the production facilities.

 

Where there is evidence that the utility of inventories, in their disposal in the ordinary course of business, will be less than cost, whether due to physical deterioration, obsolescence, changes in price levels, or other causes, the inventories are written down to net realizable value.

 

Property and Equipment, Net

 

Property and equipment are stated at cost less accumulated depreciation. Cost represents the purchase price of the asset and other costs incurred to bring the asset into its existing use. Maintenance, repairs, and betterments, including replacement of minor items, are charged to expense; major additions to physical properties are capitalized.

 

Depreciation of property and equipment is provided using the straight-line method over their estimated useful lives, which are shown as follows:

 

  Useful life
Land Indefinite, as per land titles
Equipment 3 years

 

Upon sale or disposal, the applicable amounts of asset cost and accumulated depreciation are removed from the accounts and the net amount less proceeds from disposal is charged or credited to income.

 

Land is classified as freehold and is not subject to depreciation. Freehold land represents ownership in perpetuity and, as such, is not considered a depreciable asset under applicable accounting standards.

 

Business Combination

 

For a business combination, the assets acquired, the liabilities assumed and any noncontrolling interest in the acquiree are recognized at the acquisition date and measured at their fair values as of that date. In a business combination achieved in stages, the identifiable assets and liabilities, as well as the noncontrolling interest in the acquiree, are recognized at the full amounts of their fair values. In a bargain purchase in which the total acquisition-date fair value of the identifiable net assets acquired exceeds the fair value of the consideration transferred plus any noncontrolling interest in the acquiree, that excess in earnings is recognized as a gain attributable to the acquirer.

 

Deferred tax liability and assets are recognized for the deferred tax consequences of differences between the tax bases and the recognized values of assets acquired and liabilities assumed in a business combination in accordance with Accounting Standards Codification (“ASC”) Topic 740-10.

 

 

 

 37 

 

 

Variable Interest Entity

 

A variable interest entity (“VIE”) is an entity (investee) in which the investor has obtained a controlling interest even if it has less than a majority of voting rights, according to the Financial Accounting Standards Board (FASB). A VIE is subject to consolidation if a VIE meets one of the following three criteria as elaborated in ASC Topic 810-10, Consolidation:

 

  (a) equity-at-risk is not sufficient to support the entity’s activities;

 

  (b) as a group, the equity-at-risk holders cannot control the entity; or

 

  (c) the economics do not coincide with the voting interest.

 

If a firm is the primary beneficiary of a VIE, the holdings must be disclosed on the balance sheet. The primary beneficiary is defined as the person or company with the majority of variable interests. A corporation formed, owned, and operated by two or more businesses (ventures) as a separate and discrete business or project (venture) for their mutual benefit is defined as a joint venture.

 

Goodwill and Intangible Assets

 

We recognize goodwill in accordance with ASC 350, Intangibles—Goodwill and Other. Goodwill is the excess of cost of an acquired entity over the amounts assigned to assets acquired and liabilities assumed in a business combination. Goodwill is not amortized. Goodwill is tested for impairment annually as of October 1st of each year, and is tested for impairment between annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment charge for goodwill is recognized only when the estimated fair value of a reporting unit, including goodwill, is less than its carrying amount.

 

We recognize intangible assets in accordance with ASC 350, Intangibles—Goodwill and Other. Acquired intangible assets subject to amortization are stated at cost and are amortized using the straight-line method over the estimated useful lives of the assets. Intangible assets that are subject to amortization are reviewed for potential impairment whenever events or circumstances indicate that carrying amounts may not be recoverable. Assets not subject to amortization are tested for impairment at least annually.

 

The estimates of fair value are based on the best information available as of the date of the assessment, which primarily incorporates management assumptions about expected future cash flows. Although these assets are not currently impaired, there can be no assurance that future impairments will not occur.

 

 

 

 

 

 

 38 

 

 

Share-Based Compensation

 

We determine our share-based compensation in accordance with ASC 718, Compensation—Stock Compensation (ASC 718), which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees based on the grant date fair value of the award.

 

Determining the appropriate fair value model and calculating the fair value of phantom award grants requires the input of subjective assumptions. We use the Black-Scholes pricing model to value our phantom awards. Share-based compensation expense is calculated using our best estimates, which involve inherent uncertainties and the application of management’s judgment. Significant estimates include our expected volatility. If different estimates and assumptions had been used, our phantom unit valuations could be significantly different and related share-based compensation expense may be materially impacted.

 

The Black-Scholes pricing model requires inputs such as the risk-free interest rate, expected term, expected volatility and expected dividend yield. We base the risk-free interest rate that we use in the Black-Scholes pricing model on zero coupon U.S. Treasury instruments with maturities similar to the expected term of the award being valued. The expected term of phantom awards is estimated from the vesting period of the award and represents the weighted average period that our phantom awards are expected to be outstanding. We estimated the volatility based on the historic volatility of our guideline companies, which we feel best represent our Company. We have never paid and do not anticipate paying any cash dividends in the foreseeable future and, therefore, we use an expected dividend yield of zero in the pricing model. We account for forfeitures as they occur.

 

In the opinion of management, all adjustments (which include normal recurring adjustments) necessary to present a fair presentation of our unaudited condensed consolidated financial position as of March 31, 2024, consolidated results of operations for the period ended March 31, 2024, cash flows for the year period ended March 31, 2024 and change in equity for the period ended March 31, 2024, as applicable, have been made.

 

Critical accounting policies are those that we consider the most critical to understanding our financial condition and results of operations.

 

Impairment of Long-lived Assets

 

We review our long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. When these events occur, we measure impairment by comparing the carrying value of the long-lived assets to the estimated undiscounted future cash flows expected to result from the use of the assets and their eventual disposition. If the sum of the expected undiscounted cash flow is less than the carrying amount of the assets, we would recognize an impairment loss, which is the excess of carrying amount over the fair value of the assets.

 

Commitments and Contingencies

 

In the normal course of business, we are subject to contingencies, including legal proceedings and claims arising out of our business that relate to a wide range of matters, such as government investigations and tax matters. We recognize a liability for such contingency if we determine it is probable that a loss has occurred and a reasonable estimate of the loss can be made. We may consider many factors in making these assessments including historical and the specific facts and circumstances of each matter.

 

 

 

 

 39 

 

 

Revenue Recognition

 

We have early adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606) and all subsequent ASUs that modified ASC 606 on January 1, 2017.

 

The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, we apply the following steps:

 

· Step 1: Identify the contract(s) with a customer
   
· Step 2: Identify the performance obligations in the contract
   
· Step 3: Determine the transaction price
   
· Step 4: Allocate the transaction price to the performance obligation in the contract
   
· Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation

 

The Company mainly offers and generates revenue from the fish trading business, bento box and fruit and vegetable processing business, and E-commerce live streaming business. Revenue recognition policies are discussed as follows:

 

Aquatic product trading revenue

 

The Company engages in the trading of fish, primarily eels. Revenue is generated when the Company receives customer orders specifying product types and requirements. Upon receiving an order, the Company arranges the harvesting of the eels, inspects the products to ensure compliance with the customer’s specifications, and coordinates delivery. Revenue is recognized at a point in time when control of the goods is transferred to the customer, typically upon delivery, which is the point at which the performance obligation is satisfied.

 

Bento box and produce processing revenue

 

The Company also operates a bento box and fresh produce processing business, primarily involving vegetables and fruits. The revenue recognition model for this segment is similar to the aquatic product trading business. Upon receiving customer orders, the Company processes and packages the required food or agricultural products, ensures product quality and conformity to order specifications, and arranges delivery. Revenue is recognized at a point in time, generally upon the transfer of the processed goods to the customer.

 

E-commerce live-streaming commission revenue

 

The Company acts as an agent in facilitating the sale of third-party products through live-streaming e-commerce platforms. The Company does not take control of the goods sold, and commission revenue is recognized on a net basis. Revenue is recognized at the point in time when the underlying product is sold and shipment is confirmed by the seller, which indicates the Company has fulfilled its performance obligation of facilitating the sale.

 

 

 

 40 

 

 

Cost of Sales

 

Cost of sales consists primarily of material costs, labor costs, depreciation, and related expenses, which are directly attributable to the production of the product. Write-down of inventories to lower of cost or net realizable value is also recorded in cost of sales.

 

Income Taxes

 

We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

  

Uncertain Tax Positions

 

We account for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. Interest and penalties related to uncertain tax positions are recognized and recorded as necessary in the provision for income taxes. According to the PRC Tax Administration and Collection Law, the statute of limitations is three years if the underpayment of taxes is due to computational errors made by the taxpayer or the withholding agent. The statute of limitations is extended to five years under special circumstances, where the underpayment of taxes is more than RMB 100,000. In the case of transfer pricing issues, the statute of limitation is ten years. There is no statute of limitation in the case of tax evasion. We record interest and penalties on uncertain tax provisions as income tax expense. There were no uncertain tax positions as of March 31, 2025 and 2024, and we have no accrued interest or penalties related to uncertain tax positions. We do not believe that the unrecognized tax benefits will change over the next twelve months.  

 

Comprehensive (Loss) Income

 

Comprehensive income or loss is comprised of the our net (loss) income and other comprehensive income or loss. The component of other comprehensive income or loss consists solely of foreign currency translation adjustments, net of the income tax effect.

 

Foreign Currency Translation and Transactions

 

Our reporting currency is the United States dollar (“US$”). The functional currency of our VIE in Taiwan is the New Taiwan dollar (“NT”), and the functional currency of our Hong Kong subsidiary is Hong Kong dollars (“HK$”). The functional currency of PRC companies is the Renminbi (“RMB”). In the consolidated financial statements, the financial information of our subsidiary and the consolidated VIE has been translated into US$. Assets and liabilities are translated at the exchange rates on the balance sheet date, equity amounts are translated at historical exchange rates, except for changes in accumulated deficit during the year which is the result of income statement translation process, and revenue, expense, gains or losses are translated using the average exchange rate during the year. Translation adjustments are reported as foreign currency translation adjustments and are shown as a separate component of other comprehensive income or loss in the consolidated statements of changes in equity and comprehensive (loss) income. The exchange rates for US$ to RMB as of March 31, 2025 and 2024 are 7.290018 and 7.289528, respectively. The annual average exchange rates for the three months ended March 31, 2025 and 2024 are 7.320036 and 7.232896, respectively.

 

(Loss) Earnings per Share

 

Basic (loss) earnings per share is computed by dividing net (loss) income attributable to holders of common stock by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.

 

 

 

 41 

 

 

Results of Operations

 

The following table sets forth our unaudited consolidated statements of operations for the three months ended March 31, 2025 and 2024.

 

Consolidated Statements of Operations

 

   Three months ended March 31, 
   2025   2024 
   (Unaudited)   (Unaudited) 
   $   $ 
Net sales   4,534,128    4,899,880 
Cost of sales   (4,483,178)   (4,815,919)
Gross profit   50,950    83,961 
           
Operating expenses          
General and administrative expenses   (334,371)   (451,464)
Total operating expenses   (334,371)   (451,464)
           
Loss from operations   (283,421)   (367,503)
           
Other income   25,804    195,573 
Loss before income taxes   (257,617)   (171,930)
           
Income tax expense       (124,146)
Net loss   (257,617)   (296,076)
           
Less: Net loss attributable to non-controlling interests   (9,600)   (7,500)
Net loss attributable to the Company   (248,017)   (288,576)
           
Comprehensive loss          
Net loss   (257,617)   (296,076)
Foreign currency translation (loss) gain   (2,838)   57,307 
Total comprehensive loss   (260,455)   (238,769)
           
Less: comprehensive loss attributable to non-controlling interest   (9,600)   (7,500)
Less: Foreign currency translation gain (loss) attributable to noncontrolling interest   (423)   1,878 
Comprehensive loss attributable to the Company   (250,432)   (233,147)
           
(Loss) income per share          
Basic   (0.0175)   (0.0241)
Diluted   (0.0175)   (0.0241)
           
Weighted average number of common shares outstanding          
Basic   14,159,761    11,956,987 
Diluted   14,159,761    11,956,987 

 

 

 42 

 

 

Revenue

 

Revenue of the Company for the three months ended March 31, 2025 was approximately $4.53 million compared to approximately $4.89 million for the comparable period in 2024. For the three months ended March 31, 2025, SY Culture and Xinca generated $17,486 and $40,347, respectively. The revenue for the three months ended March 31, 2025, was mostly decreased from Meixin catering business and the fish trading business from NTB with the revenue of $1.54 million and $2.93 million, respectively.

 

  · Fish Trading Business: For the three months ended March 31, 2025, the fish trading business decreased in volume, but the selling price increased, the volume decreased from 193 tons to 213 tons for the comparable period in 2024 and 2025. The average selling price of eels increased from $14.58 to $15.16 per kilogram for the comparable period in 2024 and 2025.
     
  · Catering Business: For the three months ended March 31, 2025, the fish, fruit and vegetable processing service and sales volume increased from 97,560 kilograms to 102,006 kilograms in volume with average prices increased from $14.85 to $15.10 per kilograms for the comparable period in 2024 and 2025.

 

For the three months ended March 31, 2025 and 2024, our foreign currency translation loss was $2,838 and foreign currency translation gain was $57,307 of sales and income, respectively.

 

Gross profit

 

Gross profit for the three months ended March 31, 2025 was $50,950, compared to $83,961 for the comparable period in 2024. The decrease was primarily due to the significant decrease in sales from Xinca and SY Media E-commerce for the three months ended March 31, 2025.

 

General and administrative expenses

 

General and administrative expenses were $334,371, for the three months ended March 31, 2025, compared to approximately $451,464 for the comparable period in 2024. This decrease was primarily due to the decrease of salary and commission expenses for the three months ended March 31, 2025 in connection with securities filings and other related matters.

 

Other income (expense)

 

Other income was $25,804 for the three months ended March 31, 2025, compared to $195,573 for the comparable period in 2024. The decrease in other income was mainly due to the recognition of a gain of $197,843 from the fair value remeasurement of warrant liabilities for the comparable period in 2024, while other losses of $8,426 were recognized for the three months ended March 31, 2025. 

 

Income tax expense

 

During the three months ended March 31, 2025, we recorded an income tax expense of $0 compared to income tax expense of $124,146 for the comparable period in 2024.

 

 

 

 43 

 

 

Net income attributable

 

Net loss attributable to us (excluding net loss attributable to non-controlling interest) for the three months ended March 31, 2025 was $248,017 compared to net loss attributable to us (excluding net loss attributable to non-controlling interest) of $288,576 for the comparable period in 2024. The decrease in loss was mainly due to a decrease in income tax expenses for the three months ended March 31, 2025.  

 

Segment Reporting

 

Effective as of January 1, 2024, the Company adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The Company’s Chief Operating Decision Maker (“CODM”) is its Executive Director, Song-Yuan Teng, who is responsible for reviewing the results of operations and allocating resources across the Company’s reportable segments, including Fish Trading and Catering Services. These operating segments reflect the manner in which the CODM allocates resources and evaluates performance.

 

These segments align with how management evaluates performance and allocates resources. Segment performance is evaluated based on segment revenue and operating profit, which includes direct costs and segment-specific general and administrative expenses and tax, but excludes corporate overhead and interest.

 

The summary of key information by segments for the three months ended March 31, 2025 and 2024 was as follows:

 

 For three months ended March 31, 2025

 

   Sales of Fish Trading   Sales of
Catering
   E-Commerce   Total 
                 
Revenue  $4,474,206   $2,089   $57,833   $4,534,128 
Cost of revenue  $4,465,209   $1,567   $16,402   $4,483,178 
Gross profit  $8,997   $522   $41,431   $50,950 
General and administrative expenses  $(60,323)  $(195,407)  $(78,641)  $(334,371)
Segment operating losses  $(51,326)  $(194,885)  $(37,210)  $(283,421)
Income tax expenses  $   $   $   $ 
Segment losses  $(51,326)  $(194,885)  $(37,210)  $(283,421)

 

For three months ended March 31, 2024

 

   Sales of Fish Trading   Sales of
Catering
   E-Commerce   Total 
                 
Revenue  $4,764,517   $86,373   $48,990   $4,899,880 
Cost of revenue  $4,754,614   $43,989   $17,316   $4,815,919 
Gross profit  $9,903   $42,384   $31,674   $83,961 
General and administrative expenses  $(27,955)  $(166,429)  $(257,080)  $(451,464)
Segment operating losses  $(18,052)  $(124,045)  $(225,406)  $(367,503)
Income tax expenses  $(124,146)  $   $   $(124,146)
Segment losses  $(142,198)  $(124,045)  $(225,406)  $(491,649)

 

 

 

 44 

 

 

The following tables set forth a summary of single customers who represent 10% or more of the Company’s segments revenue, net:

 

   Fish Trading 
   March 31, 2025   March 31, 2024 
           
Percentage of fish trading revenue          
Customer A   21.47%    37.45% 
Customer B   24.25%     
Customer C   18.42%     
Customer D   20.50%    10.01% 
Customer E       18.21% 
Customer F       15.35% 
    84.65%    81.01% 

 

   Catering 
   March 31, 2025   March 31, 2024 
         
Percentage of catering revenue          
Customer G   83.99%     
    83.99%     

 

Liquidity and Capital Resources

 

We had net cash used in operating activities for the year ended March 31, 2025 and the cash balance was approximately $0.53 million as of March 31, 2025. As of March 31, 2025, we had an accumulated deficit of $21,486,898, a net loss of $248,017, and net cash used in operating activities of $115,102. In their audit report for the fiscal year ended March 31, 2025 included in this report, our auditors have expressed their concern as to our ability to continue as a going concern.

 

We continue to control our cash expenses as a percentage of expected revenue on an annual basis and thus may use its cash balances in the short-term to invest in revenue growth. Management is focused on growing our existing product offering, as well as our customer base, to increase our revenues. Our ability to continue as a going concern is dependent upon our ability to generate cashflows from operations and obtain financing. We cannot give assurance that we can increase our cash balances or limit our cash consumption and thus maintain sufficient cash balances for our planned operations or future acquisitions. Future business demands may lead to cash utilization at levels greater than recently experienced. We may need to raise additional capital in the future. However, we cannot assure that we will be able to raise additional capital on acceptable terms, or at all. Subject to the foregoing, however, management believes that our current cash balances coupled with anticipated cash flow from operating activities will be sufficient to meet our working capital requirements for at least one year from the date of issuance of the accompanying consolidated financial statements.

 

To date, we have funded our operations through revenues, loans from our officers, and the issuance of equity securities. On January 25, 2025, we obtained a financial support letter from Ms. Min-Huay Cheng Lu, the estate of Mr. Yin-Chieh Cheng, our former President, Chief Executive Officer, Chairman of the Board and principal shareholder.

 

 

 

 

 45 

 

 

The Company anticipates that its primary source of liquidity over the next twelve months since December 31, 2024 will be capital raised through financing activities. We currently expect to raise approximately $40 million through a combination of equity issuance, a leveraged buyout transaction, and debt financing. These funds are intended to support our capital-intensive strategic initiatives, including business combinations and acquisitions aligned with our long-term growth strategy.

 

On the cash outflow side, we expect to utilize approximately $5.9 million to support operating activities over the next twelve months. This includes an estimated $5.0 million allocated to operating costs related to our fish business, $0.7 million for general and administrative expenses, and $0.2 million for marketing and promotional efforts associated with our e-commerce platform. In addition to operating needs, we plan to allocate approximately $30 million toward capital expenditures, primarily for business combination and acquisition transactions. These planned investments are considered critical to the Company’s growth objectives and are expected to be financed through the aforementioned capital raising efforts.

 

Management believes that the anticipated financing arrangements will provide sufficient liquidity to meet our obligations as they come due and to fund the Company’s ongoing and planned strategic initiatives over the next twelve months.

 

Financings

 

On August 15, 2022, we consummated a public offering of 1,880,000 units (the “Units”) for $3.50 per Unit pursuant to an effective registration statement on Form S-1, as amended (File No. 333-264059). Each Unit consisted of one share of common stock, par value $0.001 per share, and one warrant to purchase two shares of common stock (the “Warrants”) from the date of issuance until the fifth anniversary of the issuance date for $3.85 per share of common stock, subject to adjustment in the event of stock dividends, stock splits, stock combinations, reclassifications, reorganizations or similar events affecting the common stock. The shares of common stock and the Warrants comprising the Units were immediately separable and issued separately in the public offering. The exercise price of the Warrants will be decreased to the reset price, which means the greater of (i) 50% of the exercise price and (ii) 100% of the last volume weighted average price immediately preceding the 90th calendar day following the initial exercise date if, on the date that is 90 calendar days immediately following the initial exercise date, the exercise price is less than the reset price. We have not applied nor intend to apply to have the warrants listed on any exchange. The public offering closed on August 15, 2022, and we received total gross proceeds of $6.58 million. After deducting the underwriting commissions, discounts, and offering expenses, we received net proceeds of approximately $5.3 million.

 

In connection with the public offering and pursuant to the underwriting agreement between us and the underwriters named therein, we granted the underwriters a 45-day option to purchase up to 282,000 additional shares of common stock and warrants, equivalent to 15% of the Units sold in the public offering, at the public offering price per Unit, less underwriting discounts and commissions, to cover over-allotments, if any. On September 23, 2022, the underwriters exercised their option to purchase an additional 282,000 warrants from us for gross proceeds of $2,820. The warrants were issued to the underwriters on September 26, 2022.

 

 

 

 

 46 

 

 

The following table provides detailed information about our net cash flows for the periods indicated:

 

  

For the quarters ended

March 31,

 
   2025   2024 
   (Unaudited)   (Audited) 
   $   $ 
Net cash used in operating activities   (115,102)   (460,994)
Net cash provided by investing activities   213    201,863 
Net cash provided by (used in) financing activities   148,183    (60,678)
Effect of the exchange rate change on cash   14,316    52,006 
Increase (Decrease) in cash   47,610    (267,803)

 

Net cash used in operating activities

 

Net cash used in operating activities amounted to $115,102 for the three months ended March 31, 2025. This reflected a net loss of $257,617, depreciation of $33,674, prepaid expenses and other assets of $48,927, and other payables and accrued expenses of $30,905.

 

Net cash used in operating activities amounted to $460,994 for the three months ended March 31, 2024. This reflected a net loss of $296,076, the fair value remeasurement of warrant liabilities of $197,843, depreciation of $22,559 and share-based compensation of $14,999.

 

Net cash provided by investing activities

 

Net cash provided by investing activities was $213 for the three months ended March 31, 2025, which were primarily attributable to proceeds from financial assets in available-for-sale.

 

Net cash provided by investing activities was $201,863 for the three months ended March 31, 2024, which were primarily attributable to the cash inflow from acquisition of subsidiaries.

 

Net cash provided by (used in) financing activities

 

Net cash provided by financing activities amounted to $148,183 for the three months ended March 31, 2025, which was the issuance of common stock due to the exercise of warrants.

 

Net cash used in financing activities amounted to $60,678 for the three months ended March 31, 2024, which was repayment of bank loans.

 

Since we plan to build our land-based fish farming demo sites in the U.S., Taiwan, Brazil, Japan and Thailand to promote our fish farming systems to the global market, we expect that we will require additional capital, which includes construction costs, marketing costs, operation costs, etc., to meet our long-term operating requirements. We expect to obtain financing from shareholders or raise additional capital through, among other things, the sale of equity or debt securities. The shareholders are committed to provide additional financing required when we try to raise additional capital from third party investors or banks. However, there can be no assurance that we will be successful in raising this additional capital.

 

 

 

 47 

 

 

Business Combinations

 

We account for business acquisitions in accordance with ASC 805, Business Combinations. We measure the cost of an acquisition as the aggregate of the acquisition date fair values of the assets transferred and liabilities assumed and equity instruments issued. Transaction costs directly attributable to the acquisition are expensed as incurred. We record goodwill for the excess of (i) the total costs of acquisition, fair value of any non-controlling interests and acquisition date fair value of any previously held equity interest in the acquired business over (ii) the fair value of the identifiable net assets of the acquired business.

 

The acquisition method of accounting requires us to exercise judgment and make estimates and assumptions based on available information regarding the fair values of the elements of a business combination as of the date of acquisition, including the fair values of identifiable intangible assets, deferred tax asset valuation allowances, liabilities related to uncertain tax positions and contingencies. We must also refine these estimates over a one-year measurement period, to reflect any new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. If we are required to retroactively adjust provisional amounts that we have recorded for the fair value of assets and liabilities in connection with an acquisition, these adjustments could materially impact our results of operations and financial position. Estimates and assumptions that we must make in estimating the fair value of future acquired technology, user lists and other identifiable intangible assets include future cash flows that we expect to generate from the acquired assets. If the subsequent actual results and updated projections of the underlying business activity change compared with the assumptions and projections used to develop these values, we could record impairment charges. In addition, we have estimated the economic lives of certain acquired assets and these lives are used to calculate depreciation and amortization expense. If our estimates of the economic lives change, depreciation or amortization expenses could be accelerated or slowed, which could materially impact our results of operations.  

 

Recently Issued Accounting Pronouncements

 

Please refer to the Note 2 above.

 

 

 

 

 

 

 

 48 

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a “smaller reporting company,” as defined by Rule 12b-2 of the Exchange Act, we are not required to provide the information in this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, under the supervision of our Chief Executive Officer and Chief Financial Officer performed an evaluation (the “Evaluation”) of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide a reasonable level of assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2024, due to the presence of material weaknesses described below, our disclosure controls and procedures were ineffective.

 

The following material weaknesses in our disclosure controls and procedures at March 31, 2025 were:  

 

  · we do not have written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404;
     
  · there is insufficient monitoring and review controls over the financial reporting closing process, including the lack of individuals with current knowledge of GAAP; and
     
  · inadequate segregation of duties.
     
  · delays depositing cash proceeds from operations into bank accounts, instead storing significant amounts of cash in a physical safebox throughout the year, with deposits typically made only at year-end. This practice results in insufficient periodic verification and oversight of cash balances, increasing the risk of misappropriation or loss; and
     
  · infrequent or insufficient verification of the physical safe box used to store cash, which represents a weakness in the safeguarding of cash assets and the effectiveness of controls over cash management.

 

We believe that these material weaknesses primarily relate, in part, to our lack of sufficient staff with appropriate training in GAAP and SEC rules and regulations with respect to financial reporting functions, and the lack of robust accounting systems, as well as the lack of sufficient resources to hire such staff and implement these accounting systems.

 

 

 

 49 

 

 

We expect to remediate these material weaknesses in the second quarter of 2024. However, we may discover additional material weaknesses that may require additional time and resources to remediate. Our remediation process includes, but not limited to:

 

  · Investing in information technology systems to enhance our operational and financial reporting and internal controls.

 

  · Enhancing the organizational structure to support financial reporting processes and internal controls.

 

  · Providing guidance, education and training to employees relating to our accounting policies and procedures.

 

  · Further developing and documenting detailed policies and procedures regarding business processes for significant accounts, critical accounting policies and critical accounting estimates.

 

  · Establishing effective general controls over information technology systems to ensure that information produced can be relied upon by process level controls is relevant and reliable.

 

Notwithstanding the foregoing, there can be no assurance that our disclosure controls and procedures will detect or uncover all failures of persons within our Company and our consolidated subsidiaries to disclose material information otherwise required to be set forth in our periodic reports. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.

 

Changes in Internal Control Over Financial Reporting

 

During the quarter ended March 31, 2024, we took several actions to correct past material weaknesses, including, but not limited to, establishing an audit committee of our Board comprised of three independent directors, adding experienced accounting and financial personnel and retaining third-party consultants to review our internal controls and recommend improvements. However, we may need to take additional measures to fully mitigate these issues, and the measures we have taken, and expect to take, to improve our internal controls may not be sufficient to (1) address the issues identified, (2) ensure that our internal controls are effective or (3) ensure that the identified material weakness or other material weaknesses will not result in a material misstatement of our annual or interim financial statements.

 

 

 

 

 

 

 

 50 

 

 

PART II OTHER INFORMATION

 

 

ITEM 1. LEGAL PROCEEDINGS

 

We were not subject to any legal proceedings during the three months ended March 31, 2025 and there are currently no legal proceedings, to which we are a party, which could have a material adverse effect on our business, financial condition or operating results.

 

ITEM 1A. RISK FACTORS

 

There have been no material changes in our risk factors as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on May 6, 2025.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements

 

During the quarter ended March 31, 2025, no director or officer of the Company adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

Holding Foreign Companies Accountable Act

 

On December 2, 2021, the SEC adopted final amendments implementing the disclosure and submission requirements under the Holding Foreign Companies Accountable Act (the “HFCAA”), pursuant to which the Securities and Exchange Commission (“SEC”) will identify a “Commission-Identified Issuer” if an issuer has filed an annual report containing an audit report issued by a registered public accounting firm that the Public Company Accounting Oversight Board (the “PCAOB”) has determined it is unable to inspect or investigate completely because of a position taken by an authority in the foreign jurisdiction, and will then impose a trading prohibition on an issuer after it is identified as and remains a Commission-Identified Issuer for three consecutive years. On December 16, 2021, the PCAOB issued a report on its determinations that it is unable to inspect or investigate completely PCAOB-registered public accounting firms headquartered in mainland China and in Hong Kong, because of positions taken by one or more authorities in such jurisdictions. Since our auditor is located in Hong Kong, our auditor is included on a list of audit firms the PCAOB determined it is unable to inspect or investigate completely because of a position taken by one or more authorities in Hong Kong, and is therefore subject to the PCAOB’s determination. In May 2022, we were added to the SEC’s conclusive lists of issuers identified under the HFCAA, or a Commission-Identified Issuer. Therefore, we will be delisted and our securities will be prohibited from being traded “over-the-counter” if we remain identified as a Commission-Identified Issuer for three consecutive years. If our securities are unable to be listed on another securities exchange by then, such a delisting or prohibition of trading would have a negative impact on the price of our securities. The Accelerating Holding Foreign Companies Accountable Act (“AHFCAA”), passed by the U.S. Senate and if enacted, would require Commission-Identified Issuers to comply with the PCAOB audits within two consecutive years instead of three consecutive years. In light of the PRC government’s recent expansion of authority in Hong Kong, there are risks and uncertainties which we cannot foresee for the time being, and rules and regulations in China can change quickly with little or no advance notice.

 

 

 

 51 

 

 

ITEM 6. EXHIBITS

 

  (a) The following exhibits are filed herewith or incorporated by reference herein:

 

Exhibit
No.
  Description   Previously Filed and Incorporated by Reference Herein
31.1   Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer of Nocera, Inc.   *
31.2   Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer of Nocera, Inc.   *
32.1   Section 1350 Certification of the Chief Executive Officer of Nocera, Inc.   **
32.2   Section 1350 Certification of the Chief Financial Officer of Nocera, Inc.   **
101.INS   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)   *
101.SCH   Inline XBRL Taxonomy Extension Schema Document   *
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document   *
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document   *
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document   *
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document   *
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).  

___________________________

* Filed herewith.
** Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.

 

 

 

 

 

 

 

 

 

 

 

 

 52 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  NOCERA, INC.
     
Date: June 20, 2025 By: /s/ Andy Chin-An Jin                             
  Name: Andy Chin-An Jin
  Title: Chief Executive Officer
     
     
Date: June 20, 2025 By: /s/ Shun-Chih Chuang                            
  Name: Shun-Chih Chuang
  Title: Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 53 

EX-31.1 2 nocera_ex3101.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

I, Andy Chin-An Jin, Chief Executive Officer of Nocera, Inc. (the “Company”), certify that:

 

(1) I have reviewed this Quarterly Report on Form 10-Q/A for the fiscal period ended March 31, 2025;

 

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

(3) Based on my knowledge, the financial statements, and other financial information included in the report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods represented in this report;

 

(4) The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which the report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

 

(5) The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and to the audit committee of the board of directors (or persons fulfilling the equivalent function):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

 

June 20, 2025

 

/s/ Andy Chin-An Jin          

Andy Chin-An Jin

Chief Executive Officer

(Principal Executive Officer)

EX-31.2 3 nocera_ex3102.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

I, Shun-Chih Chuang, Chief Financial Officer of Nocera, Inc. (the “Company”), certify that:

 

(1) I have reviewed this Quarterly Report on Form 10-Q/A for the fiscal period ended March 31, 2025;

 

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

(3) Based on my knowledge, the financial statements, and other financial information included in the report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods represented in this report;

 

(4) The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which the report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

 

(5) The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and to the audit committee of the board of directors (or persons fulfilling the equivalent function):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

 

June 20, 2025

 

/s/ Shun-Chih Chuang                    

Shun-Chih Chuang

Chief Financial Officer

(Principal Financial Officer)

EX-32.1 4 nocera_ex3201.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Quarterly Report on Form 10-Q/A of Nocera, Inc. (the “Company”) for the period ended March 31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Yin-Chieh Cheng, Chief Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)        The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)        The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Andy Chin-An Jin          

Andy Chin-An Jin

Chief Executive Officer

(Principal Executive Officer)

 

June 20, 2025

EX-32.2 5 nocera_ex3202.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Quarterly Report on Form 10-Q/A of Nocera, Inc. (the “Company”) for the period ended March 31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Shun-Chih Chuang, Chief Financial Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)        The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)        The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Shun-Chih Chuang                    

Shun-Chih Chuang

Chief Financial Officer

(Principal Financial Officer)

 

June 20, 2025

EX-101.SCH 6 ncra-20250331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 999007 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION link:presentationLink link:calculationLink link:definitionLink 999008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY link:presentationLink link:calculationLink link:definitionLink 999009 - Disclosure - ACCOUNTS RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 999010 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 999011 - Disclosure - ADVANCE TO SUPPLIERS link:presentationLink link:calculationLink link:definitionLink 999012 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET link:presentationLink link:calculationLink link:definitionLink 999013 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS link:presentationLink link:calculationLink link:definitionLink 999014 - Disclosure - PROPERTY AND EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 999015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 999016 - Disclosure - OTHER BORROWINGS link:presentationLink link:calculationLink link:definitionLink 999017 - Disclosure - WARRANTS link:presentationLink link:calculationLink link:definitionLink 999018 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 999019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 999020 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 999021 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 999022 - Disclosure - COMMON STOCK link:presentationLink link:calculationLink link:definitionLink 999023 - Disclosure - SHARE-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 999024 - Disclosure - PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 999025 - Disclosure - (LOSS) INCOME PER SHARE link:presentationLink link:calculationLink link:definitionLink 999026 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 999027 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 999028 - Disclosure - SUBSEQUENT EVENT link:presentationLink link:calculationLink link:definitionLink 999030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies) link:presentationLink link:calculationLink link:definitionLink 999031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables) link:presentationLink link:calculationLink link:definitionLink 999032 - Disclosure - ACCOUNTS RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 999033 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 999034 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 999035 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Tables) link:presentationLink link:calculationLink link:definitionLink 999036 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 999037 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 999038 - Disclosure - OTHER BORROWINGS (Tables) link:presentationLink link:calculationLink link:definitionLink 999039 - Disclosure - WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 999040 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 999041 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 999042 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 999043 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 999044 - Disclosure - SHARE-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 999045 - Disclosure - (LOSS) INCOME PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 999046 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 999047 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 999048 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations) link:presentationLink link:calculationLink link:definitionLink 999050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999051 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details) link:presentationLink link:calculationLink link:definitionLink 999052 - Disclosure - INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 999053 - Disclosure - ADVANCE TO SUPPLIERS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999054 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details) link:presentationLink link:calculationLink link:definitionLink 999055 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999056 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details) link:presentationLink link:calculationLink link:definitionLink 999057 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999058 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details) link:presentationLink link:calculationLink link:definitionLink 999059 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999060 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Goodwill) link:presentationLink link:calculationLink link:definitionLink 999061 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Customer relations) link:presentationLink link:calculationLink link:definitionLink 999062 - Disclosure - OTHER BORROWINGS (Details) link:presentationLink link:calculationLink link:definitionLink 999063 - Disclosure - WARRANTS (Details - Warrant Liability) link:presentationLink link:calculationLink link:definitionLink 999064 - Disclosure - WARRANTS (Details - Warrant Activity) link:presentationLink link:calculationLink link:definitionLink 999065 - Disclosure - WARRANTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999066 - Disclosure - LEASES (Details - Lease costs) link:presentationLink link:calculationLink link:definitionLink 999067 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 999068 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999069 - Disclosure - INCOME TAXES (Details - Income tax expense) link:presentationLink link:calculationLink link:definitionLink 999070 - Disclosure - INCOME TAXES (Details - Reconciliation of income tax) link:presentationLink link:calculationLink link:definitionLink 999071 - Disclosure - INCOME TAXES (Details - Valuation Allowance) link:presentationLink link:calculationLink link:definitionLink 999072 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999073 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties) link:presentationLink link:calculationLink link:definitionLink 999074 - Disclosure - COMMON STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999075 - Disclosure - SHARE-BASED COMPENSATION (Details - Assumptions) link:presentationLink link:calculationLink link:definitionLink 999076 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999077 - Disclosure - PREFERRED STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 999078 - Disclosure - (LOSS) EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 999079 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 999080 - Disclosure - Disclosure - SEGMENT REPORTING (Details - Segment information) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 ncra-20250331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ncra-20250331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ncra-20250331_lab.xml XBRL LABEL FILE Class of Stock [Axis] Series A Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Additional Paid-in Capital [Member] Statutory And Other Reserves [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Total Nocera Stockholders Equity [Member] Noncontrolling Interest [Member] Disposal Group Classification [Axis] XFC Sale [Member] Restricted Stock [Member] Ownership [Axis] Meixin [Member] Xinca [Member] SY Culture [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Three Customers [Member] Four Customers [Member] Customer A [Member] Accounts Receivable [Member] Customer B [Member] Customer C [Member] Customer D [Member] Customer E [Member] Customer F [Member] All Customers [Member] Purchases [Member] Product Concentration Risk [Member] Supplier A [Member] Supplier B [Member] Supplier C [Member] Supplier D [Member] Supplier E [Member] Supplier F [Member] Supplier G [Member] Supplier H [Member] Supplier I [Member] All Suppliers [Member] Statement of Financial Position Location, Balance [Axis] Due From Third Parties [Member] E Commerce Live Stream Sales Deposits [Member] Xinca Employee Loans [Member] SY Media Deposits [Member] Prior-year receivables from GZ GSI [Member] Financial Instrument [Axis] Funds [Member] Financial Instrument Performance Status [Axis] Current [Member] Noncurrent [Member] Long-Lived Tangible Asset [Axis] Land [Member] Equipment [Member] Legal Entity [Axis] SY Media [Member] Debt Instrument [Axis] CITIC Car Loan [Member] Class C Warrant [Member] Class D Warrant [Member] Counterparty Name [Axis] Underwriters [Member] Sale of Stock [Axis] Public Offering 2022 [Member] Award Type [Axis] Warrant [Member] Geographical [Axis] CHINA Statistical Measurement [Axis] Minimum [Member] TAIWAN Income Tax Jurisdiction [Axis] UNITED STATES PRC [Member] Related and Nonrelated Parties [Axis] Mountain Share Transfer LLC [Member] Estate Of Yin Chieh Cheng [Member] Feng Hua Chen [Member] Public Offering [Member] Investment, Name [Axis] Stock Conversion Description [Axis] Class A Warrants Converted To Common Stock [Member] Warrant Class A [Member] Mr Yin Chieh Cheng [Member] Series A Warrant [Member] Mr Shun Chih Chuang [Member] Class A Warrant [Member] Mr Hsien Wen Yu [Member] Two Employees [Member] Mr Michael A Littman [Member] Class B Warrant [Member] Mr Shun Chih Chuang And Five Consultants [Member] Chen Chun Chung [Member] Tra Digital [Member] Investor [Member] Yu Hao Chang [Member] Andy Chin An Jin [Member] Any Chin An Jin [Member] Segments [Axis] Fish Trading [Member] Catering [Member] E Commerce [Member] Customer G [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current assets Cash and cash equivalents Accounts receivable Inventories, net Advance to suppliers Prepaid expenses and other assets, net Financial assets at fair value through profit or loss Total current assets Property and equipment, net Intangible assets - customer relations Investment Goodwill Other non-current asset Total assets LIABILITIES AND EQUITY Liabilities Current liabilities Accounts payable Other payables and accrued liabilities Contract liabilities Due to related parties Warrant liability Long-term secured other borrowing – current portion Dividend payable Income tax payable Total current liabilities Long-term secured other borrowing Total liabilities Commitments and contingencies (Note 20) Shareholder’s Equity Common stock ($0.001 par value; authorized 200,000,000 shares; 14,247,539 shares and 14,047,539 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively) (1) Preferred stock ($0.001 par value; authorized 10,000,000 shares; Series A Preferred Stock, 2,000,000 authorized, 80,000 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively) Additional paid-in capital (1) Statutory and other reserves Accumulated losses Accumulated other comprehensive income Total Nocera, Inc.’s shareholders’ equity Non-controlling interests Total shareholders’ equity Total liabilities and shareholders’ equity Statement [Table] Statement [Line Items] Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Income Statement [Abstract] Net sales Cost of sales Gross profit Operating expenses General and administrative expenses Total operating expenses Loss from operations Other income Loss before income taxes Income tax expense Net loss Less: Net loss attributable to non-controlling interests Net loss attributable to the company Comprehensive Income Net loss Foreign currency translation (loss) gain Total comprehensive loss Less: Net loss attributable to non-controlling interests Less: Foreign currency translation loss attributable to non-controlling interest Comprehensive loss attributable to the Company Loss per share Basic Diluted Weighted average number of common shares outstanding Basic Diluted Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net income to net cash used in operating activities: Depreciation expenses Deferred income tax Amortization of intangible assets Gain on disposal of financial assets at FVTPL Gain on fair value change of financial assets at FVTPL Share-based compensation Changes in operating assets and liabilities: Accounts receivable, net Inventories Advance to suppliers Prepaid expenses and other assets, net Other non-current assets Accounts payable Advance from customers Other payables and accrued liabilities Income tax payable Subtract non-cash gain (loss) on warrant liability Net cash used in operating activities Cash flows from investing activities: Net cash inflow from acquisition of a subsidiary Proceeds from gain on disposal of financial assets at FVTPL Net cash provided by investing activities Cash flows from financing activities: Repayment of short-term bank loan Proceeds from issuance of common stock Repayment of secured other borrowings Net cash provided by (used in) financing activities Effect of exchange rate changes on cash and cash equivalents Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Beginning balance, value Beginning balance, shares Foreign currency translation Adjustments Common stock issuance Common stock issuance, shares Share-based compensation Ending balance, value Ending balance, shares Organization, Consolidation and Presentation of Financial Statements [Abstract] PRINCIPAL ACTIVITIES AND ORGANIZATION Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICY Credit Loss [Abstract] ACCOUNTS RECEIVABLE Inventory Disclosure [Abstract] INVENTORIES Advance To Suppliers ADVANCE TO SUPPLIERS Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] PREPAID EXPENSES AND OTHER ASSETS, NET Fair Value Disclosures [Abstract] FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT, NET Goodwill and Intangible Assets Disclosure [Abstract] GOODWILL AND OTHER INTANGIBLE ASSETS Debt Disclosure [Abstract] OTHER BORROWINGS Warrants WARRANTS Leases LEASES Payables and Accruals [Abstract] OTHER PAYABLES AND ACCRUED LIABILITIES Income Tax Disclosure [Abstract] INCOME TAXES Related Party Transactions [Abstract] RELATED PARTY BALANCES AND TRANSACTIONS Equity [Abstract] COMMON STOCK Share-Based Payment Arrangement [Abstract] SHARE-BASED COMPENSATION PREFERRED STOCK Earnings Per Share [Abstract] (LOSS) INCOME PER SHARE Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Segment Reporting [Abstract] SEGMENT REPORTING Subsequent Events [Abstract] SUBSEQUENT EVENT Insider Trading Arrangements [Line Items] Rule 10b5-1 Arrangement Adopted [Flag] Non-Rule 10b5-1 Arrangement Adopted [Flag] Rule 10b5-1 Arrangement Terminated [Flag] Non-Rule 10b5-1 Arrangement Terminated [Flag] Basis of Presentation Concentrations of Credit Risk Revenue Recognition Recent Accounting Pronouncements Schedule of concentrations of credit risk Schedule of accounts receivable Schedule of inventories Schedule of prepaid expenses and other assets Schedule of financial assets at fair value through profit or loss Schedule of property and equipment Schedule of goodwill Schedule of customer relations Schedule of other loans Schedule of warranty liability activity Schedule of warrant activity Schedule of components of lease expenses Schedule of other payables and accrued liabilities Schedule of income tax components Schedule of reconciliation of income tax expense Schedule of movement in valuation allowance Schedule of related party transactions Schedule of assumptions of option pricing Schedule of loss per share Schedule of lease payments Schedule of segment information Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Stock issued for acquisition, shares VIE percent interest owned Payment for VIE controlling interest Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Concentration percentage Concentration risk Accounts receivable Total Raw materials Total Advances to suppliers Prepaid Expenses Other receivables from third party Other receivables Fair Value, off-Balance-Sheet Risk [Table] Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items] Fair value of financial asset Gain (Loss) on Disposition of Other Financial Assets Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Less: Accumulated depreciation Depreciation expense Less: Impairment Acquisitions Less: Accumulated amortization Customer relations, net Short-Term Debt [Table] Short-Term Debt [Line Items] Others loans current Total others loans current Total others loans noncurrent Balance at the beginning of period Fair value change of warrants included in earnings Total Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of warrants outstanding, Beginning balance Average exercise price outstanding, Beginning balance Weighted average remaining contractual term, Outstanding Number of warrants exercisable, Beginning balance Average exercise price exercisable, Beginning balance Weighted average remaining contractual term, Exercisable Number of warrants, Granted Average exercise price, Granted Number of warrants, Exercised / surrendered Average exercise price, Exercised / surrendered Number of warrants, Expired Average exercise price, Expired Number of warrants outstanding, Ending balance Average exercise price outstanding, Ending balance Number of warrants exercisable, Ending balance Average exercise price exercisable, Ending balance Warrants issued Proceeds from warrants issued Operating lease expense Total net lease costs Accrued Expenses Others Total Other payables and accrued expenses Effective Income Tax Rate Reconciliation [Table] Effective Income Tax Rate Reconciliation [Line Items] Current Total income tax expense Taiwan (2021-PRC) income tax statutory rate Tax effect of non-deductible expenses Tax effect of stock-based compensation Tax effect of non-taxable income Impact of different tax rates in other jurisdictions Others Changes in valuation allowance Effective tax rate Valuation allowance, beginning balance Additions of valuation allowance Reductions of valuation allowance Valuation allowance, ending balance Change in Unrecognized Tax Benefit, Reasonably Possible [Table] Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items] VAT tax rate Effective income tax rate including GILTI GILTI Amount Net operating loss carryforwards Effective income tax rate Related Party Transaction [Table] Related Party Transaction [Line Items] Due to related parties Stock, Class of Stock [Table] Class of Stock [Line Items] Common stock par value Reverse stock split Common stock issued shares Gross proceeds from the sale of equity Proceeds from the sale of equity Stock issued for acquisitions, shares Stock issued for acquisitions, shares Stock converted, shares converted Stock converted, shares issued Risk-free interest rate Expected term (in years) Volatility Option award Warrants granted Exercise price Warrants exercised, shares Stock issued for services, shares Adjustments to APIC for share based compensation Sale of stock, price Share price Numerator: Net loss income attributable to the Company Denominator: Weighted-average shares outstanding - Basic - Diluted Loss per share: - Basic - Diluted Within 1 year Total Schedule of Revenue by Major Customers, by Reporting Segments [Table] Revenue, Major Customer [Line Items] Revenue Cost of revenue Gross profit Segment operating losses Income tax expenses Segment losses Income tax expenses Prior-year receivables from GZ GSI [Member] Assets, Current Assets Liabilities, Current Liabilities [Default Label] Equity, Attributable to Parent Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity General and Administrative Expense Operating Expenses Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest TotalComprehensiveLoss Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Increase (Decrease) in Deferred Income Taxes Gain (Loss) on Disposition of Assets Unrealized Gain (Loss) on Investments Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Due to Related Parties, Current Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Other Noncurrent Assets Increase (Decrease) in Other Accounts Payable Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Increase (Decrease) in Accrued Taxes Payable Unrealized Gain (Loss) on Derivatives Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Investing Activities Repayments of Bank Debt Repayments of Secured Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Shares, Outstanding Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Accounts Receivable, before Allowance for Credit Loss Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Goodwill, Impaired, Accumulated Impairment Loss Finite-Lived Intangible Assets, Accumulated Amortization Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Class of Warrant or Right, Outstanding WarrantsExercisable AverageExercisePriceExerciasable Deferred Income Taxes and Tax Credits Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Deferred Tax Assets, Valuation Allowance DueToRelatedPartyCurrent1 EX-101.PRE 10 ncra-20250331_pre.xml XBRL PRESENTATION FILE XML 92 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 93 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } ZIP 98 0001683168-25-004666-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-25-004666-xbrl.zip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end XML 101 nocera_i10qa1-033125_htm.xml IDEA: XBRL DOCUMENT 0001756180 2025-01-01 2025-03-31 0001756180 2025-05-15 0001756180 2025-03-31 0001756180 2024-12-31 0001756180 us-gaap:SeriesAPreferredStockMember 2025-03-31 0001756180 us-gaap:SeriesAPreferredStockMember 2024-12-31 0001756180 2024-01-01 2024-03-31 0001756180 2023-12-31 0001756180 2024-03-31 0001756180 us-gaap:CommonStockMember 2023-12-31 0001756180 us-gaap:PreferredStockMember 2023-12-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2023-12-31 0001756180 us-gaap:RetainedEarningsMember 2023-12-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2023-12-31 0001756180 us-gaap:NoncontrollingInterestMember 2023-12-31 0001756180 us-gaap:CommonStockMember 2024-12-31 0001756180 us-gaap:PreferredStockMember 2024-12-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2024-12-31 0001756180 us-gaap:RetainedEarningsMember 2024-12-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2024-12-31 0001756180 us-gaap:NoncontrollingInterestMember 2024-12-31 0001756180 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001756180 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2024-01-01 2024-03-31 0001756180 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2024-01-01 2024-03-31 0001756180 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001756180 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001756180 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2025-01-01 2025-03-31 0001756180 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2025-01-01 2025-03-31 0001756180 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001756180 us-gaap:CommonStockMember 2024-03-31 0001756180 us-gaap:PreferredStockMember 2024-03-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2024-03-31 0001756180 us-gaap:RetainedEarningsMember 2024-03-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2024-03-31 0001756180 us-gaap:NoncontrollingInterestMember 2024-03-31 0001756180 us-gaap:CommonStockMember 2025-03-31 0001756180 us-gaap:PreferredStockMember 2025-03-31 0001756180 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001756180 NCRA:StatutoryAndOtherReservesMember 2025-03-31 0001756180 us-gaap:RetainedEarningsMember 2025-03-31 0001756180 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001756180 NCRA:TotalNoceraStockholdersEquityMember 2025-03-31 0001756180 us-gaap:NoncontrollingInterestMember 2025-03-31 0001756180 NCRA:XFCSaleMember us-gaap:RestrictedStockMember 2020-12-30 2020-12-31 0001756180 NCRA:MeixinMember 2022-09-06 2022-09-07 0001756180 NCRA:XincaMember 2024-01-30 2024-01-31 0001756180 NCRA:SYCultureMember 2024-04-13 2024-04-14 0001756180 NCRA:ThreeCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:FourCustomersMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerFMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:AllCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:AllCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:SupplierAMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:SupplierAMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:SupplierBMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:SupplierBMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:SupplierCMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:SupplierCMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:SupplierDMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:SupplierDMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:SupplierEMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:SupplierEMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:SupplierFMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:SupplierFMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:SupplierGMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:SupplierGMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:SupplierHMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:SupplierHMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:SupplierIMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:SupplierIMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:AllSuppliersMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2025-01-01 2025-03-31 0001756180 NCRA:AllSuppliersMember NCRA:PurchasesMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-03-31 0001756180 NCRA:DueFromThirdPartiesMember 2025-03-31 0001756180 NCRA:ECommerceLiveStreamSalesDepositsMember 2025-03-31 0001756180 NCRA:XincaEmployeeLoansMember 2025-03-31 0001756180 NCRA:SYMediaDepositsMember 2025-03-31 0001756180 NCRA:PriorYearReceivablesFromGZGSIMember 2025-03-31 0001756180 NCRA:FundsMember 2025-03-31 0001756180 NCRA:FundsMember 2024-12-31 0001756180 NCRA:CurrentMember 2025-03-31 0001756180 NCRA:CurrentMember 2024-12-31 0001756180 NCRA:NoncurrentMember 2025-03-31 0001756180 NCRA:NoncurrentMember 2024-12-31 0001756180 us-gaap:LandMember 2025-03-31 0001756180 us-gaap:LandMember 2024-12-31 0001756180 us-gaap:EquipmentMember 2025-03-31 0001756180 us-gaap:EquipmentMember 2024-12-31 0001756180 NCRA:MeixinMember 2025-03-31 0001756180 NCRA:MeixinMember 2024-12-31 0001756180 NCRA:XincaMember 2025-03-31 0001756180 NCRA:XincaMember 2024-12-31 0001756180 NCRA:SYMediaMember 2025-03-31 0001756180 NCRA:SYMediaMember 2024-12-31 0001756180 NCRA:CITICCarLoanMember 2025-03-31 0001756180 NCRA:CITICCarLoanMember 2024-12-31 0001756180 NCRA:ClassCWarrantMember 2021-04-01 0001756180 NCRA:ClassDWarrantMember 2021-04-01 0001756180 NCRA:ClassCWarrantMember 2021-09-27 0001756180 NCRA:ClassDWarrantMember 2021-09-27 0001756180 NCRA:UnderwritersMember NCRA:PublicOffering2022Member 2022-09-23 0001756180 NCRA:UnderwritersMember NCRA:PublicOffering2022Member 2022-09-22 2022-09-23 0001756180 us-gaap:WarrantMember 2024-12-31 0001756180 us-gaap:WarrantMember 2024-01-01 2024-12-31 0001756180 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001756180 us-gaap:WarrantMember 2025-03-31 0001756180 srt:MinimumMember country:CN 2025-03-31 0001756180 country:TW 2025-03-31 0001756180 country:US 2025-01-01 2025-03-31 0001756180 2019-01-01 2019-12-31 0001756180 country:US 2019-12-31 0001756180 NCRA:PRCMember 2025-01-01 2025-03-31 0001756180 NCRA:PRCMember 2024-01-01 2024-03-31 0001756180 2024-01-01 2024-12-31 0001756180 NCRA:MountainShareTransferLLCMember 2025-03-31 0001756180 NCRA:MountainShareTransferLLCMember 2024-12-31 0001756180 NCRA:EstateOfYinChiehChengMember 2025-03-31 0001756180 NCRA:EstateOfYinChiehChengMember 2024-12-31 0001756180 NCRA:FengHuaChenMember 2025-03-31 0001756180 NCRA:FengHuaChenMember 2024-12-31 0001756180 2022-08-09 2022-08-11 0001756180 us-gaap:CommonStockMember 2022-08-11 0001756180 NCRA:PublicOfferingMember 2022-08-09 2022-08-11 0001756180 NCRA:XincaMember 2024-02-19 2024-02-20 0001756180 NCRA:XincaMember 2024-02-20 0001756180 NCRA:SYCultureMember 2024-04-13 2024-04-14 0001756180 NCRA:SYCultureMember 2024-04-14 0001756180 NCRA:ClassAWarrantsConvertedToCommonStockMember NCRA:WarrantClassAMember 2025-02-06 2025-02-07 0001756180 NCRA:ClassAWarrantsConvertedToCommonStockMember us-gaap:CommonStockMember 2025-02-06 2025-02-07 0001756180 NCRA:ClassAWarrantsConvertedToCommonStockMember NCRA:WarrantClassAMember 2025-02-11 2025-02-12 0001756180 NCRA:ClassAWarrantsConvertedToCommonStockMember us-gaap:CommonStockMember 2025-02-11 2025-02-12 0001756180 NCRA:SeriesAWarrantMember NCRA:MrYinChiehChengMember 2018-12-26 2018-12-27 0001756180 NCRA:SeriesAWarrantMember NCRA:MrYinChiehChengMember 2018-12-27 0001756180 NCRA:ClassAWarrantMember NCRA:MrShunChihChuangMember 2020-05-29 2020-06-01 0001756180 NCRA:ClassAWarrantMember NCRA:MrHsienWenYuMember 2020-05-29 2020-06-01 0001756180 NCRA:ClassAWarrantMember NCRA:MrShunChihChuangMember 2020-06-01 0001756180 NCRA:ClassAWarrantMember NCRA:TwoEmployeesMember 2020-05-29 2020-06-01 0001756180 NCRA:ClassAWarrantMember NCRA:TwoEmployeesMember 2020-06-01 0001756180 NCRA:ClassAWarrantMember NCRA:MrMichaelALittmanMember 2020-05-29 2020-06-01 0001756180 NCRA:ClassAWarrantMember NCRA:MrMichaelALittmanMember 2020-06-01 0001756180 NCRA:ClassBWarrantMember NCRA:MrMichaelALittmanMember 2020-05-29 2020-06-01 0001756180 NCRA:ClassBWarrantMember NCRA:MrMichaelALittmanMember 2020-06-01 0001756180 NCRA:ClassAWarrantMember NCRA:MrMichaelALittmanMember 2021-08-09 2021-08-11 0001756180 NCRA:ClassBWarrantMember NCRA:MrMichaelALittmanMember 2021-08-09 2021-08-11 0001756180 NCRA:ClassAWarrantMember NCRA:MrShunChihChuangMember 2021-11-30 2021-12-02 0001756180 NCRA:ClassAWarrantMember NCRA:MrHsienWenYuMember 2021-11-30 2021-12-02 0001756180 NCRA:ClassAWarrantMember NCRA:MrShunChihChuangMember 2021-12-02 0001756180 NCRA:ClassAWarrantMember NCRA:TwoEmployeesMember 2021-11-30 2021-12-02 0001756180 NCRA:ClassAWarrantMember NCRA:TwoEmployeesMember 2021-12-02 0001756180 NCRA:MrShunChihChuangAndFiveConsultantsMember 2021-12-30 2021-12-31 0001756180 NCRA:ChenChunChungMember 2022-12-21 2022-12-22 0001756180 NCRA:TraDigitalMember 2022-12-21 2022-12-22 0001756180 us-gaap:InvestorMember 2023-03-20 2023-03-22 0001756180 NCRA:YuHaoChangMember 2023-10-10 2023-10-11 0001756180 NCRA:AndyChinAnJinMember 2023-12-02 2023-12-05 0001756180 NCRA:AnyChinAnJinMember 2024-08-25 2024-08-26 0001756180 us-gaap:SeriesAPreferredStockMember 2021-08-31 0001756180 2021-08-31 0001756180 NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 NCRA:CateringMember 2025-01-01 2025-03-31 0001756180 NCRA:ECommerceMember 2025-01-01 2025-03-31 0001756180 NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 NCRA:CateringMember 2024-01-01 2024-03-31 0001756180 NCRA:ECommerceMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerEMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerFMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerFMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2025-01-01 2025-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:FishTradingMember 2024-01-01 2024-03-31 0001756180 NCRA:CustomerGMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CateringMember 2025-01-01 2025-03-31 0001756180 NCRA:CustomerGMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CateringMember 2024-01-01 2024-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CateringMember 2025-01-01 2025-03-31 0001756180 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NCRA:CateringMember 2024-01-01 2024-03-31 iso4217:USD shares iso4217:USD shares pure true --12-31 2025 Q1 To report segment information 0001756180 10-Q/A true 2025-03-31 false 001-41434 NOCERA, INC. NV 16-1626611 3F (Building B), No. 185 Sec. 1, Datong Rd Xizhi Dist New Taipei City 221 TW 886 910 163-358 Common Stock, par value $0.001 per share NCRA NASDAQ Yes Yes Non-accelerated Filer true true false false 14367539 531771 484161 134106 144509 9608 0 1732 8404 598199 643169 0 210 1275416 1280453 1342060 1391845 93749 97825 27435 27206 2077728 2077728 4373 7505 4820761 4882562 13717 0 395793 376660 78875 72505 38518 27116 85273 76847 28868 6631 54312 54312 11028 25126 706384 639197 0 23786 706384 662983 0.001 0.001 200000000 200000000 14247539 14247539 14047539 14047539 14247 14047 0.001 0.001 10000000 10000000 2000000 2000000 80000 80000 80000 80000 80 80 25350065 25200265 191219 191219 -21486898 -21238881 15253 12415 4083966 4179145 30411 40434 4114377 4219579 4820761 4882562 4534128 4899880 4483178 4815919 50950 83961 334371 451464 334371 451464 -283421 -367503 25804 195573 -257617 -171930 -0 124146 -257617 -296076 -9600 -7500 -248017 -288576 -257617 -296076 -2838 57307 -260455 -238769 -9600 -7500 -423 1878 -250432 -233147 -0.0175 -0.0241 -0.0175 -0.0241 14159761 11956987 14159761 11956987 -257617 -296076 33674 22559 -0 922 4076 4076 3 -0 2409 0 14999 -11262 4171 9936 -0 6672 0 -48927 117346 -3076 -69 13717 0 5802 0 30905 116070 -14083 0 -8426 197843 -115102 -460994 0 201863 213 0 213 201863 -0 60678 150000 0 1817 -0 148183 -60678 14316 52006 47610 -267803 484161 1229580 531771 961777 11156987 11157 80000 80 21931112 191219 -18868420 98906 3364054 84325 3448379 -57307 -57307 -3288 -60595 1800000 1800 1978200 1980000 1980000 14999 14999 14999 -288576 -288576 -7500 -296076 12956987 12957 80000 80 23924311 191219 -19156996 41599 5013170 73537 5086707 14047539 14047 80000 80 25200265 191219 -21238881 12415 4179145 40434 4219579 2838 2838 -423 2415 200000 200 149800 150000 150000 -248017 -248017 -9600 -257617 14247539 14247 80000 80 25350065 191219 -21486898 15253 4083966 30411 4114377 <p id="xdx_800_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z748lLW4CtPc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1      <span id="xdx_822_z87eoDkckWB8">PRINCIPAL ACTIVITIES AND ORGANIZATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include the financial statements of Nocera, Inc. (“Nocera” or the “Company”) and its subsidiaries, Grand Smooth Inc. Limited (“GSI”) and Guizhou Grand Smooth Technology Ltd. (“GZ GST” or “WFOE”), and Meixin Institutional Food Development Co., Ltd. (“Meixin”) that is controlled through contractual arrangements. The Company, GSI, GZ GST and Mexin are collectively referred to as the “Company”.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera was incorporated in the State of Nevada on February 1, 2002 and is based in New Taipei City, Taiwan (R.O.C.). It did not engage in any operations and was dormant from its inception until its reverse merger with GSI on December 31, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Reverse Merger</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective December 31, 2018, Nocera completed a reverse merger transaction (the “Transaction”) pursuant to an Agreement and Plan of Merger (the “Agreement”), with (i) GSI, (ii) GSI’s shareholders, Yin-Chieh Cheng and Bi Zhang, who together owned shares constituting 100% of the issued and outstanding ordinary shares of GSI (the “GSI Shares”) and (iii) GSI Acquisition Corp. Under the terms of the Agreement, the GSI Shareholders transferred to Nocera all of the GSI Shares in exchange for the issuance of 10,000,000 shares (the “Shares”) of Nocera’s common stock (the “Share Exchange”). As a result of the reverse merger, GSI became Nocera’s wholly-owned subsidiary and Yin-Chieh Cheng and Bi Zhang, the former shareholders of GSI, became Nocera’s controlling shareholders. The share exchange transaction with GSI was treated as a reverse merger, with GSI as the accounting acquirer and Nocera as the acquired party.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GSI is a limited company established under the laws and regulations of Hong Kong on August 1, 2014, and is a holding company without any operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GZ WFH was incorporated in Xingyi City, Guizhou Province, People’s Republic of China (“PRC”) on October 25, 2017, and is engaged in providing fish farming containers service, which integrates sales, installments, and maintenance of aquaculture equipment. The registered capital of GZ WFH is RMB$5,000,000 (equal to US$733,138).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 13, 2018, GSI incorporated GZ GST in PRC with registered capital of US$15,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Divestiture</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 21, 2020, the Company filed a Current Report on Form 8-K outlining the lack of communication that led to the termination by Nocera of its relationship with its former variable interest entity, Guizhou Wan Feng Hu Intelligent Aquatic Technology Co. Limited (“GZ WFH”) and its management, and termination of the variable interest entity agreements between the parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequently on October 8, 2020, Zhang Bi and GZ WFH entered into a Settlement Agreement and Release with Nocera wherein all claims as to GZ WFH’s debt (claim to shares in Nocera or GZ GST) were compromised, settled, and otherwise resolved as to any and all claims or causes of action whatsoever against Nocera for any matter, action, or representation as to Nocera, and any debt to ownership of Nocera or GZ GST up to the date of the agreement. The consideration for the agreement was mutual waiver of any and all claims against each other and GZ GST, and GZ WFH (including Zhang Bi) waived any claims to Nocera stock, meaning the 4,750,000 shares of common stock of Nocera owned by Zhang Bi were cancelled as part of the agreement. The Settlement Agreement and Release is attached hereto as Exhibit 10.8.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">The VIE Agreements with XFC</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, we exchanged <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20201230__20201231__us-gaap--DisposalGroupClassificationAxis__custom--XFCSaleMember__us-gaap--StatementClassOfStockAxis__us-gaap--RestrictedStockMember_zoRnjRBXyTke">466,667 </span>(post-split) shares of our restricted common stock to stockholders of Xin Feng Construction Co., Ltd., a Taiwan limited liability company (“XFC”), in exchange for 100% controlling interest in XFC. We also entered into contractual arrangements with a stockholder of XFC, that enabled us to have the power to direct the activities that most significantly affects the economic performance of XFC and receive the economic benefits of XFC that could be significant to XFC. On November 30, 2022, we entered into a Purchase of Business Agreement with Han-Chieh Shih (the “Purchaser”), in which we sold our controlling interest of XFC, to the Purchaser for a total purchase cash price of $300,000 (the “XFC Sale”). The closing of the XFC Sale occurred on November 30, 2022 and the XFC variable interest entity (“VIE”) agreements were terminated in connection with the XFC Sale. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">The VIE Agreements with Meixin</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 7, 2022, we entered into a series of contractual agreements (collectively, the “Meixin VIE Agreements”) with the majority stockholder (the “Selling Stockholder”) of Meixin Institutional Food Development Co., Ltd., a Taiwan corporation and a food processing and catering company (“Meixin”), and Meixin, of which we purchased <span id="xdx_904_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20220906__20220907__srt--OwnershipAxis__custom--MeixinMember_zDzk6urugxeb" title="VIE percent interest owned">80</span>% controlling interest of Meixin for $<span id="xdx_90E_eus-gaap--PaymentsToAcquireBusinessesGross_c20220906__20220907__srt--OwnershipAxis__custom--MeixinMember_zHsI1oHFmiKj" title="Payment for VIE controlling interest">4,300,000</span>. The Meixin VIE Agreements essentially confer control and management of Meixin as well as substantially all of the economic benefits of the Selling Stockholder in Meixin to us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">The VIE Agreements with Xinca</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On January 31, 2024, we entered into a Variable Interest Entity Purchase Agreement (“Xinca Purchase Agreement”) with Zhejiang Xinca Mutual Entertainment Culture Media Co., Ltd. (“Xinca”), a domestic funded limited liability company registered in China (P.R.C). The Xinca Purchase Agreement was entered into by our wholly-owned subsidiary and foreign enterprise, Shanghai Nocera Culture Co., Ltd. (“WFOE”), through a series of contractual agreements (“VIE Agreements”), in which we exchanged <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20240130__20240131__srt--OwnershipAxis__custom--XincaMember_zUlfTLv8dgWg" title="Stock issued for acquisition, shares">1,800,000</span> shares of our restricted common stock for a <span id="xdx_906_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20240130__20240131__srt--OwnershipAxis__custom--XincaMember_zTfjbs6XZDEa" title="VIE percent interest owned">100</span>% controlling interest in Xinca. As a result, the Company has been determined to be the primary beneficiary of Xinca and Xinca became a variable interest entity (“VIE”) of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have entered into the following contractual arrangements with stockholders of Xinca, which enable us to (1) have the power to direct the activities that most significantly affect the economic performance of Xinca, and (2) receive the economic benefits of Xinca that could be significant to Xinca. We are fully and exclusively responsible for the management of Xinca, assume all of the risk of losses of Xinca, and have the exclusive right to exercise all voting rights of Xinca’s stockholders. Therefore, in accordance with ASC 810 “Consolidation,” we are considered the primary beneficiary of Xinca and have consolidated Xinca’s assets, liabilities, results of operations, and cash flows in the accompanying consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0px"> </td> <td style="width: 24px"><span style="font-size: 10pt"><i>(1)</i></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><i>Voting Rights Proxy Agreement &amp; Power of Attorney </i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Zong Hui and Upward Software (Shanghai) Co., Ltd. (the “Existing Stockholders”) have irrevocably authorized us, or the individual then designated by us (the “Attorney”), to exercise, on their behalf, the following rights available to them in their capacity as stockholders of Xinca under the then-effective articles of association of Xinca (collectively, the “Powers”): (a) to propose the convening of, and attend, stockholders’ meetings in accordance with the articles of association of Xinca on behalf of the Existing Stockholders; (b) to exercise voting rights on behalf of the Existing Stockholders on all matters required to be deliberated and resolved by the stockholders’ meeting, including, without limitation, the appointment and election of the directors and other executives to be appointed and removed by the stockholders of Xinca, and the sale or transfer of all or part of the equity held by stockholders in Xinca; (c) to exercise other stockholders’ voting rights under the articles of association of Xinca (including any other stockholders’ voting rights stipulated upon an amendment to such articles of association); and (d) other voting rights that stockholders shall enjoy under the laws of the People’s Republic of China (“China”), as amended, revised, supplemented, and re-enacted, regardless of whether they take effect before or after the conclusion of this Agreement. The Existing Stockholders shall not revoke the authorization and entrustment accorded to the Attorney unless we issue a written notice requesting the replacement of the Attorney. In such event, the Existing Stockholders shall immediately appoint such other person as we designate to exercise the foregoing Powers, and such new authorization and entrustment shall supersede, immediately upon its grant, the original authorization and entrustment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0px"> </td> <td style="width: 24px"><span style="font-size: 10pt"><i>(2)</i></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><i>Exclusive Business Cooperation Agreement </i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We agree to provide technical consulting and services, including management consulting services, general and financial advisory services, and various general and administrative services (collectively, the “Target Business”), to Xinca as its exclusive technical consulting and service provider in accordance with the terms set forth in this Agreement. Xinca agrees to accept the technical consulting and services provided by us. Xinca further agrees that, without our prior written consent, it shall not accept any technical consulting or services identical or similar to the Target Business from any third party during the term of this Agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0px"> </td> <td style="width: 24px"><span style="font-size: 10pt"><i>(3)</i></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><i>Equity Pledge Agreement </i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Equity Interest Pledge Agreement between us and Zong Hui and Upward Software (Shanghai) Co., Ltd., the stockholders of Xinca have pledged all of their equity interests in Xinca to us to guarantee the performance of Xinca’s obligations under the Exclusive Business Cooperation Agreement. Under the terms of the agreement, in the event that Xinca or the stockholders breach their respective contractual obligations under the Exclusive Business Cooperation Agreement, we, as the pledgee, will be entitled to certain rights, including, but not limited to, the right to collect dividends generated by the pledged equity interests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0px"> </td> <td style="width: 24px"><span style="font-size: 10pt"><i>(4)</i></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><i>Exclusive Call Option Agreement </i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Xinca and its stockholders, Zong Hui and Upward Software (Shanghai) Co., Ltd., have entered into an Exclusive Call Option Agreement with us. Under this agreement, the Xinca stockholders have irrevocably granted us (or our designee) an exclusive option to purchase, to the extent permitted under the laws of China, part or all of their equity interests in Xinca. According to the Exclusive Call Option Agreement, the purchase price shall be the minimum price permitted under applicable Chinese law at the time the share transfer occurs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">The Equity Purchase Agreements with SY Culture</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 14, 2024, we entered into a Equity Purchase Agreement with Hangzhou SY Culture Media Co. Ltd. (“SY Culture Purchase Agreement”), a domestic funded limited liability company registered in China (P.R.C). The SY Culture Purchase Agreement was entered into by our wholly-owned subsidiary and foreign enterprise, Gui Zhou Grand Smooth Technology Ltd. (“WFOE”), in which we exchanged <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20240413__20240414__srt--OwnershipAxis__custom--SYCultureMember_zgdJoptaKjZ4" title="Stock issued for acquisition, shares">600,000</span> shares of our restricted common stock for a <span id="xdx_905_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20240413__20240414__srt--OwnershipAxis__custom--SYCultureMember_zguzuTbebXff" title="VIE percent interest owned">100</span>% equity in SY Culture.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 466667 0.80 4300000 1800000 1 600000 1 <p id="xdx_802_eus-gaap--SignificantAccountingPoliciesTextBlock_zlseyyFY84h3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 2      <span id="xdx_82F_z9vBSEGDI2z5">SUMMARY OF SIGNIFICANT ACCOUNTING POLICY</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTpolT9wM5D9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_866_zKxsgrh4pRL6">Basis of Presentation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, these financial statements do not include all of the information and footnotes required for complete financial statements and should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on May 6, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of management, all adjustments (which include normal recurring adjustments) necessary to present a fair presentation of the Company’s unaudited condensed consolidated financial position as of March 31, 2025, its consolidated results of operations for the three months ended March 31, 2025, cash flows for the three months ended March 31, 2025 and change in equity for the three months ended March 31, 2025, as applicable, have been made. Operating results for the three months ended March 31, 2025 are not necessarily indicative of the operating results that may be expected for the year ending December 31, 2024 or any future periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zFOWn5KTh9zb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86D_zmlfvsZkac91">Concentrations of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were three customers who represent <span id="xdx_901_ecustom--ConcentrationRiskPercentage2_pip0_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zmaQq6b56Ks5" title="Concentration risk">69.67</span>% of the Company’s total revenue for the three months ended March 31, 2024. There were four customers who represent <span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_pip0_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_ztpBNOnVEBmb" title="Concentration risk">84.6</span>% of the Company’s total revenue for the three months ended March 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of single customers who represent 10% or more of the Company’s total accounts receivable, net:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zAfldNYycrA2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B9_zD0EEWmSeUN1" style="display: none">Schedule of concentrations of credit risk</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Percentage of the Company’s accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_904_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzjgf8EK2m73" title="Concentration percentage">21.46</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbcdME21ur3d" title="Concentration percentage">36.78</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z00hgE0Hq0Ek" title="Concentration percentage">24.24</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z59Ns8LqDsw" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zVIRsfGdVc19" title="Concentration percentage">18.41</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbseDiFrYBbg" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsUpB5OuZGD8" title="Concentration percentage">20.49</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zhDKESR7321f" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_znY8zX1RYTA6" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zcX8JOOdjmM3" title="Concentration percentage">17.82</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Customer F</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerFMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zccZtADSOV9g" title="Concentration percentage">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerFMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5AlORBN5Ye9" title="Concentration percentage">15.07</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--AllCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxewIKemVop2" title="Concentration percentage">84.6</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--AllCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFQo8Jig0XYd" title="Concentration percentage">69.67</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of single suppliers who represent 10% or more of the Company’s total purchase:</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Percentage of the Company’s purchase</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify">Supplier A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_906_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_zuOCZVKFVBXa" title="Concentration percentage">10.12</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_906_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_zjS4aIYgZL55" title="Concentration percentage">–</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zLa3Ypv3AHO7" title="Concentration percentage">12.40</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zMGivJjY6Ei9" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Supplier C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zHXxBf2cbZSh" title="Concentration percentage">17.60</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_z4U016mrXaWf" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierDMember_zmx3ceCS9I18" title="Concentration percentage">11.96</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierDMember_ztAfhtzNjt67" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Supplier E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zlG6YXHEifc3" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zJNIKIICWJ72" title="Concentration percentage">13.72</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierFMember_zZz3I2SemNA" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierFMember_zmUIAXkyPDol" title="Concentration percentage">12.47</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Supplier G</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierGMember_zIAZGBvkHcck" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierGMember_zyAWf3Ijbbh7" title="Concentration percentage">12.85</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier H</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierHMember_z9kOkPZliLx" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierHMember_zrR7YydiVSD1" title="Concentration percentage">11.24</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Supplier I</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierIMember_z5TLWiiFtlRh" title="Concentration percentage">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierIMember_zyPq9rbuIhQj" title="Concentration percentage">12.24</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllSuppliersMember_znqUR6S1Latd" title="Concentration percentage">52.08</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllSuppliersMember_zIsO5xVeKL1i" title="Concentration percentage">62.52</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zq76kM200bdl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_z3EpNHO7nOF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_868_zpnpbGB1H1Zi">Revenue Recognition</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies the following steps:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 1: Identify the contract(s) with a customer</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 2: Identify the performance obligations in the contract</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 3: Determine the transaction price</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 4: Allocate the transaction price to the performance obligation in the contract</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company mainly offers and generates revenue from the fish trading business, bento box and fruit and vegetable processing business, and E-commerce live streaming business. Revenue recognition policies are discussed as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Aquatic product trading revenue </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company engages in the trading of fish, primarily eels. Revenue is generated when the Company receives customer orders specifying product types and requirements. Upon receiving an order, the Company arranges the harvesting of the eels, inspects the products to ensure compliance with the customer’s specifications, and coordinates delivery. Revenue is recognized at a point in time when control of the goods is transferred to the customer, typically upon delivery, which is the point at which the performance obligation is satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Bento box and produce processing revenue </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also operates a bento box and fresh produce processing business, primarily involving vegetables and fruits. The revenue recognition model for this segment is similar to the aquatic product trading business. Upon receiving customer orders, the Company processes and packages the required food or agricultural products, ensures product quality and conformity to order specifications, and arranges delivery. Revenue is recognized at a point in time, generally upon the transfer of the processed goods to the customer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>E-commerce live-streaming commission revenue </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acts as an agent in facilitating the sale of third-party products through live-streaming e-commerce platforms. The Company does not take control of the goods sold, and commission revenue is recognized on a net basis. Revenue is recognized at the point in time when the underlying product is sold and shipment is confirmed by the seller, which indicates the Company has fulfilled its performance obligation of facilitating the sale.<span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zq81aY3sgq9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_z5T0rF2Tlxig">Recent Accounting Pronouncements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The FASB issued several updates during the period, none of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the consolidated financial statements upon adoption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zTpolT9wM5D9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_866_zKxsgrh4pRL6">Basis of Presentation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, these financial statements do not include all of the information and footnotes required for complete financial statements and should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on May 6, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of management, all adjustments (which include normal recurring adjustments) necessary to present a fair presentation of the Company’s unaudited condensed consolidated financial position as of March 31, 2025, its consolidated results of operations for the three months ended March 31, 2025, cash flows for the three months ended March 31, 2025 and change in equity for the three months ended March 31, 2025, as applicable, have been made. Operating results for the three months ended March 31, 2025 are not necessarily indicative of the operating results that may be expected for the year ending December 31, 2024 or any future periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zFOWn5KTh9zb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86D_zmlfvsZkac91">Concentrations of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were three customers who represent <span id="xdx_901_ecustom--ConcentrationRiskPercentage2_pip0_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zmaQq6b56Ks5" title="Concentration risk">69.67</span>% of the Company’s total revenue for the three months ended March 31, 2024. There were four customers who represent <span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_pip0_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_ztpBNOnVEBmb" title="Concentration risk">84.6</span>% of the Company’s total revenue for the three months ended March 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of single customers who represent 10% or more of the Company’s total accounts receivable, net:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zAfldNYycrA2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B9_zD0EEWmSeUN1" style="display: none">Schedule of concentrations of credit risk</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Percentage of the Company’s accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_904_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzjgf8EK2m73" title="Concentration percentage">21.46</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbcdME21ur3d" title="Concentration percentage">36.78</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z00hgE0Hq0Ek" title="Concentration percentage">24.24</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z59Ns8LqDsw" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zVIRsfGdVc19" title="Concentration percentage">18.41</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbseDiFrYBbg" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsUpB5OuZGD8" title="Concentration percentage">20.49</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zhDKESR7321f" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_znY8zX1RYTA6" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zcX8JOOdjmM3" title="Concentration percentage">17.82</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Customer F</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerFMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zccZtADSOV9g" title="Concentration percentage">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerFMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5AlORBN5Ye9" title="Concentration percentage">15.07</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--AllCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxewIKemVop2" title="Concentration percentage">84.6</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--AllCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFQo8Jig0XYd" title="Concentration percentage">69.67</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of single suppliers who represent 10% or more of the Company’s total purchase:</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Percentage of the Company’s purchase</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify">Supplier A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_906_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_zuOCZVKFVBXa" title="Concentration percentage">10.12</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_906_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_zjS4aIYgZL55" title="Concentration percentage">–</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zLa3Ypv3AHO7" title="Concentration percentage">12.40</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zMGivJjY6Ei9" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Supplier C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zHXxBf2cbZSh" title="Concentration percentage">17.60</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_z4U016mrXaWf" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierDMember_zmx3ceCS9I18" title="Concentration percentage">11.96</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierDMember_ztAfhtzNjt67" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Supplier E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zlG6YXHEifc3" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zJNIKIICWJ72" title="Concentration percentage">13.72</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierFMember_zZz3I2SemNA" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierFMember_zmUIAXkyPDol" title="Concentration percentage">12.47</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Supplier G</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierGMember_zIAZGBvkHcck" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierGMember_zyAWf3Ijbbh7" title="Concentration percentage">12.85</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier H</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierHMember_z9kOkPZliLx" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierHMember_zrR7YydiVSD1" title="Concentration percentage">11.24</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Supplier I</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierIMember_z5TLWiiFtlRh" title="Concentration percentage">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierIMember_zyPq9rbuIhQj" title="Concentration percentage">12.24</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllSuppliersMember_znqUR6S1Latd" title="Concentration percentage">52.08</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllSuppliersMember_zIsO5xVeKL1i" title="Concentration percentage">62.52</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zq76kM200bdl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> 0.6967 0.846 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zAfldNYycrA2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B9_zD0EEWmSeUN1" style="display: none">Schedule of concentrations of credit risk</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Percentage of the Company’s accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_904_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzjgf8EK2m73" title="Concentration percentage">21.46</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbcdME21ur3d" title="Concentration percentage">36.78</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z00hgE0Hq0Ek" title="Concentration percentage">24.24</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z59Ns8LqDsw" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zVIRsfGdVc19" title="Concentration percentage">18.41</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbseDiFrYBbg" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsUpB5OuZGD8" title="Concentration percentage">20.49</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zhDKESR7321f" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_znY8zX1RYTA6" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zcX8JOOdjmM3" title="Concentration percentage">17.82</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Customer F</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_905_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__srt--MajorCustomersAxis__custom--CustomerFMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zccZtADSOV9g" title="Concentration percentage">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--CustomerFMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5AlORBN5Ye9" title="Concentration percentage">15.07</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__srt--MajorCustomersAxis__custom--AllCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zxewIKemVop2" title="Concentration percentage">84.6</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__srt--MajorCustomersAxis__custom--AllCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFQo8Jig0XYd" title="Concentration percentage">69.67</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of single suppliers who represent 10% or more of the Company’s total purchase:</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Percentage of the Company’s purchase</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify">Supplier A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_906_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_zuOCZVKFVBXa" title="Concentration percentage">10.12</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_906_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_zjS4aIYgZL55" title="Concentration percentage">–</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zLa3Ypv3AHO7" title="Concentration percentage">12.40</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zMGivJjY6Ei9" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Supplier C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zHXxBf2cbZSh" title="Concentration percentage">17.60</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_z4U016mrXaWf" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier D</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierDMember_zmx3ceCS9I18" title="Concentration percentage">11.96</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierDMember_ztAfhtzNjt67" title="Concentration percentage">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Supplier E</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zlG6YXHEifc3" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierEMember_zJNIKIICWJ72" title="Concentration percentage">13.72</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier F</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierFMember_zZz3I2SemNA" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierFMember_zmUIAXkyPDol" title="Concentration percentage">12.47</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Supplier G</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierGMember_zIAZGBvkHcck" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierGMember_zyAWf3Ijbbh7" title="Concentration percentage">12.85</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier H</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierHMember_z9kOkPZliLx" title="Concentration percentage">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierHMember_zrR7YydiVSD1" title="Concentration percentage">11.24</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Supplier I</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierIMember_z5TLWiiFtlRh" title="Concentration percentage">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierIMember_zyPq9rbuIhQj" title="Concentration percentage">12.24</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllSuppliersMember_znqUR6S1Latd" title="Concentration percentage">52.08</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllSuppliersMember_zIsO5xVeKL1i" title="Concentration percentage">62.52</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0.2146 0.3678 0.2424 0 0.1841 0 0.2049 0 0 0.1782 0 0.1507 0.846 0.6967 0.1012 0 0.1240 0 0.1760 0 0.1196 0 0 0.1372 0 0.1247 0 0.1285 0 0.1124 0 0.1224 0.5208 0.6252 <p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_z3EpNHO7nOF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_868_zpnpbGB1H1Zi">Revenue Recognition</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies the following steps:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 1: Identify the contract(s) with a customer</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 2: Identify the performance obligations in the contract</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 3: Determine the transaction price</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 4: Allocate the transaction price to the performance obligation in the contract</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company mainly offers and generates revenue from the fish trading business, bento box and fruit and vegetable processing business, and E-commerce live streaming business. Revenue recognition policies are discussed as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Aquatic product trading revenue </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company engages in the trading of fish, primarily eels. Revenue is generated when the Company receives customer orders specifying product types and requirements. Upon receiving an order, the Company arranges the harvesting of the eels, inspects the products to ensure compliance with the customer’s specifications, and coordinates delivery. Revenue is recognized at a point in time when control of the goods is transferred to the customer, typically upon delivery, which is the point at which the performance obligation is satisfied.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Bento box and produce processing revenue </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also operates a bento box and fresh produce processing business, primarily involving vegetables and fruits. The revenue recognition model for this segment is similar to the aquatic product trading business. Upon receiving customer orders, the Company processes and packages the required food or agricultural products, ensures product quality and conformity to order specifications, and arranges delivery. Revenue is recognized at a point in time, generally upon the transfer of the processed goods to the customer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>E-commerce live-streaming commission revenue </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acts as an agent in facilitating the sale of third-party products through live-streaming e-commerce platforms. The Company does not take control of the goods sold, and commission revenue is recognized on a net basis. Revenue is recognized at the point in time when the underlying product is sold and shipment is confirmed by the seller, which indicates the Company has fulfilled its performance obligation of facilitating the sale.<span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zq81aY3sgq9l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_z5T0rF2Tlxig">Recent Accounting Pronouncements</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The FASB issued several updates during the period, none of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the consolidated financial statements upon adoption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p id="xdx_80D_eus-gaap--AccountsAndNontradeReceivableTextBlock_zdM99fhR4jZ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 3     <span id="xdx_823_zlbrfqM0KsHe">ACCOUNTS RECEIVABLE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2025 and December 31, 2024, accounts receivable consisted of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zUqDYvTfXkGj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, NET (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B4_zRsA1fOaZYWl" style="display: none">Schedule of accounts receivable</span></td> <td> </td> <td colspan="2" id="xdx_492_20250331_zCjJz5WQ1Lh3" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_494_20241231_zTEfyuDDLHI" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, <br/> 2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, <br/> 2024</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td></tr> <tr id="xdx_409_eus-gaap--AccountsReceivableGross_iI_pp0p0_maARNCz8j7_zhLoGjYXQ2oi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; width: 66%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable</span></td> <td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,106</span></td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">144,509</span></td> <td style="padding-bottom: 1pt; width: 1%"> </td></tr> <tr id="xdx_406_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNCz8j7_zzS2vdkdfvX4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,106</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">144,509</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zUqDYvTfXkGj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, NET (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B4_zRsA1fOaZYWl" style="display: none">Schedule of accounts receivable</span></td> <td> </td> <td colspan="2" id="xdx_492_20250331_zCjJz5WQ1Lh3" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_494_20241231_zTEfyuDDLHI" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, <br/> 2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, <br/> 2024</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td></tr> <tr id="xdx_409_eus-gaap--AccountsReceivableGross_iI_pp0p0_maARNCz8j7_zhLoGjYXQ2oi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; width: 66%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable</span></td> <td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,106</span></td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">144,509</span></td> <td style="padding-bottom: 1pt; width: 1%"> </td></tr> <tr id="xdx_406_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNCz8j7_zzS2vdkdfvX4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,106</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">144,509</span></td> <td> </td></tr> </table> 134106 144509 134106 144509 <p id="xdx_805_eus-gaap--InventoryDisclosureTextBlock_z1bMBA532iZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 4      <span id="xdx_823_zdNlCFameRVl">INVENTORIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2025 and December 31, 2024, inventories consisted of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zvQpiudYHid8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B1_zN2JNrQVTXLj" style="display: none">Schedule of inventories</span></td><td> </td> <td colspan="2" id="xdx_493_20250331_zXNmlBAxX7Wd" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_493_20241231_zfSwv502h3sb" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_406_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_pp0p0_d0_maINzpAZ_zfe8fvsJQP5a" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; width: 66%; text-align: justify">Raw materials</td><td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">9,608</td><td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td><td style="border-bottom: black 1pt solid; text-align: right; width: 13%">–</td><td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryNet_iTI_pp0p0_d0_mtINzpAZ_z34GCQ7LUgek" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">9,608</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zvQpiudYHid8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B1_zN2JNrQVTXLj" style="display: none">Schedule of inventories</span></td><td> </td> <td colspan="2" id="xdx_493_20250331_zXNmlBAxX7Wd" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_493_20241231_zfSwv502h3sb" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_406_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_pp0p0_d0_maINzpAZ_zfe8fvsJQP5a" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; width: 66%; text-align: justify">Raw materials</td><td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">9,608</td><td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td><td style="border-bottom: black 1pt solid; text-align: right; width: 13%">–</td><td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--InventoryNet_iTI_pp0p0_d0_mtINzpAZ_z34GCQ7LUgek" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">9,608</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 9608 0 9608 0 <p id="xdx_80F_ecustom--AdvanceToSuppliersTextBlock_zw1zY4wxRvU3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 5     <span id="xdx_828_zy7dG1aADeU3">ADVANCE TO SUPPLIERS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Balances of advances to suppliers were $<span id="xdx_909_eus-gaap--AccountsAndOtherReceivablesNetCurrent_pp0p0_c20250331_zUpO1DA6JTU" title="Advances to suppliers">1,732</span> and $<span id="xdx_90F_eus-gaap--AccountsAndOtherReceivablesNetCurrent_pp0p0_c20241231_zD6TJhkqAy68" title="Advances to suppliers">8,404</span> as of March 31, 2025 and December 31, 2024, respectively, which represented prepayments to suppliers for raw materials.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> 1732 8404 <p id="xdx_807_eus-gaap--OtherCurrentAssetsTextBlock_zbUovfyzZTYf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 6      <span id="xdx_826_zn98fzs7yiS3">PREPAID EXPENSES AND OTHER ASSETS, NET</span></b></p> <table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zDpwQIl8F1ll" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B5_ztl9IoGPwocf" style="display: none">Schedule of prepaid expenses and other assets</span></td><td> </td> <td colspan="2" id="xdx_49D_20250331_zHleuMktatD1" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_491_20241231_zmrQ7aZ7IFPe" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_409_eus-gaap--PrepaidExpenseCurrent_iI_zTujC3vWw8w2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Prepaid Expenses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">41,623</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">43,158</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PrepaidExpenseAndOtherAssets_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Other receivables from third party</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">556,576</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">600,011</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Prepaid expenses and other assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">598,199</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">643,169</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other receivables as of March 31, 2025 and December 31, 2024 were $<span id="xdx_906_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20250331_zfqIuLpsB65h" title="Other receivables">598,199</span> and $<span id="xdx_907_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_c20241231_zgiJ2P1hbPSk" title="Other receivables">643,169</span>, respectively. Other receivables include e-commerce live stream receivables for goods and e-commerce sales deposit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other receivables from third parties primarily consist of amount due from third parties of $<span id="xdx_90B_eus-gaap--PrepaidExpenseAndOtherAssets_iI_c20250331__us-gaap--BalanceSheetLocationAxis__custom--DueFromThirdPartiesMember_zeHWYqx9sYZd" title="Other receivables from third party">345,980</span>, e-commerce live stream sales deposits of $<span id="xdx_909_eus-gaap--PrepaidExpenseAndOtherAssets_iI_c20250331__us-gaap--BalanceSheetLocationAxis__custom--ECommerceLiveStreamSalesDepositsMember_zivhs4FahJ33" title="Other receivables from third party">5,487</span>, and outstanding loans to certain employees totaling $<span id="xdx_900_eus-gaap--PrepaidExpenseAndOtherAssets_iI_c20250331__us-gaap--BalanceSheetLocationAxis__custom--XincaEmployeeLoansMember_zeP75GBwalN6" title="Other receivables from third party">15,326</span> from Xinca and $<span id="xdx_908_eus-gaap--PrepaidExpenseAndOtherAssets_iI_c20250331__us-gaap--BalanceSheetLocationAxis__custom--SYMediaDepositsMember_zJ7ZvtDc47Xd" title="Other receivables from third party">187,646</span> from SY Media, related to the Company’s participation in live stream events. These receivables are expected to be collected within normal payment cycles and are considered part of ongoing operations. Additionally, $<span id="xdx_904_eus-gaap--PrepaidExpenseAndOtherAssets_iI_c20250331__us-gaap--BalanceSheetLocationAxis__custom--PriorYearReceivablesFromGZGSIMember_zHE3Lnql9Pfh" title="Other receivables from third party">1,106</span> relates to prior-year receivables from GZ GSI for fish sales in China. Management does not expect any collection issues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_881_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zDpwQIl8F1ll" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B5_ztl9IoGPwocf" style="display: none">Schedule of prepaid expenses and other assets</span></td><td> </td> <td colspan="2" id="xdx_49D_20250331_zHleuMktatD1" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_491_20241231_zmrQ7aZ7IFPe" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_409_eus-gaap--PrepaidExpenseCurrent_iI_zTujC3vWw8w2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Prepaid Expenses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">41,623</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">43,158</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PrepaidExpenseAndOtherAssets_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Other receivables from third party</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">556,576</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">600,011</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Prepaid expenses and other assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">598,199</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">643,169</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 41623 43158 556576 600011 598199 643169 598199 643169 345980 5487 15326 187646 1106 <p id="xdx_805_eus-gaap--FairValueDisclosuresTextBlock_zErHGRRZnv5a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 7      <span id="xdx_823_zdVRtO307U1">FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of each investment in equity instrument to be measured at fair value through profit or loss is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfServicingAssetsAtFairValueTextBlock_zZmSGUdrUW53" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BE_zroMbByNTaV4" style="display: none">Schedule of financial assets at fair value through profit or loss</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Financial assets mandatorily measured at fair value through profit or loss</td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Funds</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><span id="xdx_90B_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20250331__us-gaap--FinancialInstrumentAxis__custom--FundsMember_zxsUSfcwuPZj" title="Fair value of financial asset">–</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><span id="xdx_908_eus-gaap--AssetsFairValueDisclosure_iI_c20241231__us-gaap--FinancialInstrumentAxis__custom--FundsMember_zIJ6kspDsUoj" title="Fair value of financial asset">210</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20250331_zSnM0EERJx4l" title="Fair value of financial asset">–</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--AssetsFairValueDisclosure_iI_c20241231_zpyFTFoDEdX" title="Fair value of financial asset">210</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20250331__us-gaap--FinancialInstrumentPerformanceStatusAxis__custom--CurrentMember_z6IGm96bPSYa" title="Fair value of financial asset">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--AssetsFairValueDisclosure_iI_c20241231__us-gaap--FinancialInstrumentPerformanceStatusAxis__custom--CurrentMember_zX7Gj3H5ZDNa" title="Fair value of financial asset">210</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Non-Current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20250331__us-gaap--FinancialInstrumentPerformanceStatusAxis__custom--NoncurrentMember_zWY7fAYJh9qf" title="Fair value of financial asset">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20241231__us-gaap--FinancialInstrumentPerformanceStatusAxis__custom--NoncurrentMember_zuf6hgaT8yf8" title="Fair value of financial asset">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20250331_zEZ8muNpmBvf" title="Fair value of financial asset">–</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--AssetsFairValueDisclosure_iI_c20241231_zTnZVvXO9cFk" title="Fair value of financial asset">210</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net gain on disposal of financial assets at FVTPL of $<span id="xdx_90D_eus-gaap--GainLossOnDispositionOfOtherFinancialAssets_pp0p0_c20250101__20250331_zBWo7PAVjyG5">3</span> was recognized in the consolidated statement of profit or loss for the period ended March 31, 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2024, no financial assets at fair value through profit or loss were pledged with banks as collaterals.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfServicingAssetsAtFairValueTextBlock_zZmSGUdrUW53" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BE_zroMbByNTaV4" style="display: none">Schedule of financial assets at fair value through profit or loss</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: justify"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Financial assets mandatorily measured at fair value through profit or loss</td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify; padding-bottom: 1pt">Funds</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><span id="xdx_90B_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20250331__us-gaap--FinancialInstrumentAxis__custom--FundsMember_zxsUSfcwuPZj" title="Fair value of financial asset">–</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><span id="xdx_908_eus-gaap--AssetsFairValueDisclosure_iI_c20241231__us-gaap--FinancialInstrumentAxis__custom--FundsMember_zIJ6kspDsUoj" title="Fair value of financial asset">210</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20250331_zSnM0EERJx4l" title="Fair value of financial asset">–</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--AssetsFairValueDisclosure_iI_c20241231_zpyFTFoDEdX" title="Fair value of financial asset">210</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20250331__us-gaap--FinancialInstrumentPerformanceStatusAxis__custom--CurrentMember_z6IGm96bPSYa" title="Fair value of financial asset">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--AssetsFairValueDisclosure_iI_c20241231__us-gaap--FinancialInstrumentPerformanceStatusAxis__custom--CurrentMember_zX7Gj3H5ZDNa" title="Fair value of financial asset">210</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Non-Current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20250331__us-gaap--FinancialInstrumentPerformanceStatusAxis__custom--NoncurrentMember_zWY7fAYJh9qf" title="Fair value of financial asset">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20241231__us-gaap--FinancialInstrumentPerformanceStatusAxis__custom--NoncurrentMember_zuf6hgaT8yf8" title="Fair value of financial asset">–</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--AssetsFairValueDisclosure_iI_d0_c20250331_zEZ8muNpmBvf" title="Fair value of financial asset">–</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--AssetsFairValueDisclosure_iI_c20241231_zTnZVvXO9cFk" title="Fair value of financial asset">210</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0 210 0 210 0 210 0 0 0 210 3 <p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zZafaZM5CUni" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 8      <span id="xdx_822_zwnLv8OxNwR2">PROPERTY AND EQUIPMENT, NET</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2025 and December 31, 2024, property and equipment consisted of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_ztQ0howll2wg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT, NET (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zFF8jOodKBX1" style="display: none">Schedule of property and equipment</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Land</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zLsYTG008Gkj" style="width: 13%; text-align: right" title="Property and equipment, gross">877,870</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zuVqKUojAAub" style="width: 13%; text-align: right" title="Property and equipment, gross">877,870</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_z5YRMicPGzi9" style="text-align: right" title="Property and equipment, gross">901,356</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zv7dsR0ZFPg5" style="text-align: right" title="Property and equipment, gross">911,280</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20250331_zRHUsSlZndOe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation">(437,166</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20241231_z1XPiCgLYwPl" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation">(397,305</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_pp0p0_c20250331_znUfmTxTCYac" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">1,342,060</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_pp0p0_c20241231_zyGRc4e7jcHb" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">1,391,845</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expenses for the three months ended March 31, 2025 and 2024 were $<span id="xdx_909_eus-gaap--Depreciation_pp0p0_c20250101__20250331_z21R1Nz9sGsa" title="Depreciation expense">33,674</span> and $<span id="xdx_908_eus-gaap--Depreciation_pp0p0_c20240101__20240331_zShU0VnkfkO2" title="Depreciation expense">22,559</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_ztQ0howll2wg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT, NET (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B2_zFF8jOodKBX1" style="display: none">Schedule of property and equipment</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Land</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zLsYTG008Gkj" style="width: 13%; text-align: right" title="Property and equipment, gross">877,870</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LandMember_zuVqKUojAAub" style="width: 13%; text-align: right" title="Property and equipment, gross">877,870</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_z5YRMicPGzi9" style="text-align: right" title="Property and equipment, gross">901,356</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20241231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zv7dsR0ZFPg5" style="text-align: right" title="Property and equipment, gross">911,280</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20250331_zRHUsSlZndOe" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation">(437,166</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20241231_z1XPiCgLYwPl" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation">(397,305</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentNet_pp0p0_c20250331_znUfmTxTCYac" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">1,342,060</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentNet_pp0p0_c20241231_zyGRc4e7jcHb" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">1,391,845</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 877870 877870 901356 911280 437166 397305 1342060 1391845 33674 22559 <p id="xdx_800_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zT1Xu0heiTbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 9     <span id="xdx_82C_zEiwYJFKPkdc">GOODWILL AND OTHER INTANGIBLE ASSETS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2025 and December 31, 2024, goodwill consisted of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Goodwill</b></p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfGoodwillTextBlock_zoGFEtxvVsQ4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Goodwill)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B9_zzAMj9DUxVq6" style="display: none">Schedule of goodwill</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Goodwill - Meixin</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--Goodwill_iI_pp0p0_c20250331__dei--LegalEntityAxis__custom--MeixinMember_zuDMMkSLOFk1" style="width: 13%; text-align: right" title="Goodwill">3,905,735</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--Goodwill_pp0p0_c20241231__dei--LegalEntityAxis__custom--MeixinMember_zGPGVEjESalc" style="width: 13%; text-align: right" title="Goodwill">3,905,735</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Goodwill - Xinca</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Goodwill_iI_pp0p0_c20250331__dei--LegalEntityAxis__custom--XincaMember_zTxiN0wcH7Sd" style="text-align: right" title="Goodwill">1,351,703</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Goodwill_iI_pp0p0_c20241231__dei--LegalEntityAxis__custom--XincaMember_zIoXVg8Pz5B4" style="text-align: right" title="Goodwill">1,351,703</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Goodwill - SY Media</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Goodwill_iI_pp0p0_c20250331__dei--LegalEntityAxis__custom--SYMediaMember_zCiFNOjhJRx7" style="text-align: right" title="Goodwill">230,015</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Goodwill_iI_pp0p0_c20241231__dei--LegalEntityAxis__custom--SYMediaMember_z7mZavDiDuGk" style="text-align: right" title="Goodwill">230,015</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less: Impairment</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iNI_pp0p0_di_c20250331_zTn20Jt5Ixcj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Impairment">(3,409,725</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iNI_pp0p0_di_c20241231_zlxiG5dQ7saf" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Impairment">(3,409,725</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Goodwill, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--Goodwill_iI_c20250331_zQulj8QriTkg" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill">2,077,728</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--Goodwill_iI_c20241231_zR1RfnXiuce4" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill">2,077,728</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_z2sK5ACFKjx4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Customer relations</b></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zVFvQJBnUqQ9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Customer relations)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_z4Yg2sALJbA" style="display: none">Schedule of customer relations</span></td> <td> </td> <td colspan="2" id="xdx_49D_20250331_zkyIL1EvNL4d" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_496_20241231_zYMuUQleD1C9" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_zJDaVtYEEje8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisitions</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,325</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,325</span></td> <td style="width: 1%"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_zG2i5HLvrdDl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Accumulated amortization</span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41,576</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(37,500</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_z2zSQEOOCxY2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Customer relations, net</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,749</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,825</span></td> <td> </td></tr> </table> <p id="xdx_8A1_z9aTKSOGCOPb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfGoodwillTextBlock_zoGFEtxvVsQ4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Goodwill)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B9_zzAMj9DUxVq6" style="display: none">Schedule of goodwill</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Goodwill - Meixin</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--Goodwill_iI_pp0p0_c20250331__dei--LegalEntityAxis__custom--MeixinMember_zuDMMkSLOFk1" style="width: 13%; text-align: right" title="Goodwill">3,905,735</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--Goodwill_pp0p0_c20241231__dei--LegalEntityAxis__custom--MeixinMember_zGPGVEjESalc" style="width: 13%; text-align: right" title="Goodwill">3,905,735</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Goodwill - Xinca</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Goodwill_iI_pp0p0_c20250331__dei--LegalEntityAxis__custom--XincaMember_zTxiN0wcH7Sd" style="text-align: right" title="Goodwill">1,351,703</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Goodwill_iI_pp0p0_c20241231__dei--LegalEntityAxis__custom--XincaMember_zIoXVg8Pz5B4" style="text-align: right" title="Goodwill">1,351,703</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Goodwill - SY Media</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Goodwill_iI_pp0p0_c20250331__dei--LegalEntityAxis__custom--SYMediaMember_zCiFNOjhJRx7" style="text-align: right" title="Goodwill">230,015</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Goodwill_iI_pp0p0_c20241231__dei--LegalEntityAxis__custom--SYMediaMember_z7mZavDiDuGk" style="text-align: right" title="Goodwill">230,015</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less: Impairment</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iNI_pp0p0_di_c20250331_zTn20Jt5Ixcj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Impairment">(3,409,725</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--GoodwillImpairedAccumulatedImpairmentLoss_iNI_pp0p0_di_c20241231_zlxiG5dQ7saf" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Impairment">(3,409,725</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Goodwill, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98F_eus-gaap--Goodwill_iI_c20250331_zQulj8QriTkg" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill">2,077,728</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--Goodwill_iI_c20241231_zR1RfnXiuce4" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill">2,077,728</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3905735 3905735 1351703 1351703 230015 230015 3409725 3409725 2077728 2077728 <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zVFvQJBnUqQ9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Customer relations)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_z4Yg2sALJbA" style="display: none">Schedule of customer relations</span></td> <td> </td> <td colspan="2" id="xdx_49D_20250331_zkyIL1EvNL4d" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_496_20241231_zYMuUQleD1C9" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_zJDaVtYEEje8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisitions</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,325</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,325</span></td> <td style="width: 1%"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_zG2i5HLvrdDl" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Accumulated amortization</span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41,576</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(37,500</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_z2zSQEOOCxY2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Customer relations, net</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,749</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97,825</span></td> <td> </td></tr> </table> 135325 135325 41576 37500 93749 97825 <p id="xdx_80A_eus-gaap--DebtDisclosureTextBlock_zkAVQdrogdM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 10      <span id="xdx_827_zo9lYkMPw6E6"> OTHER BORROWINGS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Others loans consisted of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfDebtTableTextBlock_zY7G5dAk9iBg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER BORROWINGS (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_zPy8nBijmeXd" style="display: none">Schedule of other loans</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left; padding-bottom: 1pt">Secured car loan from CITIC Bank wholly repayable</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherLongTermDebt_iI_pp0p0_c20250331__us-gaap--DebtInstrumentAxis__custom--CITICCarLoanMember_z6hS0nVnu962" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Others loans current">28,868</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherLongTermDebt_iI_pp0p0_c20241231__us-gaap--DebtInstrumentAxis__custom--CITICCarLoanMember_zbi6hHFy5V1j" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Others loans current">30,417</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total secured car loan wholly repayable within 1 year</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OtherLongTermDebtCurrent_iI_pp0p0_c20250331__us-gaap--DebtInstrumentAxis__custom--CITICCarLoanMember_zARxaseIFqd9" style="text-align: right" title="Total others loans current">28,868</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OtherLongTermDebtCurrent_iI_pp0p0_c20241231__us-gaap--DebtInstrumentAxis__custom--CITICCarLoanMember_z0OSA6GpE8dk" style="text-align: right" title="Total others loans current">6,631</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Secured car loan from CITIC Bank wholly repayable more than 1 year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--OtherLongTermDebtNoncurrent_iI_pp0p0_d0_c20250331__us-gaap--DebtInstrumentAxis__custom--CITICCarLoanMember_zFamElZsgcj6" style="border-bottom: Black 1pt solid; text-align: right" title="Others loans noncurrent">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherLongTermDebtNoncurrent_iI_pp0p0_c20241231__us-gaap--DebtInstrumentAxis__custom--CITICCarLoanMember_zWO4SrWVIK9i" style="border-bottom: Black 1pt solid; text-align: right" title="Others loans noncurrent">23,786</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--OtherLongTermDebtNoncurrent_iI_pp0p0_c20250331_zs4DyBtG393l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total others loans noncurrent">28,868</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherLongTermDebtNoncurrent_iI_pp0p0_c20241231_zWUv3pyVpebg" style="border-bottom: Black 2.5pt double; text-align: right" title="Total others loans noncurrent">30,417</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfDebtTableTextBlock_zY7G5dAk9iBg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER BORROWINGS (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B8_zPy8nBijmeXd" style="display: none">Schedule of other loans</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: left; padding-bottom: 1pt">Secured car loan from CITIC Bank wholly repayable</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--OtherLongTermDebt_iI_pp0p0_c20250331__us-gaap--DebtInstrumentAxis__custom--CITICCarLoanMember_z6hS0nVnu962" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Others loans current">28,868</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--OtherLongTermDebt_iI_pp0p0_c20241231__us-gaap--DebtInstrumentAxis__custom--CITICCarLoanMember_zbi6hHFy5V1j" style="border-bottom: Black 1pt solid; width: 13%; text-align: right" title="Others loans current">30,417</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Total secured car loan wholly repayable within 1 year</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--OtherLongTermDebtCurrent_iI_pp0p0_c20250331__us-gaap--DebtInstrumentAxis__custom--CITICCarLoanMember_zARxaseIFqd9" style="text-align: right" title="Total others loans current">28,868</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--OtherLongTermDebtCurrent_iI_pp0p0_c20241231__us-gaap--DebtInstrumentAxis__custom--CITICCarLoanMember_z0OSA6GpE8dk" style="text-align: right" title="Total others loans current">6,631</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Secured car loan from CITIC Bank wholly repayable more than 1 year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--OtherLongTermDebtNoncurrent_iI_pp0p0_d0_c20250331__us-gaap--DebtInstrumentAxis__custom--CITICCarLoanMember_zFamElZsgcj6" style="border-bottom: Black 1pt solid; text-align: right" title="Others loans noncurrent">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--OtherLongTermDebtNoncurrent_iI_pp0p0_c20241231__us-gaap--DebtInstrumentAxis__custom--CITICCarLoanMember_zWO4SrWVIK9i" style="border-bottom: Black 1pt solid; text-align: right" title="Others loans noncurrent">23,786</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--OtherLongTermDebtNoncurrent_iI_pp0p0_c20250331_zs4DyBtG393l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total others loans noncurrent">28,868</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--OtherLongTermDebtNoncurrent_iI_pp0p0_c20241231_zWUv3pyVpebg" style="border-bottom: Black 2.5pt double; text-align: right" title="Total others loans noncurrent">30,417</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 28868 30417 28868 6631 0 23786 28868 30417 <p id="xdx_80A_ecustom--WarrantDisclosureTextBlock_zBr1o7J3fpw1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 11     <span id="xdx_825_zkE69Q9iZbXh">WARRANTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2021, the Company entered into a securities purchase agreement with certain investors for an aggregate of 80,000 shares of its preferred stock at a per share purchase price of $2.50. As part of the transaction, the investors received one Class C warrant and one Class D warrant for the subscription of each preferred share. The Class C warrants consist of the right to purchase up to <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210401__us-gaap--StatementClassOfStockAxis__custom--ClassCWarrantMember_z9EDrohTahIa" title="Warrants issued, shares">80,000</span> shares of the Company’s common stock at an exercise price of $2.50 per share exercisable for 36 months from the date of inception. The Class D warrants consist of the right to purchase up to <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210401__us-gaap--StatementClassOfStockAxis__custom--ClassDWarrantMember_zlTSAXjhCbtb" title="Warrants issued, shares">80,000</span> shares of the Company’s common stock at an exercise price of $5.00 per share exercisable for 36 months from the date of inception. The subscription was completed on August 10, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 27, 2021, the Company entered into another securities purchase agreement with the same investors, pursuant to which the Company issued in a registered direct offering, an aggregate of 48,000 shares of common stock of the Company at a per share purchase price of $2.50. In addition, the investors also received one Class C warrant and one Class D warrant for the subscription of each preferred share. The Class C warrants consist of the right to purchase up to <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210927__us-gaap--StatementClassOfStockAxis__custom--ClassCWarrantMember_zO33igYqwU82" title="Warrants issued, shares">80,000</span> shares of the Company’s common stock at an exercise price of $2.50 per share exercisable for 36 months from the date of inception. The Class D warrants consist of the right to purchase up to <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210927__us-gaap--StatementClassOfStockAxis__custom--ClassDWarrantMember_zFZOdqvY9fdg" title="Warrants issued, shares">80,000</span> shares of the Company’s common stock at an exercise price of $5.00 per share exercisable for 36 months from the date of inception.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the public offering and pursuant to a registration statement on Form S-1, amended (File No. 333-264059), originally filed with the SEC on April 1, 2022, and declared effective by the SEC on August 10, 2022 (the “Registration Statement”), the public offering price of each Unit was $3.50, and each unit consisting of one share of common stock and a warrant to purchase two shares of common stock from the date of issuance until the fifth anniversary of the date of issuance. The Shares and the Warrants comprising the Units were immediately separable and issued separately in the Offering, which closed on August 15, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the public offering and pursuant to the underwriting agreement between us and the underwriters named therein, we granted the underwriters a 45-day option to purchase up to 282,000 additional shares of common stock and warrants, equivalent to 15% of the Units sold in the public offering, at the public offering price per Unit, less underwriting discounts and commissions, to cover over-allotments, if any. On September 23, 2022, the underwriters exercised their option to purchase an additional <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220923__srt--CounterpartyNameAxis__custom--UnderwritersMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOffering2022Member_zYImEfh8SHMl" title="Warrants issued">282,000</span> warrants from us for gross proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfWarrants_c20220922__20220923__srt--CounterpartyNameAxis__custom--UnderwritersMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOffering2022Member_zBWV0D5HfIUa" title="Proceeds from warrants issued">2,820</span>. The warrants were issued to the underwriters on September 26, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise price of the Warrants shall be decreased to the reset price, which means the greater of (i) 50% of the exercise price and (ii) 100% of the last volume weighted average price immediately preceding the 90th calendar day following the initial issuance date (the greater of (i) and (ii), the “Reset Price”) if, on the date that is 90 calendar days immediately following the initial issuance date, the Reset Price is less than the exercise price on that date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a reconciliation of the beginning and ending balances of warrants liability measured at fair value on a recurring basis using Level 3 inputs:</p> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfWarrantLiabilitiesTableTextBlock_zLB8n41IhXG2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANTS (Details - Warrant Liability)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zmHaTsQLtD9c" style="display: none">Schedule of warranty liability activity</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Balance at the beginning of period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20250101__20250331_znfyvFKj3Zsk" style="width: 13%; text-align: right" title="Balance at the beginning of period">76,847</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20240101__20240331_zV3XNO6yObba" style="width: 13%; text-align: right" title="Balance at the beginning of period">874,116</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Fair value change of warrants included in earnings</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20250101__20250331_zOklIPBTVudh" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings">8,426</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20240101__20240331_z0ru5Zeg9um6" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings">(797,269</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at the end of the period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20250101__20250331_ze6K8gkhD5Wj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">85,273</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20240101__20240331_zJtqTFahm4W4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">76,847</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zRQfHmJclQU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of the warrant activities:</p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_zzm6NhCkkCB9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANTS (Details - Warrant Activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BF_zwvi2r7SY2T" style="display: none">Schedule of warrant activity</span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Warrants</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise Price</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Term in</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Years</b></p></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of January 1, 2025</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z39BJ1xsx1Jl" style="width: 11%; text-align: right" title="Number of warrants outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,239,870</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zS3JmOlzlaVd" style="width: 11%; text-align: right" title="Average exercise price outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zPYncQ6jQSr3" title="Weighted average remaining contractual term, Outstanding">2.63</span></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable as of January 1, 2025</span></td> <td> </td> <td> </td> <td id="xdx_985_ecustom--WarrantsExercisable_iS_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zd8iqBzgseq9" style="text-align: right" title="Number of warrants exercisable, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,239,870</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_983_ecustom--AverageExercisePriceExerciasable_iS_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z1QxEDpOIFpj" style="text-align: right" title="Average exercise price exercisable, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z446Qv2QyFO6" title="Weighted average remaining contractual term, Exercisable">2.63</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zKlhMcmA4SLg" style="text-align: right" title="Number of warrants, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_983_ecustom--AverageExercisePriceGranted_d0_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zCBhVBzDsiJ3" style="text-align: right" title="Average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised / surrendered</span></td> <td> </td> <td> </td> <td id="xdx_981_ecustom--WarrantsExercisedSurrendered_d0_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zcAW8nEkfbk3" style="text-align: right" title="Number of warrants, Exercised / surrendered"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_987_ecustom--AverageExercisePriceExercisedSurrendered_d0_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zZWz4Zazxmh9" style="text-align: right" title="Average exercise price, Exercised / surrendered"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_d0_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zIubEC2UNPg" style="text-align: right" title="Number of warrants, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_ecustom--WarrantWeightedAverageExercisePriceExpired_d0_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zdM73APoB38g" style="text-align: right" title="Average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of March 31, 2025</span></td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUUE1cRsP9vd" style="text-align: right" title="Number of warrants outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,239,870</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z13pc3wKcLL5" style="text-align: right" title="Average exercise price outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zpu10bSTgt8f" title="Weighted average remaining contractual term, Outstanding">2.38</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable as of March 31, 2025</span></td> <td> </td> <td> </td> <td id="xdx_98C_ecustom--WarrantsExercisable_iE_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zMEh7vWfM435" style="text-align: right" title="Number of warrants exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,239,870</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_984_ecustom--AverageExercisePriceExerciasable_iE_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zo5BTsNgmrdc" style="text-align: right" title="Average exercise price exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zrSvo0QER8Ql" title="Weighted average remaining contractual term, Exercisable">2.38</span></span></td> <td> </td></tr> </table> <p id="xdx_8A7_zh4oJGDaxBlk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 80000 80000 80000 80000 282000 2820 <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfWarrantLiabilitiesTableTextBlock_zLB8n41IhXG2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANTS (Details - Warrant Liability)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zmHaTsQLtD9c" style="display: none">Schedule of warranty liability activity</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: left">Balance at the beginning of period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20250101__20250331_znfyvFKj3Zsk" style="width: 13%; text-align: right" title="Balance at the beginning of period">76,847</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_c20240101__20240331_zV3XNO6yObba" style="width: 13%; text-align: right" title="Balance at the beginning of period">874,116</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Fair value change of warrants included in earnings</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20250101__20250331_zOklIPBTVudh" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings">8,426</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_c20240101__20240331_z0ru5Zeg9um6" style="border-bottom: Black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings">(797,269</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance at the end of the period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20250101__20250331_ze6K8gkhD5Wj" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">85,273</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_c20240101__20240331_zJtqTFahm4W4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">76,847</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 76847 874116 8426 -797269 85273 76847 <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_zzm6NhCkkCB9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - WARRANTS (Details - Warrant Activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BF_zwvi2r7SY2T" style="display: none">Schedule of warrant activity</span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Warrants</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise Price</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Term in</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Years</b></p></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 55%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of January 1, 2025</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_98C_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z39BJ1xsx1Jl" style="width: 11%; text-align: right" title="Number of warrants outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,239,870</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_980_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zS3JmOlzlaVd" style="width: 11%; text-align: right" title="Average exercise price outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zPYncQ6jQSr3" title="Weighted average remaining contractual term, Outstanding">2.63</span></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable as of January 1, 2025</span></td> <td> </td> <td> </td> <td id="xdx_985_ecustom--WarrantsExercisable_iS_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zd8iqBzgseq9" style="text-align: right" title="Number of warrants exercisable, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,239,870</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_983_ecustom--AverageExercisePriceExerciasable_iS_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z1QxEDpOIFpj" style="text-align: right" title="Average exercise price exercisable, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z446Qv2QyFO6" title="Weighted average remaining contractual term, Exercisable">2.63</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d0_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zKlhMcmA4SLg" style="text-align: right" title="Number of warrants, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_983_ecustom--AverageExercisePriceGranted_d0_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zCBhVBzDsiJ3" style="text-align: right" title="Average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised / surrendered</span></td> <td> </td> <td> </td> <td id="xdx_981_ecustom--WarrantsExercisedSurrendered_d0_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zcAW8nEkfbk3" style="text-align: right" title="Number of warrants, Exercised / surrendered"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_987_ecustom--AverageExercisePriceExercisedSurrendered_d0_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zZWz4Zazxmh9" style="text-align: right" title="Average exercise price, Exercised / surrendered"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_d0_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zIubEC2UNPg" style="text-align: right" title="Number of warrants, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98A_ecustom--WarrantWeightedAverageExercisePriceExpired_d0_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zdM73APoB38g" style="text-align: right" title="Average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding as of March 31, 2025</span></td> <td> </td> <td> </td> <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUUE1cRsP9vd" style="text-align: right" title="Number of warrants outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,239,870</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z13pc3wKcLL5" style="text-align: right" title="Average exercise price outstanding, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zpu10bSTgt8f" title="Weighted average remaining contractual term, Outstanding">2.38</span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable as of March 31, 2025</span></td> <td> </td> <td> </td> <td id="xdx_98C_ecustom--WarrantsExercisable_iE_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zMEh7vWfM435" style="text-align: right" title="Number of warrants exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,239,870</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_984_ecustom--AverageExercisePriceExerciasable_iE_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zo5BTsNgmrdc" style="text-align: right" title="Average exercise price exercisable, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250101__20250331__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zrSvo0QER8Ql" title="Weighted average remaining contractual term, Exercisable">2.38</span></span></td> <td> </td></tr> </table> 2239870 2.14 P2Y7M17D 2239870 2.14 P2Y7M17D 0 0 0 0 0 0 2239870 2.14 P2Y4M17D 2239870 2.14 P2Y4M17D <p id="xdx_80A_eus-gaap--LesseeOperatingLeasesTextBlock_zgi4aSt8YUc9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 12      <span id="xdx_827_zRr6h7C1QX59">LEASES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has two non-cancelable lease agreements for certain of the office and accommodation as well as fish farming containers for research and development of advanced technology for water circulation in fish farming containers with original lease periods expiring between 2024 and 2025. The lease terms may include options to extend or terminate the lease when it is reasonably certain the Company will exercise that option. The Company recognizes rental expense on a straight-line basis over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The components of lease expense for the three months ended March 31, 2025 and March 31, 2024 were as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--LeaseCostTableTextBlock_zjj0XlJu1WHj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Lease costs)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zzRU39Fe30Dg" style="display: none">Schedule of components of lease expenses</span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement of Income Location</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three months ended <br/> March 31, 2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three months ended <br/> March 31, 2024</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Costs</b></span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 30%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease expense</span></td> <td style="width: 2%"> </td> <td style="width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative expenses</span></td> <td style="width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td> <td id="xdx_980_eus-gaap--OperatingLeaseExpense_pp0p0_c20250101__20250331_zSkUMpEf9mO5" style="border-bottom: black 1pt solid; width: 13%; text-align: right" title="Operating lease expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,573</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td> <td id="xdx_98E_eus-gaap--OperatingLeaseExpense_pp0p0_c20240101__20240331_zq3ABM5SMmQg" style="border-bottom: black 1pt solid; width: 13%; text-align: right" title="Operating lease expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,791</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total net lease costs</span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_986_eus-gaap--LeaseCost_pp0p0_c20250101__20250331_zzJbhsmnkEGf" style="border-bottom: black 2.25pt double; text-align: right" title="Total net lease costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,573</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_985_eus-gaap--LeaseCost_pp0p0_c20240101__20240331_z5Uwfe7F3nm6" style="border-bottom: black 2.25pt double; text-align: right" title="Total net lease costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,791</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--LeaseCostTableTextBlock_zjj0XlJu1WHj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - LEASES (Details - Lease costs)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B0_zzRU39Fe30Dg" style="display: none">Schedule of components of lease expenses</span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement of Income Location</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three months ended <br/> March 31, 2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three months ended <br/> March 31, 2024</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Costs</b></span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 30%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease expense</span></td> <td style="width: 2%"> </td> <td style="width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative expenses</span></td> <td style="width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td> <td id="xdx_980_eus-gaap--OperatingLeaseExpense_pp0p0_c20250101__20250331_zSkUMpEf9mO5" style="border-bottom: black 1pt solid; width: 13%; text-align: right" title="Operating lease expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,573</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td> <td id="xdx_98E_eus-gaap--OperatingLeaseExpense_pp0p0_c20240101__20240331_zq3ABM5SMmQg" style="border-bottom: black 1pt solid; width: 13%; text-align: right" title="Operating lease expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,791</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total net lease costs</span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_986_eus-gaap--LeaseCost_pp0p0_c20250101__20250331_zzJbhsmnkEGf" style="border-bottom: black 2.25pt double; text-align: right" title="Total net lease costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,573</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_985_eus-gaap--LeaseCost_pp0p0_c20240101__20240331_z5Uwfe7F3nm6" style="border-bottom: black 2.25pt double; text-align: right" title="Total net lease costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,791</span></td> <td> </td></tr> </table> 18573 18791 18573 18791 <p id="xdx_80D_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zUbEPhFLjnbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 13     <span id="xdx_827_z9EF0asuOtmc">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z6DYnrVgp1f9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BF_zwwJHoNZ6Jz7" style="display: none">Schedule of other payables and accrued liabilities</span></td> <td> </td> <td colspan="2" id="xdx_493_20250331_zVRfEFPcSIEa" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_490_20241231" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, <br/> 2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, <br/> 2024</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td></tr> <tr id="xdx_406_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAOAzSRJ_zHXUTwKMVfid" style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; text-align: justify; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued Expenses</span></td> <td style="vertical-align: bottom; width: 2%"> </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: bottom; text-align: right; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">211,426</span></td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: bottom; width: 2%"> </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; text-align: right; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">262,156</span></td> <td style="vertical-align: bottom; width: 1%"> </td></tr> <tr id="xdx_408_eus-gaap--AccountsPayableOtherCurrent_iI_pp0p0_maAPAOAzSRJ_z9ak94tbsE8k" style="background-color: White"> <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td> <td style="vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">184,367</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,504</span></td> <td style="vertical-align: bottom"> </td></tr> <tr id="xdx_40B_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAOAzSRJ_z0zxf3m20Lpd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">395,793</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">376,660</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2025, other payables and accrued expenses were $<span id="xdx_903_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iI_c20250331_zUihzD9NkHRg" title="Other payables and accrued expenses">395,793</span>, respectively, compared to $<span id="xdx_906_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iI_c20241231_zRsXiVHsc25h" title="Other payables and accrued expenses">376,660</span> as of December 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2025, other payables and accrued expenses were $184,367 and $211,426, respectively, compared to $114,504 and $262,156 as of December 31, 2024. The accrued expenses in both periods primarily relate to audit fees. Other payables mainly consisted of amounts related to e-commerce intermediary transactions, specifically payables arising from cross-border settlements with Chinese e-commerce platforms amounting to $176,374 as of March 31, 2025 and $100,379 as of December 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z6DYnrVgp1f9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BF_zwwJHoNZ6Jz7" style="display: none">Schedule of other payables and accrued liabilities</span></td> <td> </td> <td colspan="2" id="xdx_493_20250331_zVRfEFPcSIEa" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_490_20241231" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, <br/> 2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, <br/> 2024</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td></tr> <tr id="xdx_406_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maAPAOAzSRJ_zHXUTwKMVfid" style="background-color: rgb(238,238,238)"> <td style="vertical-align: bottom; text-align: justify; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued Expenses</span></td> <td style="vertical-align: bottom; width: 2%"> </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: bottom; text-align: right; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">211,426</span></td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: bottom; width: 2%"> </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: top; text-align: right; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">262,156</span></td> <td style="vertical-align: bottom; width: 1%"> </td></tr> <tr id="xdx_408_eus-gaap--AccountsPayableOtherCurrent_iI_pp0p0_maAPAOAzSRJ_z9ak94tbsE8k" style="background-color: White"> <td style="vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td> <td style="vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">184,367</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,504</span></td> <td style="vertical-align: bottom"> </td></tr> <tr id="xdx_40B_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_iTI_pp0p0_mtAPAOAzSRJ_z0zxf3m20Lpd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">395,793</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">376,660</span></td> <td> </td></tr> </table> 211426 262156 184367 114504 395793 376660 395793 376660 <p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zepzC4TTxSd1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 14      <span id="xdx_82D_z92RBb2oRI92">INCOME TAXES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and its subsidiary, and the consolidated VIE file tax returns separately.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1) Value-added tax (“VAT”)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">PRC</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Provisional Regulation of the PRC on VAT and the related implementing rules, all entities and individuals (“taxpayers”) that are engaged in the sale of products in the PRC are generally required to pay VAT, at a rate of which was changed from 16% to <span id="xdx_902_ecustom--VATTaxRate_iI_dp_c20250331__srt--StatementGeographicalAxis__country--CN__srt--RangeAxis__srt--MinimumMember_zT4luHxAmY1f" title="VAT tax rate">13</span>% on April 1, 2019 of the gross sales proceeds received, less any deductible VAT already paid or borne by the taxpayers. GZ WFH also subjected to 10% for the installment service provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Taiwan</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Value-added and Non-value-added Business Tax Act and the related implementing rules, all entities and individuals (“taxpayers”) that are engaged in the sale of products in the Taiwan are generally required to pay VAT, at a rate of <span id="xdx_902_ecustom--VATTaxRate_iI_dp_c20250331__srt--StatementGeographicalAxis__country--TW_zpUTlsF9fp84" title="VAT tax rate">5</span>%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2) Income tax</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">United States </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, the Tax Cuts and Jobs Act (the “Tax Act”) was signed into legislation. The Tax Act significantly revises the U.S. corporate income tax by, among other things, lowering the statutory corporate tax rate from 34% to 21%, imposing a mandatory one-time tax on accumulated earnings of foreign subsidiaries, introducing new tax regimes, and changing how foreign earnings are subject to U.S. tax.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, Staff Accounting Bulletin No. 118 (“SAB 118”) was issued to provide guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740. The Company has completed the assessment of the income tax effect of the Tax Act and there were no adjustments recorded to the provisional amounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Coronavirus Aid, Relief and Economy Security Act (the “CARES Act”) was signed into law on 27 March 2020. The CARES Act temporarily eliminates the 80% taxable income limitation (as enacted under the Tax Cuts and Jobs Act of 2017) for net operating loss (“NOL”) deductions for 2018-2020 tax years and reinstated NOL carrybacks for the 2018-2020 tax years. Moreover, the CARES Act also temporarily increases the business interest deduction limitations from 30% to 50% of adjusted taxable income for the 2019 and 2020 taxable year. Lastly, the Tax Act technical correction classifies qualified improvement property as 15-year recovery period, allowing the bonus depreciation deduction to be claimed for such property retroactively as if it was included in the Tax Act at the time of enactment. The Company does not anticipate a significant tax impact on its financial statements and will continue to examine the impact the CARES Act may have on its business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluated the Global Intangible Low Taxed Income (“GILTI”) inclusion on current earnings and profits of greater than 10% owned foreign controlled corporations. The Company has evaluated whether it has additional provision amount resulted by the GILTI inclusion on current earnings and profits of its foreign controlled corporations. The law also provides that corporate taxpayers may benefit from a 50% reduction in the GILTI inclusion, which effectively reduces the 21% U.S. corporate tax rate on the foreign income to an effective rate of <span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationGiltiPercent_dp_c20250101__20250331__us-gaap--IncomeTaxAuthorityAxis__country--US_zLDn8cKCvuu1" title="Effective income tax rate including GILTI">10.5</span>%. The GILTI inclusion further provides for a foreign tax credit in connection with the foreign taxes paid. In 2019, the Company recorded a GILTI inclusion of $<span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationGiltiAmount_c20190101__20191231_zsCGOv7Ma2Xd" title="GILTI Amount">152,829</span>. The Company has elected to treat the financial statement impact of GILTI as current period expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reverse merger was completed on December 31, 2018 and the tax losses of the US subsidiary was not in the scope as of December 31, 2018. As of December 31, 2019, net operating loss carried forward which was available to offset future taxable income for the Company in the United States was $<span id="xdx_908_eus-gaap--OperatingLossCarryforwards_iI_c20191231__us-gaap--IncomeTaxAuthorityAxis__country--US_zi3tGn8HJUe4" title="Net operating loss carryforwards">99,817</span>. There was a full valuation allowance applied against these loss carry forward as management determined it was not more likely than not that these net operating losses would be utilized in the foreseeable future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Hong Kong</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The HK tax reform has introduced two-tiered profits tax rates for corporations. Under the two-tiered profits tax rates regime, the profits tax rate for the first HK$2 million (approximately $257,931) of assessable profits will be lowered to 8.25% (half of the rate specified in Schedule 8 to the Inland Revenue Ordinance) for corporations. Assessable profits above HK$2 million (approximately $257,931) will continue to be subject to the rate of 16.5% for corporations. Because the Company assessed that the HK entity will not earn a profit greater than HK$2 million (approximately $257,931), it is subject to a corporate income tax rate of 8.25%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, the Company’s subsidiary in Hong Kong had net operating loss carry forwards available to offset future taxable income. The net operating losses will be carryforward indefinitely under Hong Kong Profits Tax regulation. There is a full valuation allowance applied against these loss carry forward as management determined it was not more likely than not that these net operating losses would be utilized in the foreseeable future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">PRC</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WFOE and the consolidated VIE established in the PRC are subject to the PRC statutory income tax rate of <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20250101__20250331__us-gaap--IncomeTaxAuthorityAxis__custom--PRCMember_zO1pr53VF374" title="Effective income tax rate">25</span>%, according to the PRC Enterprise Income Tax law.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the relevant tax laws and regulations of the PRC, a company registered in the PRC is subject to income taxes within the PRC at the applicable tax rate on taxable income. All the PRC subsidiaries were subject to income tax at a rate of 25% for the year ended December 31, 2021. According to PRC tax regulations, the PRC net operating loss can generally carry forward for no longer than five years starting from the year subsequent to the year in which the loss was incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Taiwan</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s loss before income taxes is primarily derived from the operations in Taiwan and income tax expense is primarily incurred in Taiwan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of amendments to the “Taiwan Income Tax Act” enacted by the Office of the President of Taiwan on February 7, 2018, the statutory income tax rate increased from 17% to 20% and the undistributed earnings tax, or a surtax, decreased from 10% to 5% effective from January 1, 2018. As a result, the statutory income tax rate in Taiwan was 20% for the years ended August 31, 2021 and 2020. An additional surtax, of which rate was reduced from 10% to 5% being applied to the Company starting from September 1, 2018, is assessed on undistributed income for the entities in Taiwan, but only to the extent such income is not distributed or set aside as a legal reserve before the end of the following year. The 5% surtax is recorded in the period the income is earned, and the reduction in the surtax liability is recognized in the period the distribution to stockholders or the setting aside of legal reserve is finalized in the following year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The components of the income tax expense are:</p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zHTTSMh463t4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Income tax expense)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B8_zvGSrEDwyEme" style="display: none">Schedule of income tax components</span></td><td> </td> <td colspan="2" id="xdx_498_20250101_20250331_us-gaap--IncomeTaxAuthorityAxis_custom--PRCMember" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49E_20240101_20240331_us-gaap--IncomeTaxAuthorityAxis_custom--PRCMember" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three months ended </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefit_d0_maDITATzmsy_zmgvdDNkj83b" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; width: 66%; text-align: justify">Current</td><td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td><td style="border-bottom: Black 1pt solid; text-align: right; width: 13%">–</td><td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">124,146</td><td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredIncomeTaxesAndTaxCredits_iT_pp0p0_d0_mtDITATzmsy_zCxnrLMZc4Ce" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">124,146</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_z1I2f59p8Qwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reconciliation of income taxes expenses computed at the Taiwan statutory tax rate (2022: at PRC statutory rate) applicable to income tax expense is as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zDBXBTEsZ1qb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Reconciliation of income tax)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BB_zwKP9l3eOhCa" style="display: none">Schedule of reconciliation of income tax expense</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p></td><td style="padding-bottom: 1pt"> </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Taiwan (2021-PRC) income tax statutory rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20250101__20250331_zyq1UX3iS5b8" title="Taiwan (2021-PRC) income tax statutory rate">20.00</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20240101__20240331_zD9H9gw1nA75" title="Taiwan (2021-PRC) income tax statutory rate">20.00</span>%</td><td style="width: 1%; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Tax effect of non-deductible expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20250101__20250331_zdBlUIoKVGQb" title="Tax effect of non-deductible expenses">(14.51</span>%</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20240101__20240331_zSP0hukvjxNg" title="Tax effect of non-deductible expenses">(11.84</span>%</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Tax effect of stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_dp0_c20250101__20250331_zryaUzrpQ53k" title="Tax effect of stock-based compensation">–</span>%</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_dp_c20240101__20240331_zT9Y71lRDiKh" title="Tax effect of stock-based compensation">(0.6</span>%</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Tax effect of non-taxable income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCredits_dp_c20250101__20250331_zJ47VL1UwCc6" title="Tax effect of non-taxable income">(1.60</span>%</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCredits_dp0_c20240101__20240331_zlHwpmXZrbDc" title="Tax effect of non-taxable income">–</span>%</span></td><td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Impact of different tax rates in other jurisdictions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp0_c20250101__20250331_zmRTsM6WvXEk" title="Impact of different tax rates in other jurisdictions">–</span>%</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20240101__20240331_ztkScawLpcae" title="Impact of different tax rates in other jurisdictions">(0.02</span>%</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Others</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_c20250101__20250331_zLs35i6Xpuze" title="Others">(3.89</span>%</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_c20240101__20240331_zbx9XjVYq3B4" title="Others">(1.7</span>%</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Changes in valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp0_c20250101__20250331_zfIYmDvFtWQh" title="Changes in valuation allowance">–</span>%</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp0_c20240101__20240331_zECCQbcTibCh" title="Changes in valuation allowance">–</span>%</span></td><td style="padding-bottom: 1pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp0_c20250101__20250331_z3GbSvhv7ABe" title="Effective tax rate">–</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20240101__20240331_zTyRV3v0jxQ8" title="Effective tax rate">(6.1</span>%</td><td style="padding-bottom: 2.5pt; text-align: left">)</td> </tr> </table> <p id="xdx_8A1_zcg6EP6A9bw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The valuation allowance as of March 31, 2025 and December 31, 2024 was primarily provided for the deferred income tax assets if it is more likely than not that these items will expire before the Company is able to realize its benefits, or that the future deductibility is uncertain. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible or utilizable. Management considers projected future taxable income and tax planning strategies in making this assessment. The movement for the valuation allowance is as following:</p> <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--SummaryOfValuationAllowanceTextBlock_zP017wn8vrPh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Valuation Allowance)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BF_z9yX0Nxxr4f3" style="display: none">Schedule of movement in valuation allowance</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2025</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2024</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-weight: bold; text-align: justify">Balance at beginning of the period or year, as applicable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_c20250101__20250331_zJ9BqNyfWs1a" style="width: 13%; text-align: right" title="Valuation allowance, beginning balance">95,844</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_c20240101__20241231_z8UwNNkOqbI3" style="width: 13%; text-align: right" title="Valuation allowance, beginning balance">95,844</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Additions of valuation </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_d0_c20250101__20250331_zzEESqAG0c7f" style="text-align: right" title="Additions of valuation allowance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_d0_c20240101__20241231_z1qXLsAfn4Ef" style="text-align: right" title="Additions of valuation allowance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Reductions of valuation </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20250101__20250331_zPS5T99L9Rkk" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions of valuation allowance">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20240101__20241231_zVOaNQCWcJl1" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions of valuation allowance">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Balance at the end of the period or year, as applicable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20250101__20250331_zGpvo3F63sn9" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance">95,844</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20240101__20241231_z8Xw7wJdeUya" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance">95,844</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zorudfzrBVog" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>PRC Withholding Tax on Dividends</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current PRC Enterprise Income Tax Law imposes a 10% withholding income tax for dividends distributed by foreign-invested enterprises to their immediate holding companies outside the PRC. A lower withholding tax rate will be applied if there is a tax treaty arrangement between the PRC and the jurisdiction of the foreign holding company. Distributions to holding companies in Hong Kong that satisfy certain requirements specified by PRC tax authorities, for example, will be subject to a 5% withholding tax rate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, the Company had not recorded any withholding tax on the retained earnings of its foreign-invested enterprises in the PRC, since the Company intended to reinvest its earnings to potentially continue its business in mainland China, namely the manufacturing of the RASs through GZ GST, and its foreign-invested enterprises do not intend to declare dividends to their immediate foreign holding companies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022, the Company had not recorded any withholding tax on the retained earnings of its foreign-invested enterprises in the PRC, and the Company decided not to reinvest its earnings since it is not continuing its business in mainland China, and its foreign-invested enterprises do not intend to declare dividends to their immediate foreign holding companies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> 0.13 0.05 0.105 152829 99817 0.25 <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zHTTSMh463t4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Income tax expense)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B8_zvGSrEDwyEme" style="display: none">Schedule of income tax components</span></td><td> </td> <td colspan="2" id="xdx_498_20250101_20250331_us-gaap--IncomeTaxAuthorityAxis_custom--PRCMember" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49E_20240101_20240331_us-gaap--IncomeTaxAuthorityAxis_custom--PRCMember" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three months ended </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Audited)</b></span></td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefit_d0_maDITATzmsy_zmgvdDNkj83b" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; width: 66%; text-align: justify">Current</td><td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td><td style="border-bottom: Black 1pt solid; text-align: right; width: 13%">–</td><td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1pt; width: 2%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">124,146</td><td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredIncomeTaxesAndTaxCredits_iT_pp0p0_d0_mtDITATzmsy_zCxnrLMZc4Ce" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total income tax expense</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">124,146</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0 124146 0 124146 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zDBXBTEsZ1qb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Reconciliation of income tax)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BB_zwKP9l3eOhCa" style="display: none">Schedule of reconciliation of income tax expense</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Three months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p></td><td style="padding-bottom: 1pt"> </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Taiwan (2021-PRC) income tax statutory rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20250101__20250331_zyq1UX3iS5b8" title="Taiwan (2021-PRC) income tax statutory rate">20.00</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20240101__20240331_zD9H9gw1nA75" title="Taiwan (2021-PRC) income tax statutory rate">20.00</span>%</td><td style="width: 1%; text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Tax effect of non-deductible expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20250101__20250331_zdBlUIoKVGQb" title="Tax effect of non-deductible expenses">(14.51</span>%</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20240101__20240331_zSP0hukvjxNg" title="Tax effect of non-deductible expenses">(11.84</span>%</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Tax effect of stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_dp0_c20250101__20250331_zryaUzrpQ53k" title="Tax effect of stock-based compensation">–</span>%</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_dp_c20240101__20240331_zT9Y71lRDiKh" title="Tax effect of stock-based compensation">(0.6</span>%</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Tax effect of non-taxable income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCredits_dp_c20250101__20250331_zJ47VL1UwCc6" title="Tax effect of non-taxable income">(1.60</span>%</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCredits_dp0_c20240101__20240331_zlHwpmXZrbDc" title="Tax effect of non-taxable income">–</span>%</span></td><td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Impact of different tax rates in other jurisdictions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp0_c20250101__20250331_zmRTsM6WvXEk" title="Impact of different tax rates in other jurisdictions">–</span>%</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20240101__20240331_ztkScawLpcae" title="Impact of different tax rates in other jurisdictions">(0.02</span>%</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Others</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_c20250101__20250331_zLs35i6Xpuze" title="Others">(3.89</span>%</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_c20240101__20240331_zbx9XjVYq3B4" title="Others">(1.7</span>%</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Changes in valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp0_c20250101__20250331_zfIYmDvFtWQh" title="Changes in valuation allowance">–</span>%</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp0_c20240101__20240331_zECCQbcTibCh" title="Changes in valuation allowance">–</span>%</span></td><td style="padding-bottom: 1pt; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp0_c20250101__20250331_z3GbSvhv7ABe" title="Effective tax rate">–</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20240101__20240331_zTyRV3v0jxQ8" title="Effective tax rate">(6.1</span>%</td><td style="padding-bottom: 2.5pt; text-align: left">)</td> </tr> </table> 0.2000 0.2000 -0.1451 -0.1184 0 -0.006 -0.0160 0 0 -0.0002 -0.0389 -0.017 0 0 0 -0.061 <table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--SummaryOfValuationAllowanceTextBlock_zP017wn8vrPh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Valuation Allowance)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BF_z9yX0Nxxr4f3" style="display: none">Schedule of movement in valuation allowance</span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2025</b></p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2024</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Audited)</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-weight: bold; text-align: justify">Balance at beginning of the period or year, as applicable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_c20250101__20250331_zJ9BqNyfWs1a" style="width: 13%; text-align: right" title="Valuation allowance, beginning balance">95,844</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iS_pp0p0_c20240101__20241231_z8UwNNkOqbI3" style="width: 13%; text-align: right" title="Valuation allowance, beginning balance">95,844</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Additions of valuation </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_d0_c20250101__20250331_zzEESqAG0c7f" style="text-align: right" title="Additions of valuation allowance">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_d0_c20240101__20241231_z1qXLsAfn4Ef" style="text-align: right" title="Additions of valuation allowance">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Reductions of valuation </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20250101__20250331_zPS5T99L9Rkk" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions of valuation allowance">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20240101__20241231_zVOaNQCWcJl1" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions of valuation allowance">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Balance at the end of the period or year, as applicable</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20250101__20250331_zGpvo3F63sn9" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance">95,844</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20240101__20241231_z8Xw7wJdeUya" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance">95,844</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 95844 95844 0 0 0 0 95844 95844 <p id="xdx_80E_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zqiQrKZFxWY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 15     <span id="xdx_829_ziJboVSWGVgl">RELATED PARTY BALANCES AND TRANSACTIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due to related parties</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The balance due to related parties was as following:</p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_z9nZ5dlrFaB" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_zGwArIZcYF78" style="display: none">Schedule of related party transactions</span></td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, <br/> 2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, <br/> 2024</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mountain Share Transfer, LLC (1)</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_98F_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferLLCMember_fKDEp_zBjNI5PSRETg" style="width: 13%; text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,681</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_98F_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferLLCMember_fKDEp_zZirF5V4zca2" style="width: 13%; text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,681</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estate of Mr. Yin-Chieh Cheng (2)</span></td> <td> </td> <td> </td> <td id="xdx_986_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EstateOfYinChiehChengMember_fKDIp_zXyBjeOGtCa" style="text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,435</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_985_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EstateOfYinChiehChengMember_fKDIp_zEZ778AaH51a" style="text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,435</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Feng-Hua Chen (3)</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_982_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FengHuaChenMember_fKDMp_z7eRAW2xQs25" style="border-bottom: black 1pt solid; text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,402</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98E_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_d0_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FengHuaChenMember_fKDMp_z5el5qD0BAgl" style="border-bottom: black 1pt solid; text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_983_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20250331_zzXuMbAEd6fd" style="border-bottom: black 2.25pt double; text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,518</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_989_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20241231_zlkIhadNHZ2l" style="border-bottom: black 2.25pt double; text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,116</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">___________________ </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span id="xdx_F09_z1eWCTm5wn23" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: justify"><span id="xdx_F15_zHnwqtvaqe4k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mountain Share Transfer, LLC is company 100% controlled by Erik S. Nelson, the previous corporate secretary and director of the Company. The balances represented the amount paid on behalf of the Company for its daily operation purpose.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td><span id="xdx_F0C_zmWoAJTNR0Cf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: justify"><span id="xdx_F1C_zLgBgXwOeaD3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount due to Mr. Yin-Chieh Cheng relates to a prior arrangement. Mr. Yin-Chieh Cheng was vacant as of July 8, 2023, and the Company is evaluating settlement with the estate.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td><span id="xdx_F04_ztInPjismhpg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td> <td style="text-align: justify"><span id="xdx_F1E_zJx3m0UfpuBg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Feng-Hua Chen is the Chief Operating Officer of the company, the balances represented the amount paid on behalf of the Company for its daily operation purpose.</span></td></tr> </table> <p id="xdx_8A5_zC2jP48nIuL9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2025, the Company had outstanding balances with related parties that are non-trade in nature, unsecured, non-interest bearing, and repayable on demand. These balances arose in the ordinary course of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the period, the Company received a financial communication from the estate of the former Chief Executive Officer and Chair of the Board, Lu Min-Huay Cheng, which is considered a related party due to the former executive’s prior leadership position and significant ownership interest. The nature of the transaction involves the repayment of loans, debt, and other liabilities owed to the estate. While the agreement does not specify individual dollar amounts, the Company has agreed to settle these obligations over a 12-month period beginning January 25, 2025. As of the reporting date, management continues to evaluate the terms and monitor the settlement process.<b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_z9nZ5dlrFaB" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_zGwArIZcYF78" style="display: none">Schedule of related party transactions</span></td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, <br/> 2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, <br/> 2024</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mountain Share Transfer, LLC (1)</span></td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_98F_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferLLCMember_fKDEp_zBjNI5PSRETg" style="width: 13%; text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,681</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td id="xdx_98F_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferLLCMember_fKDEp_zZirF5V4zca2" style="width: 13%; text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,681</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estate of Mr. Yin-Chieh Cheng (2)</span></td> <td> </td> <td> </td> <td id="xdx_986_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EstateOfYinChiehChengMember_fKDIp_zXyBjeOGtCa" style="text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,435</span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_985_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--EstateOfYinChiehChengMember_fKDIp_zEZ778AaH51a" style="text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,435</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Feng-Hua Chen (3)</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_982_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20250331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FengHuaChenMember_fKDMp_z7eRAW2xQs25" style="border-bottom: black 1pt solid; text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,402</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98E_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_d0_c20241231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FengHuaChenMember_fKDMp_z5el5qD0BAgl" style="border-bottom: black 1pt solid; text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_983_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20250331_zzXuMbAEd6fd" style="border-bottom: black 2.25pt double; text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,518</span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_989_ecustom--DueToRelatedPartyCurrent1_iI_pp0p0_c20241231_zlkIhadNHZ2l" style="border-bottom: black 2.25pt double; text-align: right" title="Due to related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27,116</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">___________________ </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span id="xdx_F09_z1eWCTm5wn23" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: justify"><span id="xdx_F15_zHnwqtvaqe4k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mountain Share Transfer, LLC is company 100% controlled by Erik S. Nelson, the previous corporate secretary and director of the Company. The balances represented the amount paid on behalf of the Company for its daily operation purpose.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td><span id="xdx_F0C_zmWoAJTNR0Cf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: justify"><span id="xdx_F1C_zLgBgXwOeaD3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount due to Mr. Yin-Chieh Cheng relates to a prior arrangement. Mr. Yin-Chieh Cheng was vacant as of July 8, 2023, and the Company is evaluating settlement with the estate.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td><span id="xdx_F04_ztInPjismhpg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td> <td style="text-align: justify"><span id="xdx_F1E_zJx3m0UfpuBg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Feng-Hua Chen is the Chief Operating Officer of the company, the balances represented the amount paid on behalf of the Company for its daily operation purpose.</span></td></tr> </table> 7681 7681 19435 19435 11402 0 38518 27116 <p id="xdx_80B_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_ztrGN7nVHFZe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 16    <span id="xdx_82F_zfxzpWiw2sH1">COMMON STOCK</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s authorized number of common stock is <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20241231_zEdSfKU35XT4" title="Common stock, shares authorized">200,000,000</span> shares with par value of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20241231_zjezNmAIKlqf" title="Common stock par value">0.001</span> each. On August 11, 2022, the Company effected a <span id="xdx_90B_eus-gaap--StockholdersEquityReverseStockSplit_c20220809__20220811_zO4NVwxGoSbd" title="Reverse stock split">2:3 reverse stock split</span> for each share of common stock issued and outstanding. As a result of reverse stock split, the Company’s common stock issued and outstanding decreased from <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_c20220811__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zUVjoT3gs9Rg" title="Common stock, shares issued">10,707,150</span> shares to <span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20220811__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z9GSqVDZNxJg" title="Common stock, shares outstanding">7,138,587</span> shares. All shares and associated amounts have been retroactively restated to reflect the stock split on August 11, 2022. As of March 31, 2025 and December 31, 2024, issued common stock were <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_c20250331_zkdE07dkNSga" title="Common stock, shares issued">14,247,539</span> shares and <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20241231_zqxNXnyJ5UQk" title="Common stock, shares issued">14,047,539</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 11, 2022, the Company’s common stock commenced trading on The Nasdaq Capital Market under the symbol “NCRA” on a post-reverse stock split basis. During the public offering, <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220809__20220811__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zbQu0BkbOegk" title="Common stock issued shares">1,880,000</span> common stocks, at par value $0.001 each, were issued at the offering price $3.5 each. The Company received total gross proceeds of $<span id="xdx_901_ecustom--GrossProceedsFromIssuanceOrSaleOfEquity_pn4n6_c20220809__20220811__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zfa8pL302qp1" title="Gross proceeds from the sale of equity">6.58</span> million from the public offering and after deducting the underwriting commissions, discounts and offering expenses, the Company received net proceeds of approximately $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20220809__20220811__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicOfferingMember_zXhnMpkEZXM9" title="Proceeds from the sale of equity">5.3</span> million.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All number of shares, share amounts and per share data presented in the accompanying unaudited consolidated financial statements and related notes have been retroactively restated to reflect the reverse merger transaction and subsequent issuance of shares stated above, except for authorized shares of common stock, which were not affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Issuance of Common Stock</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-size: 10pt">On February 20, 2024, we entered into VIE Agreement with Xinca and issued <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20240219__20240220__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--XincaMember_zgJOJs429r16" title="Stock issued for acquisitions, shares">1,800,000</span> shares of our common stock in exchange of <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240220__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--XincaMember_zUW8Gu9fzNF6" title="Equity ownership">100</span>% controlling of Xinca;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-size: 10pt">On April 14, 2024, we entered into an Equity Purchase Agreement with SY Culture and issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20240413__20240414__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SYCultureMember_zyq1cI1lqrIe" title="Stock issued for acquisitions, shares">600,000</span> shares of our common stock in exchange of <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20240414__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SYCultureMember_ziUXVhCtfdzl" title="Stock issued for acquisitions, shares">100</span>% equity of SY Culture.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-size: 10pt">On February 7, 2025, our shareholder exercised <span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20250206__20250207__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ClassAWarrantsConvertedToCommonStockMember__us-gaap--StatementClassOfStockAxis__custom--WarrantClassAMember_zysFCRBU4PGc" title="Stock converted, shares converted">150,000</span> shares of Warrant Class A in exchange of <span id="xdx_904_eus-gaap--ConversionOfStockSharesIssued1_c20250206__20250207__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ClassAWarrantsConvertedToCommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zabp0sqsrsH1" title="Stock converted, shares issued">100,000</span> shares of common stock.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-size: 10pt">On February 12, 2025, our shareholder exercised <span id="xdx_90E_eus-gaap--ConversionOfStockSharesConverted1_c20250211__20250212__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ClassAWarrantsConvertedToCommonStockMember__us-gaap--StatementClassOfStockAxis__custom--WarrantClassAMember_zNYGq29cLhif" title="Stock converted, shares converted">150,000</span> shares of Warrant Class A in exchange of <span id="xdx_901_eus-gaap--ConversionOfStockSharesIssued1_c20250211__20250212__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ClassAWarrantsConvertedToCommonStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z8Apeqhv27Kc" title="Stock converted, shares issued">100,000</span> shares of common stock.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> 200000000 0.001 2:3 reverse stock split 10707150 7138587 14247539 14047539 1880000 6580000 5300000 1800000 1 600000 1 150000 100000 150000 100000 <p id="xdx_809_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zrmQiQO4VGyf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 17 </b>  <b>   <span id="xdx_821_zIhy8TbafDue">SHARE-BASED COMPENSATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 27, 2018, Nocera granted Mr. Yin-Chieh Cheng quarterly option awards of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20181226__20181227__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrYinChiehChengMember__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_z1MgrMeLSZCj" title="Option award">250,000</span> Series “A” Warrants for 20 quarters (5 years) for a total of <span id="xdx_908_ecustom--WarrantsGranted_c20181226__20181227__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrYinChiehChengMember__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_zNlIOUaSKtZ7" title="Warrants granted">5,000,000</span> Series “A” Warrants with exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20181227__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrYinChiehChengMember_zBsKAPTwsJWa" title="Exercise price">0.50</span> per share, subject to continued employment for services as Chairman of the Board and a Director.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2020, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu <span id="xdx_90B_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrShunChihChuangMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zNvMh74ZsIe4" title="Warrants granted">50,000</span> shares of Class A warrants and <span id="xdx_90C_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHsienWenYuMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_z4VgY87A44Id" title="Warrants granted">60,000</span> shares of Class A warrants separately, each with exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrShunChihChuangMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zXqM2WE0hkg7" title="Exercise price">0.50</span> per share, for serving as the Company’s Chief Financial Officer and Chief Operating Officer. The Company also granted 2 employees <span id="xdx_906_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoEmployeesMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zO7TmVnh02O3" title="Warrants granted">50,000</span> shares of Class A warrants with exercise price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200601__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoEmployeesMember_z6frUG5GMxni" title="Exercise price">0.50</span> per share. The Class A warrants consist of the right to purchase one share for $0.50 per share from the date of issuance until April 23, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2020, Nocera granted Mr. Michael A. Littman <span id="xdx_906_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrMichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zbC5Eetuzr0g" title="Warrants granted">50,000</span> shares of Class A warrants with exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrMichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zxx8XtGcndb6" title="Exercise price">0.50</span> per share and <span id="xdx_906_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrMichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_zCePmfXCjSyh" title="Warrants granted">50,000</span> shares of Class B warrants with exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrMichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_zI5nYNWWk3kk" title="Warrants exercise price">1.00</span> per share. Mr. Littman exercised <span id="xdx_906_ecustom--WarrantsExercisedShares_c20210809__20210811__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrMichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zvcIE6AgNkx" title="Warrants exercised, shares">50,000</span> shares of Class A warrants and <span id="xdx_903_ecustom--WarrantsExercisedShares_c20210809__20210811__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrMichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_zLcQxnKr44wd" title="Warrants exercised, shares">50,000</span> shares of Class B warrants on August 11, 2021. The Class B warrants consist of the right to purchase one share for $1.00 per share separately from the date of issuance until April 23, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 1, 2021, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu <span id="xdx_90B_ecustom--WarrantsGranted_c20211130__20211202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrShunChihChuangMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_z7K5unWtrxB1" title="Warrants granted">75,000</span> shares of Class A warrants and <span id="xdx_900_ecustom--WarrantsGranted_c20211130__20211202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHsienWenYuMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zIohAt2aYw14" title="Warrants granted">60,000</span> shares of Class A warrants separately, each with exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrShunChihChuangMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zLOkw0e2QU52" title="Exercise price">0.50</span> per share, for serving as the Company’s Chief Financial Officer and Chief Operating Officer. The Company also granted 2 employees <span id="xdx_90C_ecustom--WarrantsGranted_c20211130__20211202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoEmployeesMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zMnpijCGFYMk" title="Warrants granted">70,000</span> shares of Class A warrant with exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211202__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TwoEmployeesMember_zfNBBPfeFVn5" title="Exercise price">0.50</span> per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2021, the Company issued an aggregate of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20211230__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrShunChihChuangAndFiveConsultantsMember_zaWf2ufhT3Qh" title="Issuance of shares">505,000</span> shares of common stock to Mr. Shun-Chih Chuang and a total of five consultants in consideration for services rendered.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2022, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20221221__20221222__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ChenChunChungMember_zqjADZitiMGa" title="Issuance of shares">150,000</span> and <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20221221__20221222__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TraDigitalMember_z75FD2fnkaid" title="Issuance of shares">75,000</span> shares of common stock to Chen-Chun Chung and TraDigital respectively in consideration for services rendered.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 22, 2023, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20230320__20230322__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zgMnrZWOIA17">450,000</span> shares of our common stock to our investor relation company, Hanover One International, Inc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 11, 2023, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20231010__20231011__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YuHaoChangMember_zPa1SC7O1tJ7">20,000</span> shares of our common stock to our consultant, Yu-Hao Chang.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 5, 2023, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20231202__20231205__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AndyChinAnJinMember_zoeZpkJfWjz3" title="Stock issued for services, shares">60,000</span> shares of our common stock to our Chief Executive Officer, Andy Chin-An Jin.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 26, 2024, the Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240825__20240826__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AnyChinAnJinMember_ztx5dCgkXjHj">180,000</span> shares of our common stock to our Chief Executive Officer, Andy Chin-An Jin.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated fair value of share-based compensation for employees is recognized as a charge against income on a ratable basis over the requisite service period, which is generally the vesting period of the award. The fair value of stock option grant was estimated on the date of grant using the Black-Scholes option pricing model under the following assumptions:</p> <table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zROLXQn5ltZd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details - Assumptions)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B4_zyJXiUojg3N8" style="display: none">Schedule of assumptions of option pricing</span></td> <td style="text-align: justify"> </td> <td colspan="2" style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td colspan="2" style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, <br/> 2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, <br/> 2024</b></span></td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td colspan="2" style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td colspan="2" style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend yield</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 66%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td> <td style="width: 2%; text-align: justify"> </td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20250101__20250331_zUQeHV68yaua" title="Risk-free interest rate">4.2</span>%</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240331_zkqs9g15eIV" title="Risk-free interest rate">1.16</span>%</span></td> <td style="width: 1%; text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (in years)</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20250331_zm83xSmtd7ol" title="Expected term (in years)">2.74</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240331_zTksV5lUrxZ7" title="Expected term (in years)">4.31</span></span></td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20250101__20250331_zVB2z0QzZLh4" title="Volatility">36.25</span>%</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20240101__20240331_zgjgFgHL1ka5" title="Volatility">48.15</span>%</span></td> <td style="text-align: justify"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company estimated the grant date fair value of time-based stock option awards using the Black-Scholes option valuation model, which requires assumptions involving an estimate of the fair value of the underlying common stock on the date of grant, the expected term of the options, volatility, discount rate and dividend yield. The Company calculated expected option terms based on the “simplified” method for “plain vanilla” options due to the limited exercise information. The “simplified method” calculates the expected term as the average of the vesting term and the original contractual term of the options. The Company calculated volatility using the average adjusted volatility of quick company’s feature of Capital IQ for a period of time reflective of the expected option term, while the discount rate was estimated using the interest rate for a treasury note with the same contractual term as the options granted. Dividend yield is estimated at our current dividend rate, which adjustments for any known future changes in the rate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2024, $<span id="xdx_900_eus-gaap--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_c20240101__20241231_zSkct1grXa0e" title="Adjustments to APIC for share based compensation">60,831</span> share-based compensation expenses were recognized into additional paid-in capital of the Company, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> 250000 5000000 0.50 50000 60000 0.50 50000 0.50 50000 0.50 50000 1.00 50000 50000 75000 60000 0.50 70000 0.50 505000 150000 75000 450000 20000 60000 180000 <table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zROLXQn5ltZd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details - Assumptions)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B4_zyJXiUojg3N8" style="display: none">Schedule of assumptions of option pricing</span></td> <td style="text-align: justify"> </td> <td colspan="2" style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td colspan="2" style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, <br/> 2025</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, <br/> 2024</b></span></td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td colspan="2" style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td colspan="2" style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend yield</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 66%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td> <td style="width: 2%; text-align: justify"> </td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20250101__20250331_zUQeHV68yaua" title="Risk-free interest rate">4.2</span>%</span></td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20240101__20240331_zkqs9g15eIV" title="Risk-free interest rate">1.16</span>%</span></td> <td style="width: 1%; text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (in years)</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20250331_zm83xSmtd7ol" title="Expected term (in years)">2.74</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240331_zTksV5lUrxZ7" title="Expected term (in years)">4.31</span></span></td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20250101__20250331_zVB2z0QzZLh4" title="Volatility">36.25</span>%</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20240101__20240331_zgjgFgHL1ka5" title="Volatility">48.15</span>%</span></td> <td style="text-align: justify"> </td></tr> </table> 0.042 0.0116 P2Y8M26D P4Y3M21D 0.3625 0.4815 60831 <p id="xdx_80D_eus-gaap--PreferredStockTextBlock_zoBVYsMKca35" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 18     <span id="xdx_825_z0oubfkybkAf">PREFERRED STOCK</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2021, the Company issued <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_c20210831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_pdd" title="Preferred stock, shares issued">80,000</span> preferred shares, par value $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_c20210831_pdd" title="Sale of stock, price">0.001</span> per share, at an issue price of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_c20210831_pdd" title="Share price">2.50</span> per share to certain investors credited as fully paid. The preferred shares are non-voting and non-redeemable. The holder of the preferred shares will have priority over the holders of the common stock of the Company on the assets and funds of the Company available for distribution in a distribution of assets on liquidation, winding up or dissolution of the Company. The holder of the preferred shares shall not have the right to attend or vote at any general meeting of the Company (except a general meeting for winding up of the Company or a resolution is to be proposed which if passed would vary or abrogate the rights or privileges of such holder).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 11, 2022, the Company effected a <span id="xdx_901_eus-gaap--StockholdersEquityReverseStockSplit_c20220809__20220811_zmWgbWMyVXte" title="Reverse stock split">2:3 reverse stock split</span> for each share of common stock issued and outstanding. As a result of reverse stock split, the shares of common stock issuable upon the conversion of Series A Preferred Stock decreased from 80,000 shares to 53,334 shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 80000 0.001 2.50 2:3 reverse stock split <p id="xdx_803_eus-gaap--EarningsPerShareTextBlock_zlJAgVqDAN2c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 19     <span id="xdx_82D_z2a7OhfePHmc">(LOSS) INCOME PER SHARE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the computation of basic and diluted income (loss) per common share for the quarters ended March 31, 2025 and 2024.</p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zwAHjukuFQmb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - (LOSS) EARNINGS PER SHARE (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B1_zsraeGqfv2M" style="display: none">Schedule of loss per share</span></td><td> </td> <td colspan="2" id="xdx_49D_20250101__20250331_zF5ZCQiTSFBg" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49B_20240101__20240331_znngwahrZeCc" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For three months ended </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_400_ecustom--NumeratorAbstract_iB_zwjr4sKh53o8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zuaFGrG0YAAf" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify; padding-bottom: 2.5pt">Net loss income attributable to the Company</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">(248,017</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">(288,576</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--DenominatorAbstract_iB_z0RbpFPBTGGj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_z7sSgzo0QTPl" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Weighted-average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zWT6yfq5Qzw1" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">- Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">14,159,761</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">11,956,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zISXzY14lBT4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">14,159,761</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">11,956,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--LossPerShareBasicAndDilutedAbstract_iB_znPKFX39Xyi9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_zYtWucsdKnl5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">- Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0175</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0241</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_zqa0DPeXhMsf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0175</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0241</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zwAHjukuFQmb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - (LOSS) EARNINGS PER SHARE (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B1_zsraeGqfv2M" style="display: none">Schedule of loss per share</span></td><td> </td> <td colspan="2" id="xdx_49D_20250101__20250331_zF5ZCQiTSFBg" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49B_20240101__20240331_znngwahrZeCc" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For three months ended </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>March 31,</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_400_ecustom--NumeratorAbstract_iB_zwjr4sKh53o8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zuaFGrG0YAAf" style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify; padding-bottom: 2.5pt">Net loss income attributable to the Company</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">(248,017</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">(288,576</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--DenominatorAbstract_iB_z0RbpFPBTGGj" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_z7sSgzo0QTPl" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Weighted-average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zWT6yfq5Qzw1" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">- Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">14,159,761</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">11,956,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zISXzY14lBT4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">14,159,761</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">11,956,987</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--LossPerShareBasicAndDilutedAbstract_iB_znPKFX39Xyi9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Loss per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_zYtWucsdKnl5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">- Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0175</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0241</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_zqa0DPeXhMsf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0175</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0241</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -248017 -288576 14159761 11956987 14159761 11956987 -0.0175 -0.0241 -0.0175 -0.0241 <p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z3jdgGr1qG01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 20     <span id="xdx_82E_zry0lCXExx78">COMMITMENTS AND CONTINGENCIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Lease Commitment</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has entered into operating lease agreement for certain office and accommodation as well as fish farming containers for research and develop advanced technology for water circulation applying in fishery. Future minimum lease payments under non-cancellable operating leases with initial terms within one year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The total future minimum lease payments under non-cancellable short-term leases as of March 31, 2025 are payable as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zuboPzXHnq0j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B7_zwU87encw6j8" style="display: none">Schedule of lease payments</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20250331_z1wMiCXxsrO2" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lease Commitment</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: justify; padding-bottom: 1pt">Within 1 year</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">1,827</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,827</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zuboPzXHnq0j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B7_zwU87encw6j8" style="display: none">Schedule of lease payments</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20250331_z1wMiCXxsrO2" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lease Commitment</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="padding-bottom: 1pt; text-align: center">$</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 83%; text-align: justify; padding-bottom: 1pt">Within 1 year</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 13%; text-align: right">1,827</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,827</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1827 1827 <p id="xdx_800_eus-gaap--SegmentReportingDisclosureTextBlock_z8PafYA6i1ub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 21     <span id="xdx_82F_z93JCgvV1Uyi">SEGMENT REPORTING</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective as of January 1, 2024, the Company adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The Company’s Chief Operating Decision Maker (“CODM”) is its Executive Director, Song-Yuan Teng, who is responsible for reviewing the results of operations and allocating resources across the Company’s reportable segments, including Fish Trading and Catering Services. These operating segments reflect the manner in which the CODM allocates resources and evaluates performance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These segments align with how management evaluates performance and allocates resources. Segment performance is evaluated based on segment revenue and operating profit, which includes direct costs and segment-specific general and administrative expenses and tax, but excludes corporate overhead and interest.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The summary of key information by segments for the three months ended March 31, 2025 and 2024 was as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>For three months ended March 31, 2025</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zDCVb8fvCuRi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Disclosure - SEGMENT REPORTING (Details - Segment information)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span id="xdx_8B6_zT9M8sVytxY7"><b style="display: none">Schedule of segment information</b></span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Sales of Fish Trading</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Sales of <br/> Catering</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">E-Commerce</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%; font-size: 10pt">Revenue</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_z6BsIEp46yS1" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">4,474,206</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--Revenues_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zvAUA1nfGJ4l" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">2,089</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zhjoZ2b3MwPg" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">57,833</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20250101__20250331_zVYmFSy68iK2" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">4,534,128</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Cost of revenue</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zyrppDOapEX6" style="font-size: 10pt; text-align: right" title="Cost of revenue">4,465,209</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zf92Ln5WsXAe" style="font-size: 10pt; text-align: right" title="Cost of revenue">1,567</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zqsXvOp6nkub" style="font-size: 10pt; text-align: right" title="Cost of revenue">16,402</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--CostOfGoodsAndServicesSold_c20250101__20250331_zzOs3bBnLJgj" style="font-size: 10pt; text-align: right" title="Cost of revenue">4,483,178</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">Gross profit</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--GrossProfit_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zkR9YYnnAMi4" style="font-size: 10pt; text-align: right" title="Gross profit">8,997</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--GrossProfit_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zr5GYUeAF8l2" style="font-size: 10pt; text-align: right" title="Gross profit">522</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--GrossProfit_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zkSr4E83wl36" style="font-size: 10pt; text-align: right" title="Gross profit">41,431</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--GrossProfit_c20250101__20250331_z0RRmJNzFz84" style="font-size: 10pt; text-align: right" title="Gross profit">50,950</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">General and administrative expenses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zKBfl2nErwme" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(60,323</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zS50UM4N36z" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(195,407</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zihihq9I3xZc" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(78,641</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20250101__20250331_zVh33IoxRUi" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(334,371</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">Segment operating losses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zvgR5vHRbBK" style="font-size: 10pt; text-align: right" title="Segment operating losses">(51,326</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--OperatingIncomeLoss_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zvGxR37wOLkc" style="font-size: 10pt; text-align: right" title="Segment operating losses">(194,885</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingIncomeLoss_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zvxe6piJdwae" style="font-size: 10pt; text-align: right" title="Segment operating losses">(37,210</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_c20250101__20250331_zTmW59sANOx8" style="font-size: 10pt; text-align: right" title="Segment operating losses">(283,421</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Income tax expenses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeTaxExpenseBenefit_d0_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zByc5c2iCv58" style="font-size: 10pt; text-align: right" title="Income tax expenses">–</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeTaxExpenseBenefit_d0_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_z1hCE2eCENj2" style="font-size: 10pt; text-align: right" title="Income tax expenses">–</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_d0_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zxV0V6EZf0Qe" style="font-size: 10pt; text-align: right" title="Income tax expenses">–</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeTaxExpenseBenefit_d0_c20250101__20250331_zEybUaueZcsl" style="font-size: 10pt; text-align: right" title="Income tax expenses">–</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">Segment losses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_989_ecustom--SegmentLosses_d0_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zK1fCkQOvsXk" style="font-size: 10pt; text-align: right" title="Segment losses">(51,326</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_987_ecustom--SegmentLosses_d0_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zkQ9RDQy3Wfe" style="font-size: 10pt; text-align: right" title="Segment losses">(194,885</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_982_ecustom--SegmentLosses_d0_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zWih48NY0Gdc" style="font-size: 10pt; text-align: right" title="Segment losses">(37,210</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_982_ecustom--SegmentLosses_d0_c20250101__20250331_zp7s7W5p15zd" style="font-size: 10pt; text-align: right" title="Segment losses">(283,421</td><td style="font-size: 10pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>For three months ended March 31, 2024</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Sales of Fish Trading</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Sales of <br/> Catering</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">E-Commerce</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%; font-size: 10pt">Revenue</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zQtJm67I7hu1" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">4,764,517</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zh3BHVGFpE5l" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">86,373</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_z9Ipfj9rUOr9" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">48,990</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20240101__20240331_zC0WEsC2Dw61" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">4,899,880</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Cost of revenue</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--CostOfGoodsAndServicesSold_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_z8fQyKuzD0Q9" style="font-size: 10pt; text-align: right" title="Cost of revenue">4,754,614</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--CostOfGoodsAndServicesSold_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zaHV6qyQgxFb" style="font-size: 10pt; text-align: right" title="Cost of revenue">43,989</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--CostOfGoodsAndServicesSold_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zAwolwizOJBa" style="font-size: 10pt; text-align: right" title="Cost of revenue">17,316</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--CostOfGoodsAndServicesSold_c20240101__20240331_zSyz5LcOhxz7" style="font-size: 10pt; text-align: right" title="Cost of revenue">4,815,919</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">Gross profit</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--GrossProfit_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zUY7yOFfnhVb" style="font-size: 10pt; text-align: right" title="Gross profit">9,903</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--GrossProfit_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_z3f2DxT2T3y2" style="font-size: 10pt; text-align: right" title="Gross profit">42,384</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--GrossProfit_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zvfPpxt94vA7" style="font-size: 10pt; text-align: right" title="Gross profit">31,674</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--GrossProfit_c20240101__20240331_zdnySOL2Qj4l" style="font-size: 10pt; text-align: right" title="Gross profit">83,961</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">General and administrative expenses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zN1egKlKBMl4" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(27,955</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zidsw6UHiqua" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(166,429</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_z9LdVKAnPlzk" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(257,080</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20240101__20240331_zD7fWRhvC19d" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(451,464</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">Segment operating losses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zi0iGpdfkqtj" style="font-size: 10pt; text-align: right" title="Segment operating losses">(18,052</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingIncomeLoss_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zulJneBbgsqc" style="font-size: 10pt; text-align: right" title="Segment operating losses">(124,045</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zVuoRf4CZ9Lc" style="font-size: 10pt; text-align: right" title="Segment operating losses">(225,406</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingIncomeLoss_c20240101__20240331_zXz0SHKu1QBa" style="font-size: 10pt; text-align: right" title="Segment operating losses">(367,503</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Income tax expenses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_iN_di0_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zGGUcCWdskR1" style="font-size: 10pt; text-align: right" title="Income tax expenses">(124,146</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_d0_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zaytHHKkR5tk" style="font-size: 10pt; text-align: right" title="Income tax expenses">–</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_d0_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zzTz52Hr6xVh" style="font-size: 10pt; text-align: right" title="Income tax expenses">–</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeTaxExpenseBenefit_iN_di0_c20240101__20240331_zf8e7Hd60tLh" style="font-size: 10pt; text-align: right" title="Income tax expenses">(124,146</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">Segment losses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_989_ecustom--SegmentLosses_d0_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zHYqeEizoha8" style="font-size: 10pt; text-align: right" title="Segment losses">(142,198</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98F_ecustom--SegmentLosses_d0_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_z2SY4EmG04Ei" style="font-size: 10pt; text-align: right" title="Segment losses">(124,045</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_987_ecustom--SegmentLosses_d0_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zLnmH0LPUB99" style="font-size: 10pt; text-align: right" title="Segment losses">(225,406</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98C_ecustom--SegmentLosses_d0_c20240101__20240331_zh6BUgsYVjzl" style="font-size: 10pt; text-align: right" title="Segment losses">(491,649</td><td style="font-size: 10pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables set forth a summary of single customers who represent 10% or more of the Company’s segments revenue, net:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt"></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Fish Trading</b></span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>March 31, 2025</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>March 31, 2024</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: justify"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify">Percentage of fish trading revenue</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-size: 10pt; text-align: justify">Customer A</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_982_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zaxtd6evdce8" style="width: 13%; font-size: 10pt; text-align: right" title="Concentration percentage">21.47%</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_983_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zZGx22AGMhe6" style="width: 13%; font-size: 10pt; text-align: right" title="Concentration percentage">37.45%</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify">Customer B</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_984_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zyRa6m05cwr1" style="font-size: 10pt; text-align: right" title="Concentration percentage">24.25%</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98F_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zvOHsQFFQRRk" style="font-size: 10pt; text-align: right" title="Concentration percentage">–</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: justify">Customer C</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_980_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zWYl7NsG5Ef5" style="font-size: 10pt; text-align: right" title="Concentration percentage">18.42%</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_981_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_z14bnyXfPSv4" style="font-size: 10pt; text-align: right" title="Concentration percentage">–</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify">Customer D</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98A_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zdPCKrAeLV5b" style="font-size: 10pt; text-align: right" title="Concentration percentage">20.50%</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_982_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zu9HWm40ZW6j" style="font-size: 10pt; text-align: right" title="Concentration percentage">10.01%</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: justify">Customer E</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_980_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_z1SKRGr13KH1" style="font-size: 10pt; text-align: right" title="Concentration percentage">–</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_985_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zHH9JgY1voSf" style="font-size: 10pt; text-align: right" title="Concentration percentage">18.21%</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">Customer F</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98D_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zvJwg5V2yPNi" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Concentration percentage">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_983_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zeFu5wJVePij" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Concentration percentage">15.35%</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_98A_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zyWomDU4ozM1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Concentration percentage">84.65%</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_983_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zWHGLwoew4me" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Concentration percentage">81.01%</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: justify"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Catering</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: justify"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31, 2025</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: justify"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: justify">Percentage of catering revenue</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; font-size: 10pt; text-align: justify">Customer G</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_988_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerGMember__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_ztvGcdtowiYd" style="width: 13%; font-size: 10pt; text-align: right" title="Concentration percentage">83.99%</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_983_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerGMember__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_z349NOfYLJy2" style="width: 13%; font-size: 10pt; text-align: right" title="Concentration percentage">–</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_986_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zt2wuNl2ztq1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Concentration percentage">83.99%</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_986_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zedTxbqcjtG6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Concentration percentage">–</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_zDCVb8fvCuRi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Disclosure - SEGMENT REPORTING (Details - Segment information)"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"><span id="xdx_8B6_zT9M8sVytxY7"><b style="display: none">Schedule of segment information</b></span></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Sales of Fish Trading</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Sales of <br/> Catering</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">E-Commerce</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%; font-size: 10pt">Revenue</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_z6BsIEp46yS1" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">4,474,206</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--Revenues_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zvAUA1nfGJ4l" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">2,089</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zhjoZ2b3MwPg" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">57,833</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20250101__20250331_zVYmFSy68iK2" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">4,534,128</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Cost of revenue</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zyrppDOapEX6" style="font-size: 10pt; text-align: right" title="Cost of revenue">4,465,209</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zf92Ln5WsXAe" style="font-size: 10pt; text-align: right" title="Cost of revenue">1,567</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--CostOfGoodsAndServicesSold_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zqsXvOp6nkub" style="font-size: 10pt; text-align: right" title="Cost of revenue">16,402</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--CostOfGoodsAndServicesSold_c20250101__20250331_zzOs3bBnLJgj" style="font-size: 10pt; text-align: right" title="Cost of revenue">4,483,178</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">Gross profit</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--GrossProfit_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zkR9YYnnAMi4" style="font-size: 10pt; text-align: right" title="Gross profit">8,997</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--GrossProfit_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zr5GYUeAF8l2" style="font-size: 10pt; text-align: right" title="Gross profit">522</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--GrossProfit_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zkSr4E83wl36" style="font-size: 10pt; text-align: right" title="Gross profit">41,431</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--GrossProfit_c20250101__20250331_z0RRmJNzFz84" style="font-size: 10pt; text-align: right" title="Gross profit">50,950</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">General and administrative expenses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zKBfl2nErwme" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(60,323</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zS50UM4N36z" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(195,407</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_985_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zihihq9I3xZc" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(78,641</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20250101__20250331_zVh33IoxRUi" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(334,371</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">Segment operating losses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zvgR5vHRbBK" style="font-size: 10pt; text-align: right" title="Segment operating losses">(51,326</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--OperatingIncomeLoss_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zvGxR37wOLkc" style="font-size: 10pt; text-align: right" title="Segment operating losses">(194,885</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--OperatingIncomeLoss_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zvxe6piJdwae" style="font-size: 10pt; text-align: right" title="Segment operating losses">(37,210</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_c20250101__20250331_zTmW59sANOx8" style="font-size: 10pt; text-align: right" title="Segment operating losses">(283,421</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Income tax expenses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--IncomeTaxExpenseBenefit_d0_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zByc5c2iCv58" style="font-size: 10pt; text-align: right" title="Income tax expenses">–</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--IncomeTaxExpenseBenefit_d0_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_z1hCE2eCENj2" style="font-size: 10pt; text-align: right" title="Income tax expenses">–</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_d0_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zxV0V6EZf0Qe" style="font-size: 10pt; text-align: right" title="Income tax expenses">–</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeTaxExpenseBenefit_d0_c20250101__20250331_zEybUaueZcsl" style="font-size: 10pt; text-align: right" title="Income tax expenses">–</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">Segment losses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_989_ecustom--SegmentLosses_d0_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zK1fCkQOvsXk" style="font-size: 10pt; text-align: right" title="Segment losses">(51,326</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_987_ecustom--SegmentLosses_d0_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zkQ9RDQy3Wfe" style="font-size: 10pt; text-align: right" title="Segment losses">(194,885</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_982_ecustom--SegmentLosses_d0_c20250101__20250331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zWih48NY0Gdc" style="font-size: 10pt; text-align: right" title="Segment losses">(37,210</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_982_ecustom--SegmentLosses_d0_c20250101__20250331_zp7s7W5p15zd" style="font-size: 10pt; text-align: right" title="Segment losses">(283,421</td><td style="font-size: 10pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>For three months ended March 31, 2024</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Sales of Fish Trading</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Sales of <br/> Catering</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">E-Commerce</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%; font-size: 10pt">Revenue</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zQtJm67I7hu1" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">4,764,517</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zh3BHVGFpE5l" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">86,373</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_z9Ipfj9rUOr9" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">48,990</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20240101__20240331_zC0WEsC2Dw61" style="width: 11%; font-size: 10pt; text-align: right" title="Revenue">4,899,880</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt">Cost of revenue</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_988_eus-gaap--CostOfGoodsAndServicesSold_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_z8fQyKuzD0Q9" style="font-size: 10pt; text-align: right" title="Cost of revenue">4,754,614</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--CostOfGoodsAndServicesSold_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zaHV6qyQgxFb" style="font-size: 10pt; text-align: right" title="Cost of revenue">43,989</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--CostOfGoodsAndServicesSold_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zAwolwizOJBa" style="font-size: 10pt; text-align: right" title="Cost of revenue">17,316</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--CostOfGoodsAndServicesSold_c20240101__20240331_zSyz5LcOhxz7" style="font-size: 10pt; text-align: right" title="Cost of revenue">4,815,919</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">Gross profit</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--GrossProfit_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zUY7yOFfnhVb" style="font-size: 10pt; text-align: right" title="Gross profit">9,903</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_982_eus-gaap--GrossProfit_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_z3f2DxT2T3y2" style="font-size: 10pt; text-align: right" title="Gross profit">42,384</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--GrossProfit_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zvfPpxt94vA7" style="font-size: 10pt; text-align: right" title="Gross profit">31,674</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--GrossProfit_c20240101__20240331_zdnySOL2Qj4l" style="font-size: 10pt; text-align: right" title="Gross profit">83,961</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">General and administrative expenses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_980_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zN1egKlKBMl4" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(27,955</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zidsw6UHiqua" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(166,429</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_z9LdVKAnPlzk" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(257,080</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_987_eus-gaap--GeneralAndAdministrativeExpense_iN_di_c20240101__20240331_zD7fWRhvC19d" style="font-size: 10pt; text-align: right" title="General and administrative expenses">(451,464</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">Segment operating losses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--OperatingIncomeLoss_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zi0iGpdfkqtj" style="font-size: 10pt; text-align: right" title="Segment operating losses">(18,052</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--OperatingIncomeLoss_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zulJneBbgsqc" style="font-size: 10pt; text-align: right" title="Segment operating losses">(124,045</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zVuoRf4CZ9Lc" style="font-size: 10pt; text-align: right" title="Segment operating losses">(225,406</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingIncomeLoss_c20240101__20240331_zXz0SHKu1QBa" style="font-size: 10pt; text-align: right" title="Segment operating losses">(367,503</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: left">Income tax expenses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_iN_di0_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zGGUcCWdskR1" style="font-size: 10pt; text-align: right" title="Income tax expenses">(124,146</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeTaxExpenseBenefit_d0_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zaytHHKkR5tk" style="font-size: 10pt; text-align: right" title="Income tax expenses">–</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98D_eus-gaap--IncomeTaxExpenseBenefit_d0_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zzTz52Hr6xVh" style="font-size: 10pt; text-align: right" title="Income tax expenses">–</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_986_eus-gaap--IncomeTaxExpenseBenefit_iN_di0_c20240101__20240331_zf8e7Hd60tLh" style="font-size: 10pt; text-align: right" title="Income tax expenses">(124,146</td><td style="font-size: 10pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: left">Segment losses</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_989_ecustom--SegmentLosses_d0_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zHYqeEizoha8" style="font-size: 10pt; text-align: right" title="Segment losses">(142,198</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98F_ecustom--SegmentLosses_d0_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_z2SY4EmG04Ei" style="font-size: 10pt; text-align: right" title="Segment losses">(124,045</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_987_ecustom--SegmentLosses_d0_c20240101__20240331__us-gaap--StatementBusinessSegmentsAxis__custom--ECommerceMember_zLnmH0LPUB99" style="font-size: 10pt; text-align: right" title="Segment losses">(225,406</td><td style="font-size: 10pt; text-align: left">)</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left">$</td><td id="xdx_98C_ecustom--SegmentLosses_d0_c20240101__20240331_zh6BUgsYVjzl" style="font-size: 10pt; text-align: right" title="Segment losses">(491,649</td><td style="font-size: 10pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables set forth a summary of single customers who represent 10% or more of the Company’s segments revenue, net:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt"></td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Fish Trading</b></span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>March 31, 2025</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>March 31, 2024</b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: justify"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify">Percentage of fish trading revenue</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; font-size: 10pt; text-align: justify">Customer A</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_982_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zaxtd6evdce8" style="width: 13%; font-size: 10pt; text-align: right" title="Concentration percentage">21.47%</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_983_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zZGx22AGMhe6" style="width: 13%; font-size: 10pt; text-align: right" title="Concentration percentage">37.45%</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify">Customer B</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_984_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zyRa6m05cwr1" style="font-size: 10pt; text-align: right" title="Concentration percentage">24.25%</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98F_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zvOHsQFFQRRk" style="font-size: 10pt; text-align: right" title="Concentration percentage">–</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: justify">Customer C</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_980_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zWYl7NsG5Ef5" style="font-size: 10pt; text-align: right" title="Concentration percentage">18.42%</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_981_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_z14bnyXfPSv4" style="font-size: 10pt; text-align: right" title="Concentration percentage">–</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify">Customer D</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_98A_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zdPCKrAeLV5b" style="font-size: 10pt; text-align: right" title="Concentration percentage">20.50%</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_982_ecustom--ConcentrationRiskPercentage2_dp_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zu9HWm40ZW6j" style="font-size: 10pt; text-align: right" title="Concentration percentage">10.01%</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: justify">Customer E</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_980_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_z1SKRGr13KH1" style="font-size: 10pt; text-align: right" title="Concentration percentage">–</td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td id="xdx_985_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zHH9JgY1voSf" style="font-size: 10pt; text-align: right" title="Concentration percentage">18.21%</td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 1pt">Customer F</td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_98D_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zvJwg5V2yPNi" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Concentration percentage">–</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"> </td><td id="xdx_983_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zeFu5wJVePij" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Concentration percentage">15.35%</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_98A_ecustom--ConcentrationRiskPercentage2_dp0_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zyWomDU4ozM1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Concentration percentage">84.65%</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_983_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--StatementBusinessSegmentsAxis__custom--FishTradingMember_zWHGLwoew4me" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Concentration percentage">81.01%</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: justify"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Catering</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: justify"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31, 2025</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">March 31, 2024</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: justify"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td><td style="font-size: 10pt"> </td> <td colspan="2" style="font-size: 10pt; text-align: center"> </td><td style="font-size: 10pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: justify">Percentage of catering revenue</td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt"> </td> <td style="font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; text-align: right"> </td><td style="font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; font-size: 10pt; text-align: justify">Customer G</td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_988_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerGMember__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_ztvGcdtowiYd" style="width: 13%; font-size: 10pt; text-align: right" title="Concentration percentage">83.99%</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td><td style="width: 2%; font-size: 10pt"> </td> <td style="width: 1%; font-size: 10pt; text-align: left"> </td><td id="xdx_983_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerGMember__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_z349NOfYLJy2" style="width: 13%; font-size: 10pt; text-align: right" title="Concentration percentage">–</td><td style="width: 1%; font-size: 10pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-size: 10pt; text-align: justify; padding-bottom: 2.5pt"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_986_ecustom--ConcentrationRiskPercentage2_dp_c20250101__20250331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zt2wuNl2ztq1" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Concentration percentage">83.99%</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td><td style="font-size: 10pt; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"> </td><td id="xdx_986_ecustom--ConcentrationRiskPercentage2_dp0_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--StatementBusinessSegmentsAxis__custom--CateringMember_zedTxbqcjtG6" style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right" title="Concentration percentage">–</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <b> </b></p> 4474206 2089 57833 4534128 4465209 1567 16402 4483178 8997 522 41431 50950 60323 195407 78641 334371 -51326 -194885 -37210 -283421 0 0 0 0 -51326 -194885 -37210 -283421 4764517 86373 48990 4899880 4754614 43989 17316 4815919 9903 42384 31674 83961 27955 166429 257080 451464 -18052 -124045 -225406 -367503 124146 0 0 124146 -142198 -124045 -225406 -491649 0.2147 0.3745 0.2425 0 0.1842 0 0.2050 0.1001 0 0.1821 0 0.1535 0.8465 0.8101 0.8399 0 0.8399 0 <p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zW0hvicES8y8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 22      <span id="xdx_828_zRregIMpSj1b">SUBSEQUENT EVENT</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has evaluated subsequent events through the issuance of the unaudited condensed consolidated financial statements and there are no subsequent events that would have required adjustment or disclosure in the consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> false false false false Mountain Share Transfer, LLC is company 100% controlled by Erik S. Nelson, the previous corporate secretary and director of the Company. The balances represented the amount paid on behalf of the Company for its daily operation purpose. The amount due to Mr. Yin-Chieh Cheng relates to a prior arrangement. Mr. Yin-Chieh Cheng was vacant as of July 8, 2023, and the Company is evaluating settlement with the estate. Feng-Hua Chen is the Chief Operating Officer of the company, the balances represented the amount paid on behalf of the Company for its daily operation purpose. XML 102 R1.htm IDEA: XBRL DOCUMENT v3.25.2
Cover - shares
3 Months Ended
Mar. 31, 2025
May 15, 2025
Cover [Abstract]    
Document Type 10-Q/A  
Amendment Flag true  
Amendment Description To report segment information  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2025  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2025  
Current Fiscal Year End Date --12-31  
Entity File Number 001-41434  
Entity Registrant Name NOCERA, INC.  
Entity Central Index Key 0001756180  
Entity Tax Identification Number 16-1626611  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 3F (Building B), No. 185  
Entity Address, Address Line Two Sec. 1, Datong Rd  
Entity Address, Address Line Three Xizhi Dist  
Entity Address, City or Town New Taipei City  
Entity Address, Country TW  
Entity Address, Postal Zip Code 221  
Country Region 886  
City Area Code 910  
Local Phone Number 163-358  
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol NCRA  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   14,367,539

XML 103 R2.htm IDEA: XBRL DOCUMENT v3.25.2
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 531,771 $ 484,161
Accounts receivable 134,106 144,509
Inventories, net 9,608 0
Advance to suppliers 1,732 8,404
Prepaid expenses and other assets, net 598,199 643,169
Financial assets at fair value through profit or loss 0 210
Total current assets 1,275,416 1,280,453
Property and equipment, net 1,342,060 1,391,845
Intangible assets - customer relations 93,749 97,825
Investment 27,435 27,206
Goodwill 2,077,728 2,077,728
Other non-current asset 4,373 7,505
Total assets 4,820,761 4,882,562
Current liabilities    
Accounts payable 13,717 0
Other payables and accrued liabilities 395,793 376,660
Contract liabilities 78,875 72,505
Due to related parties 38,518 27,116
Warrant liability 85,273 76,847
Long-term secured other borrowing – current portion 28,868 6,631
Dividend payable 54,312 54,312
Income tax payable 11,028 25,126
Total current liabilities 706,384 639,197
Long-term secured other borrowing 0 23,786
Total liabilities 706,384 662,983
Commitments and contingencies (Note 20)
Shareholder’s Equity    
Common stock ($0.001 par value; authorized 200,000,000 shares; 14,247,539 shares and 14,047,539 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively) (1) 14,247 14,047
Preferred stock ($0.001 par value; authorized 10,000,000 shares; Series A Preferred Stock, 2,000,000 authorized, 80,000 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively) 80 80
Additional paid-in capital (1) 25,350,065 25,200,265
Statutory and other reserves 191,219 191,219
Accumulated losses (21,486,898) (21,238,881)
Accumulated other comprehensive income 15,253 12,415
Total Nocera, Inc.’s shareholders’ equity 4,083,966 4,179,145
Non-controlling interests 30,411 40,434
Total shareholders’ equity 4,114,377 4,219,579
Total liabilities and shareholders’ equity $ 4,820,761 $ 4,882,562
XML 104 R3.htm IDEA: XBRL DOCUMENT v3.25.2
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Mar. 31, 2025
Dec. 31, 2024
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 14,247,539 14,047,539
Common stock, shares outstanding 14,247,539 14,047,539
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Series A Preferred Stock [Member]    
Preferred stock, shares authorized 2,000,000 2,000,000
Preferred stock, shares issued 80,000 80,000
Preferred stock, shares outstanding 80,000 80,000
XML 105 R4.htm IDEA: XBRL DOCUMENT v3.25.2
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Net sales $ 4,534,128 $ 4,899,880
Cost of sales (4,483,178) (4,815,919)
Gross profit 50,950 83,961
Operating expenses    
General and administrative expenses (334,371) (451,464)
Total operating expenses (334,371) (451,464)
Loss from operations (283,421) (367,503)
Other income 25,804 195,573
Loss before income taxes (257,617) (171,930)
Income tax expense 0 (124,146)
Net loss (257,617) (296,076)
Less: Net loss attributable to non-controlling interests (9,600) (7,500)
Net loss attributable to the company (248,017) (288,576)
Comprehensive Income    
Net loss (257,617) (296,076)
Foreign currency translation (loss) gain (2,838) 57,307
Total comprehensive loss (260,455) (238,769)
Less: Net loss attributable to non-controlling interests (9,600) (7,500)
Less: Foreign currency translation loss attributable to non-controlling interest (423) 1,878
Comprehensive loss attributable to the Company $ (250,432) $ (233,147)
Loss per share    
Basic $ (0.0175) $ (0.0241)
Diluted $ (0.0175) $ (0.0241)
Weighted average number of common shares outstanding    
Basic 14,159,761 11,956,987
Diluted 14,159,761 11,956,987
XML 106 R5.htm IDEA: XBRL DOCUMENT v3.25.2
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (257,617) $ (296,076)
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation expenses 33,674 22,559
Deferred income tax 0 (922)
Amortization of intangible assets 4,076 4,076
Gain on disposal of financial assets at FVTPL (3)
Gain on fair value change of financial assets at FVTPL 0 (2,409)
Share-based compensation 0 14,999
Changes in operating assets and liabilities:    
Accounts receivable, net 11,262 (4,171)
Inventories (9,936) 0
Advance to suppliers 6,672 0
Prepaid expenses and other assets, net 48,927 (117,346)
Other non-current assets 3,076 69
Accounts payable 13,717 0
Advance from customers 5,802 0
Other payables and accrued liabilities 30,905 116,070
Income tax payable (14,083) 0
Subtract non-cash gain (loss) on warrant liability 8,426 (197,843)
Net cash used in operating activities (115,102) (460,994)
Cash flows from investing activities:    
Net cash inflow from acquisition of a subsidiary 0 201,863
Proceeds from gain on disposal of financial assets at FVTPL 213 0
Net cash provided by investing activities 213 201,863
Cash flows from financing activities:    
Repayment of short-term bank loan 0 (60,678)
Proceeds from issuance of common stock 150,000 0
Repayment of secured other borrowings (1,817) 0
Net cash provided by (used in) financing activities 148,183 (60,678)
Effect of exchange rate changes on cash and cash equivalents 14,316 52,006
Net increase (decrease) in cash and cash equivalents 47,610 (267,803)
Cash and cash equivalents at beginning of period 484,161 1,229,580
Cash and cash equivalents at end of period $ 531,771 $ 961,777
XML 107 R6.htm IDEA: XBRL DOCUMENT v3.25.2
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Statutory And Other Reserves [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total Nocera Stockholders Equity [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2023 $ 11,157 $ 80 $ 21,931,112 $ 191,219 $ (18,868,420) $ 98,906 $ 3,364,054 $ 84,325 $ 3,448,379
Beginning balance, shares at Dec. 31, 2023 11,156,987 80,000              
Foreign currency translation Adjustments (57,307) (57,307) (3,288) (60,595)
Common stock issuance $ 1,800 1,978,200 1,980,000 1,980,000
Common stock issuance, shares 1,800,000                
Share-based compensation 14,999 14,999 14,999
Net loss (288,576) (288,576) (7,500) (296,076)
Ending balance, value at Mar. 31, 2024 $ 12,957 $ 80 23,924,311 191,219 (19,156,996) 41,599 5,013,170 73,537 5,086,707
Ending balance, shares at Mar. 31, 2024 12,956,987 80,000              
Beginning balance, value at Dec. 31, 2024 $ 14,047 $ 80 25,200,265 191,219 (21,238,881) 12,415 4,179,145 40,434 4,219,579
Beginning balance, shares at Dec. 31, 2024 14,047,539 80,000              
Foreign currency translation Adjustments 2,838 2,838 (423) 2,415
Common stock issuance $ 200 149,800 150,000 150,000
Common stock issuance, shares 200,000                
Net loss (248,017) (248,017) (9,600) (257,617)
Ending balance, value at Mar. 31, 2025 $ 14,247 $ 80 $ 25,350,065 $ 191,219 $ (21,486,898) $ 15,253 $ 4,083,966 $ 30,411 $ 4,114,377
Ending balance, shares at Mar. 31, 2025 14,247,539 80,000              
XML 108 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2025
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted [Flag] false
Non-Rule 10b5-1 Arrangement Adopted [Flag] false
Rule 10b5-1 Arrangement Terminated [Flag] false
Non-Rule 10b5-1 Arrangement Terminated [Flag] false
XML 109 R8.htm IDEA: XBRL DOCUMENT v3.25.2
PRINCIPAL ACTIVITIES AND ORGANIZATION
3 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
PRINCIPAL ACTIVITIES AND ORGANIZATION

Note 1      PRINCIPAL ACTIVITIES AND ORGANIZATION

 

The consolidated financial statements include the financial statements of Nocera, Inc. (“Nocera” or the “Company”) and its subsidiaries, Grand Smooth Inc. Limited (“GSI”) and Guizhou Grand Smooth Technology Ltd. (“GZ GST” or “WFOE”), and Meixin Institutional Food Development Co., Ltd. (“Meixin”) that is controlled through contractual arrangements. The Company, GSI, GZ GST and Mexin are collectively referred to as the “Company”.

 

Nocera was incorporated in the State of Nevada on February 1, 2002 and is based in New Taipei City, Taiwan (R.O.C.). It did not engage in any operations and was dormant from its inception until its reverse merger with GSI on December 31, 2018.

 

Reverse Merger

 

Effective December 31, 2018, Nocera completed a reverse merger transaction (the “Transaction”) pursuant to an Agreement and Plan of Merger (the “Agreement”), with (i) GSI, (ii) GSI’s shareholders, Yin-Chieh Cheng and Bi Zhang, who together owned shares constituting 100% of the issued and outstanding ordinary shares of GSI (the “GSI Shares”) and (iii) GSI Acquisition Corp. Under the terms of the Agreement, the GSI Shareholders transferred to Nocera all of the GSI Shares in exchange for the issuance of 10,000,000 shares (the “Shares”) of Nocera’s common stock (the “Share Exchange”). As a result of the reverse merger, GSI became Nocera’s wholly-owned subsidiary and Yin-Chieh Cheng and Bi Zhang, the former shareholders of GSI, became Nocera’s controlling shareholders. The share exchange transaction with GSI was treated as a reverse merger, with GSI as the accounting acquirer and Nocera as the acquired party.

 

GSI is a limited company established under the laws and regulations of Hong Kong on August 1, 2014, and is a holding company without any operations.

 

GZ WFH was incorporated in Xingyi City, Guizhou Province, People’s Republic of China (“PRC”) on October 25, 2017, and is engaged in providing fish farming containers service, which integrates sales, installments, and maintenance of aquaculture equipment. The registered capital of GZ WFH is RMB$5,000,000 (equal to US$733,138).

 

On November 13, 2018, GSI incorporated GZ GST in PRC with registered capital of US$15,000.

 

Divestiture

 

On September 21, 2020, the Company filed a Current Report on Form 8-K outlining the lack of communication that led to the termination by Nocera of its relationship with its former variable interest entity, Guizhou Wan Feng Hu Intelligent Aquatic Technology Co. Limited (“GZ WFH”) and its management, and termination of the variable interest entity agreements between the parties.

 

Subsequently on October 8, 2020, Zhang Bi and GZ WFH entered into a Settlement Agreement and Release with Nocera wherein all claims as to GZ WFH’s debt (claim to shares in Nocera or GZ GST) were compromised, settled, and otherwise resolved as to any and all claims or causes of action whatsoever against Nocera for any matter, action, or representation as to Nocera, and any debt to ownership of Nocera or GZ GST up to the date of the agreement. The consideration for the agreement was mutual waiver of any and all claims against each other and GZ GST, and GZ WFH (including Zhang Bi) waived any claims to Nocera stock, meaning the 4,750,000 shares of common stock of Nocera owned by Zhang Bi were cancelled as part of the agreement. The Settlement Agreement and Release is attached hereto as Exhibit 10.8.

 

The VIE Agreements with XFC

 

On December 31, 2020, we exchanged 466,667 (post-split) shares of our restricted common stock to stockholders of Xin Feng Construction Co., Ltd., a Taiwan limited liability company (“XFC”), in exchange for 100% controlling interest in XFC. We also entered into contractual arrangements with a stockholder of XFC, that enabled us to have the power to direct the activities that most significantly affects the economic performance of XFC and receive the economic benefits of XFC that could be significant to XFC. On November 30, 2022, we entered into a Purchase of Business Agreement with Han-Chieh Shih (the “Purchaser”), in which we sold our controlling interest of XFC, to the Purchaser for a total purchase cash price of $300,000 (the “XFC Sale”). The closing of the XFC Sale occurred on November 30, 2022 and the XFC variable interest entity (“VIE”) agreements were terminated in connection with the XFC Sale. 

 

The VIE Agreements with Meixin

 

On September 7, 2022, we entered into a series of contractual agreements (collectively, the “Meixin VIE Agreements”) with the majority stockholder (the “Selling Stockholder”) of Meixin Institutional Food Development Co., Ltd., a Taiwan corporation and a food processing and catering company (“Meixin”), and Meixin, of which we purchased 80% controlling interest of Meixin for $4,300,000. The Meixin VIE Agreements essentially confer control and management of Meixin as well as substantially all of the economic benefits of the Selling Stockholder in Meixin to us.

 

The VIE Agreements with Xinca

 

On January 31, 2024, we entered into a Variable Interest Entity Purchase Agreement (“Xinca Purchase Agreement”) with Zhejiang Xinca Mutual Entertainment Culture Media Co., Ltd. (“Xinca”), a domestic funded limited liability company registered in China (P.R.C). The Xinca Purchase Agreement was entered into by our wholly-owned subsidiary and foreign enterprise, Shanghai Nocera Culture Co., Ltd. (“WFOE”), through a series of contractual agreements (“VIE Agreements”), in which we exchanged 1,800,000 shares of our restricted common stock for a 100% controlling interest in Xinca. As a result, the Company has been determined to be the primary beneficiary of Xinca and Xinca became a variable interest entity (“VIE”) of the Company.

 

We have entered into the following contractual arrangements with stockholders of Xinca, which enable us to (1) have the power to direct the activities that most significantly affect the economic performance of Xinca, and (2) receive the economic benefits of Xinca that could be significant to Xinca. We are fully and exclusively responsible for the management of Xinca, assume all of the risk of losses of Xinca, and have the exclusive right to exercise all voting rights of Xinca’s stockholders. Therefore, in accordance with ASC 810 “Consolidation,” we are considered the primary beneficiary of Xinca and have consolidated Xinca’s assets, liabilities, results of operations, and cash flows in the accompanying consolidated financial statements.

 

  (1) Voting Rights Proxy Agreement & Power of Attorney

 

Zong Hui and Upward Software (Shanghai) Co., Ltd. (the “Existing Stockholders”) have irrevocably authorized us, or the individual then designated by us (the “Attorney”), to exercise, on their behalf, the following rights available to them in their capacity as stockholders of Xinca under the then-effective articles of association of Xinca (collectively, the “Powers”): (a) to propose the convening of, and attend, stockholders’ meetings in accordance with the articles of association of Xinca on behalf of the Existing Stockholders; (b) to exercise voting rights on behalf of the Existing Stockholders on all matters required to be deliberated and resolved by the stockholders’ meeting, including, without limitation, the appointment and election of the directors and other executives to be appointed and removed by the stockholders of Xinca, and the sale or transfer of all or part of the equity held by stockholders in Xinca; (c) to exercise other stockholders’ voting rights under the articles of association of Xinca (including any other stockholders’ voting rights stipulated upon an amendment to such articles of association); and (d) other voting rights that stockholders shall enjoy under the laws of the People’s Republic of China (“China”), as amended, revised, supplemented, and re-enacted, regardless of whether they take effect before or after the conclusion of this Agreement. The Existing Stockholders shall not revoke the authorization and entrustment accorded to the Attorney unless we issue a written notice requesting the replacement of the Attorney. In such event, the Existing Stockholders shall immediately appoint such other person as we designate to exercise the foregoing Powers, and such new authorization and entrustment shall supersede, immediately upon its grant, the original authorization and entrustment.

 

  (2) Exclusive Business Cooperation Agreement

 

We agree to provide technical consulting and services, including management consulting services, general and financial advisory services, and various general and administrative services (collectively, the “Target Business”), to Xinca as its exclusive technical consulting and service provider in accordance with the terms set forth in this Agreement. Xinca agrees to accept the technical consulting and services provided by us. Xinca further agrees that, without our prior written consent, it shall not accept any technical consulting or services identical or similar to the Target Business from any third party during the term of this Agreement.

 

  (3) Equity Pledge Agreement

 

Under the Equity Interest Pledge Agreement between us and Zong Hui and Upward Software (Shanghai) Co., Ltd., the stockholders of Xinca have pledged all of their equity interests in Xinca to us to guarantee the performance of Xinca’s obligations under the Exclusive Business Cooperation Agreement. Under the terms of the agreement, in the event that Xinca or the stockholders breach their respective contractual obligations under the Exclusive Business Cooperation Agreement, we, as the pledgee, will be entitled to certain rights, including, but not limited to, the right to collect dividends generated by the pledged equity interests.

 

  (4) Exclusive Call Option Agreement

 

Xinca and its stockholders, Zong Hui and Upward Software (Shanghai) Co., Ltd., have entered into an Exclusive Call Option Agreement with us. Under this agreement, the Xinca stockholders have irrevocably granted us (or our designee) an exclusive option to purchase, to the extent permitted under the laws of China, part or all of their equity interests in Xinca. According to the Exclusive Call Option Agreement, the purchase price shall be the minimum price permitted under applicable Chinese law at the time the share transfer occurs.

 

The Equity Purchase Agreements with SY Culture

 

On April 14, 2024, we entered into a Equity Purchase Agreement with Hangzhou SY Culture Media Co. Ltd. (“SY Culture Purchase Agreement”), a domestic funded limited liability company registered in China (P.R.C). The SY Culture Purchase Agreement was entered into by our wholly-owned subsidiary and foreign enterprise, Gui Zhou Grand Smooth Technology Ltd. (“WFOE”), in which we exchanged 600,000 shares of our restricted common stock for a 100% equity in SY Culture.

 

XML 110 R9.htm IDEA: XBRL DOCUMENT v3.25.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICY
3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICY

Note 2      SUMMARY OF SIGNIFICANT ACCOUNTING POLICY

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, these financial statements do not include all of the information and footnotes required for complete financial statements and should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on May 6, 2025.

 

In the opinion of management, all adjustments (which include normal recurring adjustments) necessary to present a fair presentation of the Company’s unaudited condensed consolidated financial position as of March 31, 2025, its consolidated results of operations for the three months ended March 31, 2025, cash flows for the three months ended March 31, 2025 and change in equity for the three months ended March 31, 2025, as applicable, have been made. Operating results for the three months ended March 31, 2025 are not necessarily indicative of the operating results that may be expected for the year ending December 31, 2024 or any future periods.

 

Concentrations of Credit Risk

 

Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.

 

There were three customers who represent 69.67% of the Company’s total revenue for the three months ended March 31, 2024. There were four customers who represent 84.6% of the Company’s total revenue for the three months ended March 31, 2025.

 

The following table sets forth a summary of single customers who represent 10% or more of the Company’s total accounts receivable, net:

 

        
   March 31,
2025
   March 31,
2024
 
   (Unaudited)   (Audited) 
Percentage of the Company’s accounts receivable          
Customer A   21.46%    36.78% 
Customer B   24.24%     
Customer C   18.41%     
Customer D   20.49%     
Customer E       17.82% 
Customer F       15.07% 
    84.6%    69.67% 

 

The following table sets forth a summary of single suppliers who represent 10% or more of the Company’s total purchase:

   March 31,
2025
   March 31,
2024
 
   (Unaudited)   (Audited) 
Percentage of the Company’s purchase          
Supplier A   10.12%     
Supplier B   12.40%     
Supplier C   17.60%     
Supplier D   11.96%     
Supplier E       13.72% 
Supplier F       12.47% 
Supplier G       12.85% 
Supplier H       11.24% 
Supplier I       12.24% 
    52.08%    62.52% 

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers.”

 

The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies the following steps:

 

  · Step 1: Identify the contract(s) with a customer
     
  · Step 2: Identify the performance obligations in the contract
     
  · Step 3: Determine the transaction price
     
  · Step 4: Allocate the transaction price to the performance obligation in the contract
     
  · Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation

 

The Company mainly offers and generates revenue from the fish trading business, bento box and fruit and vegetable processing business, and E-commerce live streaming business. Revenue recognition policies are discussed as follows:

 

Aquatic product trading revenue

 

The Company engages in the trading of fish, primarily eels. Revenue is generated when the Company receives customer orders specifying product types and requirements. Upon receiving an order, the Company arranges the harvesting of the eels, inspects the products to ensure compliance with the customer’s specifications, and coordinates delivery. Revenue is recognized at a point in time when control of the goods is transferred to the customer, typically upon delivery, which is the point at which the performance obligation is satisfied.

 

Bento box and produce processing revenue

 

The Company also operates a bento box and fresh produce processing business, primarily involving vegetables and fruits. The revenue recognition model for this segment is similar to the aquatic product trading business. Upon receiving customer orders, the Company processes and packages the required food or agricultural products, ensures product quality and conformity to order specifications, and arranges delivery. Revenue is recognized at a point in time, generally upon the transfer of the processed goods to the customer.

 

E-commerce live-streaming commission revenue

 

The Company acts as an agent in facilitating the sale of third-party products through live-streaming e-commerce platforms. The Company does not take control of the goods sold, and commission revenue is recognized on a net basis. Revenue is recognized at the point in time when the underlying product is sold and shipment is confirmed by the seller, which indicates the Company has fulfilled its performance obligation of facilitating the sale. 

 

Recent Accounting Pronouncements

 

The FASB issued several updates during the period, none of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the consolidated financial statements upon adoption.

 

XML 111 R10.htm IDEA: XBRL DOCUMENT v3.25.2
ACCOUNTS RECEIVABLE
3 Months Ended
Mar. 31, 2025
Credit Loss [Abstract]  
ACCOUNTS RECEIVABLE

Note 3     ACCOUNTS RECEIVABLE

 

As of March 31, 2025 and December 31, 2024, accounts receivable consisted of the following:

           
    March 31,
2025
    December 31,
2024
 
    (Unaudited)     (Audited)  
    $     $  
Accounts receivable     134,106       144,509  
Total     134,106       144,509  

 

XML 112 R11.htm IDEA: XBRL DOCUMENT v3.25.2
INVENTORIES
3 Months Ended
Mar. 31, 2025
Inventory Disclosure [Abstract]  
INVENTORIES

Note 4      INVENTORIES

 

As of March 31, 2025 and December 31, 2024, inventories consisted of the following:

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Raw materials   9,608     
Total   9,608     

 

XML 113 R12.htm IDEA: XBRL DOCUMENT v3.25.2
ADVANCE TO SUPPLIERS
3 Months Ended
Mar. 31, 2025
Advance To Suppliers  
ADVANCE TO SUPPLIERS

Note 5     ADVANCE TO SUPPLIERS

 

Balances of advances to suppliers were $1,732 and $8,404 as of March 31, 2025 and December 31, 2024, respectively, which represented prepayments to suppliers for raw materials.

 

XML 114 R13.htm IDEA: XBRL DOCUMENT v3.25.2
PREPAID EXPENSES AND OTHER ASSETS, NET
3 Months Ended
Mar. 31, 2025
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
PREPAID EXPENSES AND OTHER ASSETS, NET

Note 6      PREPAID EXPENSES AND OTHER ASSETS, NET

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Prepaid Expenses   41,623    43,158 
Other receivables from third party   556,576    600,011 
Prepaid expenses and other assets, net   598,199    643,169 

 

Other receivables as of March 31, 2025 and December 31, 2024 were $598,199 and $643,169, respectively. Other receivables include e-commerce live stream receivables for goods and e-commerce sales deposit.

 

Other receivables from third parties primarily consist of amount due from third parties of $345,980, e-commerce live stream sales deposits of $5,487, and outstanding loans to certain employees totaling $15,326 from Xinca and $187,646 from SY Media, related to the Company’s participation in live stream events. These receivables are expected to be collected within normal payment cycles and are considered part of ongoing operations. Additionally, $1,106 relates to prior-year receivables from GZ GSI for fish sales in China. Management does not expect any collection issues.

 

XML 115 R14.htm IDEA: XBRL DOCUMENT v3.25.2
FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS
3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS

Note 7      FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS

 

The fair value of each investment in equity instrument to be measured at fair value through profit or loss is as follows:

 

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
Financial assets mandatorily measured at fair value through profit or loss  $   $ 
Funds       210 
Total       210 
           
Current       210 
Non-Current        
Total       210 

 

Net gain on disposal of financial assets at FVTPL of $3 was recognized in the consolidated statement of profit or loss for the period ended March 31, 2025.

 

As of December 31, 2024, no financial assets at fair value through profit or loss were pledged with banks as collaterals.

 

XML 116 R15.htm IDEA: XBRL DOCUMENT v3.25.2
PROPERTY AND EQUIPMENT, NET
3 Months Ended
Mar. 31, 2025
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET

Note 8      PROPERTY AND EQUIPMENT, NET

 

As of March 31, 2025 and December 31, 2024, property and equipment consisted of the following:

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Land   877,870    877,870 
Equipment   901,356    911,280 
Less: Accumulated depreciation   (437,166)   (397,305)
Property and equipment, net   1,342,060    1,391,845 

 

Depreciation expenses for the three months ended March 31, 2025 and 2024 were $33,674 and $22,559, respectively.

 

XML 117 R16.htm IDEA: XBRL DOCUMENT v3.25.2
GOODWILL AND OTHER INTANGIBLE ASSETS
3 Months Ended
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS

Note 9     GOODWILL AND OTHER INTANGIBLE ASSETS

 

As of March 31, 2025 and December 31, 2024, goodwill consisted of the following:

 

Goodwill

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Goodwill - Meixin   3,905,735    3,905,735 
Goodwill - Xinca   1,351,703    1,351,703 
Goodwill - SY Media   230,015    230,015 
Less: Impairment   (3,409,725)   (3,409,725)
Goodwill, net   2,077,728    2,077,728 

 

 

Customer relations

           
    March 31,     December 31,  
    2025     2024  
    (Unaudited)     (Audited)  
    $     $  
Acquisitions     135,325       135,325  
Less: Accumulated amortization     (41,576 )     (37,500 )
Customer relations, net     93,749       97,825  

 

XML 118 R17.htm IDEA: XBRL DOCUMENT v3.25.2
OTHER BORROWINGS
3 Months Ended
Mar. 31, 2025
Debt Disclosure [Abstract]  
OTHER BORROWINGS

Note 10       OTHER BORROWINGS

 

Others loans consisted of the following:

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
           
Secured car loan from CITIC Bank wholly repayable  $28,868   $30,417 
Total secured car loan wholly repayable within 1 year   28,868    6,631 
Secured car loan from CITIC Bank wholly repayable more than 1 year       23,786 
Total  $28,868   $30,417 

 

XML 119 R18.htm IDEA: XBRL DOCUMENT v3.25.2
WARRANTS
3 Months Ended
Mar. 31, 2025
Warrants  
WARRANTS

Note 11     WARRANTS

 

On April 1, 2021, the Company entered into a securities purchase agreement with certain investors for an aggregate of 80,000 shares of its preferred stock at a per share purchase price of $2.50. As part of the transaction, the investors received one Class C warrant and one Class D warrant for the subscription of each preferred share. The Class C warrants consist of the right to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $2.50 per share exercisable for 36 months from the date of inception. The Class D warrants consist of the right to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $5.00 per share exercisable for 36 months from the date of inception. The subscription was completed on August 10, 2021.

 

On September 27, 2021, the Company entered into another securities purchase agreement with the same investors, pursuant to which the Company issued in a registered direct offering, an aggregate of 48,000 shares of common stock of the Company at a per share purchase price of $2.50. In addition, the investors also received one Class C warrant and one Class D warrant for the subscription of each preferred share. The Class C warrants consist of the right to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $2.50 per share exercisable for 36 months from the date of inception. The Class D warrants consist of the right to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $5.00 per share exercisable for 36 months from the date of inception.

 

In connection with the public offering and pursuant to a registration statement on Form S-1, amended (File No. 333-264059), originally filed with the SEC on April 1, 2022, and declared effective by the SEC on August 10, 2022 (the “Registration Statement”), the public offering price of each Unit was $3.50, and each unit consisting of one share of common stock and a warrant to purchase two shares of common stock from the date of issuance until the fifth anniversary of the date of issuance. The Shares and the Warrants comprising the Units were immediately separable and issued separately in the Offering, which closed on August 15, 2022.

 

In connection with the public offering and pursuant to the underwriting agreement between us and the underwriters named therein, we granted the underwriters a 45-day option to purchase up to 282,000 additional shares of common stock and warrants, equivalent to 15% of the Units sold in the public offering, at the public offering price per Unit, less underwriting discounts and commissions, to cover over-allotments, if any. On September 23, 2022, the underwriters exercised their option to purchase an additional 282,000 warrants from us for gross proceeds of $2,820. The warrants were issued to the underwriters on September 26, 2022.

 

The exercise price of the Warrants shall be decreased to the reset price, which means the greater of (i) 50% of the exercise price and (ii) 100% of the last volume weighted average price immediately preceding the 90th calendar day following the initial issuance date (the greater of (i) and (ii), the “Reset Price”) if, on the date that is 90 calendar days immediately following the initial issuance date, the Reset Price is less than the exercise price on that date.

 

The following is a reconciliation of the beginning and ending balances of warrants liability measured at fair value on a recurring basis using Level 3 inputs:

        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Balance at the beginning of period   76,847    874,116 
Fair value change of warrants included in earnings   8,426    (797,269)
Balance at the end of the period   85,273    76,847 

 

The following is a summary of the warrant activities:

                 
   

Number of

Warrants

   

Average

Exercise Price

   

Weighted

Average

Remaining

Contractual

Term in

Years

 
                   
Outstanding as of January 1, 2025     2,239,870       2.14       2.63  
Exercisable as of January 1, 2025     2,239,870       2.14       2.63  
Granted                  
Exercised / surrendered                  
Expired                  
Outstanding as of March 31, 2025     2,239,870       2.14       2.38  
Exercisable as of March 31, 2025     2,239,870       2.14       2.38  

 

XML 120 R19.htm IDEA: XBRL DOCUMENT v3.25.2
LEASES
3 Months Ended
Mar. 31, 2025
Leases  
LEASES

Note 12      LEASES

 

The Company has two non-cancelable lease agreements for certain of the office and accommodation as well as fish farming containers for research and development of advanced technology for water circulation in fish farming containers with original lease periods expiring between 2024 and 2025. The lease terms may include options to extend or terminate the lease when it is reasonably certain the Company will exercise that option. The Company recognizes rental expense on a straight-line basis over the lease term.

 

The components of lease expense for the three months ended March 31, 2025 and March 31, 2024 were as follows:

               
    Statement of Income Location   Three months ended
March 31, 2025
    Three months ended
March 31, 2024
 
        (Unaudited)     (Unaudited)  
        $     $  
Lease Costs                    
Operating lease expense   General and administrative expenses     18,573       18,791  
Total net lease costs         18,573       18,791  

 

XML 121 R20.htm IDEA: XBRL DOCUMENT v3.25.2
OTHER PAYABLES AND ACCRUED LIABILITIES
3 Months Ended
Mar. 31, 2025
Payables and Accruals [Abstract]  
OTHER PAYABLES AND ACCRUED LIABILITIES

Note 13     OTHER PAYABLES AND ACCRUED LIABILITIES

           
    March 31,
2025
    December 31,
2024
 
    (Unaudited)     (Audited)  
    $     $  
Accrued Expenses     211,426       262,156  
Others     184,367       114,504  
Total     395,793       376,660  

  

As of March 31, 2025, other payables and accrued expenses were $395,793, respectively, compared to $376,660 as of December 31, 2024.

 

As of March 31, 2025, other payables and accrued expenses were $184,367 and $211,426, respectively, compared to $114,504 and $262,156 as of December 31, 2024. The accrued expenses in both periods primarily relate to audit fees. Other payables mainly consisted of amounts related to e-commerce intermediary transactions, specifically payables arising from cross-border settlements with Chinese e-commerce platforms amounting to $176,374 as of March 31, 2025 and $100,379 as of December 31, 2024.

 

XML 122 R21.htm IDEA: XBRL DOCUMENT v3.25.2
INCOME TAXES
3 Months Ended
Mar. 31, 2025
Income Tax Disclosure [Abstract]  
INCOME TAXES

Note 14      INCOME TAXES

 

The Company and its subsidiary, and the consolidated VIE file tax returns separately.

 

1) Value-added tax (“VAT”)

 

PRC

 

Pursuant to the Provisional Regulation of the PRC on VAT and the related implementing rules, all entities and individuals (“taxpayers”) that are engaged in the sale of products in the PRC are generally required to pay VAT, at a rate of which was changed from 16% to 13% on April 1, 2019 of the gross sales proceeds received, less any deductible VAT already paid or borne by the taxpayers. GZ WFH also subjected to 10% for the installment service provided.

 

Taiwan

 

Pursuant to the Value-added and Non-value-added Business Tax Act and the related implementing rules, all entities and individuals (“taxpayers”) that are engaged in the sale of products in the Taiwan are generally required to pay VAT, at a rate of 5%.

 

2) Income tax

 

United States

 

On December 22, 2017, the Tax Cuts and Jobs Act (the “Tax Act”) was signed into legislation. The Tax Act significantly revises the U.S. corporate income tax by, among other things, lowering the statutory corporate tax rate from 34% to 21%, imposing a mandatory one-time tax on accumulated earnings of foreign subsidiaries, introducing new tax regimes, and changing how foreign earnings are subject to U.S. tax.

 

On December 22, 2017, Staff Accounting Bulletin No. 118 (“SAB 118”) was issued to provide guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740. The Company has completed the assessment of the income tax effect of the Tax Act and there were no adjustments recorded to the provisional amounts.

 

The Coronavirus Aid, Relief and Economy Security Act (the “CARES Act”) was signed into law on 27 March 2020. The CARES Act temporarily eliminates the 80% taxable income limitation (as enacted under the Tax Cuts and Jobs Act of 2017) for net operating loss (“NOL”) deductions for 2018-2020 tax years and reinstated NOL carrybacks for the 2018-2020 tax years. Moreover, the CARES Act also temporarily increases the business interest deduction limitations from 30% to 50% of adjusted taxable income for the 2019 and 2020 taxable year. Lastly, the Tax Act technical correction classifies qualified improvement property as 15-year recovery period, allowing the bonus depreciation deduction to be claimed for such property retroactively as if it was included in the Tax Act at the time of enactment. The Company does not anticipate a significant tax impact on its financial statements and will continue to examine the impact the CARES Act may have on its business.

 

The Company evaluated the Global Intangible Low Taxed Income (“GILTI”) inclusion on current earnings and profits of greater than 10% owned foreign controlled corporations. The Company has evaluated whether it has additional provision amount resulted by the GILTI inclusion on current earnings and profits of its foreign controlled corporations. The law also provides that corporate taxpayers may benefit from a 50% reduction in the GILTI inclusion, which effectively reduces the 21% U.S. corporate tax rate on the foreign income to an effective rate of 10.5%. The GILTI inclusion further provides for a foreign tax credit in connection with the foreign taxes paid. In 2019, the Company recorded a GILTI inclusion of $152,829. The Company has elected to treat the financial statement impact of GILTI as current period expenses.

 

The reverse merger was completed on December 31, 2018 and the tax losses of the US subsidiary was not in the scope as of December 31, 2018. As of December 31, 2019, net operating loss carried forward which was available to offset future taxable income for the Company in the United States was $99,817. There was a full valuation allowance applied against these loss carry forward as management determined it was not more likely than not that these net operating losses would be utilized in the foreseeable future.

 

Hong Kong

 

The HK tax reform has introduced two-tiered profits tax rates for corporations. Under the two-tiered profits tax rates regime, the profits tax rate for the first HK$2 million (approximately $257,931) of assessable profits will be lowered to 8.25% (half of the rate specified in Schedule 8 to the Inland Revenue Ordinance) for corporations. Assessable profits above HK$2 million (approximately $257,931) will continue to be subject to the rate of 16.5% for corporations. Because the Company assessed that the HK entity will not earn a profit greater than HK$2 million (approximately $257,931), it is subject to a corporate income tax rate of 8.25%.

 

As of December 31, 2021, the Company’s subsidiary in Hong Kong had net operating loss carry forwards available to offset future taxable income. The net operating losses will be carryforward indefinitely under Hong Kong Profits Tax regulation. There is a full valuation allowance applied against these loss carry forward as management determined it was not more likely than not that these net operating losses would be utilized in the foreseeable future.

 

PRC

 

WFOE and the consolidated VIE established in the PRC are subject to the PRC statutory income tax rate of 25%, according to the PRC Enterprise Income Tax law.

 

In accordance with the relevant tax laws and regulations of the PRC, a company registered in the PRC is subject to income taxes within the PRC at the applicable tax rate on taxable income. All the PRC subsidiaries were subject to income tax at a rate of 25% for the year ended December 31, 2021. According to PRC tax regulations, the PRC net operating loss can generally carry forward for no longer than five years starting from the year subsequent to the year in which the loss was incurred.

 

Taiwan

 

The Company’s loss before income taxes is primarily derived from the operations in Taiwan and income tax expense is primarily incurred in Taiwan.

 

As a result of amendments to the “Taiwan Income Tax Act” enacted by the Office of the President of Taiwan on February 7, 2018, the statutory income tax rate increased from 17% to 20% and the undistributed earnings tax, or a surtax, decreased from 10% to 5% effective from January 1, 2018. As a result, the statutory income tax rate in Taiwan was 20% for the years ended August 31, 2021 and 2020. An additional surtax, of which rate was reduced from 10% to 5% being applied to the Company starting from September 1, 2018, is assessed on undistributed income for the entities in Taiwan, but only to the extent such income is not distributed or set aside as a legal reserve before the end of the following year. The 5% surtax is recorded in the period the income is earned, and the reduction in the surtax liability is recognized in the period the distribution to stockholders or the setting aside of legal reserve is finalized in the following year.

 

The components of the income tax expense are:

        
  

Three months ended

March 31,

 
   2025   2024 
   (Unaudited)   (Audited) 
   $   $ 
Current       124,146 
Total income tax expense       124,146 

 

The reconciliation of income taxes expenses computed at the Taiwan statutory tax rate (2022: at PRC statutory rate) applicable to income tax expense is as follows:

        
  

Three months ended

March 31,

 
   2025   2024 
   (Unaudited)   (Audited) 
Taiwan (2021-PRC) income tax statutory rate   20.00%    20.00% 
Tax effect of non-deductible expenses   (14.51%)   (11.84%)
Tax effect of stock-based compensation   %    (0.6%)
Tax effect of non-taxable income   (1.60%)   % 
Impact of different tax rates in other jurisdictions   %    (0.02%)
Others   (3.89%)   (1.7%)
Changes in valuation allowance   %    (%)
Effective tax rate       (6.1%)

 

The valuation allowance as of March 31, 2025 and December 31, 2024 was primarily provided for the deferred income tax assets if it is more likely than not that these items will expire before the Company is able to realize its benefits, or that the future deductibility is uncertain. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible or utilizable. Management considers projected future taxable income and tax planning strategies in making this assessment. The movement for the valuation allowance is as following:

        
  

March 31,

2025

  

December 31,

2024

 
   (Unaudited)   (Audited) 
   $   $ 
Balance at beginning of the period or year, as applicable   95,844    95,844 
Additions of valuation         
Reductions of valuation         
Balance at the end of the period or year, as applicable   95,844    95,844 

 

PRC Withholding Tax on Dividends

 

The current PRC Enterprise Income Tax Law imposes a 10% withholding income tax for dividends distributed by foreign-invested enterprises to their immediate holding companies outside the PRC. A lower withholding tax rate will be applied if there is a tax treaty arrangement between the PRC and the jurisdiction of the foreign holding company. Distributions to holding companies in Hong Kong that satisfy certain requirements specified by PRC tax authorities, for example, will be subject to a 5% withholding tax rate.

 

As of December 31, 2021, the Company had not recorded any withholding tax on the retained earnings of its foreign-invested enterprises in the PRC, since the Company intended to reinvest its earnings to potentially continue its business in mainland China, namely the manufacturing of the RASs through GZ GST, and its foreign-invested enterprises do not intend to declare dividends to their immediate foreign holding companies.

 

As of March 31, 2022, the Company had not recorded any withholding tax on the retained earnings of its foreign-invested enterprises in the PRC, and the Company decided not to reinvest its earnings since it is not continuing its business in mainland China, and its foreign-invested enterprises do not intend to declare dividends to their immediate foreign holding companies.

 

XML 123 R22.htm IDEA: XBRL DOCUMENT v3.25.2
RELATED PARTY BALANCES AND TRANSACTIONS
3 Months Ended
Mar. 31, 2025
Related Party Transactions [Abstract]  
RELATED PARTY BALANCES AND TRANSACTIONS

Note 15     RELATED PARTY BALANCES AND TRANSACTIONS

 

Due to related parties

 

The balance due to related parties was as following:

           
    March 31,
2025
    December 31,
2024
 
    $     $  
Mountain Share Transfer, LLC (1)     7,681       7,681  
Estate of Mr. Yin-Chieh Cheng (2)     19,435       19,435  
Feng-Hua Chen (3)     11,402        
      38,518       27,116  

___________________ 

Note:

 

(1) Mountain Share Transfer, LLC is company 100% controlled by Erik S. Nelson, the previous corporate secretary and director of the Company. The balances represented the amount paid on behalf of the Company for its daily operation purpose.
   
(2) The amount due to Mr. Yin-Chieh Cheng relates to a prior arrangement. Mr. Yin-Chieh Cheng was vacant as of July 8, 2023, and the Company is evaluating settlement with the estate.
   
(3) Feng-Hua Chen is the Chief Operating Officer of the company, the balances represented the amount paid on behalf of the Company for its daily operation purpose.

 

As of March 31, 2025, the Company had outstanding balances with related parties that are non-trade in nature, unsecured, non-interest bearing, and repayable on demand. These balances arose in the ordinary course of operations.

 

During the period, the Company received a financial communication from the estate of the former Chief Executive Officer and Chair of the Board, Lu Min-Huay Cheng, which is considered a related party due to the former executive’s prior leadership position and significant ownership interest. The nature of the transaction involves the repayment of loans, debt, and other liabilities owed to the estate. While the agreement does not specify individual dollar amounts, the Company has agreed to settle these obligations over a 12-month period beginning January 25, 2025. As of the reporting date, management continues to evaluate the terms and monitor the settlement process. 

 

XML 124 R23.htm IDEA: XBRL DOCUMENT v3.25.2
COMMON STOCK
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
COMMON STOCK

Note 16    COMMON STOCK

 

The Company’s authorized number of common stock is 200,000,000 shares with par value of $0.001 each. On August 11, 2022, the Company effected a 2:3 reverse stock split for each share of common stock issued and outstanding. As a result of reverse stock split, the Company’s common stock issued and outstanding decreased from 10,707,150 shares to 7,138,587 shares. All shares and associated amounts have been retroactively restated to reflect the stock split on August 11, 2022. As of March 31, 2025 and December 31, 2024, issued common stock were 14,247,539 shares and 14,047,539, respectively.

 

On August 11, 2022, the Company’s common stock commenced trading on The Nasdaq Capital Market under the symbol “NCRA” on a post-reverse stock split basis. During the public offering, 1,880,000 common stocks, at par value $0.001 each, were issued at the offering price $3.5 each. The Company received total gross proceeds of $6.58 million from the public offering and after deducting the underwriting commissions, discounts and offering expenses, the Company received net proceeds of approximately $5.3 million.

 

All number of shares, share amounts and per share data presented in the accompanying unaudited consolidated financial statements and related notes have been retroactively restated to reflect the reverse merger transaction and subsequent issuance of shares stated above, except for authorized shares of common stock, which were not affected.

 

Issuance of Common Stock

 

  · On February 20, 2024, we entered into VIE Agreement with Xinca and issued 1,800,000 shares of our common stock in exchange of 100% controlling of Xinca;
     
  · On April 14, 2024, we entered into an Equity Purchase Agreement with SY Culture and issued 600,000 shares of our common stock in exchange of 100% equity of SY Culture.
     
  · On February 7, 2025, our shareholder exercised 150,000 shares of Warrant Class A in exchange of 100,000 shares of common stock.
     
  · On February 12, 2025, our shareholder exercised 150,000 shares of Warrant Class A in exchange of 100,000 shares of common stock.

  

XML 125 R24.htm IDEA: XBRL DOCUMENT v3.25.2
SHARE-BASED COMPENSATION
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION

Note 17      SHARE-BASED COMPENSATION

 

On December 27, 2018, Nocera granted Mr. Yin-Chieh Cheng quarterly option awards of 250,000 Series “A” Warrants for 20 quarters (5 years) for a total of 5,000,000 Series “A” Warrants with exercise price of $0.50 per share, subject to continued employment for services as Chairman of the Board and a Director.

 

On June 1, 2020, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu 50,000 shares of Class A warrants and 60,000 shares of Class A warrants separately, each with exercise price of $0.50 per share, for serving as the Company’s Chief Financial Officer and Chief Operating Officer. The Company also granted 2 employees 50,000 shares of Class A warrants with exercise price of $0.50 per share. The Class A warrants consist of the right to purchase one share for $0.50 per share from the date of issuance until April 23, 2026.

 

On June 1, 2020, Nocera granted Mr. Michael A. Littman 50,000 shares of Class A warrants with exercise price of $0.50 per share and 50,000 shares of Class B warrants with exercise price of $1.00 per share. Mr. Littman exercised 50,000 shares of Class A warrants and 50,000 shares of Class B warrants on August 11, 2021. The Class B warrants consist of the right to purchase one share for $1.00 per share separately from the date of issuance until April 23, 2026.

 

On December 1, 2021, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu 75,000 shares of Class A warrants and 60,000 shares of Class A warrants separately, each with exercise price of $0.50 per share, for serving as the Company’s Chief Financial Officer and Chief Operating Officer. The Company also granted 2 employees 70,000 shares of Class A warrant with exercise price of $0.50 per share.

 

On December 31, 2021, the Company issued an aggregate of 505,000 shares of common stock to Mr. Shun-Chih Chuang and a total of five consultants in consideration for services rendered.

 

On December 22, 2022, the Company issued 150,000 and 75,000 shares of common stock to Chen-Chun Chung and TraDigital respectively in consideration for services rendered.

 

On March 22, 2023, the Company issued 450,000 shares of our common stock to our investor relation company, Hanover One International, Inc.

 

On October 11, 2023, the Company issued 20,000 shares of our common stock to our consultant, Yu-Hao Chang.

 

On December 5, 2023, the Company issued 60,000 shares of our common stock to our Chief Executive Officer, Andy Chin-An Jin.

 

On August 26, 2024, the Company issued 180,000 shares of our common stock to our Chief Executive Officer, Andy Chin-An Jin.

 

The estimated fair value of share-based compensation for employees is recognized as a charge against income on a ratable basis over the requisite service period, which is generally the vesting period of the award. The fair value of stock option grant was estimated on the date of grant using the Black-Scholes option pricing model under the following assumptions:

           
    March 31,
2025
    March 31,
2024
 
             
Dividend yield     N/A       N/A  
Risk-free interest rate     4.2%       1.16%  
Expected term (in years)     2.74       4.31  
Volatility     36.25%       48.15%  

  

The Company estimated the grant date fair value of time-based stock option awards using the Black-Scholes option valuation model, which requires assumptions involving an estimate of the fair value of the underlying common stock on the date of grant, the expected term of the options, volatility, discount rate and dividend yield. The Company calculated expected option terms based on the “simplified” method for “plain vanilla” options due to the limited exercise information. The “simplified method” calculates the expected term as the average of the vesting term and the original contractual term of the options. The Company calculated volatility using the average adjusted volatility of quick company’s feature of Capital IQ for a period of time reflective of the expected option term, while the discount rate was estimated using the interest rate for a treasury note with the same contractual term as the options granted. Dividend yield is estimated at our current dividend rate, which adjustments for any known future changes in the rate.

 

For the years ended December 31, 2024, $60,831 share-based compensation expenses were recognized into additional paid-in capital of the Company, respectively.

  

XML 126 R25.htm IDEA: XBRL DOCUMENT v3.25.2
PREFERRED STOCK
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
PREFERRED STOCK

Note 18     PREFERRED STOCK

 

In August 2021, the Company issued 80,000 preferred shares, par value $0.001 per share, at an issue price of $2.50 per share to certain investors credited as fully paid. The preferred shares are non-voting and non-redeemable. The holder of the preferred shares will have priority over the holders of the common stock of the Company on the assets and funds of the Company available for distribution in a distribution of assets on liquidation, winding up or dissolution of the Company. The holder of the preferred shares shall not have the right to attend or vote at any general meeting of the Company (except a general meeting for winding up of the Company or a resolution is to be proposed which if passed would vary or abrogate the rights or privileges of such holder).

 

On August 11, 2022, the Company effected a 2:3 reverse stock split for each share of common stock issued and outstanding. As a result of reverse stock split, the shares of common stock issuable upon the conversion of Series A Preferred Stock decreased from 80,000 shares to 53,334 shares.

 

XML 127 R26.htm IDEA: XBRL DOCUMENT v3.25.2
(LOSS) INCOME PER SHARE
3 Months Ended
Mar. 31, 2025
Loss per share  
(LOSS) INCOME PER SHARE

Note 19     (LOSS) INCOME PER SHARE

 

The following table sets forth the computation of basic and diluted income (loss) per common share for the quarters ended March 31, 2025 and 2024.

        
  

For three months ended

March 31,

 
   2025   2024 
   (Unaudited)   (Unaudited) 
   $   $ 
Numerator:          
Net loss income attributable to the Company   (248,017)   (288,576)
           
Denominator:          
Weighted-average shares outstanding          
- Basic   14,159,761    11,956,987 
- Diluted   14,159,761    11,956,987 
           
Loss per share:          
- Basic   (0.0175)   (0.0241)
- Diluted   (0.0175)   (0.0241)

 

XML 128 R27.htm IDEA: XBRL DOCUMENT v3.25.2
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Mar. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

Note 20     COMMITMENTS AND CONTINGENCIES

 

Lease Commitment

 

The Company has entered into operating lease agreement for certain office and accommodation as well as fish farming containers for research and develop advanced technology for water circulation applying in fishery. Future minimum lease payments under non-cancellable operating leases with initial terms within one year.

 

The total future minimum lease payments under non-cancellable short-term leases as of March 31, 2025 are payable as follows:

     
   Lease Commitment 
   $ 
Within 1 year   1,827 
Total   1,827 

 

XML 129 R28.htm IDEA: XBRL DOCUMENT v3.25.2
SEGMENT REPORTING
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
SEGMENT REPORTING

Note 21     SEGMENT REPORTING

 

Effective as of January 1, 2024, the Company adopted ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The Company’s Chief Operating Decision Maker (“CODM”) is its Executive Director, Song-Yuan Teng, who is responsible for reviewing the results of operations and allocating resources across the Company’s reportable segments, including Fish Trading and Catering Services. These operating segments reflect the manner in which the CODM allocates resources and evaluates performance.

 

These segments align with how management evaluates performance and allocates resources. Segment performance is evaluated based on segment revenue and operating profit, which includes direct costs and segment-specific general and administrative expenses and tax, but excludes corporate overhead and interest.

 

The summary of key information by segments for the three months ended March 31, 2025 and 2024 was as follows:

 

For three months ended March 31, 2025

 

Schedule of segment information  Sales of Fish Trading   Sales of
Catering
   E-Commerce   Total 
                 
Revenue  $4,474,206   $2,089   $57,833   $4,534,128 
Cost of revenue  $4,465,209   $1,567   $16,402   $4,483,178 
Gross profit  $8,997   $522   $41,431   $50,950 
General and administrative expenses  $(60,323)  $(195,407)  $(78,641)  $(334,371)
Segment operating losses  $(51,326)  $(194,885)  $(37,210)  $(283,421)
Income tax expenses  $   $   $   $ 
Segment losses  $(51,326)  $(194,885)  $(37,210)  $(283,421)

 

For three months ended March 31, 2024

 

   Sales of Fish Trading   Sales of
Catering
   E-Commerce   Total 
                 
Revenue  $4,764,517   $86,373   $48,990   $4,899,880 
Cost of revenue  $4,754,614   $43,989   $17,316   $4,815,919 
Gross profit  $9,903   $42,384   $31,674   $83,961 
General and administrative expenses  $(27,955)  $(166,429)  $(257,080)  $(451,464)
Segment operating losses  $(18,052)  $(124,045)  $(225,406)  $(367,503)
Income tax expenses  $(124,146)  $   $   $(124,146)
Segment losses  $(142,198)  $(124,045)  $(225,406)  $(491,649)

 

The following tables set forth a summary of single customers who represent 10% or more of the Company’s segments revenue, net:

 

  Fish Trading 
   March 31, 2025   March 31, 2024 
           
Percentage of fish trading revenue          
Customer A   21.47%    37.45% 
Customer B   24.25%     
Customer C   18.42%     
Customer D   20.50%    10.01% 
Customer E       18.21% 
Customer F       15.35% 
    84.65%    81.01% 

 

   Catering 
   March 31, 2025   March 31, 2024 
         
Percentage of catering revenue          
Customer G   83.99%     
    83.99%     

  

XML 130 R29.htm IDEA: XBRL DOCUMENT v3.25.2
SUBSEQUENT EVENT
3 Months Ended
Mar. 31, 2025
Subsequent Events [Abstract]  
SUBSEQUENT EVENT

Note 22      SUBSEQUENT EVENT

 

The Company has evaluated subsequent events through the issuance of the unaudited condensed consolidated financial statements and there are no subsequent events that would have required adjustment or disclosure in the consolidated financial statements.

 

XML 131 R30.htm IDEA: XBRL DOCUMENT v3.25.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies)
3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, these financial statements do not include all of the information and footnotes required for complete financial statements and should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on May 6, 2025.

 

In the opinion of management, all adjustments (which include normal recurring adjustments) necessary to present a fair presentation of the Company’s unaudited condensed consolidated financial position as of March 31, 2025, its consolidated results of operations for the three months ended March 31, 2025, cash flows for the three months ended March 31, 2025 and change in equity for the three months ended March 31, 2025, as applicable, have been made. Operating results for the three months ended March 31, 2025 are not necessarily indicative of the operating results that may be expected for the year ending December 31, 2024 or any future periods.

 

Concentrations of Credit Risk

Concentrations of Credit Risk

 

Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.

 

There were three customers who represent 69.67% of the Company’s total revenue for the three months ended March 31, 2024. There were four customers who represent 84.6% of the Company’s total revenue for the three months ended March 31, 2025.

 

The following table sets forth a summary of single customers who represent 10% or more of the Company’s total accounts receivable, net:

 

        
   March 31,
2025
   March 31,
2024
 
   (Unaudited)   (Audited) 
Percentage of the Company’s accounts receivable          
Customer A   21.46%    36.78% 
Customer B   24.24%     
Customer C   18.41%     
Customer D   20.49%     
Customer E       17.82% 
Customer F       15.07% 
    84.6%    69.67% 

 

The following table sets forth a summary of single suppliers who represent 10% or more of the Company’s total purchase:

   March 31,
2025
   March 31,
2024
 
   (Unaudited)   (Audited) 
Percentage of the Company’s purchase          
Supplier A   10.12%     
Supplier B   12.40%     
Supplier C   17.60%     
Supplier D   11.96%     
Supplier E       13.72% 
Supplier F       12.47% 
Supplier G       12.85% 
Supplier H       11.24% 
Supplier I       12.24% 
    52.08%    62.52% 

 

Revenue Recognition

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers.”

 

The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies the following steps:

 

  · Step 1: Identify the contract(s) with a customer
     
  · Step 2: Identify the performance obligations in the contract
     
  · Step 3: Determine the transaction price
     
  · Step 4: Allocate the transaction price to the performance obligation in the contract
     
  · Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation

 

The Company mainly offers and generates revenue from the fish trading business, bento box and fruit and vegetable processing business, and E-commerce live streaming business. Revenue recognition policies are discussed as follows:

 

Aquatic product trading revenue

 

The Company engages in the trading of fish, primarily eels. Revenue is generated when the Company receives customer orders specifying product types and requirements. Upon receiving an order, the Company arranges the harvesting of the eels, inspects the products to ensure compliance with the customer’s specifications, and coordinates delivery. Revenue is recognized at a point in time when control of the goods is transferred to the customer, typically upon delivery, which is the point at which the performance obligation is satisfied.

 

Bento box and produce processing revenue

 

The Company also operates a bento box and fresh produce processing business, primarily involving vegetables and fruits. The revenue recognition model for this segment is similar to the aquatic product trading business. Upon receiving customer orders, the Company processes and packages the required food or agricultural products, ensures product quality and conformity to order specifications, and arranges delivery. Revenue is recognized at a point in time, generally upon the transfer of the processed goods to the customer.

 

E-commerce live-streaming commission revenue

 

The Company acts as an agent in facilitating the sale of third-party products through live-streaming e-commerce platforms. The Company does not take control of the goods sold, and commission revenue is recognized on a net basis. Revenue is recognized at the point in time when the underlying product is sold and shipment is confirmed by the seller, which indicates the Company has fulfilled its performance obligation of facilitating the sale. 

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

The FASB issued several updates during the period, none of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the consolidated financial statements upon adoption.

 

XML 132 R31.htm IDEA: XBRL DOCUMENT v3.25.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables)
3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
Schedule of concentrations of credit risk
        
   March 31,
2025
   March 31,
2024
 
   (Unaudited)   (Audited) 
Percentage of the Company’s accounts receivable          
Customer A   21.46%    36.78% 
Customer B   24.24%     
Customer C   18.41%     
Customer D   20.49%     
Customer E       17.82% 
Customer F       15.07% 
    84.6%    69.67% 

 

The following table sets forth a summary of single suppliers who represent 10% or more of the Company’s total purchase:

   March 31,
2025
   March 31,
2024
 
   (Unaudited)   (Audited) 
Percentage of the Company’s purchase          
Supplier A   10.12%     
Supplier B   12.40%     
Supplier C   17.60%     
Supplier D   11.96%     
Supplier E       13.72% 
Supplier F       12.47% 
Supplier G       12.85% 
Supplier H       11.24% 
Supplier I       12.24% 
    52.08%    62.52% 
XML 133 R32.htm IDEA: XBRL DOCUMENT v3.25.2
ACCOUNTS RECEIVABLE (Tables)
3 Months Ended
Mar. 31, 2025
Credit Loss [Abstract]  
Schedule of accounts receivable
           
    March 31,
2025
    December 31,
2024
 
    (Unaudited)     (Audited)  
    $     $  
Accounts receivable     134,106       144,509  
Total     134,106       144,509  
XML 134 R33.htm IDEA: XBRL DOCUMENT v3.25.2
INVENTORIES (Tables)
3 Months Ended
Mar. 31, 2025
Inventory Disclosure [Abstract]  
Schedule of inventories
        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Raw materials   9,608     
Total   9,608     
XML 135 R34.htm IDEA: XBRL DOCUMENT v3.25.2
PREPAID EXPENSES AND OTHER ASSETS, NET (Tables)
3 Months Ended
Mar. 31, 2025
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of prepaid expenses and other assets
        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Prepaid Expenses   41,623    43,158 
Other receivables from third party   556,576    600,011 
Prepaid expenses and other assets, net   598,199    643,169 
XML 136 R35.htm IDEA: XBRL DOCUMENT v3.25.2
FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Tables)
3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of financial assets at fair value through profit or loss
        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
Financial assets mandatorily measured at fair value through profit or loss  $   $ 
Funds       210 
Total       210 
           
Current       210 
Non-Current        
Total       210 
XML 137 R36.htm IDEA: XBRL DOCUMENT v3.25.2
PROPERTY AND EQUIPMENT, NET (Tables)
3 Months Ended
Mar. 31, 2025
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment
        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Land   877,870    877,870 
Equipment   901,356    911,280 
Less: Accumulated depreciation   (437,166)   (397,305)
Property and equipment, net   1,342,060    1,391,845 
XML 138 R37.htm IDEA: XBRL DOCUMENT v3.25.2
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
3 Months Ended
Mar. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of goodwill
        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Goodwill - Meixin   3,905,735    3,905,735 
Goodwill - Xinca   1,351,703    1,351,703 
Goodwill - SY Media   230,015    230,015 
Less: Impairment   (3,409,725)   (3,409,725)
Goodwill, net   2,077,728    2,077,728 
Schedule of customer relations
           
    March 31,     December 31,  
    2025     2024  
    (Unaudited)     (Audited)  
    $     $  
Acquisitions     135,325       135,325  
Less: Accumulated amortization     (41,576 )     (37,500 )
Customer relations, net     93,749       97,825  
XML 139 R38.htm IDEA: XBRL DOCUMENT v3.25.2
OTHER BORROWINGS (Tables)
3 Months Ended
Mar. 31, 2025
Debt Disclosure [Abstract]  
Schedule of other loans
        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
           
Secured car loan from CITIC Bank wholly repayable  $28,868   $30,417 
Total secured car loan wholly repayable within 1 year   28,868    6,631 
Secured car loan from CITIC Bank wholly repayable more than 1 year       23,786 
Total  $28,868   $30,417 
XML 140 R39.htm IDEA: XBRL DOCUMENT v3.25.2
WARRANTS (Tables)
3 Months Ended
Mar. 31, 2025
Warrants  
Schedule of warranty liability activity
        
   March 31,
2025
   December 31,
2024
 
   (Unaudited)   (Audited) 
   $   $ 
Balance at the beginning of period   76,847    874,116 
Fair value change of warrants included in earnings   8,426    (797,269)
Balance at the end of the period   85,273    76,847 
Schedule of warrant activity
                 
   

Number of

Warrants

   

Average

Exercise Price

   

Weighted

Average

Remaining

Contractual

Term in

Years

 
                   
Outstanding as of January 1, 2025     2,239,870       2.14       2.63  
Exercisable as of January 1, 2025     2,239,870       2.14       2.63  
Granted                  
Exercised / surrendered                  
Expired                  
Outstanding as of March 31, 2025     2,239,870       2.14       2.38  
Exercisable as of March 31, 2025     2,239,870       2.14       2.38  
XML 141 R40.htm IDEA: XBRL DOCUMENT v3.25.2
LEASES (Tables)
3 Months Ended
Mar. 31, 2025
Leases  
Schedule of components of lease expenses
               
    Statement of Income Location   Three months ended
March 31, 2025
    Three months ended
March 31, 2024
 
        (Unaudited)     (Unaudited)  
        $     $  
Lease Costs                    
Operating lease expense   General and administrative expenses     18,573       18,791  
Total net lease costs         18,573       18,791  
XML 142 R41.htm IDEA: XBRL DOCUMENT v3.25.2
OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)
3 Months Ended
Mar. 31, 2025
Payables and Accruals [Abstract]  
Schedule of other payables and accrued liabilities
           
    March 31,
2025
    December 31,
2024
 
    (Unaudited)     (Audited)  
    $     $  
Accrued Expenses     211,426       262,156  
Others     184,367       114,504  
Total     395,793       376,660  
XML 143 R42.htm IDEA: XBRL DOCUMENT v3.25.2
INCOME TAXES (Tables)
3 Months Ended
Mar. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of income tax components
        
  

Three months ended

March 31,

 
   2025   2024 
   (Unaudited)   (Audited) 
   $   $ 
Current       124,146 
Total income tax expense       124,146 
Schedule of reconciliation of income tax expense
        
  

Three months ended

March 31,

 
   2025   2024 
   (Unaudited)   (Audited) 
Taiwan (2021-PRC) income tax statutory rate   20.00%    20.00% 
Tax effect of non-deductible expenses   (14.51%)   (11.84%)
Tax effect of stock-based compensation   %    (0.6%)
Tax effect of non-taxable income   (1.60%)   % 
Impact of different tax rates in other jurisdictions   %    (0.02%)
Others   (3.89%)   (1.7%)
Changes in valuation allowance   %    (%)
Effective tax rate       (6.1%)
Schedule of movement in valuation allowance
        
  

March 31,

2025

  

December 31,

2024

 
   (Unaudited)   (Audited) 
   $   $ 
Balance at beginning of the period or year, as applicable   95,844    95,844 
Additions of valuation         
Reductions of valuation         
Balance at the end of the period or year, as applicable   95,844    95,844 
XML 144 R43.htm IDEA: XBRL DOCUMENT v3.25.2
RELATED PARTY BALANCES AND TRANSACTIONS (Tables)
3 Months Ended
Mar. 31, 2025
Related Party Transactions [Abstract]  
Schedule of related party transactions
           
    March 31,
2025
    December 31,
2024
 
    $     $  
Mountain Share Transfer, LLC (1)     7,681       7,681  
Estate of Mr. Yin-Chieh Cheng (2)     19,435       19,435  
Feng-Hua Chen (3)     11,402        
      38,518       27,116  

___________________ 

Note:

 

(1) Mountain Share Transfer, LLC is company 100% controlled by Erik S. Nelson, the previous corporate secretary and director of the Company. The balances represented the amount paid on behalf of the Company for its daily operation purpose.
   
(2) The amount due to Mr. Yin-Chieh Cheng relates to a prior arrangement. Mr. Yin-Chieh Cheng was vacant as of July 8, 2023, and the Company is evaluating settlement with the estate.
   
(3) Feng-Hua Chen is the Chief Operating Officer of the company, the balances represented the amount paid on behalf of the Company for its daily operation purpose.
XML 145 R44.htm IDEA: XBRL DOCUMENT v3.25.2
SHARE-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of assumptions of option pricing
           
    March 31,
2025
    March 31,
2024
 
             
Dividend yield     N/A       N/A  
Risk-free interest rate     4.2%       1.16%  
Expected term (in years)     2.74       4.31  
Volatility     36.25%       48.15%  
XML 146 R45.htm IDEA: XBRL DOCUMENT v3.25.2
(LOSS) INCOME PER SHARE (Tables)
3 Months Ended
Mar. 31, 2025
Loss per share  
Schedule of loss per share
        
  

For three months ended

March 31,

 
   2025   2024 
   (Unaudited)   (Unaudited) 
   $   $ 
Numerator:          
Net loss income attributable to the Company   (248,017)   (288,576)
           
Denominator:          
Weighted-average shares outstanding          
- Basic   14,159,761    11,956,987 
- Diluted   14,159,761    11,956,987 
           
Loss per share:          
- Basic   (0.0175)   (0.0241)
- Diluted   (0.0175)   (0.0241)
XML 147 R46.htm IDEA: XBRL DOCUMENT v3.25.2
COMMITMENTS AND CONTINGENCIES (Tables)
3 Months Ended
Mar. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of lease payments
     
   Lease Commitment 
   $ 
Within 1 year   1,827 
Total   1,827 
XML 148 R47.htm IDEA: XBRL DOCUMENT v3.25.2
SEGMENT REPORTING (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of segment information
Schedule of segment information  Sales of Fish Trading   Sales of
Catering
   E-Commerce   Total 
                 
Revenue  $4,474,206   $2,089   $57,833   $4,534,128 
Cost of revenue  $4,465,209   $1,567   $16,402   $4,483,178 
Gross profit  $8,997   $522   $41,431   $50,950 
General and administrative expenses  $(60,323)  $(195,407)  $(78,641)  $(334,371)
Segment operating losses  $(51,326)  $(194,885)  $(37,210)  $(283,421)
Income tax expenses  $   $   $   $ 
Segment losses  $(51,326)  $(194,885)  $(37,210)  $(283,421)

 

For three months ended March 31, 2024

 

   Sales of Fish Trading   Sales of
Catering
   E-Commerce   Total 
                 
Revenue  $4,764,517   $86,373   $48,990   $4,899,880 
Cost of revenue  $4,754,614   $43,989   $17,316   $4,815,919 
Gross profit  $9,903   $42,384   $31,674   $83,961 
General and administrative expenses  $(27,955)  $(166,429)  $(257,080)  $(451,464)
Segment operating losses  $(18,052)  $(124,045)  $(225,406)  $(367,503)
Income tax expenses  $(124,146)  $   $   $(124,146)
Segment losses  $(142,198)  $(124,045)  $(225,406)  $(491,649)

 

The following tables set forth a summary of single customers who represent 10% or more of the Company’s segments revenue, net:

 

  Fish Trading 
   March 31, 2025   March 31, 2024 
           
Percentage of fish trading revenue          
Customer A   21.47%    37.45% 
Customer B   24.25%     
Customer C   18.42%     
Customer D   20.50%    10.01% 
Customer E       18.21% 
Customer F       15.35% 
    84.65%    81.01% 

 

   Catering 
   March 31, 2025   March 31, 2024 
         
Percentage of catering revenue          
Customer G   83.99%     
    83.99%     

  

XML 149 R48.htm IDEA: XBRL DOCUMENT v3.25.2
PRINCIPAL ACTIVITIES AND ORGANIZATION (Details Narrative) - USD ($)
Apr. 14, 2024
Jan. 31, 2024
Sep. 07, 2022
Dec. 31, 2020
Meixin [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
VIE percent interest owned     80.00%  
Payment for VIE controlling interest     $ 4,300,000  
Xinca [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Stock issued for acquisition, shares   1,800,000    
VIE percent interest owned   100.00%    
SY Culture [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Stock issued for acquisition, shares 600,000      
VIE percent interest owned 100.00%      
XFC Sale [Member] | Restricted Stock [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Stock issued for acquisition, shares       466,667
XML 150 R49.htm IDEA: XBRL DOCUMENT v3.25.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Customer A [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 21.46% 36.78%
Customer B [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 24.24% 0.00%
Customer C [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 18.41% 0.00%
Customer D [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 20.49% 0.00%
Customer E [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 0.00% 17.82%
Customer F [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 0.00% 15.07%
All Customers [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 84.60% 69.67%
Supplier A [Member] | Purchases [Member] | Product Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 10.12% 0.00%
Supplier B [Member] | Purchases [Member] | Product Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 12.40% 0.00%
Supplier C [Member] | Purchases [Member] | Product Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 17.60% 0.00%
Supplier D [Member] | Purchases [Member] | Product Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 11.96% 0.00%
Supplier E [Member] | Purchases [Member] | Product Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 0.00% 13.72%
Supplier F [Member] | Purchases [Member] | Product Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 0.00% 12.47%
Supplier G [Member] | Purchases [Member] | Product Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 0.00% 12.85%
Supplier H [Member] | Purchases [Member] | Product Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 0.00% 11.24%
Supplier I [Member] | Purchases [Member] | Product Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 0.00% 12.24%
All Suppliers [Member] | Purchases [Member] | Product Concentration Risk [Member]    
Product Information [Line Items]    
Concentration percentage 52.08% 62.52%
XML 151 R50.htm IDEA: XBRL DOCUMENT v3.25.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative) - Revenue Benchmark [Member] - Customer Concentration Risk [Member]
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Three Customers [Member]    
Product Information [Line Items]    
Concentration risk   69.67%
Four Customers [Member]    
Product Information [Line Items]    
Concentration risk 84.60%  
XML 152 R51.htm IDEA: XBRL DOCUMENT v3.25.2
ACCOUNTS RECEIVABLE, NET (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Credit Loss [Abstract]    
Accounts receivable $ 134,106 $ 144,509
Total $ 134,106 $ 144,509
XML 153 R52.htm IDEA: XBRL DOCUMENT v3.25.2
INVENTORIES (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Inventory Disclosure [Abstract]    
Raw materials $ 9,608 $ 0
Total $ 9,608 $ 0
XML 154 R53.htm IDEA: XBRL DOCUMENT v3.25.2
ADVANCE TO SUPPLIERS (Details Narrative) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Advance To Suppliers    
Advances to suppliers $ 1,732 $ 8,404
XML 155 R54.htm IDEA: XBRL DOCUMENT v3.25.2
PREPAID EXPENSES AND OTHER ASSETS, NET (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepaid Expenses $ 41,623 $ 43,158
Other receivables from third party 556,576 600,011
Prepaid expenses and other assets, net $ 598,199 $ 643,169
XML 156 R55.htm IDEA: XBRL DOCUMENT v3.25.2
PREPAID EXPENSES AND OTHER ASSETS, NET (Details Narrative) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Other receivables $ 598,199 $ 643,169
Other receivables from third party 556,576 $ 600,011
Due From Third Parties [Member]    
Other receivables from third party 345,980  
E Commerce Live Stream Sales Deposits [Member]    
Other receivables from third party 5,487  
Xinca Employee Loans [Member]    
Other receivables from third party 15,326  
SY Media Deposits [Member]    
Other receivables from third party 187,646  
Prior-year receivables from GZ GSI [Member]    
Other receivables from third party $ 1,106  
XML 157 R56.htm IDEA: XBRL DOCUMENT v3.25.2
FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]    
Fair value of financial asset $ 0 $ 210
Current [Member]    
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]    
Fair value of financial asset 0 210
Noncurrent [Member]    
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]    
Fair value of financial asset 0 0
Funds [Member]    
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]    
Fair value of financial asset $ 0 $ 210
XML 158 R57.htm IDEA: XBRL DOCUMENT v3.25.2
FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details Narrative)
3 Months Ended
Mar. 31, 2025
USD ($)
Fair Value Disclosures [Abstract]  
Gain (Loss) on Disposition of Other Financial Assets $ 3
XML 159 R58.htm IDEA: XBRL DOCUMENT v3.25.2
PROPERTY AND EQUIPMENT, NET (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Property, Plant and Equipment [Line Items]    
Less: Accumulated depreciation $ (437,166) $ (397,305)
Property and equipment, net 1,342,060 1,391,845
Land [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 877,870 877,870
Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 901,356 $ 911,280
XML 160 R59.htm IDEA: XBRL DOCUMENT v3.25.2
PROPERTY AND EQUIPMENT, NET (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 33,674 $ 22,559
XML 161 R60.htm IDEA: XBRL DOCUMENT v3.25.2
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Goodwill) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Goodwill $ 2,077,728 $ 2,077,728
Less: Impairment (3,409,725) (3,409,725)
Meixin [Member]    
Goodwill 3,905,735 3,905,735
Xinca [Member]    
Goodwill 1,351,703 1,351,703
SY Media [Member]    
Goodwill $ 230,015 $ 230,015
XML 162 R61.htm IDEA: XBRL DOCUMENT v3.25.2
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Customer relations) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]    
Acquisitions $ 135,325 $ 135,325
Less: Accumulated amortization (41,576) (37,500)
Customer relations, net $ 93,749 $ 97,825
XML 163 R62.htm IDEA: XBRL DOCUMENT v3.25.2
OTHER BORROWINGS (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Short-Term Debt [Line Items]    
Total others loans current $ 28,868 $ 6,631
Total others loans noncurrent 28,868 30,417
CITIC Car Loan [Member]    
Short-Term Debt [Line Items]    
Others loans current 28,868 30,417
Total others loans current 28,868 6,631
Total others loans noncurrent $ 0 $ 23,786
XML 164 R63.htm IDEA: XBRL DOCUMENT v3.25.2
WARRANTS (Details - Warrant Liability) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Warrants    
Balance at the beginning of period $ 76,847 $ 874,116
Fair value change of warrants included in earnings 8,426 (797,269)
Total $ 85,273 $ 76,847
XML 165 R64.htm IDEA: XBRL DOCUMENT v3.25.2
WARRANTS (Details - Warrant Activity) - Warrant [Member] - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants outstanding, Beginning balance 2,239,870  
Average exercise price outstanding, Beginning balance $ 2.14  
Weighted average remaining contractual term, Outstanding 2 years 4 months 17 days 2 years 7 months 17 days
Number of warrants exercisable, Beginning balance 2,239,870  
Average exercise price exercisable, Beginning balance $ 2.14  
Weighted average remaining contractual term, Exercisable 2 years 4 months 17 days 2 years 7 months 17 days
Number of warrants, Granted 0  
Average exercise price, Granted $ 0  
Number of warrants, Exercised / surrendered 0  
Average exercise price, Exercised / surrendered $ 0  
Number of warrants, Expired 0  
Average exercise price, Expired $ 0  
Number of warrants outstanding, Ending balance 2,239,870 2,239,870
Average exercise price outstanding, Ending balance $ 2.14 $ 2.14
Number of warrants exercisable, Ending balance 2,239,870 2,239,870
Average exercise price exercisable, Ending balance $ 2.14 $ 2.14
XML 166 R65.htm IDEA: XBRL DOCUMENT v3.25.2
WARRANTS (Details Narrative) - USD ($)
Sep. 23, 2022
Sep. 27, 2021
Apr. 01, 2021
Underwriters [Member] | Public Offering 2022 [Member]      
Warrants issued 282,000    
Proceeds from warrants issued $ 2,820    
Class C Warrant [Member]      
Warrants issued   80,000 80,000
Class D Warrant [Member]      
Warrants issued   80,000 80,000
XML 167 R66.htm IDEA: XBRL DOCUMENT v3.25.2
LEASES (Details - Lease costs) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Leases    
Operating lease expense $ 18,573 $ 18,791
Total net lease costs $ 18,573 $ 18,791
XML 168 R67.htm IDEA: XBRL DOCUMENT v3.25.2
OTHER PAYABLES AND ACCRUED LIABILITIES (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Payables and Accruals [Abstract]    
Accrued Expenses $ 211,426 $ 262,156
Others 184,367 114,504
Total $ 395,793 $ 376,660
XML 169 R68.htm IDEA: XBRL DOCUMENT v3.25.2
OTHER PAYABLES AND ACCRUED LIABILITIES (Details Narrative) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Payables and Accruals [Abstract]    
Other payables and accrued expenses $ 395,793 $ 376,660
XML 170 R69.htm IDEA: XBRL DOCUMENT v3.25.2
INCOME TAXES (Details - Income tax expense) - PRC [Member] - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Effective Income Tax Rate Reconciliation [Line Items]    
Current $ 0 $ 124,146
Total income tax expense $ 0 $ 124,146
XML 171 R70.htm IDEA: XBRL DOCUMENT v3.25.2
INCOME TAXES (Details - Reconciliation of income tax)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Tax Disclosure [Abstract]    
Taiwan (2021-PRC) income tax statutory rate 20.00% 20.00%
Tax effect of non-deductible expenses (14.51%) (11.84%)
Tax effect of stock-based compensation 0.00% (0.60%)
Tax effect of non-taxable income (1.60%) 0.00%
Impact of different tax rates in other jurisdictions 0.00% (0.02%)
Others (3.89%) (1.70%)
Changes in valuation allowance 0.00% 0.00%
Effective tax rate 0.00% (6.10%)
XML 172 R71.htm IDEA: XBRL DOCUMENT v3.25.2
INCOME TAXES (Details - Valuation Allowance) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Valuation allowance, beginning balance $ 95,844 $ 95,844
Additions of valuation allowance 0 0
Reductions of valuation allowance 0 0
Valuation allowance, ending balance $ 95,844 $ 95,844
XML 173 R72.htm IDEA: XBRL DOCUMENT v3.25.2
INCOME TAXES (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2019
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
GILTI Amount     $ 152,829
Effective income tax rate 0.00% (6.10%)  
UNITED STATES      
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
Effective income tax rate including GILTI 10.50%    
Net operating loss carryforwards     $ 99,817
PRC [Member]      
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
Effective income tax rate 25.00%    
CHINA | Minimum [Member]      
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
VAT tax rate 13.00%    
TAIWAN      
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]      
VAT tax rate 5.00%    
XML 174 R73.htm IDEA: XBRL DOCUMENT v3.25.2
RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Related Party Transaction [Line Items]    
Due to related parties $ 38,518 $ 27,116
Mountain Share Transfer LLC [Member]    
Related Party Transaction [Line Items]    
Due to related parties [1] 7,681 7,681
Estate Of Yin Chieh Cheng [Member]    
Related Party Transaction [Line Items]    
Due to related parties [2] 19,435 19,435
Feng Hua Chen [Member]    
Related Party Transaction [Line Items]    
Due to related parties [3] $ 11,402 $ 0
[1] Mountain Share Transfer, LLC is company 100% controlled by Erik S. Nelson, the previous corporate secretary and director of the Company. The balances represented the amount paid on behalf of the Company for its daily operation purpose.
[2] The amount due to Mr. Yin-Chieh Cheng relates to a prior arrangement. Mr. Yin-Chieh Cheng was vacant as of July 8, 2023, and the Company is evaluating settlement with the estate.
[3] Feng-Hua Chen is the Chief Operating Officer of the company, the balances represented the amount paid on behalf of the Company for its daily operation purpose.
XML 175 R74.htm IDEA: XBRL DOCUMENT v3.25.2
COMMON STOCK (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
Feb. 12, 2025
Feb. 07, 2025
Apr. 14, 2024
Feb. 20, 2024
Aug. 11, 2022
Mar. 31, 2025
Dec. 31, 2024
Class of Stock [Line Items]              
Common stock, shares authorized           200,000,000 200,000,000
Common stock par value           $ 0.001 $ 0.001
Reverse stock split         2:3 reverse stock split    
Common stock, shares issued           14,247,539 14,047,539
Common stock, shares outstanding           14,247,539 14,047,539
Xinca [Member]              
Class of Stock [Line Items]              
Stock issued for acquisitions, shares       1,800,000      
Stock issued for acquisitions, shares       100.00%      
SY Culture [Member]              
Class of Stock [Line Items]              
Stock issued for acquisitions, shares     600,000        
Stock issued for acquisitions, shares     100.00%        
Public Offering [Member]              
Class of Stock [Line Items]              
Common stock issued shares         1,880,000    
Gross proceeds from the sale of equity         $ 6,580    
Proceeds from the sale of equity         $ 5,300    
Common Stock [Member]              
Class of Stock [Line Items]              
Common stock, shares issued         10,707,150    
Common stock, shares outstanding         7,138,587    
Common Stock [Member] | Class A Warrants Converted To Common Stock [Member]              
Class of Stock [Line Items]              
Stock converted, shares issued 100,000 100,000          
Warrant Class A [Member] | Class A Warrants Converted To Common Stock [Member]              
Class of Stock [Line Items]              
Stock converted, shares converted 150,000 150,000          
XML 176 R75.htm IDEA: XBRL DOCUMENT v3.25.2
SHARE-BASED COMPENSATION (Details - Assumptions)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]    
Risk-free interest rate 4.20% 1.16%
Expected term (in years) 2 years 8 months 26 days 4 years 3 months 21 days
Volatility 36.25% 48.15%
XML 177 R76.htm IDEA: XBRL DOCUMENT v3.25.2
SHARE-BASED COMPENSATION (Details Narrative) - USD ($)
12 Months Ended
Aug. 26, 2024
Dec. 05, 2023
Oct. 11, 2023
Mar. 22, 2023
Dec. 22, 2022
Dec. 31, 2021
Dec. 02, 2021
Aug. 11, 2021
Jun. 01, 2020
Dec. 27, 2018
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Adjustments to APIC for share based compensation                     $ 60,831
Mr Yin Chieh Cheng [Member] | Series A Warrant [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Option award                   250,000  
Warrants granted                   5,000,000  
Exercise price                   $ 0.50  
Mr Shun Chih Chuang [Member] | Class A Warrant [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Warrants granted             75,000   50,000    
Exercise price             $ 0.50   $ 0.50    
Mr Hsien Wen Yu [Member] | Class A Warrant [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Warrants granted             60,000   60,000    
Two Employees [Member] | Class A Warrant [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Warrants granted             70,000   50,000    
Exercise price             $ 0.50   $ 0.50    
Mr Michael A Littman [Member] | Class A Warrant [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Warrants granted                 50,000    
Exercise price                 $ 0.50    
Warrants exercised, shares               50,000      
Mr Michael A Littman [Member] | Class B Warrant [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Warrants granted                 50,000    
Exercise price                 $ 1.00    
Warrants exercised, shares               50,000      
Mr Shun Chih Chuang And Five Consultants [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Stock issued for services, shares           505,000          
Chen Chun Chung [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Stock issued for services, shares         150,000            
Tra Digital [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Stock issued for services, shares         75,000            
Investor [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Stock issued for services, shares       450,000              
Yu Hao Chang [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Stock issued for services, shares     20,000                
Andy Chin An Jin [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Stock issued for services, shares   60,000                  
Any Chin An Jin [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                      
Stock issued for services, shares 180,000                    
XML 178 R77.htm IDEA: XBRL DOCUMENT v3.25.2
PREFERRED STOCK (Details Narrative) - $ / shares
Aug. 11, 2022
Mar. 31, 2025
Dec. 31, 2024
Aug. 31, 2021
Class of Stock [Line Items]        
Sale of stock, price       $ 0.001
Share price       $ 2.50
Reverse stock split 2:3 reverse stock split      
Series A Preferred Stock [Member]        
Class of Stock [Line Items]        
Preferred stock, shares issued   80,000 80,000 80,000
XML 179 R78.htm IDEA: XBRL DOCUMENT v3.25.2
(LOSS) EARNINGS PER SHARE (Details) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Numerator:    
Net loss income attributable to the Company $ (248,017) $ (288,576)
Weighted-average shares outstanding    
- Basic 14,159,761 11,956,987
- Diluted 14,159,761 11,956,987
Loss per share:    
- Basic $ (0.0175) $ (0.0241)
- Diluted $ (0.0175) $ (0.0241)
XML 180 R79.htm IDEA: XBRL DOCUMENT v3.25.2
COMMITMENTS AND CONTINGENCIES (Details)
Mar. 31, 2025
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Within 1 year $ 1,827
Total $ 1,827
XML 181 R80.htm IDEA: XBRL DOCUMENT v3.25.2
Disclosure - SEGMENT REPORTING (Details - Segment information) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue, Major Customer [Line Items]    
Revenue $ 4,534,128 $ 4,899,880
Cost of revenue 4,483,178 4,815,919
Gross profit 50,950 83,961
General and administrative expenses (334,371) (451,464)
Segment operating losses (283,421) (367,503)
Income tax expenses (0) 124,146
Segment losses (283,421) (491,649)
Income tax expenses 0 (124,146)
Fish Trading [Member]    
Revenue, Major Customer [Line Items]    
Revenue 4,474,206 4,764,517
Cost of revenue 4,465,209 4,754,614
Gross profit 8,997 9,903
General and administrative expenses (60,323) (27,955)
Segment operating losses (51,326) (18,052)
Income tax expenses 0 124,146
Segment losses (51,326) (142,198)
Income tax expenses $ 0 $ (124,146)
Fish Trading [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
Revenue, Major Customer [Line Items]    
Concentration percentage 84.65% 81.01%
Fish Trading [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer A [Member]    
Revenue, Major Customer [Line Items]    
Concentration percentage 21.47% 37.45%
Fish Trading [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer B [Member]    
Revenue, Major Customer [Line Items]    
Concentration percentage 24.25% 0.00%
Fish Trading [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer C [Member]    
Revenue, Major Customer [Line Items]    
Concentration percentage 18.42% 0.00%
Fish Trading [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer D [Member]    
Revenue, Major Customer [Line Items]    
Concentration percentage 20.50% 10.01%
Fish Trading [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer E [Member]    
Revenue, Major Customer [Line Items]    
Concentration percentage 0.00% 18.21%
Fish Trading [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer F [Member]    
Revenue, Major Customer [Line Items]    
Concentration percentage 0.00% 15.35%
Catering [Member]    
Revenue, Major Customer [Line Items]    
Revenue $ 2,089 $ 86,373
Cost of revenue 1,567 43,989
Gross profit 522 42,384
General and administrative expenses (195,407) (166,429)
Segment operating losses (194,885) (124,045)
Income tax expenses 0 0
Segment losses (194,885) (124,045)
Income tax expenses $ 0 $ 0
Catering [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
Revenue, Major Customer [Line Items]    
Concentration percentage 83.99% 0.00%
Catering [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer G [Member]    
Revenue, Major Customer [Line Items]    
Concentration percentage 83.99% 0.00%
E Commerce [Member]    
Revenue, Major Customer [Line Items]    
Revenue $ 57,833 $ 48,990
Cost of revenue 16,402 17,316
Gross profit 41,431 31,674
General and administrative expenses (78,641) (257,080)
Segment operating losses (37,210) (225,406)
Income tax expenses 0 0
Segment losses (37,210) (225,406)
Income tax expenses $ 0 $ 0
XML 182 FilingSummary.xml IDEA: XBRL DOCUMENT 3.25.2 html 206 257 1 true 90 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://nocera.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://nocera.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED Sheet http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED Statements 4 false false R5.htm 00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 5 false false R6.htm 00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) Sheet http://nocera.com/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) Statements 6 false false R7.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 7 false false R8.htm 999007 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION Sheet http://nocera.com/role/PrincipalActivitiesAndOrganization PRINCIPAL ACTIVITIES AND ORGANIZATION Notes 8 false false R9.htm 999008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY Sheet http://nocera.com/role/SummaryOfSignificantAccountingPolicy SUMMARY OF SIGNIFICANT ACCOUNTING POLICY Notes 9 false false R10.htm 999009 - Disclosure - ACCOUNTS RECEIVABLE Sheet http://nocera.com/role/AccountsReceivable ACCOUNTS RECEIVABLE Notes 10 false false R11.htm 999010 - Disclosure - INVENTORIES Sheet http://nocera.com/role/Inventories INVENTORIES Notes 11 false false R12.htm 999011 - Disclosure - ADVANCE TO SUPPLIERS Sheet http://nocera.com/role/AdvanceToSuppliers ADVANCE TO SUPPLIERS Notes 12 false false R13.htm 999012 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET Sheet http://nocera.com/role/PrepaidExpensesAndOtherAssetsNet PREPAID EXPENSES AND OTHER ASSETS, NET Notes 13 false false R14.htm 999013 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS Sheet http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLoss FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS Notes 14 false false R15.htm 999014 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://nocera.com/role/PropertyAndEquipmentNet PROPERTY AND EQUIPMENT, NET Notes 15 false false R16.htm 999015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Sheet http://nocera.com/role/GoodwillAndOtherIntangibleAssets GOODWILL AND OTHER INTANGIBLE ASSETS Notes 16 false false R17.htm 999016 - Disclosure - OTHER BORROWINGS Sheet http://nocera.com/role/OtherBorrowings OTHER BORROWINGS Notes 17 false false R18.htm 999017 - Disclosure - WARRANTS Sheet http://nocera.com/role/Warrants WARRANTS Notes 18 false false R19.htm 999018 - Disclosure - LEASES Sheet http://nocera.com/role/Leases LEASES Notes 19 false false R20.htm 999019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES Sheet http://nocera.com/role/OtherPayablesAndAccruedLiabilities OTHER PAYABLES AND ACCRUED LIABILITIES Notes 20 false false R21.htm 999020 - Disclosure - INCOME TAXES Sheet http://nocera.com/role/IncomeTaxes INCOME TAXES Notes 21 false false R22.htm 999021 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS Sheet http://nocera.com/role/RelatedPartyBalancesAndTransactions RELATED PARTY BALANCES AND TRANSACTIONS Notes 22 false false R23.htm 999022 - Disclosure - COMMON STOCK Sheet http://nocera.com/role/CommonStock COMMON STOCK Notes 23 false false R24.htm 999023 - Disclosure - SHARE-BASED COMPENSATION Sheet http://nocera.com/role/Share-basedCompensation SHARE-BASED COMPENSATION Notes 24 false false R25.htm 999024 - Disclosure - PREFERRED STOCK Sheet http://nocera.com/role/PreferredStock PREFERRED STOCK Notes 25 false false R26.htm 999025 - Disclosure - (LOSS) INCOME PER SHARE Sheet http://nocera.com/role/LossIncomePerShare (LOSS) INCOME PER SHARE Notes 26 false false R27.htm 999026 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://nocera.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 27 false false R28.htm 999027 - Disclosure - SEGMENT REPORTING Sheet http://nocera.com/role/SegmentReporting SEGMENT REPORTING Notes 28 false false R29.htm 999028 - Disclosure - SUBSEQUENT EVENT Sheet http://nocera.com/role/SubsequentEvent SUBSEQUENT EVENT Notes 29 false false R30.htm 999030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies) Sheet http://nocera.com/role/SummaryOfSignificantAccountingPolicyPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies) Policies 30 false false R31.htm 999031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables) Sheet http://nocera.com/role/SummaryOfSignificantAccountingPolicyTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables) Tables http://nocera.com/role/SummaryOfSignificantAccountingPolicy 31 false false R32.htm 999032 - Disclosure - ACCOUNTS RECEIVABLE (Tables) Sheet http://nocera.com/role/AccountsReceivableTables ACCOUNTS RECEIVABLE (Tables) Tables http://nocera.com/role/AccountsReceivable 32 false false R33.htm 999033 - Disclosure - INVENTORIES (Tables) Sheet http://nocera.com/role/InventoriesTables INVENTORIES (Tables) Tables http://nocera.com/role/Inventories 33 false false R34.htm 999034 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Tables) Sheet http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetTables PREPAID EXPENSES AND OTHER ASSETS, NET (Tables) Tables http://nocera.com/role/PrepaidExpensesAndOtherAssetsNet 34 false false R35.htm 999035 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Tables) Sheet http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossTables FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Tables) Tables http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLoss 35 false false R36.htm 999036 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) Sheet http://nocera.com/role/PropertyAndEquipmentNetTables PROPERTY AND EQUIPMENT, NET (Tables) Tables http://nocera.com/role/PropertyAndEquipmentNet 36 false false R37.htm 999037 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Sheet http://nocera.com/role/GoodwillAndOtherIntangibleAssetsTables GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Tables http://nocera.com/role/GoodwillAndOtherIntangibleAssets 37 false false R38.htm 999038 - Disclosure - OTHER BORROWINGS (Tables) Sheet http://nocera.com/role/OtherBorrowingsTables OTHER BORROWINGS (Tables) Tables http://nocera.com/role/OtherBorrowings 38 false false R39.htm 999039 - Disclosure - WARRANTS (Tables) Sheet http://nocera.com/role/WarrantsTables WARRANTS (Tables) Tables http://nocera.com/role/Warrants 39 false false R40.htm 999040 - Disclosure - LEASES (Tables) Sheet http://nocera.com/role/LeasesTables LEASES (Tables) Tables http://nocera.com/role/Leases 40 false false R41.htm 999041 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) Sheet http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesTables OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) Tables http://nocera.com/role/OtherPayablesAndAccruedLiabilities 41 false false R42.htm 999042 - Disclosure - INCOME TAXES (Tables) Sheet http://nocera.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://nocera.com/role/IncomeTaxes 42 false false R43.htm 999043 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables) Sheet http://nocera.com/role/RelatedPartyBalancesAndTransactionsTables RELATED PARTY BALANCES AND TRANSACTIONS (Tables) Tables http://nocera.com/role/RelatedPartyBalancesAndTransactions 43 false false R44.htm 999044 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://nocera.com/role/Share-basedCompensationTables SHARE-BASED COMPENSATION (Tables) Tables http://nocera.com/role/Share-basedCompensation 44 false false R45.htm 999045 - Disclosure - (LOSS) INCOME PER SHARE (Tables) Sheet http://nocera.com/role/LossIncomePerShareTables (LOSS) INCOME PER SHARE (Tables) Tables http://nocera.com/role/LossIncomePerShare 45 false false R46.htm 999046 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://nocera.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://nocera.com/role/CommitmentsAndContingencies 46 false false R47.htm 999047 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://nocera.com/role/SegmentReportingTables SEGMENT REPORTING (Tables) Tables http://nocera.com/role/SegmentReporting 47 false false R48.htm 999048 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION (Details Narrative) Sheet http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative PRINCIPAL ACTIVITIES AND ORGANIZATION (Details Narrative) Details http://nocera.com/role/PrincipalActivitiesAndOrganization 48 false false R49.htm 999049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations) Sheet http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations) Details http://nocera.com/role/SummaryOfSignificantAccountingPolicyTables 49 false false R50.htm 999050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative) Sheet http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative) Details http://nocera.com/role/SummaryOfSignificantAccountingPolicyTables 50 false false R51.htm 999051 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details) Sheet http://nocera.com/role/AccountsReceivableNetDetails ACCOUNTS RECEIVABLE, NET (Details) Details 51 false false R52.htm 999052 - Disclosure - INVENTORIES (Details) Sheet http://nocera.com/role/InventoriesDetails INVENTORIES (Details) Details http://nocera.com/role/InventoriesTables 52 false false R53.htm 999053 - Disclosure - ADVANCE TO SUPPLIERS (Details Narrative) Sheet http://nocera.com/role/AdvanceToSuppliersDetailsNarrative ADVANCE TO SUPPLIERS (Details Narrative) Details http://nocera.com/role/AdvanceToSuppliers 53 false false R54.htm 999054 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details) Sheet http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetails PREPAID EXPENSES AND OTHER ASSETS, NET (Details) Details http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetTables 54 false false R55.htm 999055 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details Narrative) Sheet http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetailsNarrative PREPAID EXPENSES AND OTHER ASSETS, NET (Details Narrative) Details http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetTables 55 false false R56.htm 999056 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details) Sheet http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetails FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details) Details http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossTables 56 false false R57.htm 999057 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details Narrative) Sheet http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetailsNarrative FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details Narrative) Details http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossTables 57 false false R58.htm 999058 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details) Sheet http://nocera.com/role/PropertyAndEquipmentNetDetails PROPERTY AND EQUIPMENT, NET (Details) Details http://nocera.com/role/PropertyAndEquipmentNetTables 58 false false R59.htm 999059 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) Sheet http://nocera.com/role/PropertyAndEquipmentNetDetailsNarrative PROPERTY AND EQUIPMENT, NET (Details Narrative) Details http://nocera.com/role/PropertyAndEquipmentNetTables 59 false false R60.htm 999060 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Goodwill) Sheet http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-Goodwill GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Goodwill) Details http://nocera.com/role/GoodwillAndOtherIntangibleAssetsTables 60 false false R61.htm 999061 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Customer relations) Sheet http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-CustomerRelations GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Customer relations) Details http://nocera.com/role/GoodwillAndOtherIntangibleAssetsTables 61 false false R62.htm 999062 - Disclosure - OTHER BORROWINGS (Details) Sheet http://nocera.com/role/OtherBorrowingsDetails OTHER BORROWINGS (Details) Details http://nocera.com/role/OtherBorrowingsTables 62 false false R63.htm 999063 - Disclosure - WARRANTS (Details - Warrant Liability) Sheet http://nocera.com/role/WarrantsDetails-WarrantLiability WARRANTS (Details - Warrant Liability) Details http://nocera.com/role/WarrantsTables 63 false false R64.htm 999064 - Disclosure - WARRANTS (Details - Warrant Activity) Sheet http://nocera.com/role/WarrantsDetails-WarrantActivity WARRANTS (Details - Warrant Activity) Details http://nocera.com/role/WarrantsTables 64 false false R65.htm 999065 - Disclosure - WARRANTS (Details Narrative) Sheet http://nocera.com/role/WarrantsDetailsNarrative WARRANTS (Details Narrative) Details http://nocera.com/role/WarrantsTables 65 false false R66.htm 999066 - Disclosure - LEASES (Details - Lease costs) Sheet http://nocera.com/role/LeasesDetails-LeaseCosts LEASES (Details - Lease costs) Details http://nocera.com/role/LeasesTables 66 false false R67.htm 999067 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details) Sheet http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesDetails OTHER PAYABLES AND ACCRUED LIABILITIES (Details) Details http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesTables 67 false false R68.htm 999068 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details Narrative) Sheet http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesDetailsNarrative OTHER PAYABLES AND ACCRUED LIABILITIES (Details Narrative) Details http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesTables 68 false false R69.htm 999069 - Disclosure - INCOME TAXES (Details - Income tax expense) Sheet http://nocera.com/role/IncomeTaxesDetails-IncomeTaxExpense INCOME TAXES (Details - Income tax expense) Details http://nocera.com/role/IncomeTaxesTables 69 false false R70.htm 999070 - Disclosure - INCOME TAXES (Details - Reconciliation of income tax) Sheet http://nocera.com/role/IncomeTaxesDetails-ReconciliationOfIncomeTax INCOME TAXES (Details - Reconciliation of income tax) Details http://nocera.com/role/IncomeTaxesTables 70 false false R71.htm 999071 - Disclosure - INCOME TAXES (Details - Valuation Allowance) Sheet http://nocera.com/role/IncomeTaxesDetails-ValuationAllowance INCOME TAXES (Details - Valuation Allowance) Details http://nocera.com/role/IncomeTaxesTables 71 false false R72.htm 999072 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://nocera.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://nocera.com/role/IncomeTaxesTables 72 false false R73.htm 999073 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties) Sheet http://nocera.com/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties) Details http://nocera.com/role/RelatedPartyBalancesAndTransactionsTables 73 false false R74.htm 999074 - Disclosure - COMMON STOCK (Details Narrative) Sheet http://nocera.com/role/CommonStockDetailsNarrative COMMON STOCK (Details Narrative) Details http://nocera.com/role/CommonStock 74 false false R75.htm 999075 - Disclosure - SHARE-BASED COMPENSATION (Details - Assumptions) Sheet http://nocera.com/role/Share-basedCompensationDetails-Assumptions SHARE-BASED COMPENSATION (Details - Assumptions) Details http://nocera.com/role/Share-basedCompensationTables 75 false false R76.htm 999076 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative) Sheet http://nocera.com/role/Share-basedCompensationDetailsNarrative SHARE-BASED COMPENSATION (Details Narrative) Details http://nocera.com/role/Share-basedCompensationTables 76 false false R77.htm 999077 - Disclosure - PREFERRED STOCK (Details Narrative) Sheet http://nocera.com/role/PreferredStockDetailsNarrative PREFERRED STOCK (Details Narrative) Details http://nocera.com/role/PreferredStock 77 false false R78.htm 999078 - Disclosure - (LOSS) EARNINGS PER SHARE (Details) Sheet http://nocera.com/role/LossEarningsPerShareDetails (LOSS) EARNINGS PER SHARE (Details) Details 78 false false R79.htm 999079 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://nocera.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://nocera.com/role/CommitmentsAndContingenciesTables 79 false false R80.htm 999080 - Disclosure - Disclosure - SEGMENT REPORTING (Details - Segment information) Sheet http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation Disclosure - SEGMENT REPORTING (Details - Segment information) Details 80 false false All Reports Book All Reports ncra-20250331.xsd ncra-20250331_cal.xml ncra-20250331_def.xml ncra-20250331_lab.xml ncra-20250331_pre.xml nocera_i10qa1-033125.htm http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 184 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "nocera_i10qa1-033125.htm": { "nsprefix": "NCRA", "nsuri": "http://nocera.com/20250331", "dts": { "schema": { "local": [ "ncra-20250331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "ncra-20250331_cal.xml" ] }, "definitionLink": { "local": [ "ncra-20250331_def.xml" ] }, "labelLink": { "local": [ "ncra-20250331_lab.xml" ] }, "presentationLink": { "local": [ "ncra-20250331_pre.xml" ] }, "inline": { "local": [ "nocera_i10qa1-033125.htm" ] } }, "keyStandard": 238, "keyCustom": 19, "axisStandard": 23, "axisCustom": 0, "memberStandard": 20, "memberCustom": 65, "hidden": { "total": 45, "http://fasb.org/us-gaap/2024": 39, "http://xbrl.sec.gov/dei/2024": 6 }, "contextCount": 206, "entityCount": 1, "segmentCount": 90, "elementCount": 480, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 581, "http://xbrl.sec.gov/dei/2024": 34, "http://xbrl.sec.gov/ecd/2024": 4 }, "report": { "R1": { "role": "http://nocera.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R2": { "role": "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets", "longName": "00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS", "shortName": "INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R3": { "role": "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical", "longName": "00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "unique": true } }, "R4": { "role": "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited", "longName": "00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED", "shortName": "INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:OperatingExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "unique": true } }, "R5": { "role": "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "longName": "00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "shortName": "INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:IncreaseDecreaseInDeferredIncomeTaxes", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "unique": true } }, "R6": { "role": "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity", "longName": "00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)", "shortName": "INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R8": { "role": "http://nocera.com/role/PrincipalActivitiesAndOrganization", "longName": "999007 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION", "shortName": "PRINCIPAL ACTIVITIES AND ORGANIZATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R9": { "role": "http://nocera.com/role/SummaryOfSignificantAccountingPolicy", "longName": "999008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R10": { "role": "http://nocera.com/role/AccountsReceivable", "longName": "999009 - Disclosure - ACCOUNTS RECEIVABLE", "shortName": "ACCOUNTS RECEIVABLE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R11": { "role": "http://nocera.com/role/Inventories", "longName": "999010 - Disclosure - INVENTORIES", "shortName": "INVENTORIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R12": { "role": "http://nocera.com/role/AdvanceToSuppliers", "longName": "999011 - Disclosure - ADVANCE TO SUPPLIERS", "shortName": "ADVANCE TO SUPPLIERS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "NCRA:AdvanceToSuppliersTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "NCRA:AdvanceToSuppliersTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R13": { "role": "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNet", "longName": "999012 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET", "shortName": "PREPAID EXPENSES AND OTHER ASSETS, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:OtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:OtherCurrentAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R14": { "role": "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLoss", "longName": "999013 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS", "shortName": "FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R15": { "role": "http://nocera.com/role/PropertyAndEquipmentNet", "longName": "999014 - Disclosure - PROPERTY AND EQUIPMENT, NET", "shortName": "PROPERTY AND EQUIPMENT, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R16": { "role": "http://nocera.com/role/GoodwillAndOtherIntangibleAssets", "longName": "999015 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R17": { "role": "http://nocera.com/role/OtherBorrowings", "longName": "999016 - Disclosure - OTHER BORROWINGS", "shortName": "OTHER BORROWINGS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R18": { "role": "http://nocera.com/role/Warrants", "longName": "999017 - Disclosure - WARRANTS", "shortName": "WARRANTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "NCRA:WarrantDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "NCRA:WarrantDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R19": { "role": "http://nocera.com/role/Leases", "longName": "999018 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R20": { "role": "http://nocera.com/role/OtherPayablesAndAccruedLiabilities", "longName": "999019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R21": { "role": "http://nocera.com/role/IncomeTaxes", "longName": "999020 - Disclosure - INCOME TAXES", "shortName": "INCOME TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R22": { "role": "http://nocera.com/role/RelatedPartyBalancesAndTransactions", "longName": "999021 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS", "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R23": { "role": "http://nocera.com/role/CommonStock", "longName": "999022 - Disclosure - COMMON STOCK", "shortName": "COMMON STOCK", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R24": { "role": "http://nocera.com/role/Share-basedCompensation", "longName": "999023 - Disclosure - SHARE-BASED COMPENSATION", "shortName": "SHARE-BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R25": { "role": "http://nocera.com/role/PreferredStock", "longName": "999024 - Disclosure - PREFERRED STOCK", "shortName": "PREFERRED STOCK", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:PreferredStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:PreferredStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R26": { "role": "http://nocera.com/role/LossIncomePerShare", "longName": "999025 - Disclosure - (LOSS) INCOME PER SHARE", "shortName": "(LOSS) INCOME PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R27": { "role": "http://nocera.com/role/CommitmentsAndContingencies", "longName": "999026 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R28": { "role": "http://nocera.com/role/SegmentReporting", "longName": "999027 - Disclosure - SEGMENT REPORTING", "shortName": "SEGMENT REPORTING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R29": { "role": "http://nocera.com/role/SubsequentEvent", "longName": "999028 - Disclosure - SUBSEQUENT EVENT", "shortName": "SUBSEQUENT EVENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R30": { "role": "http://nocera.com/role/SummaryOfSignificantAccountingPolicyPolicies", "longName": "999030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "30", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R31": { "role": "http://nocera.com/role/SummaryOfSignificantAccountingPolicyTables", "longName": "999031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R32": { "role": "http://nocera.com/role/AccountsReceivableTables", "longName": "999032 - Disclosure - ACCOUNTS RECEIVABLE (Tables)", "shortName": "ACCOUNTS RECEIVABLE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R33": { "role": "http://nocera.com/role/InventoriesTables", "longName": "999033 - Disclosure - INVENTORIES (Tables)", "shortName": "INVENTORIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R34": { "role": "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetTables", "longName": "999034 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Tables)", "shortName": "PREPAID EXPENSES AND OTHER ASSETS, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R35": { "role": "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossTables", "longName": "999035 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Tables)", "shortName": "FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfServicingAssetsAtFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfServicingAssetsAtFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R36": { "role": "http://nocera.com/role/PropertyAndEquipmentNetTables", "longName": "999036 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)", "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R37": { "role": "http://nocera.com/role/GoodwillAndOtherIntangibleAssetsTables", "longName": "999037 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R38": { "role": "http://nocera.com/role/OtherBorrowingsTables", "longName": "999038 - Disclosure - OTHER BORROWINGS (Tables)", "shortName": "OTHER BORROWINGS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R39": { "role": "http://nocera.com/role/WarrantsTables", "longName": "999039 - Disclosure - WARRANTS (Tables)", "shortName": "WARRANTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "NCRA:ScheduleOfWarrantLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "NCRA:WarrantDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "NCRA:ScheduleOfWarrantLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "NCRA:WarrantDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R40": { "role": "http://nocera.com/role/LeasesTables", "longName": "999040 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R41": { "role": "http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesTables", "longName": "999041 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R42": { "role": "http://nocera.com/role/IncomeTaxesTables", "longName": "999042 - Disclosure - INCOME TAXES (Tables)", "shortName": "INCOME TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R43": { "role": "http://nocera.com/role/RelatedPartyBalancesAndTransactionsTables", "longName": "999043 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)", "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R44": { "role": "http://nocera.com/role/Share-basedCompensationTables", "longName": "999044 - Disclosure - SHARE-BASED COMPENSATION (Tables)", "shortName": "SHARE-BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R45": { "role": "http://nocera.com/role/LossIncomePerShareTables", "longName": "999045 - Disclosure - (LOSS) INCOME PER SHARE (Tables)", "shortName": "(LOSS) INCOME PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R46": { "role": "http://nocera.com/role/CommitmentsAndContingenciesTables", "longName": "999046 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R47": { "role": "http://nocera.com/role/SegmentReportingTables", "longName": "999047 - Disclosure - SEGMENT REPORTING (Tables)", "shortName": "SEGMENT REPORTING (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R48": { "role": "http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative", "longName": "999048 - Disclosure - PRINCIPAL ACTIVITIES AND ORGANIZATION (Details Narrative)", "shortName": "PRINCIPAL ACTIVITIES AND ORGANIZATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "From2022-09-062022-09-07_custom_MeixinMember", "name": "us-gaap:VariableInterestEntityOwnershipPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-09-062022-09-07_custom_MeixinMember", "name": "us-gaap:VariableInterestEntityOwnershipPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R49": { "role": "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations", "longName": "999049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "From2025-01-012025-03-31_custom_CustomerAMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember", "name": "NCRA:ConcentrationRiskPercentage2", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-03-31_custom_CustomerAMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember", "name": "NCRA:ConcentrationRiskPercentage2", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R50": { "role": "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative", "longName": "999050 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember", "name": "NCRA:ConcentrationRiskPercentage2", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-03-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember", "name": "NCRA:ConcentrationRiskPercentage2", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R51": { "role": "http://nocera.com/role/AccountsReceivableNetDetails", "longName": "999051 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details)", "shortName": "ACCOUNTS RECEIVABLE, NET (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:AccountsReceivableGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:AccountsReceivableGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R52": { "role": "http://nocera.com/role/InventoriesDetails", "longName": "999052 - Disclosure - INVENTORIES (Details)", "shortName": "INVENTORIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R53": { "role": "http://nocera.com/role/AdvanceToSuppliersDetailsNarrative", "longName": "999053 - Disclosure - ADVANCE TO SUPPLIERS (Details Narrative)", "shortName": "ADVANCE TO SUPPLIERS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:AccountsAndOtherReceivablesNetCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "NCRA:AdvanceToSuppliersTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:AccountsAndOtherReceivablesNetCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "NCRA:AdvanceToSuppliersTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R54": { "role": "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetails", "longName": "999054 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)", "shortName": "PREPAID EXPENSES AND OTHER ASSETS, NET (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:PrepaidExpenseCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:PrepaidExpenseCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R55": { "role": "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetailsNarrative", "longName": "999055 - Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details Narrative)", "shortName": "PREPAID EXPENSES AND OTHER ASSETS, NET (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31_custom_DueFromThirdPartiesMember", "name": "us-gaap:PrepaidExpenseAndOtherAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "unique": true } }, "R56": { "role": "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetails", "longName": "999056 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details)", "shortName": "FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfServicingAssetsAtFairValueTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfServicingAssetsAtFairValueTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R57": { "role": "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetailsNarrative", "longName": "999057 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details Narrative)", "shortName": "FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:GainLossOnDispositionOfOtherFinancialAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:GainLossOnDispositionOfOtherFinancialAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R58": { "role": "http://nocera.com/role/PropertyAndEquipmentNetDetails", "longName": "999058 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)", "shortName": "PROPERTY AND EQUIPMENT, NET (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R59": { "role": "http://nocera.com/role/PropertyAndEquipmentNetDetailsNarrative", "longName": "999059 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)", "shortName": "PROPERTY AND EQUIPMENT, NET (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": null }, "R60": { "role": "http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-Goodwill", "longName": "999060 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Goodwill)", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Goodwill)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:Goodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "unique": true } }, "R61": { "role": "http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-CustomerRelations", "longName": "999061 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Customer relations)", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL (Details - Customer relations)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R62": { "role": "http://nocera.com/role/OtherBorrowingsDetails", "longName": "999062 - Disclosure - OTHER BORROWINGS (Details)", "shortName": "OTHER BORROWINGS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:OtherLongTermDebtCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:OtherLongTermDebtNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "unique": true } }, "R63": { "role": "http://nocera.com/role/WarrantsDetails-WarrantLiability", "longName": "999063 - Disclosure - WARRANTS (Details - Warrant Liability)", "shortName": "WARRANTS (Details - Warrant Liability)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "NCRA:ScheduleOfWarrantLiabilitiesTableTextBlock", "NCRA:WarrantDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "NCRA:ScheduleOfWarrantLiabilitiesTableTextBlock", "NCRA:WarrantDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R64": { "role": "http://nocera.com/role/WarrantsDetails-WarrantActivity", "longName": "999064 - Disclosure - WARRANTS (Details - Warrant Activity)", "shortName": "WARRANTS (Details - Warrant Activity)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "AsOf2024-12-31_us-gaap_WarrantMember", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock", "NCRA:WarrantDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-03-31_us-gaap_WarrantMember", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock", "NCRA:WarrantDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "unique": true } }, "R65": { "role": "http://nocera.com/role/WarrantsDetailsNarrative", "longName": "999065 - Disclosure - WARRANTS (Details Narrative)", "shortName": "WARRANTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "AsOf2022-09-23_custom_UnderwritersMember_custom_PublicOffering2022Member", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "NCRA:WarrantDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-09-23_custom_UnderwritersMember_custom_PublicOffering2022Member", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "NCRA:WarrantDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R66": { "role": "http://nocera.com/role/LeasesDetails-LeaseCosts", "longName": "999066 - Disclosure - LEASES (Details - Lease costs)", "shortName": "LEASES (Details - Lease costs)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R67": { "role": "http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesDetails", "longName": "999067 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:OtherAccruedLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:OtherAccruedLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R68": { "role": "http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesDetailsNarrative", "longName": "999068 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details Narrative)", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": null }, "R69": { "role": "http://nocera.com/role/IncomeTaxesDetails-IncomeTaxExpense", "longName": "999069 - Disclosure - INCOME TAXES (Details - Income tax expense)", "shortName": "INCOME TAXES (Details - Income tax expense)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "From2025-01-012025-03-31_custom_PRCMember", "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-012025-03-31_custom_PRCMember", "name": "us-gaap:CurrentIncomeTaxExpenseBenefit", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R70": { "role": "http://nocera.com/role/IncomeTaxesDetails-ReconciliationOfIncomeTax", "longName": "999070 - Disclosure - INCOME TAXES (Details - Reconciliation of income tax)", "shortName": "INCOME TAXES (Details - Reconciliation of income tax)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R71": { "role": "http://nocera.com/role/IncomeTaxesDetails-ValuationAllowance", "longName": "999071 - Disclosure - INCOME TAXES (Details - Valuation Allowance)", "shortName": "INCOME TAXES (Details - Valuation Allowance)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "AsOf2024-12-31", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfValuationAllowanceTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:SummaryOfValuationAllowanceTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "unique": true } }, "R72": { "role": "http://nocera.com/role/IncomeTaxesDetailsNarrative", "longName": "999072 - Disclosure - INCOME TAXES (Details Narrative)", "shortName": "INCOME TAXES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "From2019-01-012019-12-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2019-01-012019-12-31", "name": "us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R73": { "role": "http://nocera.com/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties", "longName": "999073 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)", "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "NCRA:DueToRelatedPartyCurrent1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "NCRA:DueToRelatedPartyCurrent1", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R74": { "role": "http://nocera.com/role/CommonStockDetailsNarrative", "longName": "999074 - Disclosure - COMMON STOCK (Details Narrative)", "shortName": "COMMON STOCK (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2024-02-192024-02-20_custom_XincaMember", "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "unique": true } }, "R75": { "role": "http://nocera.com/role/Share-basedCompensationDetails-Assumptions", "longName": "999075 - Disclosure - SHARE-BASED COMPENSATION (Details - Assumptions)", "shortName": "SHARE-BASED COMPENSATION (Details - Assumptions)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R76": { "role": "http://nocera.com/role/Share-basedCompensationDetailsNarrative", "longName": "999076 - Disclosure - SHARE-BASED COMPENSATION (Details Narrative)", "shortName": "SHARE-BASED COMPENSATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "From2024-01-012024-12-31", "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2024-01-012024-12-31", "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R77": { "role": "http://nocera.com/role/PreferredStockDetailsNarrative", "longName": "999077 - Disclosure - PREFERRED STOCK (Details Narrative)", "shortName": "PREFERRED STOCK (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "AsOf2021-08-31", "name": "us-gaap:SaleOfStockPricePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-08-31", "name": "us-gaap:SaleOfStockPricePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R78": { "role": "http://nocera.com/role/LossEarningsPerShareDetails", "longName": "999078 - Disclosure - (LOSS) EARNINGS PER SHARE (Details)", "shortName": "(LOSS) EARNINGS PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": null }, "R79": { "role": "http://nocera.com/role/CommitmentsAndContingenciesDetails", "longName": "999079 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2025-03-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true, "unique": true } }, "R80": { "role": "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "longName": "999080 - Disclosure - Disclosure - SEGMENT REPORTING (Details - Segment information)", "shortName": "Disclosure - SEGMENT REPORTING (Details - Segment information)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2025-01-01to2025-03-31", "name": "NCRA:SegmentLosses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nocera_i10qa1-033125.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsAndNontradeReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsAndNontradeReceivableTextBlock", "presentation": [ "http://nocera.com/role/AccountsReceivable" ], "lang": { "en-us": { "role": { "label": "ACCOUNTS RECEIVABLE", "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable." } } }, "auth_ref": [ "r251", "r288" ] }, "us-gaap_AccountsAndOtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsAndOtherReceivablesNetCurrent", "crdr": "debit", "presentation": [ "http://nocera.com/role/AdvanceToSuppliersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Advances to suppliers", "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "presentation": [ "http://nocera.com/role/OtherPayablesAndAccruedLiabilities" ], "lang": { "en-us": { "role": { "label": "OTHER PAYABLES AND ACCRUED LIABILITIES", "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period." } } }, "auth_ref": [ "r430" ] }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets", "http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesDetails", "http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other payables and accrued liabilities", "totalLabel": "Total", "verboseLabel": "Other payables and accrued expenses", "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r57", "r834" ] }, "us-gaap_AccountsPayableOtherCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableOtherCurrent", "crdr": "credit", "calculation": { "http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Others", "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r57" ] }, "us-gaap_AccountsReceivableGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableGross", "crdr": "debit", "calculation": { "http://nocera.com/role/AccountsReceivableNetDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/AccountsReceivableNetDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts receivable", "label": "Accounts Receivable, before Allowance for Credit Loss", "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r156", "r252", "r253", "r995" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableMember", "presentation": [ "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r770" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 }, "http://nocera.com/role/AccountsReceivableNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://nocera.com/role/AccountsReceivableNetDetails", "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts receivable", "totalLabel": "Total", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r921" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Income tax payable", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r59", "r118" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://nocera.com/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r31", "r147", "r615" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive income", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r13", "r14", "r78", "r157", "r610", "r645", "r646" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r8", "r14", "r476", "r479", "r519", "r641", "r642", "r900", "r901", "r902", "r910", "r911", "r912", "r913" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital (1)", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r68", "r834", "r1029" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r663", "r910", "r911", "r912", "r913", "r967", "r1030" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Adjustments to APIC for share based compensation", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net income to net cash used in operating activities:" } } }, "auth_ref": [] }, "NCRA_AdvanceToSuppliersTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://nocera.com/20250331", "localname": "AdvanceToSuppliersTextBlock", "presentation": [ "http://nocera.com/role/AdvanceToSuppliers" ], "lang": { "en-us": { "role": { "label": "ADVANCE TO SUPPLIERS" } } }, "auth_ref": [] }, "us-gaap_AdvancesOnInventoryPurchases": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdvancesOnInventoryPurchases", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Advance to suppliers", "documentation": "Carrying value of capitalized payments made in advance for inventory that is expected to be received within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r898" ] }, "NCRA_AllCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "AllCustomersMember", "presentation": [ "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" ], "lang": { "en-us": { "role": { "label": "All Customers [Member]" } } }, "auth_ref": [] }, "NCRA_AllSuppliersMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "AllSuppliersMember", "presentation": [ "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" ], "lang": { "en-us": { "role": { "label": "All Suppliers [Member]" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of intangible assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r6", "r314", "r316", "r808" ] }, "NCRA_AndyChinAnJinMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "AndyChinAnJinMember", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Andy Chin An Jin [Member]" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r874" ] }, "NCRA_AnyChinAnJinMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "AnyChinAnJinMember", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Any Chin An Jin [Member]" } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r116", "r128", "r151", "r181", "r213", "r221", "r239", "r243", "r287", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r469", "r473", "r503", "r604", "r707", "r800", "r801", "r834", "r859", "r950", "r951", "r985" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r142", "r160", "r181", "r287", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r469", "r473", "r503", "r834", "r950", "r951", "r985" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Fair value of financial asset", "documentation": "Fair value portion of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r486", "r487", "r822" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r874" ] }, "NCRA_AverageExercisePriceExerciasable": { "xbrltype": "perShareItemType", "nsuri": "http://nocera.com/20250331", "localname": "AverageExercisePriceExerciasable", "presentation": [ "http://nocera.com/role/WarrantsDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Average exercise price exercisable, Beginning balance", "periodEndLabel": "Average exercise price exercisable, Ending balance", "label": "AverageExercisePriceExerciasable" } } }, "auth_ref": [] }, "NCRA_AverageExercisePriceExercisedSurrendered": { "xbrltype": "perShareItemType", "nsuri": "http://nocera.com/20250331", "localname": "AverageExercisePriceExercisedSurrendered", "presentation": [ "http://nocera.com/role/WarrantsDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Average exercise price, Exercised / surrendered" } } }, "auth_ref": [] }, "NCRA_AverageExercisePriceGranted": { "xbrltype": "perShareItemType", "nsuri": "http://nocera.com/20250331", "localname": "AverageExercisePriceGranted", "presentation": [ "http://nocera.com/role/WarrantsDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Average exercise price, Granted" } } }, "auth_ref": [] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative", "http://nocera.com/role/WarrantsDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement of Financial Position Location, Balance [Axis]", "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported." } } }, "auth_ref": [ "r325", "r997", "r998" ] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported." } } }, "auth_ref": [ "r48", "r49", "r325", "r997", "r998" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://nocera.com/role/SummaryOfSignificantAccountingPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "NCRA_CITICCarLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "CITICCarLoanMember", "presentation": [ "http://nocera.com/role/OtherBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "CITIC Car Loan [Member]" } } }, "auth_ref": [] }, "country_CN": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "CN", "presentation": [ "http://nocera.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "CHINA" } } }, "auth_ref": [] }, "us-gaap_CashAcquiredFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAcquiredFromAcquisition", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net cash inflow from acquisition of a subsidiary", "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)." } } }, "auth_ref": [ "r16" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r18", "r144", "r785" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r18", "r89", "r177" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r89" ] }, "NCRA_CateringMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "CateringMember", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation" ], "lang": { "en-us": { "role": { "label": "Catering [Member]" } } }, "auth_ref": [] }, "NCRA_ChenChunChungMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "ChenChunChungMember", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chen Chun Chung [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "NCRA_ClassAWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "ClassAWarrantMember", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class A Warrant [Member]" } } }, "auth_ref": [] }, "NCRA_ClassAWarrantsConvertedToCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "ClassAWarrantsConvertedToCommonStockMember", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class A Warrants Converted To Common Stock [Member]" } } }, "auth_ref": [] }, "NCRA_ClassBWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "ClassBWarrantMember", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class B Warrant [Member]" } } }, "auth_ref": [] }, "NCRA_ClassCWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "ClassCWarrantMember", "presentation": [ "http://nocera.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class C Warrant [Member]" } } }, "auth_ref": [] }, "NCRA_ClassDWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "ClassDWarrantMember", "presentation": [ "http://nocera.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class D Warrant [Member]" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative", "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical", "http://nocera.com/role/PreferredStockDetailsNarrative", "http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative", "http://nocera.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r136", "r153", "r154", "r155", "r181", "r203", "r204", "r206", "r208", "r215", "r216", "r287", "r336", "r338", "r339", "r340", "r343", "r344", "r373", "r374", "r377", "r380", "r387", "r503", "r652", "r653", "r654", "r655", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r695", "r716", "r738", "r762", "r763", "r764", "r765", "r766", "r882", "r905", "r914" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockLineItems", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative", "http://nocera.com/role/PreferredStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r153", "r154", "r155", "r215", "r373", "r374", "r375", "r377", "r380", "r385", "r387", "r652", "r653", "r654", "r655", "r814", "r882", "r905" ] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative", "http://nocera.com/role/WarrantsDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Average exercise price outstanding, Beginning balance", "periodEndLabel": "Average exercise price outstanding, Ending balance", "label": "Exercise price", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r388" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://nocera.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants issued", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r388" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://nocera.com/role/WarrantsDetails-WarrantActivity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of warrants outstanding, Beginning balance", "periodEndLabel": "Number of warrants outstanding, Ending balance", "label": "Class of Warrant or Right, Outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies (Note 20)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r63", "r120", "r606", "r694" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://nocera.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r100", "r328", "r329", "r771", "r944", "r949" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative", "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r849", "r850", "r851", "r853", "r854", "r855", "r856", "r910", "r911", "r913", "r967", "r1027", "r1030" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative", "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "verboseLabel": "Common stock par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r66" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative", "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r66", "r695" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative", "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r66" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative", "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r10", "r66", "r695", "r713", "r1030", "r1031" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock ($0.001 par value; authorized 200,000,000 shares; 14,247,539 shares and 14,047,539 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively) (1)", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r66", "r608", "r834" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss attributable to the Company", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r15", "r164", "r166", "r172", "r599", "r623", "r625" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTaxAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Less: Net loss attributable to non-controlling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r42", "r46", "r164", "r166", "r171", "r598", "r623", "r624" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r24", "r25", "r51", "r52", "r250", "r770" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r24", "r25", "r51", "r52", "r250", "r648", "r770" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r24", "r25", "r51", "r52", "r250", "r770", "r888" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://nocera.com/role/SummaryOfSignificantAccountingPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Concentrations of Credit Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r55", "r131" ] }, "NCRA_ConcentrationRiskPercentage2": { "xbrltype": "percentItemType", "nsuri": "http://nocera.com/20250331", "localname": "ConcentrationRiskPercentage2", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration percentage", "verboseLabel": "Concentration risk" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r24", "r25", "r51", "r52", "r250", "r770" ] }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems", "presentation": [ "http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable", "presentation": [ "http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table]", "documentation": "Disclosure of information about effect of change in parent's ownership interest in subsidiary on equity attributable to parent. Excludes change from deconsolidation of subsidiary." } } }, "auth_ref": [ "r9", "r47" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Contract liabilities", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r390", "r391", "r392" ] }, "us-gaap_ConversionOfStockByUniqueDescriptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConversionOfStockByUniqueDescriptionAxis", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock Conversion Description [Axis]", "documentation": "Information by description of stock conversions." } } }, "auth_ref": [ "r19", "r20", "r21" ] }, "us-gaap_ConversionOfStockNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConversionOfStockNameDomain", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The unique name of a noncash or part noncash stock conversion." } } }, "auth_ref": [ "r19", "r20", "r21" ] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock converted, shares converted", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r19", "r20", "r21" ] }, "us-gaap_ConversionOfStockSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConversionOfStockSharesIssued1", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock converted, shares issued", "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r19", "r20", "r21" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Cost of sales", "label": "Cost of revenue", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r81", "r82", "r563" ] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "CounterpartyNameAxis", "presentation": [ "http://nocera.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r183", "r184", "r349", "r375", "r525", "r545", "r603", "r789", "r791" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditLossAbstract", "lang": { "en-us": { "role": { "label": "Credit Loss [Abstract]" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://nocera.com/role/IncomeTaxesDetails-IncomeTaxExpense": { "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-IncomeTaxExpense" ], "lang": { "en-us": { "role": { "label": "Current", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r451", "r908" ] }, "NCRA_CurrentMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "CurrentMember", "presentation": [ "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Current [Member]" } } }, "auth_ref": [] }, "NCRA_CustomerAMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "CustomerAMember", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" ], "lang": { "en-us": { "role": { "label": "Customer A [Member]" } } }, "auth_ref": [] }, "NCRA_CustomerBMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "CustomerBMember", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" ], "lang": { "en-us": { "role": { "label": "Customer B [Member]" } } }, "auth_ref": [] }, "NCRA_CustomerCMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "CustomerCMember", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" ], "lang": { "en-us": { "role": { "label": "Customer C [Member]" } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r93", "r250" ] }, "NCRA_CustomerDMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "CustomerDMember", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" ], "lang": { "en-us": { "role": { "label": "Customer D [Member]" } } }, "auth_ref": [] }, "NCRA_CustomerEMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "CustomerEMember", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" ], "lang": { "en-us": { "role": { "label": "Customer E [Member]" } } }, "auth_ref": [] }, "NCRA_CustomerFMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "CustomerFMember", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" ], "lang": { "en-us": { "role": { "label": "Customer F [Member]" } } }, "auth_ref": [] }, "NCRA_CustomerGMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "CustomerGMember", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation" ], "lang": { "en-us": { "role": { "label": "Customer G [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://nocera.com/role/OtherBorrowings" ], "lang": { "en-us": { "role": { "label": "OTHER BORROWINGS", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r101", "r179", "r320", "r321", "r322", "r323", "r324", "r334", "r335", "r345", "r351", "r352", "r353", "r354", "r355", "r356", "r361", "r368", "r369", "r371", "r511" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentAxis", "presentation": [ "http://nocera.com/role/OtherBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r11", "r58", "r59", "r117", "r119", "r185", "r346", "r347", "r348", "r349", "r350", "r352", "r357", "r358", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r367", "r809", "r810", "r811", "r812", "r813", "r832", "r906", "r945", "r946", "r947", "r977", "r978" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://nocera.com/role/OtherBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r11", "r185", "r346", "r347", "r348", "r349", "r350", "r352", "r357", "r358", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r367", "r809", "r810", "r811", "r812", "r813", "r832", "r906", "r945", "r946", "r947", "r977", "r978" ] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "presentation": [ "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetTables" ], "lang": { "en-us": { "role": { "label": "Schedule of prepaid expenses and other assets", "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs." } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxesAndTaxCredits", "crdr": "debit", "calculation": { "http://nocera.com/role/IncomeTaxesDetails-IncomeTaxExpense": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-IncomeTaxExpense" ], "lang": { "en-us": { "role": { "totalLabel": "Total income tax expense", "label": "Deferred Income Taxes and Tax Credits", "documentation": "Amount of deferred income tax expense (benefit) and income tax credits." } } }, "auth_ref": [ "r91" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-ValuationAllowance" ], "lang": { "en-us": { "role": { "periodStartLabel": "Valuation allowance, beginning balance", "periodEndLabel": "Valuation allowance, ending balance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r447" ] }, "NCRA_DenominatorAbstract": { "xbrltype": "stringItemType", "nsuri": "http://nocera.com/20250331", "localname": "DenominatorAbstract", "presentation": [ "http://nocera.com/role/LossEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Denominator:" } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://nocera.com/role/PropertyAndEquipmentNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation expenses", "verboseLabel": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r6", "r30" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeAssets", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Financial assets at fair value through profit or loss", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r161", "r162", "r486", "r487", "r494", "r502", "r675", "r676", "r677", "r678", "r679", "r681", "r682", "r683", "r684", "r685", "r701", "r702", "r753", "r754", "r756", "r757", "r758", "r759", "r791", "r822", "r825", "r851", "r969", "r970", "r971", "r1028" ] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Warrant liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r161" ] }, "NCRA_DisclosureAdvanceToSuppliersAbstract": { "xbrltype": "stringItemType", "nsuri": "http://nocera.com/20250331", "localname": "DisclosureAdvanceToSuppliersAbstract", "lang": { "en-us": { "role": { "label": "Advance To Suppliers" } } }, "auth_ref": [] }, "NCRA_DisclosureLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://nocera.com/20250331", "localname": "DisclosureLeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://nocera.com/role/Share-basedCompensation" ], "lang": { "en-us": { "role": { "label": "SHARE-BASED COMPENSATION", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r396", "r399", "r426", "r427", "r428", "r818" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "NCRA_DisclosureWarrantsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://nocera.com/20250331", "localname": "DisclosureWarrantsAbstract", "lang": { "en-us": { "role": { "label": "Warrants" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r140" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DividendsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendsPayableCurrent", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Dividend payable", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r59" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r873" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r871", "r873", "r874" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r872" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r860" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r873" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r873" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r875" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r863" ] }, "NCRA_DueFromThirdPartiesMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "DueFromThirdPartiesMember", "presentation": [ "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Due From Third Parties [Member]" } } }, "auth_ref": [] }, "NCRA_DueToRelatedPartiesCurrent1": { "xbrltype": "monetaryItemType", "nsuri": "http://nocera.com/20250331", "localname": "DueToRelatedPartiesCurrent1", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Due to related parties" } } }, "auth_ref": [] }, "NCRA_DueToRelatedPartyCurrent1": { "xbrltype": "monetaryItemType", "nsuri": "http://nocera.com/20250331", "localname": "DueToRelatedPartyCurrent1", "crdr": "credit", "presentation": [ "http://nocera.com/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" ], "lang": { "en-us": { "role": { "verboseLabel": "Due to related parties", "label": "DueToRelatedPartyCurrent1" } } }, "auth_ref": [] }, "NCRA_ECommerceLiveStreamSalesDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "ECommerceLiveStreamSalesDepositsMember", "presentation": [ "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "E Commerce Live Stream Sales Deposits [Member]" } } }, "auth_ref": [] }, "NCRA_ECommerceMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "ECommerceMember", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation" ], "lang": { "en-us": { "role": { "label": "E Commerce [Member]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Loss per share", "verboseLabel": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited", "http://nocera.com/role/LossEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Basic", "verboseLabel": "- Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r173", "r191", "r192", "r193", "r194", "r195", "r196", "r201", "r203", "r206", "r207", "r208", "r212", "r463", "r467", "r484", "r485", "r600", "r626", "r793" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited", "http://nocera.com/role/LossEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Diluted", "verboseLabel": "- Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r173", "r191", "r192", "r193", "r194", "r195", "r196", "r203", "r206", "r207", "r208", "r212", "r463", "r467", "r484", "r485", "r600", "r626", "r793" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://nocera.com/role/LossIncomePerShare" ], "lang": { "en-us": { "role": { "label": "(LOSS) INCOME PER SHARE", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r200", "r209", "r210", "r211" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate changes on cash and cash equivalents", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r504" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-ReconciliationOfIncomeTax", "http://nocera.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Effective tax rate", "verboseLabel": "Effective income tax rate", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r433", "r819" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-ReconciliationOfIncomeTax" ], "lang": { "en-us": { "role": { "label": "Changes in valuation allowance", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r438", "r819", "r909", "r957" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-ReconciliationOfIncomeTax" ], "lang": { "en-us": { "role": { "label": "Impact of different tax rates in other jurisdictions", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile." } } }, "auth_ref": [ "r434", "r436", "r819", "r909", "r957" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationGiltiAmount", "crdr": "debit", "presentation": [ "http://nocera.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "GILTI Amount", "documentation": "Amount of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI)." } } }, "auth_ref": [ "r819", "r957", "r959" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationGiltiPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationGiltiPercent", "presentation": [ "http://nocera.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Effective income tax rate including GILTI", "documentation": "Percentage of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI)." } } }, "auth_ref": [ "r819", "r957", "r959" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationLineItems", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-IncomeTaxExpense" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r433", "r434", "r819" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-ReconciliationOfIncomeTax" ], "lang": { "en-us": { "role": { "label": "Tax effect of non-deductible expenses", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses." } } }, "auth_ref": [ "r439", "r440", "r909", "r957" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-ReconciliationOfIncomeTax" ], "lang": { "en-us": { "role": { "verboseLabel": "Others", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses." } } }, "auth_ref": [ "r819", "r909", "r957", "r959" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-ReconciliationOfIncomeTax" ], "lang": { "en-us": { "role": { "label": "Taiwan (2021-PRC) income tax statutory rate", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings." } } }, "auth_ref": [ "r909", "r957", "r958" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-ReconciliationOfIncomeTax" ], "lang": { "en-us": { "role": { "label": "Tax effect of stock-based compensation", "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r886", "r957", "r958" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationTable", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-IncomeTaxExpense" ], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation [Table]", "documentation": "Disclosure of information about income tax rate reconciliation between amount of reported income tax expense (benefit) attributable to continuing operation to amount of income tax expense(benefit) that would result from applying statutory federal (national) tax rate to pretax income (loss) from continuing operation." } } }, "auth_ref": [ "r433", "r434", "r819" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-ReconciliationOfIncomeTax" ], "lang": { "en-us": { "role": { "label": "Tax effect of non-taxable income", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits." } } }, "auth_ref": [ "r437", "r440", "r909", "r957" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r866" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r862" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityDomain", "presentation": [ "http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-Goodwill" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r862" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r881" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r862" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r878" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r874" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r862" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r862" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r862" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r862" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r879" ] }, "us-gaap_EntityWideRevenueMajorCustomerLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EntityWideRevenueMajorCustomerLineItems", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation" ], "lang": { "en-us": { "role": { "label": "Revenue, Major Customer [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquipmentMember", "presentation": [ "http://nocera.com/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services." } } }, "auth_ref": [] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r10", "r137", "r167", "r168", "r169", "r186", "r187", "r188", "r190", "r195", "r197", "r199", "r214", "r289", "r290", "r318", "r389", "r452", "r453", "r460", "r461", "r462", "r464", "r466", "r467", "r475", "r476", "r477", "r478", "r479", "r480", "r483", "r505", "r506", "r507", "r508", "r509", "r510", "r512", "r515", "r519", "r621", "r641", "r642", "r643", "r663", "r738" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative" ], "auth_ref": [ "r284", "r285", "r286", "r459", "r883", "r884", "r885", "r963", "r964", "r965", "r966" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock issued for acquisitions, shares", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r284" ] }, "NCRA_EstateOfYinChiehChengMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "EstateOfYinChiehChengMember", "presentation": [ "http://nocera.com/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" ], "lang": { "en-us": { "role": { "label": "Estate Of Yin Chieh Cheng [Member]" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLoss" ], "lang": { "en-us": { "role": { "label": "FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r490", "r491", "r492", "r493", "r496", "r497", "r498", "r499", "r500", "r596", "r822", "r826" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "presentation": [ "http://nocera.com/role/WarrantsDetails-WarrantLiability" ], "lang": { "en-us": { "role": { "label": "Fair value change of warrants included in earnings", "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r972", "r974" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://nocera.com/role/WarrantsDetails-WarrantLiability" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at the beginning of period", "periodEndLabel": "Total", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r489", "r495" ] }, "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems", "presentation": [ "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "NCRA_FengHuaChenMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "FengHuaChenMember", "presentation": [ "http://nocera.com/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" ], "lang": { "en-us": { "role": { "label": "Feng Hua Chen [Member]" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialInstrumentAxis", "presentation": [ "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r370", "r385", "r481", "r501", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r622", "r806", "r822", "r824", "r825", "r826", "r827", "r828", "r829", "r830", "r831", "r835", "r889", "r890", "r891", "r892", "r893", "r894", "r895", "r922", "r923", "r924", "r925", "r968", "r969", "r970", "r971", "r973", "r975" ] }, "us-gaap_FinancialInstrumentPerformanceStatusAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialInstrumentPerformanceStatusAxis", "presentation": [ "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument Performance Status [Axis]", "documentation": "Information by category of performance or non-performance status of financial instruments." } } }, "auth_ref": [ "r927" ] }, "us-gaap_FinancialInstrumentPerformanceStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinancialInstrumentPerformanceStatusDomain", "presentation": [ "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "documentation": "Category of performance or non-performance status of financial instruments, including but not limited to, financing receivables, loans, debt, and investments." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-CustomerRelations" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r149", "r302", "r315", "r808" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-CustomerRelations" ], "lang": { "en-us": { "role": { "label": "Acquisitions", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r302", "r315", "r565", "r808" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "presentation": [ "http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-CustomerRelations" ], "lang": { "en-us": { "role": { "label": "Customer relations, net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r564", "r942" ] }, "NCRA_FishTradingMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "FishTradingMember", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation" ], "lang": { "en-us": { "role": { "label": "Fish Trading [Member]" } } }, "auth_ref": [] }, "NCRA_FourCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "FourCustomersMember", "presentation": [ "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Four Customers [Member]" } } }, "auth_ref": [] }, "NCRA_FundsMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "FundsMember", "presentation": [ "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Funds [Member]" } } }, "auth_ref": [] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain on disposal of financial assets at FVTPL", "label": "Gain (Loss) on Disposition of Assets", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r904" ] }, "us-gaap_GainLossOnDispositionOfOtherFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnDispositionOfOtherFinancialAssets", "crdr": "credit", "presentation": [ "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gain (Loss) on Disposition of Other Financial Assets", "documentation": "Amount of gain (loss) on disposal of other assets utilized in financial service operations." } } }, "auth_ref": [ "r91" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "General and administrative expenses", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r85", "r718" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-Goodwill", "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r148", "r303", "r597", "r801", "r807", "r823", "r834", "r930", "r937" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://nocera.com/role/GoodwillAndOtherIntangibleAssets" ], "lang": { "en-us": { "role": { "label": "GOODWILL AND OTHER INTANGIBLE ASSETS", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r928", "r940" ] }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "crdr": "credit", "presentation": [ "http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-Goodwill" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Impairment", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "documentation": "Amount of accumulated impairment loss for asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r305", "r312", "r807" ] }, "NCRA_GrossProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://nocera.com/20250331", "localname": "GrossProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gross proceeds from the sale of equity" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r79", "r83", "r127", "r181", "r287", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r503", "r795", "r800", "r916", "r917", "r918", "r919", "r920", "r950" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r80", "r123", "r127", "r601", "r617", "r795", "r800", "r916", "r917", "r918", "r919", "r920" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-IncomeTaxExpense", "http://nocera.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Income Tax Jurisdiction [Axis]", "documentation": "Information by income tax jurisdiction." } } }, "auth_ref": [ "r176", "r433", "r434", "r444", "r449", "r819", "r961" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-IncomeTaxExpense", "http://nocera.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Income tax jurisdiction." } } }, "auth_ref": [ "r176", "r433", "r434", "r444", "r449", "r819", "r961" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://nocera.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "label": "INCOME TAXES", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r182", "r431", "r433", "r441", "r442", "r443", "r445", "r448", "r454", "r456", "r457", "r458", "r657", "r819" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax expense", "label": "Income tax expenses", "negatedTerseLabel": "Income tax expenses", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r130", "r135", "r198", "r199", "r213", "r229", "r243", "r432", "r433", "r455", "r627", "r819" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable, net", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccruedTaxesPayable", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Income tax payable", "label": "Increase (Decrease) in Accrued Taxes Payable", "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes." } } }, "auth_ref": [ "r903" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Advance from customers", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r562", "r903" ] }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred income tax", "label": "Increase (Decrease) in Deferred Income Taxes", "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInDueToRelatedPartiesCurrent", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Advance to suppliers", "label": "Increase (Decrease) in Due to Related Parties, Current", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherAccountsPayable", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable", "label": "Increase (Decrease) in Other Accounts Payable", "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Other payables and accrued liabilities", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid." } } }, "auth_ref": [ "r5" ] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other non-current assets", "label": "Increase (Decrease) in Other Noncurrent Assets", "documentation": "Amount of increase (decrease) in noncurrent assets classified as other." } } }, "auth_ref": [ "r903" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other assets, net", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r5" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r876" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible assets - customer relations", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r313", "r942", "r943" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://nocera.com/role/Inventories" ], "lang": { "en-us": { "role": { "label": "INVENTORIES", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r299" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://nocera.com/role/InventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets", "http://nocera.com/role/InventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Inventories, net", "totalLabel": "Total", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r158", "r786", "r834" ] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://nocera.com/role/InventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/InventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Raw materials", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r97", "r788" ] }, "us-gaap_InvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestorMember", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investor [Member]", "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value." } } }, "auth_ref": [ "r982", "r983" ] }, "us-gaap_LandMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LandMember", "presentation": [ "http://nocera.com/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Land [Member]", "documentation": "Part of earth's surface not covered by water." } } }, "auth_ref": [ "r955" ] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseCost", "crdr": "debit", "presentation": [ "http://nocera.com/role/LeasesDetails-LeaseCosts" ], "lang": { "en-us": { "role": { "label": "Total net lease costs", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r516", "r833" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://nocera.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of components of lease expenses", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r980" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LegalEntityAxis", "presentation": [ "http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-Goodwill" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://nocera.com/role/CommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of lease payments", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r981" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "presentation": [ "http://nocera.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Total", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r517" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "presentation": [ "http://nocera.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Within 1 year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r517" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://nocera.com/role/Leases" ], "lang": { "en-us": { "role": { "label": "LEASES", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r514" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities [Default Label]", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r11", "r58", "r59", "r60", "r61", "r62", "r63", "r64", "r181", "r287", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r470", "r473", "r474", "r503", "r693", "r794", "r859", "r950", "r985", "r986" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and shareholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r73", "r122", "r613", "r834", "r907", "r926", "r976" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r60", "r143", "r181", "r287", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r470", "r473", "r474", "r503", "r834", "r950", "r985", "r986" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-term secured other borrowing", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r152" ] }, "us-gaap_LongTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermInvestments", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Investment", "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)." } } }, "auth_ref": [ "r145" ] }, "NCRA_LossPerShareBasicAndDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://nocera.com/20250331", "localname": "LossPerShareBasicAndDilutedAbstract", "presentation": [ "http://nocera.com/role/LossEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Loss per share:" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MajorCustomersAxis", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r250", "r816", "r844", "r848", "r954", "r996", "r999", "r1000", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025", "r1026" ] }, "NCRA_MeixinMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "MeixinMember", "presentation": [ "http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-Goodwill", "http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Meixin [Member]" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://nocera.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r330", "r331", "r332", "r333", "r395", "r429", "r488", "r561", "r639", "r640", "r647", "r684", "r685", "r746", "r748", "r750", "r751", "r760", "r781", "r782", "r805", "r814", "r817", "r825", "r826", "r830", "r845", "r952", "r987", "r988", "r989", "r990", "r991", "r992" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r72", "r121", "r181", "r287", "r336", "r338", "r339", "r340", "r343", "r344", "r503", "r612", "r697" ] }, "NCRA_MountainShareTransferLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "MountainShareTransferLLCMember", "presentation": [ "http://nocera.com/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" ], "lang": { "en-us": { "role": { "label": "Mountain Share Transfer LLC [Member]" } } }, "auth_ref": [] }, "NCRA_MrHsienWenYuMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "MrHsienWenYuMember", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Mr Hsien Wen Yu [Member]" } } }, "auth_ref": [] }, "NCRA_MrMichaelALittmanMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "MrMichaelALittmanMember", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Mr Michael A Littman [Member]" } } }, "auth_ref": [] }, "NCRA_MrShunChihChuangAndFiveConsultantsMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "MrShunChihChuangAndFiveConsultantsMember", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Mr Shun Chih Chuang And Five Consultants [Member]" } } }, "auth_ref": [] }, "NCRA_MrShunChihChuangMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "MrShunChihChuangMember", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Mr Shun Chih Chuang [Member]" } } }, "auth_ref": [] }, "NCRA_MrYinChiehChengMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "MrYinChiehChengMember", "presentation": [ "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Mr Yin Chieh Cheng [Member]" } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" ], "auth_ref": [ "r250", "r816", "r844", "r848", "r954", "r996", "r999", "r1000", "r1002", "r1003", "r1004", "r1005", "r1006", "r1007", "r1008", "r1009", "r1010", "r1011", "r1012", "r1013", "r1014", "r1015", "r1016", "r1017", "r1018", "r1019", "r1020", "r1021", "r1022", "r1023", "r1024", "r1025", "r1026" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r175" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r175" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r89", "r90", "r91" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited", "http://nocera.com/role/LossEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss attributable to the company", "label": "Net loss income attributable to the Company", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r84", "r91", "r124", "r141", "r163", "r165", "r169", "r181", "r189", "r191", "r192", "r193", "r194", "r195", "r198", "r199", "r205", "r287", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r463", "r467", "r485", "r503", "r620", "r715", "r736", "r737", "r857", "r950" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Less: Net loss attributable to non-controlling interests", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r45", "r113", "r163", "r165", "r195", "r198", "r199", "r619", "r902" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://nocera.com/role/SummaryOfSignificantAccountingPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r877" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r877" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NoncontrollingInterestMember", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r40", "r389", "r910", "r911", "r912", "r913", "r1030" ] }, "NCRA_NoncurrentMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "NoncurrentMember", "presentation": [ "http://nocera.com/role/FinancialAssetsAtFairValueThroughProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Noncurrent [Member]" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Other income", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r86" ] }, "NCRA_NumeratorAbstract": { "xbrltype": "stringItemType", "nsuri": "http://nocera.com/20250331", "localname": "NumeratorAbstract", "presentation": [ "http://nocera.com/role/LossEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Numerator:" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Segment operating losses", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r127", "r795", "r916", "r917", "r918", "r919", "r920" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://nocera.com/role/LeasesDetails-LeaseCosts" ], "lang": { "en-us": { "role": { "label": "Operating lease expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r979" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://nocera.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net operating loss carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r450" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://nocera.com/role/PrincipalActivitiesAndOrganization" ], "lang": { "en-us": { "role": { "label": "PRINCIPAL ACTIVITIES AND ORGANIZATION", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r56", "r111", "r649", "r650" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesDetails": { "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Expenses", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r59" ] }, "us-gaap_OtherAdditionalCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAdditionalCapital", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Statutory and other reserves", "documentation": "Amount of additional paid-in capital (APIC) classified as other." } } }, "auth_ref": [ "r69", "r609" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other non-current asset", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r150" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Less: Foreign currency translation loss attributable to non-controlling interest", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to noncontrolling interests." } } }, "auth_ref": [ "r4", "r8", "r112" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation Adjustments", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r4", "r8", "r112" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "NCRA_TotalComprehensiveLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation (loss) gain", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r2", "r621" ] }, "us-gaap_OtherCurrentAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCurrentAssetsTextBlock", "presentation": [ "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNet" ], "lang": { "en-us": { "role": { "label": "PREPAID EXPENSES AND OTHER ASSETS, NET", "documentation": "The entire disclosure for other current assets." } } }, "auth_ref": [] }, "us-gaap_OtherLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLongTermDebt", "crdr": "credit", "presentation": [ "http://nocera.com/role/OtherBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Others loans current", "documentation": "Amount of long-term debt classified as other." } } }, "auth_ref": [ "r11", "r119", "r994" ] }, "us-gaap_OtherLongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLongTermDebtCurrent", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets", "http://nocera.com/role/OtherBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Long-term secured other borrowing \u2013 current portion", "verboseLabel": "Total others loans current", "documentation": "Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer." } } }, "auth_ref": [ "r58", "r59", "r692" ] }, "us-gaap_OtherLongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLongTermDebtNoncurrent", "crdr": "credit", "presentation": [ "http://nocera.com/role/OtherBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Total others loans noncurrent", "documentation": "Amount of long-term debt classified as other, payable after one year or the operating cycle, if longer." } } }, "auth_ref": [ "r11", "r692" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r873" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "OwnershipAxis", "presentation": [ "http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "OwnershipDomain", "presentation": [ "http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative" ], "auth_ref": [] }, "NCRA_PRCMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "PRCMember", "presentation": [ "http://nocera.com/role/IncomeTaxesDetails-IncomeTaxExpense", "http://nocera.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "PRC [Member]" } } }, "auth_ref": [] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payment for VIE controlling interest", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r17", "r465" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r867" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://nocera.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r869" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockMember", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r849", "r850", "r853", "r854", "r855", "r856", "r1027", "r1030" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r65", "r373" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r65", "r695" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical", "http://nocera.com/role/PreferredStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r65", "r373" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r65", "r695", "r713", "r1030", "r1031" ] }, "us-gaap_PreferredStockTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockTextBlock", "presentation": [ "http://nocera.com/role/PreferredStock" ], "lang": { "en-us": { "role": { "label": "PREFERRED STOCK", "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock." } } }, "auth_ref": [ "r103" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred stock ($0.001 par value; authorized 10,000,000 shares; Series A Preferred Stock, 2,000,000 authorized, 80,000 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively)", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r65", "r607", "r834" ] }, "us-gaap_PrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssets", "crdr": "debit", "presentation": [ "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetails", "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other receivables from third party", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets." } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets", "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetails", "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other assets, net", "verboseLabel": "Other receivables", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r899" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "presentation": [ "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid Expenses", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r159", "r300", "r301", "r787" ] }, "NCRA_PriorYearReceivablesFromGZGSIMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "PriorYearReceivablesFromGZGSIMember", "presentation": [ "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prior-year receivables from GZ GSI [Member]", "documentation": "Prior-year receivables from GZ GSI [Member]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of common stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r3" ] }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfWarrants", "crdr": "debit", "presentation": [ "http://nocera.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from warrants issued", "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)." } } }, "auth_ref": [ "r3" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from the sale of equity", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r3", "r652" ] }, "us-gaap_ProceedsFromSaleOfOtherProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromSaleOfOtherProductiveAssets", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from gain on disposal of financial assets at FVTPL", "documentation": "Amount of cash inflow from the sale of tangible or intangible assets used to produce goods or deliver services, classified as other." } } }, "auth_ref": [ "r87" ] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" ], "lang": { "en-us": { "role": { "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r94" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductInformationLineItems", "presentation": [ "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "NCRA_TotalComprehensiveLoss", "weight": 1.0, "order": 1.0 }, "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity", "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "label": "Net loss", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r141", "r163", "r165", "r174", "r181", "r189", "r195", "r198", "r199", "r287", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r463", "r467", "r468", "r471", "r472", "r485", "r503", "r601", "r618", "r662", "r715", "r736", "r737", "r820", "r821", "r858", "r902", "r950" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://nocera.com/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r7", "r518" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://nocera.com/role/PropertyAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "PROPERTY AND EQUIPMENT, NET", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r98", "r132", "r133", "r134" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "presentation": [ "http://nocera.com/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r99", "r146", "r616" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://nocera.com/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r518" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets", "http://nocera.com/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r7", "r518", "r602", "r616", "r834" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://nocera.com/role/PropertyAndEquipmentNetTables" ], "lang": { "en-us": { "role": { "label": "Schedule of property and equipment", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r7" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://nocera.com/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r99", "r518" ] }, "NCRA_PublicOffering2022Member": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "PublicOffering2022Member", "presentation": [ "http://nocera.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Public Offering 2022 [Member]" } } }, "auth_ref": [] }, "NCRA_PublicOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "PublicOfferingMember", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Public Offering [Member]" } } }, "auth_ref": [] }, "NCRA_PurchasesMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "PurchasesMember", "presentation": [ "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetails-Concentrations" ], "lang": { "en-us": { "role": { "label": "Purchases [Member]" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://nocera.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r330", "r331", "r332", "r333", "r393", "r395", "r422", "r423", "r424", "r429", "r488", "r535", "r544", "r561", "r639", "r640", "r647", "r684", "r685", "r746", "r748", "r750", "r751", "r760", "r781", "r782", "r805", "r814", "r817", "r825", "r826", "r830", "r831", "r845", "r851", "r948", "r952", "r970", "r988", "r989", "r990", "r991", "r992" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://nocera.com/role/IncomeTaxesDetailsNarrative" ], "auth_ref": [ "r330", "r331", "r332", "r333", "r393", "r395", "r422", "r423", "r424", "r429", "r488", "r535", "r544", "r561", "r639", "r640", "r647", "r684", "r685", "r746", "r748", "r750", "r751", "r760", "r781", "r782", "r805", "r814", "r817", "r825", "r826", "r830", "r831", "r845", "r851", "r948", "r952", "r970", "r988", "r989", "r990", "r991", "r992" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://nocera.com/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties", "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r252", "r394", "r523", "r524", "r605", "r614", "r687", "r688", "r689", "r690", "r691", "r712", "r714", "r745" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://nocera.com/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r252", "r719", "r720", "r723" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://nocera.com/role/RelatedPartyBalancesAndTransactionsDetails-DueToRelatedParties", "http://nocera.com/role/Share-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r252", "r394", "r523", "r524", "r605", "r614", "r687", "r688", "r689", "r690", "r691", "r712", "r714", "r745", "r984" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://nocera.com/role/RelatedPartyBalancesAndTransactions" ], "lang": { "en-us": { "role": { "label": "RELATED PARTY BALANCES AND TRANSACTIONS", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r520", "r521", "r522", "r524", "r526", "r658", "r659", "r660", "r721", "r722", "r723", "r742", "r744" ] }, "us-gaap_RepaymentsOfBankDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfBankDebt", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of short-term bank loan", "label": "Repayments of Bank Debt", "documentation": "The cash outflow to settle a bank borrowing during the year." } } }, "auth_ref": [ "r88" ] }, "us-gaap_RepaymentsOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfSecuredDebt", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of secured other borrowings", "label": "Repayments of Secured Debt", "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt." } } }, "auth_ref": [ "r88" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://nocera.com/role/WarrantsDetailsNarrative" ], "auth_ref": [ "r183", "r184", "r349", "r375", "r525", "r545", "r603", "r790", "r791" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockMember", "presentation": [ "http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r22" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated losses", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r70", "r106", "r611", "r644", "r646", "r656", "r696", "r834" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r137", "r186", "r187", "r188", "r190", "r195", "r197", "r199", "r289", "r290", "r318", "r452", "r453", "r460", "r461", "r462", "r464", "r466", "r467", "r475", "r477", "r478", "r480", "r483", "r512", "r515", "r641", "r643", "r663", "r1030" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://nocera.com/role/SummaryOfSignificantAccountingPolicyPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r717", "r783", "r792" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Revenues", "crdr": "credit", "calculation": { "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" ], "lang": { "en-us": { "role": { "label": "Net sales", "verboseLabel": "Revenue", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r125", "r126", "r170", "r181", "r213", "r222", "r223", "r237", "r243", "r246", "r248", "r250", "r287", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r503", "r601", "r800", "r950" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r877" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r877" ] }, "NCRA_SYCultureMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "SYCultureMember", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative", "http://nocera.com/role/PrincipalActivitiesAndOrganizationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "SY Culture [Member]" } } }, "auth_ref": [] }, "NCRA_SYMediaDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "SYMediaDepositsMember", "presentation": [ "http://nocera.com/role/PrepaidExpensesAndOtherAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "SY Media Deposits [Member]" } } }, "auth_ref": [] }, "NCRA_SYMediaMember": { "xbrltype": "domainItemType", "nsuri": "http://nocera.com/20250331", "localname": "SYMediaMember", "presentation": [ "http://nocera.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails-Goodwill" ], "lang": { "en-us": { "role": { "label": "SY Media [Member]" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://nocera.com/role/CommonStockDetailsNarrative", "http://nocera.com/role/WarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://nocera.com/role/PreferredStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of stock, price", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesRevenueNetMember", "presentation": [ "http://nocera.com/role/Disclosure-SegmentReportingDetails-SegmentInformation", "http://nocera.com/role/SummaryOfSignificantAccountingPolicyDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r250", "r887" ] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "presentation": [ "http://nocera.com/role/AccountsReceivableTables" ], "lang": { "en-us": { "role": { "label": "Schedule of accounts receivable", "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r67", "r74" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://nocera.com/role/OtherPayablesAndAccruedLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of other payables and accrued liabilities", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://nocera.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of income tax components", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r962" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://nocera.com/role/OtherBorrowingsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of other loans", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presenta